Gene	Gene synonym	Ensembl	Gene description	Chromosome	Position	Protein class	Evidence	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Prognostic p-value	RNA cancer category	RNA tissue category	RNA TS	RNA TS TPM	TPM max in non-specific	RNA cell line category	RNA CS	RNA CS TPM
ADNP	ADNP1, KIAA0784	ENSG00000101126	Activity dependent neuroprotector homeobox	20	50888919-50931240	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006371	Supported		Approved	Nucleoplasm	Liver cancer:1.65e-5 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 81.7	Expressed in all		
ADNP2	KIAA0863, ZNF508	ENSG00000101544	ADNP homeobox 2	18	80109031-80147523	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007126	Uncertain		Approved	Mitochondria<br>Cytosol	Renal cancer:6.39e-5 (favourable), Thyroid cancer:9.90e-4 (unfavourable)	Expressed in all	Mixed			testis: 39.7	Mixed		
AEBP2	MGC17922	ENSG00000139154	AE binding protein 2	12	19404045-19720801	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020893, HPA022282	Uncertain		Supported	Nucleus	Liver cancer:3.24e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 57.5	Expressed in all		
AHR	bHLHe76	ENSG00000106546	Aryl hydrocarbon receptor	7	17298622-17346152	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005072, HPA029722, HPA029723	Enhanced		Supported	Nucleoplasm<br>Cytosol		Expressed in all	Mixed			lung: 56.4	Mixed		
AHRR	AHH, AHHR, bHLHe77, KIAA1234	ENSG00000063438	Aryl-hydrocarbon receptor repressor	5	304176-438291	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021483			Supported	Nucleoplasm<br>Cytosol		Mixed	Tissue enriched	8	testis: 65.2	skin: 7.9	Cell line enhanced		HMC-1: 89.0;NB-4: 80.8;WM-115: 71.5
AIRE	APECED, APS1, PGA1	ENSG00000160224	Autoimmune regulator	21	44285838-44298648	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038267	Uncertain					Tissue enriched	Not detected			lymph node: 0.3	Not detected		
ALX1	CART1	ENSG00000180318	ALX homeobox 1	12	85280107-85301784	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001598, HPA018905	Uncertain		Supported	Nucleoplasm<br>Nuclear bodies<br>Golgi apparatus		Tissue enriched	Tissue enhanced		epididymis: 4.3;kidney: 3.1	ovary: 1.8	Cell line enhanced		HEK 293: 19.4;HUVEC TERT2: 13.0;SK-MEL-30: 20.2;THP-1: 11.5;WM-115: 13.3
ALX3	FND	ENSG00000156150	ALX homeobox 3	1	110059994-110070700	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Mixed			skin: 7.7	Mixed		
ALX4	FPP, KIAA1788, PFM, PFM2	ENSG00000052850	ALX homeobox 4	11	44260444-44310166	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001903			Supported	Nucleoplasm		Tissue enhanced	Tissue enhanced		breast: 2.2	endometrium,testis: 1.0	Cell line enhanced		AN3-CA: 3.7;BJ: 2.8;HAP1: 4.8;HEK 293: 4.4;HEL: 6.0;K-562: 2.8;SiHa: 7.4
AR	AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1	ENSG00000169083	Androgen receptor	X	67544032-67730619	Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000001, HPA065701, CAB065764	Enhanced		Approved	Mitochondria	Renal cancer:1.03e-8 (favourable), Liver cancer:8.77e-4 (favourable)	Mixed	Mixed			fallopian tube: 42.3	Cell line enhanced		AF22: 15.6;HAP1: 21.1;LHCN-M2: 14.9;RH-30: 28.3
ARGFX		ENSG00000186103	Arginine-fifty homeobox	3	121570704-121586634	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA043049	Uncertain					Tissue enriched	Not detected			testis: 0.6	Not detected		
ARID1A	B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1	ENSG00000117713	AT-rich interaction domain 1A	1	26693236-26782104	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005456, CAB016334	Supported		Enhanced	Nucleoplasm	Liver cancer:4.18e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 40.4	Expressed in all		
ARID1B	6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R	ENSG00000049618	AT-rich interaction domain 1B	6	156777374-157210779	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016511, HPA075291	Approved		Supported	Nucleoplasm	Breast cancer:1.04e-4 (unfavourable), Ovarian cancer:4.16e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 71.2	Expressed in all		
ARID2	BAF200, DKFZp686G052, FLJ30619, KIAA1557	ENSG00000189079	AT-rich interaction domain 2	12	45729665-45908040	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063044			Supported	Nucleoplasm<br>Plasma membrane	Head and neck cancer:5.75e-4 (favourable)	Expressed in all	Expressed in all			testis: 47.3	Expressed in all		
ARID3A	BRIGHT, DRIL1	ENSG00000116017	AT-rich interaction domain 3A	19	925781-975934	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004793, HPA076330	Enhanced		Supported	Nucleoplasm<br>Vesicles<br>Cytosol	Pancreatic cancer:1.95e-5 (favourable), Renal cancer:3.22e-4 (unfavourable)	Expressed in all	Tissue enhanced		placenta: 33.4	testis: 9.7	Cell line enhanced		BEWO: 199.1;K-562: 85.1
ARID3B	BDP, DRIL2	ENSG00000179361	AT-rich interaction domain 3B	15	74541177-74598131	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050320	Enhanced		Supported	Nucleoplasm		Expressed in all	Tissue enhanced		testis: 35.9	placenta: 22.3	Cell line enhanced		NTERA-2: 86.8
ARID3C		ENSG00000205143	AT-rich interaction domain 3C	9	34621379-34628107	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Group enriched	Tissue enriched	8	liver: 5.9	cerebral cortex: 0.7	Cell line enhanced		HDLM-2: 1.8;Karpas-707: 1.8;T-47d: 2.4
ARID4A	RBBP1, RBP-1, RBP1	ENSG00000032219	AT-rich interaction domain 4A	14	58298385-58373887	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048899			Supported	Nucleoplasm<br>Plasma membrane<br>Cytosol	Head and neck cancer:1.91e-4 (favourable), Lung cancer:7.82e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 24.0	Expressed in all		
ARID4B	BCAA, BRCAA1, RBP1L1, SAP180	ENSG00000054267	AT-rich interaction domain 4B	1	235131634-235328219	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027333, HPA053692	Approved		Approved	Nucleoplasm<br>Vesicles	Renal cancer:2.23e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 32.0	Expressed in all		
ARID5A	MRF-1, RP11-363D14	ENSG00000196843	AT-rich interaction domain 5A	2	96536743-96552638	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002860, HPA023879	Approved		Supported	Nucleus<br>Nucleoli	Renal cancer:4.24e-8 (unfavourable), Breast cancer:2.05e-6 (favourable)	Expressed in all	Expressed in all			appendix: 25.4	Group enriched	6	HDLM-2: 239.9;RPMI-8226: 78.9
ARID5B	FLJ21150, MRF2	ENSG00000150347	AT-rich interaction domain 5B	10	61901300-62096944	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015037	Uncertain		Approved	Nucleoplasm<br>Endoplasmic reticulum<br>Plasma membrane<br>Cytosol		Expressed in all	Expressed in all			smooth muscle: 62.1	Cell line enhanced		BJ hTERT+: 91.0
ARNT	bHLHe2, HIF-1beta	ENSG00000143437	Aryl hydrocarbon receptor nuclear translocator	1	150809705-150876768	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001759, CAB004318	Enhanced		Supported	Nucleus<br>Nuclear bodies		Expressed in all	Expressed in all			ovary: 46.7	Cell line enriched	7	U-698: 274.9
ARNT2	bHLHe1, KIAA0307	ENSG00000172379	Aryl hydrocarbon receptor nuclear translocator 2	15	80404350-80597937	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001056, CAB005081	Enhanced		Supported	Nucleus	Pancreatic cancer:1.46e-6 (favourable), Renal cancer:7.51e-4 (favourable)	Expressed in all	Tissue enriched	8	cerebral cortex: 153.7	testis: 18.8	Mixed		
ARNTL	bHLHe5, BMAL1, JAP3, MOP3, PASD3	ENSG00000133794	Aryl hydrocarbon receptor nuclear translocator like	11	13276652-13387266	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	CAB045962, HPA050938	Supported		Supported	Nucleoplasm<br>Vesicles		Expressed in all	Expressed in all			adrenal gland: 26.3	Mixed		
ARNTL2	bHLHe6, BMAL2, CLIF, MOP9, PASD9	ENSG00000029153	Aryl hydrocarbon receptor nuclear translocator like 2	12	27332854-27425289	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059074, HPA065355	Uncertain		Enhanced	Nucleus<br>Nucleoli	Pancreatic cancer:5.29e-6 (unfavourable), Renal cancer:1.56e-5 (unfavourable)	Mixed	Tissue enhanced		esophagus: 31.2	tonsil: 20.2	Cell line enhanced		U-2197: 148.2
ARX	CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS	ENSG00000004848	Aristaless related homeobox	X	25003694-25016420	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Endometrial cancer:3.54e-7 (unfavourable)	Mixed	Tissue enriched	7	ovary: 97.7	testis: 14.0	Cell line enhanced		HAP1: 2.0;PC-3: 3.6;U-266/70: 6.3
ASCL1	ASH1, bHLHa46, HASH1	ENSG00000139352	Achaete-scute family bHLH transcription factor 1	12	102957686-102960516	Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA029217	Enhanced					Group enriched	Group enriched	8	cerebral cortex: 16.2;liver: 6.4	adrenal gland: 1.4	Group enriched	23	SCLC-21H: 63.4;SH-SY5Y: 30.9
ASCL2	ASH2, bHLHa45, HASH2	ENSG00000183734	Achaete-scute family bHLH transcription factor 2	11	2268495-2270952	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Pancreatic cancer:4.73e-4 (favourable), Cervical cancer:5.11e-4 (favourable)	Group enriched	Mixed			placenta: 6.4	Group enriched	6	BEWO: 19.9;NB-4: 4.0;SCLC-21H: 19.8
ASCL3	bHLHa42, HASH3, Sgn1	ENSG00000176009	Achaete-scute family bHLH transcription factor 3	11	8937579-8938211	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA027032	Uncertain					Not detected	Tissue enriched	15	salivary gland: 3.3	spleen,testis: 0.2	Not detected		
ASCL4	bHLHa44, HASH4	ENSG00000187855	Achaete-scute family bHLH transcription factor 4	12	107774385-107776644	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036116	Uncertain					Tissue enhanced	Not detected			parathyroid gland: 0.7	Not detected		
ASCL5	bHLHa47	ENSG00000232237	Achaete-scute family bHLH transcription factor 5	1	201113953-201127184	Predicted intracellular proteins, Transcription factors	No evidence							Mixed	Not detected			endometrium: 0.6	Not detected		
ATF1	TREB36	ENSG00000123268	Activating transcription factor 1	12	50763710-50821122	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB016222, HPA055069, HPA055406	Enhanced		Enhanced	Nucleoplasm	Liver cancer:1.53e-5 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 39.6	Expressed in all		
ATF2	CRE-BP1, CREB2, HB16, TREB7	ENSG00000115966	Activating transcription factor 2	2	175072250-175168382	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB003769, HPA022134	Supported		Enhanced	Nucleoplasm	Liver cancer:7.08e-5 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 54.0	Expressed in all		
ATF3		ENSG00000162772	Activating transcription factor 3	1	212565334-212620777	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001562	Approved		Enhanced	Nucleus<br>Nucleoli		Expressed in all	Expressed in all			smooth muscle: 450.5	Cell line enhanced		BEWO: 126.9
ATF4	CREB-2, TAXREB67, TXREB	ENSG00000128272	Activating transcription factor 4	22	39519695-39522685	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB011596	Approved		Supported	Microtubule organizing center<br>Cytosol	Renal cancer:9.77e-5 (unfavourable), Liver cancer:4.07e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 530.2	Expressed in all		
ATF5		ENSG00000169136	Activating transcription factor 5	19	49928702-49933935	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030187	Uncertain		Supported	Nucleoplasm<br>Cytosol	Renal cancer:3.39e-7 (unfavourable), Cervical cancer:1.14e-4 (favourable), Endometrial cancer:1.16e-4 (unfavourable)	Tissue enriched	Group enriched	7	liver: 387.6;thyroid gland: 190.2	appendix: 42.4	Expressed in all		
ATF6	ATF6A	ENSG00000118217	Activating transcription factor 6	1	161766294-161964070	Disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA005935	Approved		Approved	Cytosol		Expressed in all	Expressed in all			parathyroid gland: 41.3	Expressed in all		
ATF6B	CREBL1, G13	ENSG00000213676	Activating transcription factor 6 beta	6	32098176-32128253	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA046871	Uncertain		Supported	Nucleus<br>Nucleoli		Expressed in all	Expressed in all			parathyroid gland: 56.8	Expressed in all		
ATF7	ATFA	ENSG00000170653	Activating transcription factor 7	12	53507856-53626410	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA003384	Approved		Approved	Nucleus<br>Cytosol	Stomach cancer:2.10e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 40.3	Expressed in all		
ATOH1	bHLHa14, HATH1, MATH-1, Math1	ENSG00000172238	Atonal bHLH transcription factor 1	4	93828753-93830964	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Colorectal cancer:3.26e-5 (favourable)	Tissue enhanced	Group enriched	9	colon: 17.6;duodenum: 11.1;rectum: 19.7;small intestine: 22.4	appendix: 1.9	Not detected		
ATOH7	bHLHa13, Math5	ENSG00000179774	Atonal bHLH transcription factor 7	10	68230624-68232103	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027008	Uncertain					Not detected	Tissue enriched	7	cerebral cortex: 2.2	endometrium,kidney,small intestine: 0.3	Cell line enriched	14	SCLC-21H: 9.1
ATOH8	bHLHa21, FLJ14708, HATH6	ENSG00000168874	Atonal bHLH transcription factor 8	2	85751344-85788066	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028406			Supported	Nucleoplasm	Pancreatic cancer:8.98e-6 (favourable), Renal cancer:3.80e-5 (favourable)	Tissue enhanced	Tissue enhanced		adipose tissue: 31.6	lung: 17.0	Cell line enhanced		RH-30: 29.0;TIME: 23.5
ATRX	JMS, MRX52, RAD54, XH2, XNP	ENSG00000085224	ATRX, chromatin remodeler	X	77504878-77786269	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001906, CAB009372, HPA064684, CAB068176	Supported		Supported	Nuclear bodies		Expressed in all	Expressed in all			parathyroid gland: 54.4	Expressed in all		
BACH1	BACH-1, BTBD24	ENSG00000156273	BTB domain and CNC homolog 1	21	29194071-29630751	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034949	Approved		Approved	Nucleus<br>Cytosol	Pancreatic cancer:3.11e-5 (unfavourable), Renal cancer:7.14e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 71.9	Expressed in all		
BACH2	BTBD25	ENSG00000112182	BTB domain and CNC homolog 2	6	89926529-90296908	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051384, HPA058384	Enhanced		Supported	Nucleus<br>Cytosol		Mixed	Tissue enhanced		lymph node: 21.2	tonsil: 12.1	Cell line enhanced		Daudi: 101.9;U-698: 57.4
BARHL1		ENSG00000125492	BarH like homeobox 1	9	132582185-132590266	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA004809	Approved					Not detected	Not detected			all non-specific tissues: 0.0	Cell line enriched	154	SCLC-21H: 19.7
BARHL2		ENSG00000143032	BarH like homeobox 2	1	90711539-90717237	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	37	testis: 3.6	all non-specific tissues: 0.0	Cell line enhanced		HAP1: 1.1;HEK 293: 3.4
BARX1		ENSG00000131668	BARX homeobox 1	9	93951622-93955372	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055858			Approved	Nucleoplasm<br>Vesicles	Endometrial cancer:8.16e-6 (unfavourable), Head and neck cancer:1.02e-4 (unfavourable)	Tissue enhanced	Tissue enriched	7	stomach: 11.1	testis: 1.5	Group enriched	6	AN3-CA: 27.2;HMC-1: 61.1;NTERA-2: 20.7;THP-1: 19.2
BARX2		ENSG00000043039	BARX homeobox 2	11	129375940-129452279	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB033311, HPA068414	Enhanced		Supported	Nucleoplasm<br>Cytosol	Urothelial cancer:3.06e-4 (unfavourable)	Mixed	Tissue enhanced		esophagus: 103.8;salivary gland: 60.3	fallopian tube: 28.0	Cell line enriched	5	HDLM-2: 158.6
BATF	B-ATF, BATF1, SFA-2	ENSG00000156127	Basic leucine zipper ATF-like transcription factor	14	75522425-75547015	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059588, HPA064962	Approved		Enhanced	Nucleoplasm	Renal cancer:3.74e-9 (unfavourable), Endometrial cancer:5.35e-6 (favourable), Head and neck cancer:7.91e-5 (favourable), Urothelial cancer:4.30e-4 (favourable), Colorectal cancer:8.30e-4 (unfavourable)	Expressed in all	Tissue enhanced		lymph node: 31.4	appendix: 26.5	Cell line enhanced		HDLM-2: 321.9;MCF7: 99.6;RT4: 64.2;U-937: 74.7
BATF2	MGC20410	ENSG00000168062	Basic leucine zipper ATF-like transcription factor 2	11	64987943-64997045	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062496	Approved		Approved	Nucleoli	Ovarian cancer:9.39e-5 (favourable), Pancreatic cancer:2.12e-4 (unfavourable)	Expressed in all	Mixed			spleen: 17.5	Cell line enhanced		BJ hTERT+ SV40 Large T+: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 19.1
BATF3	JDP1, JUNDM1, SNFT	ENSG00000123685	Basic leucine zipper ATF-like transcription factor 3	1	212686418-212699985	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Mixed			spleen: 4.6	Cell line enriched	25	HDLM-2: 359.9
BBX	HBP2, HSPC339, MDS001	ENSG00000114439	BBX, HMG-box containing	3	107522936-107811324	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006049, HPA050646	Enhanced		Enhanced	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			testis: 115.7	Expressed in all		
BCL11A	BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856	ENSG00000119866	B-cell CLL/lymphoma 11A	2	60451167-60553567	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB014891, HPA029003	Enhanced		Enhanced	Nucleoplasm<br>Nuclear bodies		Mixed	Tissue enhanced		skin: 41.0	tonsil: 30.6	Cell line enhanced		Daudi: 24.7;MOLT-4: 28.5;REH: 32.5;U-698: 43.2
BCL11B	CTIP-2, CTIP2, hRIT1-alpha, ZNF856B	ENSG00000127152	B-cell CLL/lymphoma 11B	14	99169287-99271524	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049117	Enhanced	Supported	Approved	Nucleus<br>Nucleoli fibrillar center	Urothelial cancer:7.48e-4 (favourable)	Mixed	Tissue enhanced		lymph node: 12.2;skin: 18.7	tonsil: 7.4	Cell line enriched	6	MOLT-4: 41.1
BCL3	BCL4, D19S37	ENSG00000069399	B-cell CLL/lymphoma 3	19	44747705-44760044	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002051, HPA047514	Approved		Supported	Nucleoplasm<br>Vesicles<br>Midbody	Renal cancer:3.13e-14 (unfavourable), Melanoma:3.74e-4 (favourable), Glioma:5.58e-4 (unfavourable), Breast cancer:9.67e-4 (favourable)	Expressed in all	Expressed in all			appendix: 30.1	Cell line enhanced		HDLM-2: 55.4;SiHa: 65.8
BCL6	BCL5, BCL6A, LAZ3, ZBTB27, ZNF51	ENSG00000113916	B-cell CLL/lymphoma 6	3	187721377-187745727	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000307, HPA004899, HPA050645	Enhanced		Enhanced	Nucleoplasm<br>Golgi apparatus	Renal cancer:1.27e-9 (unfavourable)	Expressed in all	Expressed in all			adipose tissue: 113.5	Cell line enhanced		Daudi: 112.8;U-698: 150.4
BCL6B	BAZF, ZBTB28, ZNF62	ENSG00000161940	B-cell CLL/lymphoma 6B	17	7023020-7030290	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA059147, HPA075112	Uncertain		Approved	Vesicles	Head and neck cancer:8.56e-5 (favourable), Renal cancer:4.04e-4 (unfavourable)	Expressed in all	Mixed			adipose tissue: 34.6	Group enriched	14	HEL: 16.2;HMC-1: 46.5;HUVEC TERT2: 79.9;TIME: 30.9
BHLHA15	bHLHa15, BHLHB8, MIST1	ENSG00000180535	Basic helix-loop-helix family member a15	7	98211427-98212979	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB034083, HPA047834	Enhanced		Approved	Nucleoplasm<br>Golgi apparatus		Tissue enhanced	Group enriched	7	pancreas: 85.5;salivary gland: 54.0	prostate: 9.3	Group enriched	8	Karpas-707: 27.3;RPMI-8226: 50.7;U-266/70: 63.7
BHLHA9	bHLHa9, BHLHF42	ENSG00000205899	Basic helix-loop-helix family member a9	17	1270559-1271460	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062632	Uncertain					Tissue enhanced	Not detected			cerebral cortex: 0.8	Not detected		
BHLHE22	Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20	ENSG00000180828	Basic helix-loop-helix family member e22	8	64580367-64583628	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064128, HPA064872, HPA067500	Enhanced					Mixed	Tissue enhanced		cerebral cortex: 12.2	seminal vesicle: 3.3	Cell line enriched	15	THP-1: 52.6
BHLHE23	bA305P22.3, Beta4, BHLHB4, bHLHe23	ENSG00000125533	Basic helix-loop-helix family member e23	20	63005927-63007035	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA030575	Uncertain					Tissue enriched	Not detected			testis: 0.1	Cell line enriched	22	MOLT-4: 10.3
BHLHE40	BHLHB2, bHLHe40, Clast5, DEC1, SHARP2, STRA13	ENSG00000134107	Basic helix-loop-helix family member e40	3	4979116-4985323	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028922	Uncertain		Supported	Nuclear bodies	Pancreatic cancer:8.74e-4 (unfavourable)	Expressed in all	Expressed in all			esophagus: 230.0	Cell line enhanced		HDLM-2: 406.6;U-87 MG: 191.8
BHLHE41	BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1	ENSG00000123095	Basic helix-loop-helix family member e41	12	26120026-26125127	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056035			Approved	Nucleoplasm	Renal cancer:8.73e-5 (unfavourable), Urothelial cancer:1.09e-4 (favourable)	Expressed in all	Tissue enhanced		thyroid gland: 94.5	fallopian tube: 70.9	Cell line enhanced		RT4: 97.9;U-266/70: 39.0;U-87 MG: 42.7
BNC1	BNC, HsT19447	ENSG00000169594	Basonuclin 1	15	83255903-83284714	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA063183, HPA066947, HPA077428			Enhanced	Nucleoplasm		Tissue enhanced	Tissue enhanced		testis: 56.0	esophagus: 11.8	Cell line enhanced		HBEC3-KT: 83.5;hTCEpi: 92.6;hTERT-HME1: 95.2
BNC2	BSN2, FLJ20043	ENSG00000173068	Basonuclin 2	9	16409503-16870843	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018525, HPA059419	Approved		Supported	Nucleoplasm		Mixed	Tissue enhanced		endometrium: 44.5;ovary: 39.4;smooth muscle: 48.0	fallopian tube: 19.3	Mixed		
BSX	BSX1	ENSG00000188909	Brain specific homeobox	11	122977570-122981720	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA015654	Uncertain					Not detected	Not detected			testis: 0.2	Not detected		
CASZ1	castor, cst, FLJ20321, SRG, ZNF693	ENSG00000130940	Castor zinc finger 1	1	10636604-10796650	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028222, HPA029927	Approved		Supported	Nucleoplasm<br>Cytosol		Mixed	Tissue enhanced		skin: 26.9	prostate: 15.9	Cell line enhanced		HDLM-2: 12.4;SCLC-21H: 23.3;SK-BR-3: 14.1
CDC5L	CDC5, CEF1, hCDC5, PCDC5RP	ENSG00000096401	Cell division cycle 5 like	6	44387525-44450426	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006302, HPA011361, CAB012275	Supported		Supported	Nucleoplasm	Melanoma:7.02e-5 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 36.0	Expressed in all		
CDX1		ENSG00000113722	Caudal type homeobox 1	5	150166795-150184558	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055196	Enhanced					Tissue enhanced	Group enriched	9	colon: 129.9;duodenum: 64.5;rectum: 134.7;small intestine: 104.9	appendix: 12.1	Cell line enhanced		BJ hTERT+: 5.4;SH-SY5Y: 1.3
CDX2	CDX3	ENSG00000165556	Caudal type homeobox 2	13	27962137-27971139	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002221, HPA045669, HPA049580	Enhanced		Supported	Nucleoplasm		Tissue enriched	Group enriched	6	colon: 30.8;duodenum: 22.3;rectum: 24.9;small intestine: 30.2	appendix: 4.7	Cell line enhanced		CACO-2: 9.4;CAPAN-2: 3.3;HEK 293: 5.6
CDX4		ENSG00000131264	Caudal type homeobox 4	X	73447254-73455245	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056528	Uncertain					Tissue enriched	Tissue enriched	8	skin: 1.3	seminal vesicle,testis: 0.1	Not detected		
CEBPA	C/EBP-alpha, CEBP	ENSG00000245848	CCAAT/enhancer binding protein alpha	19	33299934-33302564	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052734, HPA065037, HPA067937	Approved		Approved	Nucleoplasm<br>Vesicles		Expressed in all	Expressed in all			adipose tissue: 108.0	Cell line enhanced		BEWO: 187.4;THP-1: 270.7;U-937: 100.7
CEBPB	C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5	ENSG00000172216	CCAAT/enhancer binding protein beta	20	50190734-50192689	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004213, HPA061355, HPA062267	Supported		Enhanced	Nucleoplasm	Renal cancer:2.44e-12 (unfavourable)	Expressed in all	Expressed in all			adrenal gland: 112.4	Expressed in all		
CEBPD	C/EBP-delta, CELF, CRP3, NF-IL6-beta	ENSG00000221869	CCAAT/enhancer binding protein delta	8	47736909-47739086	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067581			Supported	Nucleoplasm	Renal cancer:2.87e-7 (unfavourable), Breast cancer:2.28e-5 (favourable)	Expressed in all	Expressed in all			adipose tissue: 71.1	Cell line enhanced		HHSteC: 29.5;NB-4: 50.0;SiHa: 33.7
CEBPE	CRP1	ENSG00000092067	CCAAT/enhancer binding protein epsilon	14	23117304-23119616	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002928, CAB005113	Enhanced		Enhanced	Nucleoplasm		Not detected	Tissue enriched	9	bone marrow: 26.0	small intestine: 2.7	Cell line enhanced		HL-60: 143.2;HMC-1: 26.7;NB-4: 58.7
CEBPG	GPE1BP, IG/EBP-1	ENSG00000153879	CCAAT/enhancer binding protein gamma	19	33373330-33382686	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA012024	Enhanced		Supported	Nucleoplasm	Endometrial cancer:7.97e-5 (unfavourable), Renal cancer:7.23e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 41.3	Expressed in all		
CIC	KIAA0306	ENSG00000079432	Capicua transcriptional repressor	19	42268537-42295797	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB026388, HPA044341, HPA064725	Approved		Supported	Nucleoplasm<br>Vesicles		Expressed in all	Expressed in all			testis: 54.9	Expressed in all		
CLOCK	bHLHe8, KAT13D, KIAA0334	ENSG00000134852	Clock circadian regulator	4	55427903-55547138	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001867, HPA027565	Supported		Enhanced	Nucleoplasm		Expressed in all	Mixed			testis: 26.4	Expressed in all		
CNOT4	CLONE243, NOT4, NOT4H	ENSG00000080802	CCR4-NOT transcription complex subunit 4	7	135361795-135510127	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005737	Approved				Renal cancer:7.67e-6 (favourable), Liver cancer:1.19e-4 (unfavourable), Ovarian cancer:1.61e-4 (favourable)	Expressed in all	Expressed in all			testis: 33.3	Expressed in all		
CRAMP1	CRAMP1L, KIAA1426	ENSG00000007545	Cramped chromatin regulator homolog 1	16	1612325-1677908	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041752	Uncertain		Approved	Nucleus<br>Nucleoli<br>Cytosol	Stomach cancer:4.93e-4 (favourable)	Expressed in all	Mixed			testis: 31.8	Expressed in all		
CREB1		ENSG00000118260	CAMP responsive element binding protein 1	2	207529737-207603431	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB003803, HPA019150	Supported		Enhanced	Nucleoplasm	Liver cancer:2.77e-5 (unfavourable)	Expressed in all	Expressed in all			testis: 59.1	Expressed in all		
CREB3	Luman, LZIP, sLZIP	ENSG00000107175	CAMP responsive element binding protein 3	9	35732335-35737004	Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA030978			Supported	Cytosol	Renal cancer:3.77e-5 (favourable), Ovarian cancer:5.40e-4 (favourable), Liver cancer:5.57e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 55.8	Expressed in all		
CREB3L1	OASIS	ENSG00000157613	CAMP responsive element binding protein 3 like 1	11	46277661-46321422	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA024069, CAB026151	Enhanced		Approved	Plasma membrane<br>Cytosol	Renal cancer:2.97e-4 (unfavourable), Endometrial cancer:3.92e-4 (favourable), Thyroid cancer:8.59e-4 (unfavourable)	Expressed in all	Mixed			cervix, uterine: 66.0	Cell line enhanced		fHDF/TERT166: 248.2
CREB3L2	BBF2H7, TCAG_1951439	ENSG00000182158	CAMP responsive element binding protein 3 like 2	7	137874979-138002067	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA015068, HPA015534	Uncertain		Supported	Nucleoplasm<br>Endoplasmic reticulum		Expressed in all	Expressed in all			parathyroid gland: 110.9	Mixed		
CREB3L3	CREB-H	ENSG00000060566	CAMP responsive element binding protein 3 like 3	19	4153601-4173054	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA040671, HPA056228	Enhanced				Renal cancer:3.53e-6 (unfavourable)	Tissue enriched	Group enriched	104	duodenum: 241.6;liver: 61.0;small intestine: 278.7	colon,stomach: 1.8	Cell line enhanced		HDLM-2: 44.9;Hep G2: 10.3;U-266/70: 7.7
CREB3L4	AIbZIP, ATCE1, CREB3, CREB4, hJAL	ENSG00000143578	CAMP responsive element binding protein 3 like 4	1	153967534-153974363	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA038122	Enhanced		Approved	Nucleoplasm<br>Nuclear membrane<br>Mitochondria	Endometrial cancer:7.21e-4 (favourable)	Group enriched	Expressed in all			prostate: 170.5	Expressed in all		
CREB5	CRE-BPA, H_GS165L15.1	ENSG00000146592	CAMP responsive element binding protein 5	7	28299321-28825894	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050020, HPA061622			Approved	Nucleus<br>Vesicles<br>Plasma membrane		Mixed	Mixed			gallbladder: 18.6	Cell line enhanced		HL-60: 49.5
CREBL2		ENSG00000111269	CAMP responsive element binding protein like 2	12	12611827-12645108	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043738	Uncertain		Approved	Nucleoplasm<br>Mitochondria<br>Cytosol	Renal cancer:2.26e-5 (favourable)	Expressed in all	Expressed in all			adrenal gland: 173.3	Expressed in all		
CREBZF	ZF	ENSG00000137504	CREB/ATF bZIP transcription factor	11	85659708-85682908	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021526, HPA063652	Uncertain		Approved	Nucleus<br>Mitochondria		Expressed in all	Expressed in all			parathyroid gland: 31.7	Expressed in all		
CREM	hCREM-2	ENSG00000095794	CAMP responsive element modulator	10	35126791-35212958	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001818, CAB018352	Enhanced		Supported	Nucleus<br>Vesicles	Renal cancer:1.23e-5 (unfavourable)	Expressed in all	Expressed in all			testis: 339.8	Expressed in all		
CRX	CORD2, CRD, LCA7, OTX3	ENSG00000105392	Cone-rod homeobox	19	47819779-47843330	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036762, HPA036763	Enhanced					Not detected	Not detected			testis: 0.3	Not detected		
CSRNP1	AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1	ENSG00000144655	Cysteine and serine rich nuclear protein 1	3	39141855-39154562	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045207, HPA058463			Enhanced	Nucleoplasm<br>Vesicles	Renal cancer:1.07e-4 (favourable), Stomach cancer:6.47e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 123.5	Cell line enhanced		SK-BR-3: 48.5
CSRNP2	C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12	ENSG00000110925	Cysteine and serine rich nuclear protein 2	12	51061205-51083664	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018503, HPA019914	Approved		Approved	Nuclear speckles	Liver cancer:1.08e-4 (unfavourable), Urothelial cancer:2.78e-4 (favourable), Renal cancer:6.51e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 49.2	Expressed in all		
CSRNP3	FAM130A2, FLJ32093, PPP1R73, TAIP-2	ENSG00000178662	Cysteine and serine rich nuclear protein 3	2	165469647-165689407	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA017905	Supported		Approved	Nucleus<br>Nucleoli		Mixed	Tissue enhanced		cerebral cortex: 16.1	endometrium: 4.6	Group enriched	5	AF22: 9.7;PC-3: 2.2;SCLC-21H: 8.4;SH-SY5Y: 6.2
CTCF		ENSG00000102974	CCCTC-binding factor	16	67562407-67639183	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004122, CAB062550, CAB068181, CAB068182	Supported		Supported	Nucleoplasm	Renal cancer:4.06e-4 (favourable), Liver cancer:4.21e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 58.6	Expressed in all		
CTCFL	BORIS, CT27, dJ579F20.2	ENSG00000124092	CCCTC-binding factor like	20	57495966-57525652	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA001472	Enhanced					Tissue enhanced	Tissue enriched	20	testis: 20.6	bone marrow: 1.0	Group enriched	41	HMC-1: 70.0;K-562: 103.5
CUX1	CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6	ENSG00000257923	Cut like homeobox 1	7	101815904-102283957	Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA003277, HPA003317	Approved		Supported	Nucleoplasm<br>Golgi apparatus	Renal cancer:5.72e-7 (favourable), Glioma:9.90e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 82.5	Expressed in all		
CUX2	CDP2, CUTL2, KIAA0293	ENSG00000111249	Cut like homeobox 2	12	111034024-111350554	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Tissue enhanced		cerebral cortex: 12.2;liver: 9.6;prostate: 18.0	thyroid gland: 6.8	Cell line enhanced		HBEC3-KT: 4.6;SCLC-21H: 7.5;SH-SY5Y: 14.5
CXXC1	CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1	ENSG00000154832	CXXC finger protein 1	18	50282343-50288304	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044511	Supported		Enhanced	Nucleus	Liver cancer:4.18e-6 (unfavourable), Pancreatic cancer:2.60e-4 (favourable)	Expressed in all	Expressed in all			fallopian tube: 28.8	Expressed in all		
DBP	DABP	ENSG00000105516	D-box binding PAR bZIP transcription factor	19	48630030-48637438	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Lung cancer:1.16e-5 (favourable), Renal cancer:2.41e-5 (favourable), Head and neck cancer:5.49e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 41.4	Cell line enhanced		NB-4: 148.5
DBX1		ENSG00000109851	Developing brain homeobox 1	11	20156155-20160613	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA039802	Uncertain					Not detected	Not detected			testis: 0.2	Cell line enriched	9	NTERA-2: 1.0
DBX2	FLJ16139	ENSG00000185610	Developing brain homeobox 2	12	45014672-45051099	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA066053	Uncertain					Tissue enriched	Group enriched	5	cerebral cortex: 4.1;testis: 1.2	skin: 0.5	Not detected		
DDIT3	CHOP, CHOP10, GADD153	ENSG00000175197	DNA damage inducible transcript 3	12	57516588-57520517	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058416, HPA068416	Approved		Supported	Nucleoplasm	Liver cancer:6.55e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 263.6	Expressed in all		
DEAF1	NUDR, SPN, ZMYND5	ENSG00000177030	DEAF1, transcription factor	11	644233-706715	Disease related genes, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA030302	Approved		Supported	Nucleus<br>Nucleoli fibrillar center	Liver cancer:1.75e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 40.6	Expressed in all		
DLX1		ENSG00000144355	Distal-less homeobox 1	2	172084740-172089677	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035666, HPA045884	Approved		Approved	Nucleus<br>Vesicles<br>Cell Junctions		Tissue enhanced	Tissue enhanced		adrenal gland: 1.6;cerebral cortex: 5.0	prostate: 0.8	Cell line enhanced		AN3-CA: 103.9
DLX2	TES-1	ENSG00000115844	Distal-less homeobox 2	2	172099439-172102900	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056965			Approved	Nuclear speckles		Mixed	Not detected			cerebral cortex: 0.8	Group enriched	11	AN3-CA: 73.7;HEK 293: 46.5
DLX3		ENSG00000064195	Distal-less homeobox 3	17	49990005-49995224	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Endometrial cancer:4.61e-4 (unfavourable)	Mixed	Group enriched	5	placenta: 10.7;skin: 21.9	thyroid gland: 3.1	Cell line enhanced		BEWO: 131.0;SK-BR-3: 33.0
DLX4	BP1, DLX7, DLX8, DLX9	ENSG00000108813	Distal-less homeobox 4	17	49968970-49974959	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059933	Uncertain		Approved	Nucleoplasm		Mixed	Tissue enhanced		placenta: 5.4	skin: 1.2	Cell line enhanced		BEWO: 22.0;CACO-2: 13.7;HAP1: 11.5;K-562: 12.0
DLX5		ENSG00000105880	Distal-less homeobox 5	7	97020392-97025097	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005670	Approved		Approved	Nucleus		Tissue enriched	Tissue enhanced		endometrium: 20.2;placenta: 13.5;skin: 17.1	cervix, uterine: 9.6	Group enriched	5	BEWO: 41.0;HAP1: 24.0
DLX6		ENSG00000006377	Distal-less homeobox 6	7	97005548-97011039	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA030608, HPA061460	Uncertain		Approved	Nuclear bodies		Tissue enriched	Tissue enhanced		endometrium: 4.4;placenta: 4.3;testis: 5.4	cervix, uterine: 3.0	Cell line enhanced		AN3-CA: 9.4;BEWO: 32.1;HAP1: 15.7;SCLC-21H: 8.6;SH-SY5Y: 11.6
DMAP1	DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4	ENSG00000178028	DNA methyltransferase 1 associated protein 1	1	44213455-44220681	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028419, CAB033018	Uncertain		Supported	Nucleoplasm<br>Cytosol	Liver cancer:1.44e-4 (unfavourable)	Expressed in all	Expressed in all			adrenal gland: 40.4	Expressed in all		
DMBX1	OTX3, PAXB	ENSG00000197587	Diencephalon/mesencephalon homeobox 1	1	46506996-46514226	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026811	Uncertain				Endometrial cancer:7.13e-5 (unfavourable)	Mixed	Tissue enhanced		testis: 1.2	adrenal gland,thyroid gland: 0.4	Cell line enhanced		AN3-CA: 11.9;CAPAN-2: 3.6;K-562: 3.9;SiHa: 4.4
DMRT1	CT154, DMT1	ENSG00000137090	Doublesex and mab-3 related transcription factor 1	9	841690-969090	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027850	Enhanced					Tissue enriched	Tissue enriched	107	testis: 50.7	thyroid gland: 0.4	Cell line enriched	8	SCLC-21H: 3.8
DMRT2		ENSG00000173253	Doublesex and mab-3 related transcription factor 2	9	1049858-1057552	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at transcript level	HPA029297	Uncertain					Tissue enhanced	Tissue enriched	7	parathyroid gland: 108.9	kidney: 16.2	Cell line enhanced		HaCaT: 3.3;RH-30: 4.8;RPMI-8226: 13.4;SCLC-21H: 3.4;SK-MEL-30: 4.0;WM-115: 3.5
DMRT3	DMRTA3	ENSG00000064218	Doublesex and mab-3 related transcription factor 3	9	976964-991731	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA077685	Approved					Tissue enhanced	Tissue enriched	6	parathyroid gland: 65.3	thyroid gland: 10.4	Cell line enhanced		HAP1: 1.3;HEK 293: 1.5;SCLC-21H: 1.1;THP-1: 1.8
DMRTA1		ENSG00000176399	DMRT like family A1	9	22446841-22455740	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044764, HPA062253	Uncertain		Approved	Vesicles	Renal cancer:1.14e-6 (favourable)	Mixed	Tissue enhanced		parathyroid gland: 6.5	liver: 4.3	Cell line enhanced		BJ hTERT+: 5.1
DMRTA2		ENSG00000142700	DMRT like family A2	1	50417550-50423500	Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA043098, HPA062958	Uncertain		Approved	Nucleoplasm<br>Mitochondria		Tissue enhanced	Not detected			testis: 0.7	Cell line enhanced		BEWO: 3.0;HBEC3-KT: 2.3;RH-30: 11.1;SH-SY5Y: 2.6;SiHa: 2.5
DMRTB1		ENSG00000143006	DMRT like family B with proline rich C-terminal 1	1	53459399-53467488	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036490, HPA058553	Enhanced					Tissue enhanced	Tissue enriched	67	testis: 69.6	epididymis: 1.0	Not detected		
DMRTC1		ENSG00000269502	DMRT like family C1	X	72872025-72943814	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA046874, HPA046992	Uncertain					Not detected	Tissue enhanced		cerebral cortex: 2.3	fallopian tube,thyroid gland: 1.3	Not detected		
DMRTC1B		ENSG00000184911	DMRT like family C1B	X	72777009-72848802	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA046874, HPA046992	Uncertain					Not detected	Tissue enhanced		cerebral cortex: 16.6	ovary: 10.3	Not detected		
DMRTC2		ENSG00000142025	DMRT like family C2	19	41844743-41852333	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045016	Uncertain					Not detected	Tissue enriched	128	testis: 48.6	lymph node,parathyroid gland,thyroid gland: 0.3	Not detected		
DMTF1	DMP1, DMTF, hDMP1, MRUL	ENSG00000135164	Cyclin D binding myb like transcription factor 1	7	87152361-87196337	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023846	Supported		Supported	Nucleoplasm	Renal cancer:4.39e-5 (unfavourable)	Expressed in all	Expressed in all			testis: 84.1	Expressed in all		
DNAJC1	DNAJL1, ERdj1, MTJ1	ENSG00000136770	DnaJ heat shock protein family (Hsp40) member C1	10	21756537-22003769	Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA013432	Approved		Approved	Endoplasmic reticulum	Liver cancer:1.96e-5 (unfavourable), Renal cancer:2.33e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 57.8	Expressed in all		
DNAJC2	MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin	ENSG00000105821	DnaJ heat shock protein family (Hsp40) member C2	7	103312474-103344873	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020454	Approved		Supported	Cytosol	Renal cancer:1.12e-5 (unfavourable)	Expressed in all	Expressed in all			testis: 61.7	Expressed in all		
DNMT1	CXXC9, DNMT, MCMT	ENSG00000130816	DNA methyltransferase 1	19	10133345-10231286	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002694, CAB005876	Enhanced		Enhanced	Nucleoplasm	Liver cancer:1.46e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 51.2	Expressed in all		
DNMT3A		ENSG00000119772	DNA methyltransferase 3 alpha	2	25227855-25342590	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009469, HPA026588	Approved		Supported	Nucleoplasm	Pancreatic cancer:1.18e-4 (favourable), Endometrial cancer:1.55e-4 (unfavourable), Liver cancer:1.58e-4 (unfavourable), Renal cancer:2.49e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 22.8	Cell line enhanced		NTERA-2: 59.7;SH-SY5Y: 76.5
DNMT3B		ENSG00000088305	DNA methyltransferase 3 beta	20	32762385-32809356	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001595, CAB069896	Enhanced		Approved	Nucleoplasm<br>Vesicles	Renal cancer:1.87e-7 (unfavourable), Endometrial cancer:5.04e-4 (unfavourable)	Tissue enriched	Tissue enhanced		testis: 9.2	skin: 4.5	Cell line enhanced		BEWO: 236.9;NTERA-2: 333.3
DNMT3L	MGC1090	ENSG00000142182	DNA methyltransferase 3 like	21	44246339-44262216	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055234, HPA066780	Uncertain		Approved	Nuclear speckles		Tissue enriched	Group enriched	6	kidney: 7.2;liver: 10.4;lymph node: 2.3	spleen: 1.1	Cell line enriched	7	BEWO: 40.9
DPRX		ENSG00000204595	Divergent-paired related homeobox	19	53632056-53637009	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA043682	Uncertain					Tissue enriched	Tissue enhanced		placenta: 1.8	epididymis,testis: 0.5	Not detected		
DRGX	DRG11, PRRXL1	ENSG00000165606	Dorsal root ganglia homeobox	10	49364181-49396016	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA043978	Uncertain		Approved	Nucleus<br>Nucleoli<br>Cytosol		Mixed	Tissue enriched	11	adrenal gland: 8.9	skin: 0.8	Group enriched	16	RH-30: 13.8;SH-SY5Y: 68.3;U-2197: 21.7
DUX4		ENSG00000260596	Double homeobox 4	4	190173774-190185942	Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters	Evidence at protein level	HPA058451			Supported	Nucleus<br>Nucleoli<br>Golgi apparatus<br>Cytosol		Not detected	Tissue enhanced		testis: 1.4	prostate: 0.4	Cell line enhanced		A549: 1.3;U-2 OS: 2.2;U-266/70: 3.6;U-266/84: 4.6
DUXA		ENSG00000258873	Double homeobox A	19	57154021-57167443	Predicted intracellular proteins, Transcription factors	No evidence	HPA059358	Uncertain					Not detected	Not detected			appendix,testis: 0.3	Not detected		
E2F1	RBBP3, RBP3	ENSG00000101412	E2F transcription factor 1	20	33675683-33686404	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000329, HPA008003, CAB019308, HPA029735	Enhanced		Enhanced	Nucleoplasm<br>Centrosome	Cervical cancer:9.22e-6 (favourable), Liver cancer:3.83e-5 (unfavourable), Endometrial cancer:4.33e-5 (unfavourable), Renal cancer:8.99e-5 (unfavourable), Thyroid cancer:1.62e-4 (favourable), Pancreatic cancer:4.18e-4 (unfavourable)	Expressed in all	Tissue enhanced		bone marrow: 22.9	testis: 12.7	Mixed		
E2F2	E2F-2	ENSG00000007968	E2F transcription factor 2	1	23506430-23531220	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB016313	Uncertain					Mixed	Tissue enhanced		bone marrow: 15.3	lymph node: 3.8	Cell line enhanced		Daudi: 33.3
E2F3		ENSG00000112242	E2F transcription factor 3	6	20401906-20493715	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029779, HPA065012			Supported	Nucleoplasm<br>Nuclear speckles<br>Cytosol	Renal cancer:1.63e-8 (unfavourable), Ovarian cancer:1.69e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 14.4	Expressed in all		
E2F4	E2F-4	ENSG00000205250	E2F transcription factor 4	16	67192169-67198918	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054128			Supported	Nucleoplasm		Expressed in all	Expressed in all			placenta: 64.2	Expressed in all		
E2F5		ENSG00000133740	E2F transcription factor 5	8	85177225-85217158	Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA055723			Supported	Nucleus<br>Nucleoli	Renal cancer:1.89e-6 (unfavourable)	Expressed in all	Mixed			lymph node: 30.9	Cell line enhanced		AF22: 76.4;Daudi: 112.8
E2F6	E2F-6	ENSG00000169016	E2F transcription factor 6	2	11444375-11466177	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA075185			Supported	Nucleoplasm	Liver cancer:1.20e-5 (unfavourable), Endometrial cancer:7.13e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 7.2	Expressed in all		
E2F7		ENSG00000165891	E2F transcription factor 7	12	77021247-77065580	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064866			Supported	Nuclear speckles		Mixed	Tissue enhanced		testis: 5.1	bone marrow: 3.0	Mixed		
E2F8	FLJ23311	ENSG00000129173	E2F transcription factor 8	11	19224063-19241620	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064882			Supported	Nucleus<br>Nucleoli<br>Cytosol		Mixed	Mixed			bone marrow: 9.2	Mixed		
E4F1	E4F	ENSG00000167967	E4F transcription factor 1	16	2223566-2235742	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052042, HPA071325			Enhanced	Nucleoplasm	Head and neck cancer:1.10e-4 (favourable), Renal cancer:5.50e-4 (unfavourable), Cervical cancer:9.13e-4 (favourable)	Expressed in all	Expressed in all			skin: 12.8	Expressed in all		
EBF1	EBF, OLF1	ENSG00000164330	Early B-cell factor 1	5	158695916-159099761	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA061169			Approved	Nucleoplasm<br>Vesicles	Renal cancer:9.62e-7 (unfavourable), Stomach cancer:7.80e-4 (unfavourable)	Mixed	Tissue enhanced		adipose tissue: 41.6	placenta: 16.2	Cell line enhanced		ASC diff: 27.3;HSkMC: 22.6;REH: 81.2
EBF2	COE2, FLJ11500	ENSG00000221818	Early B-cell factor 2	8	25841730-26045397	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:2.51e-6 (unfavourable)	Mixed	Tissue enhanced		adipose tissue: 20.8	heart muscle: 6.6	Group enriched	16	ASC diff: 15.6;ASC TERT1: 32.1;HSkMC: 34.2;hTEC/SVTERT24-B: 26.8;U-138 MG: 17.0;U-2197: 21.1;U-87 MG: 18.8
EBF3	COE3, DKFZp667B0210	ENSG00000108001	Early B-cell factor 3	10	129835283-129963841	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA061169			Approved	Nucleoplasm<br>Vesicles		Mixed	Tissue enhanced		adipose tissue: 20.1	lymph node: 12.7	Cell line enhanced		HAP1: 23.0;LHCN-M2: 29.6;NB-4: 29.2;RH-30: 18.6;SCLC-21H: 53.2
EBF4	COE4, KIAA1442, O/E-4, RP5-860F19.3	ENSG00000088881	Early B-cell factor 4	20	2692878-2760108	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Pancreatic cancer:2.47e-5 (favourable), Colorectal cancer:6.59e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 23.7	Cell line enhanced		SH-SY5Y: 15.8
EGR1	AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225	ENSG00000120738	Early growth response 1	5	138465490-138469315	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB019427, HPA029937, HPA029938	Enhanced		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			ovary: 1188.8	Cell line enhanced		hTCEpi: 208.0;U-266/84: 325.4
EGR2	KROX20	ENSG00000122877	Early growth response 2	10	62811996-62919900	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031165			Supported	Nucleoplasm	Breast cancer:7.30e-5 (favourable)	Expressed in all	Tissue enhanced		thyroid gland: 234.3	epididymis: 73.8	Cell line enriched	7	U-87 MG: 22.2
EGR3	PILOT	ENSG00000179388	Early growth response 3	8	22687659-22693302	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA006206, CAB009373	Uncertain		Uncertain	Nucleus<br>Vesicles	Breast cancer:1.83e-4 (favourable), Melanoma:4.78e-4 (favourable)	Mixed	Mixed			gallbladder: 49.6	Cell line enhanced		HMC-1: 8.5;MCF7: 25.2;SK-MEL-30: 17.0
EGR4	NGFI-C, PAT133	ENSG00000135625	Early growth response 4	2	73290929-73293705	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028983	Enhanced					Mixed	Group enriched	29	cerebral cortex: 9.7;testis: 3.2	adipose tissue,appendix: 0.2	Cell line enriched	6	HMC-1: 1.4
EHF	ESE3, ESEJ	ENSG00000135373	ETS homologous factor	11	34621093-34661057	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA050923, HPA060734	Enhanced		Supported	Nucleoplasm<br>Golgi apparatus	Colorectal cancer:5.81e-4 (favourable), Pancreatic cancer:6.94e-4 (unfavourable)	Mixed	Mixed			esophagus: 228.3	Cell line enhanced		CAPAN-2: 122.7;HaCaT: 85.2;HBEC3-KT: 76.2;RT4: 172.3;T-47d: 201.8
ELF1		ENSG00000120690	E74 like ETS transcription factor 1	13	40932028-41061440	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001755, CAB005172	Approved		Supported	Nucleoplasm		Expressed in all	Expressed in all			bone marrow: 129.2	Expressed in all		
ELF2	EU32, NERF, NERF-1A, NERF-1B, NERF-2	ENSG00000109381	E74 like ETS transcription factor 2	4	139028112-139177218	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006057, HPA071166	Enhanced		Supported	Nucleoplasm<br>Nuclear bodies		Expressed in all	Expressed in all			testis: 69.4	Expressed in all		
ELF3	EPR-1, ERT, ESE-1, ESX	ENSG00000163435	E74 like ETS transcription factor 3	1	202007945-202017188	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003316, HPA003479	Enhanced		Enhanced	Nucleoplasm		Mixed	Mixed			small intestine: 161.7	Cell line enhanced		A549: 188.9;CAPAN-2: 259.7;RT4: 171.2;SK-BR-3: 304.2
ELF4	ELFR, MEF	ENSG00000102034	E74 like ETS transcription factor 4	X	130064874-130110716	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058595, HPA060277	Enhanced		Supported	Nucleoplasm<br>Nuclear bodies	Renal cancer:6.49e-6 (unfavourable), Urothelial cancer:1.42e-4 (favourable)	Expressed in all	Mixed			placenta: 34.9	Mixed		
ELF5		ENSG00000135374	E74 like ETS transcription factor 5	11	34478793-34513805	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062706			Supported	Nucleoplasm	Lung cancer:3.64e-4 (favourable)	Tissue enhanced	Tissue enhanced		breast: 172.6;salivary gland: 64.2	seminal vesicle: 42.2	Group enriched	10	RT4: 24.0;T-47d: 53.3
ELK1		ENSG00000126767	ELK1, ETS transcription factor	X	47635521-47650604	Predicted intracellular proteins, RAS pathway related proteins, Transcription factors	Evidence at protein level	CAB003808, HPA036084, HPA064381	Enhanced		Enhanced	Nucleoplasm	Renal cancer:3.25e-5 (unfavourable)	Expressed in all	Expressed in all			ovary: 50.9	Expressed in all		
ELK3	ERP, NET, SAP2	ENSG00000111145	ELK3, ETS transcription factor	12	96194382-96269835	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001600	Approved		Supported	Nucleoplasm<br>Mitochondria	Ovarian cancer:4.93e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 58.4	Expressed in all		
ELK4	SAP1	ENSG00000158711	ELK4, ETS transcription factor	1	205597556-205631962	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028863	Uncertain		Supported	Nucleoplasm	Renal cancer:2.94e-6 (unfavourable), Head and neck cancer:4.65e-4 (favourable)	Expressed in all	Expressed in all			prostate: 42.8	Expressed in all		
ELMSAN1	C14orf117, C14orf43, LSR68	ENSG00000156030	ELM2 and Myb/SANT domain containing 1	14	73715122-73790285	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003111	Approved		Enhanced	Nucleoplasm	Ovarian cancer:3.86e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 22.2	Expressed in all		
EMX1		ENSG00000135638	Empty spiracles homeobox 1	2	72916260-72936071	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006230, HPA006421	Approved		Approved	Nucleoli	Renal cancer:1.54e-6 (favourable)	Tissue enhanced	Tissue enhanced		cerebral cortex: 8.3;kidney: 15.5;parathyroid gland: 5.0	testis: 2.6	Cell line enhanced		BEWO: 2.2;CACO-2: 3.1;HEK 293: 7.5
EMX2		ENSG00000170370	Empty spiracles homeobox 2	10	117542444-117549546	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003497, HPA065294	Enhanced	Supported	Approved	Nucleus	Renal cancer:2.28e-13 (favourable), Cervical cancer:2.80e-4 (favourable)	Group enriched	Group enriched	5	cervix, uterine: 59.5;endometrium: 114.9;epididymis: 115.2;fallopian tube: 73.0;kidney: 38.4;seminal vesicle: 65.3;smooth muscle: 59.8	cerebral cortex: 14.0	Cell line enhanced		EFO-21: 22.1;fHDF/TERT166: 20.9;RPTEC TERT1: 19.9
EN1		ENSG00000163064	Engrailed homeobox 1	2	118842171-118847678	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB014884, HPA073141	Approved		Supported	Nucleus<br>Nucleoli		Tissue enhanced	Group enriched	13	adipose tissue: 1.3;breast: 1.0;lymph node: 1.9;skeletal muscle: 4.7;skin: 2.2	testis: 0.1	Cell line enhanced		ASC diff: 10.8;fHDF/TERT166: 10.2;HSkMC: 9.7;PC-3: 7.1;U-138 MG: 9.6;U-2197: 10.2
EN2		ENSG00000164778	Engrailed homeobox 2	7	155458129-155464831	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045646, HPA069809			Supported	Nucleus<br>Nucleoli fibrillar center	Glioma:2.82e-6 (unfavourable)	Tissue enhanced	Tissue enhanced		parathyroid gland: 2.0;testis: 1.1	endometrium: 0.6	Cell line enhanced		AF22: 40.5;AN3-CA: 14.1;HEK 293: 23.0
EOMES	TBR2	ENSG00000163508	Eomesodermin	3	27715949-27722711	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028896	Uncertain				Renal cancer:9.45e-6 (unfavourable)	Tissue enhanced	Tissue enhanced		lymph node: 18.2;spleen: 19.4	tonsil: 5.3	Cell line enhanced		HDLM-2: 7.3;SCLC-21H: 4.9
EPAS1	bHLHe73, HIF2A, HLF, MOP2, PASD2	ENSG00000116016	Endothelial PAS domain protein 1	2	46293667-46386703	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031200, HPA069697			Supported	Nucleoplasm<br>Cytosol	Renal cancer:2.63e-4 (favourable)	Expressed in all	Expressed in all			placenta: 642.0	Cell line enhanced		U-138 MG: 279.3
ERF	PE-2, PE2	ENSG00000105722	ETS2 repressor factor	19	42247572-42255157	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058532, HPA067952	Approved		Enhanced	Nucleoplasm	Breast cancer:8.07e-4 (favourable)	Expressed in all	Expressed in all			gallbladder: 78.9	Expressed in all		
ERG	erg-3, p55	ENSG00000157554	ERG, ETS transcription factor	21	38380027-38661780	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB018377, HPA046598	Approved		Approved	Nucleoplasm<br>Cytosol	Cervical cancer:6.18e-6 (unfavourable), Renal cancer:3.94e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 36.8	Cell line enhanced		HUVEC TERT2: 115.5;MOLT-4: 38.1;REH: 138.0;TIME: 92.4
ESR1	Era, ESR, NR3A1	ENSG00000091831	Estrogen receptor 1	6	151656691-152129619	Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000037, HPA000449, HPA000450, CAB055099, CAB072858	Enhanced		Approved	Nucleus<br>Vesicles	Endometrial cancer:5.47e-7 (favourable)	Group enriched	Group enriched	8	breast: 37.6;cervix, uterine: 127.8;endometrium: 180.8;fallopian tube: 106.4;smooth muscle: 76.5	seminal vesicle: 13.5	Group enriched	11	MCF7: 34.7;T-47d: 53.2
ESR2	Erb, NR3A2	ENSG00000140009	Estrogen receptor 2	14	64084232-64338112	Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB065126	Enhanced					Not detected	Tissue enhanced		testis: 10.4	adrenal gland: 6.3	Cell line enhanced		U-266/70: 7.3;U-698: 11.3
ESRRA	ERR1, ERRa, ERRalpha, ESRL1, NR3B1	ENSG00000173153	Estrogen related receptor alpha	11	64305572-64316743	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053785			Supported	Nucleus<br>Nucleoli fibrillar center<br>Microtubules<br>Cytokinetic bridge	Renal cancer:1.34e-7 (favourable)	Expressed in all	Expressed in all			duodenum: 86.6	Expressed in all		
ESRRB	DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2	ENSG00000119715	Estrogen related receptor beta	14	76310614-76501841	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Group enriched	7	heart muscle: 2.3;kidney: 5.2;skeletal muscle: 1.7;stomach: 1.5;testis: 1.4	breast: 0.3	Cell line enhanced		HMC-1: 1.0;K-562: 3.3;U-266/70: 1.2
ESRRG	NR3B3	ENSG00000196482	Estrogen related receptor gamma	1	216503246-217137755	FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044678	Uncertain		Approved	Nucleus	Renal cancer:1.13e-11 (favourable)	Mixed	Tissue enhanced		parathyroid gland: 77.5	kidney: 31.3	Group enriched	7	RPMI-8226: 16.0;SCLC-21H: 9.4;SH-SY5Y: 44.7
ESX1	ESX1L, ESXR1	ENSG00000123576	ESX homeobox 1	X	104250038-104254933	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051992	Enhanced		Supported	Nuclear speckles		Tissue enriched	Tissue enriched	63	testis: 12.0	placenta: 0.1	Cell line enriched	9	TIME: 20.3
ETS1	ETS-1, EWSR2, FLJ10768	ENSG00000134954	ETS proto-oncogene 1, transcription factor	11	128458761-128587558	Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors	Evidence at protein level	CAB002575, HPA063230	Enhanced		Enhanced	Nucleoplasm	Renal cancer:1.30e-5 (unfavourable)	Expressed in all	Expressed in all			lymph node: 320.7	Cell line enhanced		U-698: 322.0
ETS2		ENSG00000157557	ETS proto-oncogene 2, transcription factor	21	38805307-38824955	Predicted intracellular proteins, RAS pathway related proteins, Transcription factors	Evidence at protein level	HPA003176			Enhanced	Nucleoplasm<br>Plasma membrane<br>Cytosol		Expressed in all	Expressed in all			spleen: 252.7	Cell line enhanced		HEL: 249.9
ETV1	ER81	ENSG00000006468	ETS variant 1	7	13891228-13991425	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA077249			Approved	Nucleoplasm		Expressed in all	Tissue enhanced		cerebral cortex: 106.3	lung: 43.1	Cell line enhanced		SCLC-21H: 93.4;U-87 MG: 152.1;WM-115: 77.6
ETV2	ER71	ENSG00000105672	ETS variant 2	19	35641745-35644871	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Tissue enhanced		testis: 8.7	duodenum: 2.1	Mixed		
ETV3	PE-1	ENSG00000117036	ETS variant 3	1	157121191-157138474	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004794	Supported		Approved	Nucleus		Expressed in all	Expressed in all			parathyroid gland: 45.4	Expressed in all		
ETV3L	FLJ16478	ENSG00000253831	ETS variant 3 like	1	157092044-157099808	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Not detected	Not detected			breast: 0.9	Cell line enriched	16	HDLM-2: 32.0
ETV4	E1A-F, E1AF, PEA3	ENSG00000175832	ETS variant 4	17	43527844-43579620	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005768	Approved		Supported	Nucleoli	Liver cancer:2.48e-4 (unfavourable), Thyroid cancer:7.60e-4 (favourable)	Expressed in all	Tissue enhanced		parathyroid gland: 30.3	cerebral cortex: 13.6	Cell line enhanced		AN3-CA: 164.6;SK-MEL-30: 152.6
ETV5	ERM	ENSG00000244405	ETS variant 5	3	186046308-186110318	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009590, HPA063065	Approved		Supported	Nucleoplasm	Liver cancer:7.85e-9 (unfavourable)	Expressed in all	Tissue enhanced		parathyroid gland: 114.5	cerebral cortex: 74.7	Cell line enhanced		SK-MEL-30: 141.2
ETV6	TEL	ENSG00000139083	ETS variant 6	12	11649854-11895402	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000264	Enhanced		Enhanced	Nucleoli<br>Cytosol	Renal cancer:4.66e-8 (unfavourable), Urothelial cancer:1.54e-5 (favourable), Pancreatic cancer:9.38e-5 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 26.4	Cell line enhanced		HDLM-2: 80.8
ETV7	TEL-2, TEL2	ENSG00000010030	ETS variant 7	6	36354091-36387800	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029033, HPA049689	Uncertain		Enhanced	Nucleoplasm	Urothelial cancer:2.95e-6 (favourable), Cervical cancer:5.16e-4 (favourable), Ovarian cancer:5.32e-4 (favourable)	Expressed in all	Mixed			skin: 19.9	Cell line enhanced		BEWO: 26.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.4;HDLM-2: 55.2
EVX1		ENSG00000106038	Even-skipped homeobox 1	7	27242700-27250493	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055132			Approved	Nucleoplasm		Mixed	Tissue enhanced		adrenal gland: 3.7;prostate: 4.5;seminal vesicle: 4.0	testis: 1.3	Cell line enriched	10	RT4: 11.7
EVX2		ENSG00000174279	Even-skipped homeobox 2	2	176077472-176083913	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA041576	Uncertain					Not detected	Tissue enhanced		prostate: 2.0;seminal vesicle: 2.2;testis: 2.7	cervix, uterine: 1.1	Not detected		
FERD3L	bHLHa31, N-TWIST, NATO3	ENSG00000146618	Fer3 like bHLH transcription factor	7	19144782-19145421	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043494	Uncertain					Not detected	Not detected			cerebral cortex: 0.5	Cell line enriched	129	SCLC-21H: 12.8
FEV	Pet-1	ENSG00000163497	FEV, ETS transcription factor	2	218981087-218985657	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067679		Supported	Supported	Nuclear speckles	Pancreatic cancer:4.85e-4 (favourable)	Group enriched	Tissue enhanced		adrenal gland: 2.1;duodenum: 2.9;prostate: 1.9;stomach: 2.4	small intestine: 1.6	Group enriched	6	HMC-1: 22.4;SH-SY5Y: 34.6
FEZF1	ZNF312B	ENSG00000128610	FEZ family zinc finger 1	7	122301394-122310691	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064639, HPA073693	Approved		Supported	Nucleus<br>Cytosol		Mixed	Tissue enriched	44	testis: 7.0	adipose tissue,cerebral cortex: 0.1	Group enriched	10	NTERA-2: 161.5;SCLC-21H: 82.6
FEZF2	FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312	ENSG00000153266	FEZ family zinc finger 2	3	62369681-62374324	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Tissue enriched	30	cerebral cortex: 11.7	colon: 0.3	Cell line enhanced		AF22: 1.4;NTERA-2: 1.0
FIGLA	bHLHc8	ENSG00000183733	Folliculogenesis specific bHLH transcription factor	2	70777310-70790643	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	6	testis: 1.2	cervix, uterine: 0.2	Not detected		
FIZ1	FLJ14768, ZNF798	ENSG00000179943	FLT3 interacting zinc finger 1	19	55591371-55601970	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA074026			Approved	Nucleus	Urothelial cancer:2.02e-4 (favourable), Pancreatic cancer:8.42e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 19.6	Expressed in all		
FLI1	EWSR2, SIC-1	ENSG00000151702	Fli-1 proto-oncogene, ETS transcription factor	11	128686535-128813267	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA073099			Supported	Nucleus<br>Nuclear bodies	Renal cancer:4.60e-4 (unfavourable)	Expressed in all	Tissue enhanced		spleen: 46.1	placenta: 15.6	Cell line enhanced		HEL: 93.0;HUVEC TERT2: 46.8;REH: 44.4;TIME: 47.8
FOS	AP-1, c-fos	ENSG00000170345	Fos proto-oncogene, AP-1 transcription factor subunit	14	75278774-75282230	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018531	Approved		Supported	Nucleoplasm	Prostate cancer:7.81e-4 (favourable)	Expressed in all	Expressed in all			fallopian tube: 1853.4	Cell line enriched	5	hTCEpi: 324.8
FOSB	AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291	ENSG00000125740	FosB proto-oncogene, AP-1 transcription factor subunit	19	45467995-45475179	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB010267, HPA054663	Approved		Supported	Nucleoplasm<br>Vesicles		Expressed in all	Mixed			gallbladder: 558.7	Cell line enhanced		HMC-1: 11.7;SK-BR-3: 7.4
FOSL1	fra-1	ENSG00000175592	FOS like 1, AP-1 transcription factor subunit	11	65892049-65900573	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004396, HPA066901	Uncertain		Enhanced	Nucleoplasm	Renal cancer:6.40e-6 (unfavourable), Pancreatic cancer:9.26e-5 (unfavourable), Lung cancer:1.95e-4 (unfavourable), Head and neck cancer:2.05e-4 (unfavourable), Glioma:2.46e-4 (unfavourable)	Expressed in all	Tissue enhanced		adipose tissue: 35.6;gallbladder: 51.7	urinary bladder: 26.8	Cell line enhanced		PC-3: 759.0;WM-115: 1227.8
FOSL2	FLJ23306, FRA2	ENSG00000075426	FOS like 2, AP-1 transcription factor subunit	2	28392448-28417312	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004817, CAB013460, HPA061417	Supported		Enhanced	Nucleus		Expressed in all	Expressed in all			adrenal gland: 224.8	Mixed		
FOXA1	HNF3A	ENSG00000129514	Forkhead box A1	14	37589984-37596059	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB011595, HPA050505	Enhanced		Supported	Nucleoplasm<br>Nucleoli fibrillar center	Urothelial cancer:1.00e-4 (favourable)	Tissue enhanced	Tissue enhanced		prostate: 146.0	breast: 36.3	Cell line enhanced		MCF7: 98.8;PC-3: 81.2;RT4: 94.9;SK-BR-3: 88.5;T-47d: 157.4
FOXA2	HNF3B	ENSG00000125798	Forkhead box A2	20	22581005-22585455	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB001388, HPA066846	Enhanced		Supported	Nucleoplasm<br>Cell Junctions	Endometrial cancer:7.57e-6 (favourable), Pancreatic cancer:2.34e-4 (favourable), Ovarian cancer:6.28e-4 (favourable)	Mixed	Tissue enhanced		cervix, uterine: 21.4;lung: 20.5;stomach: 31.0	liver: 11.5	Cell line enhanced		A549: 16.1;HBEC3-KT: 14.5;Hep G2: 19.5;PC-3: 24.0;SCLC-21H: 52.3
FOXA3	HNF3G	ENSG00000170608	Forkhead box A3	19	45863989-45873797	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB015154, HPA054034	Uncertain		Approved	Nucleoplasm		Mixed	Group enriched	5	colon: 16.7;duodenum: 10.3;liver: 32.5;pancreas: 9.8;rectum: 17.9;small intestine: 13.9;stomach: 33.8	gallbladder: 3.6	Cell line enhanced		CACO-2: 8.4;HDLM-2: 11.2;Hep G2: 18.9;K-562: 20.1;NTERA-2: 10.8
FOXB1	FKH5, HFKH-5	ENSG00000171956	Forkhead box B1	15	60004222-60061730	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA073369			Approved	Nucleoplasm<br>Mitochondria		Tissue enhanced	Not detected			testis: 0.7	Cell line enhanced		AF22: 6.3;HDLM-2: 13.5;HEK 293: 9.8
FOXB2	bA159H20.4	ENSG00000204612	Forkhead box B2	9	77019655-77020953	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA067947	Uncertain					Tissue enhanced	Not detected			all non-specific tissues: 0.0	Cell line enriched	10	NTERA-2: 1.3
FOXC1	ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1	ENSG00000054598	Forkhead box C1	6	1609972-1613897	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA040670	Enhanced		Supported	Nucleoplasm<br>Cytosol	Colorectal cancer:3.53e-4 (unfavourable)	Expressed in all	Tissue enhanced		salivary gland: 66.2	kidney: 21.8	Cell line enhanced		AN3-CA: 86.7;HEK 293: 85.3
FOXC2	FKHL14, MFH-1	ENSG00000176692	Forkhead box C2	16	86567251-86569728	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056302			Supported	Nucleoplasm<br>Nuclear bodies	Renal cancer:3.57e-7 (unfavourable)	Mixed	Mixed			kidney: 2.8	Cell line enhanced		hTEC/SVTERT24-B: 29.9;LHCN-M2: 30.9;TIME: 34.0;U-2197: 34.2;U-87 MG: 27.6
FOXD1	FKHL8, FREAC4	ENSG00000251493	Forkhead box D1	5	73444827-73448527	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Head and neck cancer:2.73e-4 (unfavourable), Urothelial cancer:9.65e-4 (unfavourable)	Mixed	Tissue enhanced		testis: 4.5	adrenal gland: 2.6	Cell line enhanced		hTEC/SVTERT24-B: 60.8;U-138 MG: 79.5
FOXD2	FKHL17, FREAC9	ENSG00000186564	Forkhead box D2	1	47436017-47440691	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Tissue enhanced		colon: 3.4;rectum: 2.7	prostate: 1.1	Cell line enhanced		AN3-CA: 11.3;WM-115: 17.4
FOXD3	Genesis, HFH2	ENSG00000187140	Forkhead box D3	1	63323041-63325126	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB022455	Uncertain					Group enriched	Mixed			testis: 1.0	Cell line enhanced		NTERA-2: 14.7;SK-MEL-30: 9.4;WM-115: 18.2
FOXD4	FKHL9, FOXD4a, FREAC5	ENSG00000170122	Forkhead box D4	9	116231-118204	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA012836	Uncertain		Approved	Nucleus		Mixed	Not detected			testis: 0.8	Cell line enhanced		THP-1: 2.9
FOXD4L1	FOXD5	ENSG00000184492	Forkhead box D4-like 1	2	113498665-113501155	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA012836	Uncertain		Approved	Nucleus		Not detected	Not detected			testis: 0.6	Cell line enhanced		RH-30: 1.6
FOXD4L3	FOXD6	ENSG00000187559	Forkhead box D4-like 3	9	68302867-68304905	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA012836	Uncertain		Approved	Nucleus		Not detected	Not detected			spleen: 0.3	Not detected		
FOXD4L4	bA460E7.2, FOXD4L2	ENSG00000184659	Forkhead box D4-like 4	9	65736555-65738784	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA012836	Uncertain		Approved	Nucleus		Not detected	Not detected			cerebral cortex: 0.1	Not detected		
FOXD4L5	bA15J10.2	ENSG00000204779	Forkhead box D4-like 5	9	65282101-65285209	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA012836	Uncertain		Approved	Nucleus		Not detected	Not detected			cerebral cortex: 0.6	Mixed		
FOXD4L6		ENSG00000273514	Forkhead box D4-like 6	9	41126430-41128463	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA012836	Uncertain		Approved	Nucleus		Not detected	Not detected			cerebral cortex: 0.3	Not detected		
FOXE1	FKHL15, FOXE2, HFKH4, TITF2, TTF-2	ENSG00000178919	Forkhead box E1	9	97853254-97856715	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Tissue enriched	15	thyroid gland: 327.9	tonsil: 22.1	Cell line enhanced		A-431: 12.2;HeLa: 13.5;RPTEC TERT1: 14.9;SiHa: 15.7
FOXE3	FKHL12, FREAC8	ENSG00000186790	Forkhead box E3	1	47416072-47418052	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Not detected			testis: 0.5	Not detected		
FOXF1	FKHL5, FREAC1	ENSG00000103241	Forkhead box F1	16	86510527-86515418	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028886			Approved	Nucleoplasm		Mixed	Mixed			placenta: 33.0	Cell line enhanced		BJ: 10.8;BJ hTERT+: 22.8;HHSteC: 22.2;U-2197: 11.1
FOXF2	FKHL6, FREAC2	ENSG00000137273	Forkhead box F2	6	1389834-1395597	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Mixed			lung: 18.4	Cell line enhanced		BJ hTERT+: 64.9;HEK 293: 24.6;U-2197: 30.0
FOXG1	BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN	ENSG00000176165	Forkhead box G1	14	28760330-28770277	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Tissue enriched	6	cerebral cortex: 29.6	testis: 5.2	Cell line enhanced		HEK 293: 10.3;SCLC-21H: 34.2;U-138 MG: 17.5;U-251 MG: 15.3
FOXH1	FAST1	ENSG00000160973	Forkhead box H1	8	144473412-144476335	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Not detected			small intestine: 0.9	Cell line enriched	21	NTERA-2: 20.6
FOXI1	FKHL10, FREAC6	ENSG00000168269	Forkhead box I1	5	170105897-170109725	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071469	Enhanced		Uncertain	Nucleoli<br>Vesicles		Group enriched	Tissue enhanced		breast: 10.4;kidney: 20.0	salivary gland: 6.2	Cell line enhanced		MCF7: 1.2
FOXI2	FLJ46831	ENSG00000186766	Forkhead box I2	10	127737235-127741186	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:4.23e-7 (favourable)	Tissue enriched	Tissue enhanced		cervix, uterine: 2.6	kidney: 1.6	Not detected		
FOXI3		ENSG00000214336	Forkhead box I3	2	88446787-88452656	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Tissue enriched	9	placenta: 7.4	testis: 0.8	Cell line enhanced		BEWO: 42.3;HAP1: 6.2;NTERA-2: 11.0
FOXJ1	FKHL13, HFH-4, HFH4	ENSG00000129654	Forkhead box J1	17	76136333-76141299	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005714	Enhanced				Renal cancer:2.03e-5 (unfavourable), Breast cancer:9.39e-4 (favourable)	Tissue enhanced	Tissue enriched	8	fallopian tube: 83.6	lung: 10.3	Group enriched	10	BEWO: 28.2;CAPAN-2: 21.8
FOXJ2	FHX	ENSG00000065970	Forkhead box J2	12	8032703-8055503	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008723	Approved		Supported	Nucleus<br>Nucleoli fibrillar center	Renal cancer:4.63e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 28.7	Mixed		
FOXJ3	KIAA1041	ENSG00000198815	Forkhead box J3	1	42176539-42335877	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067284			Approved	Nucleoplasm<br>Nuclear speckles<br>Vesicles	Renal cancer:4.51e-7 (unfavourable), Liver cancer:5.17e-6 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 40.1	Expressed in all		
FOXK1	IMAGE:5164497	ENSG00000164916	Forkhead box K1	7	4682309-4771443	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA017998, HPA018864	Enhanced		Supported	Nucleoplasm<br>Nucleoli fibrillar center	Liver cancer:2.54e-6 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 12.4	Expressed in all		
FOXK2	ILF, ILF1	ENSG00000141568	Forkhead box K2	17	82519713-82644662	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027523	Approved		Supported	Nucleoplasm<br>Vesicles	Liver cancer:1.24e-6 (unfavourable)	Expressed in all	Expressed in all			testis: 53.2	Expressed in all		
FOXL1	FKH6, FKHL11, FREAC7	ENSG00000176678	Forkhead box L1	16	86576368-86582160	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Tissue enhanced		gallbladder: 8.3	duodenum: 3.1	Cell line enhanced		CAPAN-2: 33.6;PC-3: 45.9;U-87 MG: 104.7
FOXL2	BPES, BPES1	ENSG00000183770	Forkhead box L2	3	138944224-138947140	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA069613	Enhanced		Supported	Nucleus<br>Cytokinetic bridge		Mixed	Tissue enhanced		endometrium: 12.1;ovary: 29.6;parathyroid gland: 24.4	fallopian tube: 7.7	Cell line enhanced		A-431: 4.3;fHDF/TERT166: 4.3;HEL: 7.2;hTCEpi: 5.1;K-562: 7.5;SiHa: 5.9
FOXM1	FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident	ENSG00000111206	Forkhead box M1	12	2857681-2877155	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017832	Uncertain		Supported	Nucleus<br>Nucleoli<br>Cytosol	Renal cancer:0.00e+0 (unfavourable), Liver cancer:1.95e-6 (unfavourable), Pancreatic cancer:3.03e-5 (unfavourable), Lung cancer:2.92e-4 (unfavourable)	Expressed in all	Tissue enhanced		testis: 39.6	bone marrow: 15.9	Expressed in all		
FOXN1	FKHL20, RONU, WHN	ENSG00000109101	Forkhead box N1	17	28506243-28538896	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Head and neck cancer:5.00e-4 (favourable), Cervical cancer:6.43e-4 (favourable)	Tissue enhanced	Tissue enhanced		esophagus: 7.2;skin: 35.2	tonsil: 5.1	Cell line enriched	8	HaCaT: 10.3
FOXN2	HTLF	ENSG00000170802	Forkhead box N2	2	48314637-48379294	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003485	Supported		Supported	Nucleus<br>Vesicles	Renal cancer:2.81e-5 (unfavourable), Glioma:5.14e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 36.4	Expressed in all		
FOXN3	C14orf116, CHES1	ENSG00000053254	Forkhead box N3	14	89124871-89619149	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059209	Approved		Approved	Nucleus<br>Plasma membrane	Renal cancer:9.58e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 111.0	Mixed		
FOXN4		ENSG00000139445	Forkhead box N4	12	109277979-109309220	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050018	Uncertain		Approved	Nucleus<br>Mitochondria<br>Cytosol		Tissue enhanced	Tissue enriched	13	testis: 10.7	cervix, uterine: 0.8	Cell line enhanced		SCLC-21H: 4.2;SH-SY5Y: 3.9;U-266/70: 3.9
FOXO1	FKH1, FKHR, FOXO1A	ENSG00000150907	Forkhead box O1	13	40469953-40666597	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001252, CAB022326	Approved	Approved	Supported	Nucleoplasm<br>Cytosol	Renal cancer:1.33e-5 (favourable), Liver cancer:3.74e-4 (favourable)	Expressed in all	Expressed in all			ovary: 80.7	Cell line enhanced		HSkMC: 39.2;U-698: 40.3
FOXO3	AF6q21, FKHRL1, FOXO2, FOXO3A	ENSG00000118689	Forkhead box O3	6	108559835-108684774	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004074, HPA063104	Supported		Enhanced	Nucleus		Expressed in all	Expressed in all			ovary: 55.1	Expressed in all		
FOXO4	AFX1, MLLT7	ENSG00000184481	Forkhead box O4	X	71096197-71103535	Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors	Evidence at protein level	HPA039560, HPA040232	Approved		Supported	Nuclear speckles<br>Cytosol	Renal cancer:3.46e-4 (favourable), Head and neck cancer:4.61e-4 (favourable)	Expressed in all	Expressed in all			placenta: 172.7	Cell line enriched	8	BEWO: 154.9
FOXP1	12CC4, hFKH1B, HSPC215, QRF1	ENSG00000114861	Forkhead box P1	3	70954693-71583989	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003876, CAB011501	Supported		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			ovary: 39.7	Expressed in all		
FOXP2	CAGH44, SPCH1, TNRC10	ENSG00000128573	Forkhead box P2	7	114086327-114693772	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000382, HPA000383, HPA001679	Enhanced		Enhanced	Nucleoplasm		Mixed	Mixed			endometrium: 13.7	Cell line enhanced		AF22: 20.9;RH-30: 37.7
FOXP3	AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID	ENSG00000049768	Forkhead box P3	X	49250436-49264826	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB026301, HPA045943	Enhanced		Supported	Nucleoplasm	Cervical cancer:1.91e-4 (favourable), Head and neck cancer:4.90e-4 (favourable), Endometrial cancer:7.02e-4 (favourable)	Mixed	Tissue enhanced		appendix: 8.7	lymph node: 6.0	Cell line enhanced		MCF7: 2.8;SiHa: 2.3
FOXP4	FLJ40908	ENSG00000137166	Forkhead box P4	6	41546426-41602384	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007176	Approved		Approved	Nucleoplasm<br>Cytosol	Endometrial cancer:1.17e-6 (unfavourable), Liver cancer:9.72e-4 (unfavourable)	Expressed in all	Expressed in all			stomach: 36.9	Expressed in all		
FOXQ1	HFH1	ENSG00000164379	Forkhead box Q1	6	1312440-1314748	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059700			Supported	Nucleus	Prostate cancer:6.68e-4 (favourable)	Expressed in all	Tissue enhanced		stomach: 105.8;urinary bladder: 43.8	skin: 33.1	Cell line enhanced		CACO-2: 32.2;HaCaT: 39.8;Hep G2: 65.9;RT4: 32.0
FOXR1	DLNB13, FOXN5	ENSG00000176302	Forkhead box R1	11	118971707-118981291	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Tissue enriched	14	testis: 3.1	thyroid gland: 0.2	Not detected		
FOXR2	FOXN6, MGC21658	ENSG00000189299	Forkhead box R2	X	55623400-55625325	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034487, HPA057358	Uncertain		Supported	Nucleoplasm		Tissue enhanced	Tissue enriched	15	testis: 2.8	epididymis: 0.1	Group enriched	107	NTERA-2: 12.2;SH-SY5Y: 11.3;U-266/70: 5.4;U-266/84: 13.9
FOXS1	FKHL18, FREAC10	ENSG00000179772	Forkhead box S1	20	31844301-31845619	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042475	Approved		Approved	Nucleoplasm<br>Cytosol	Renal cancer:1.10e-8 (unfavourable)	Expressed in all	Mixed			placenta: 7.0	Cell line enhanced		EFO-21: 3.0;RH-30: 10.5;U-2 OS: 15.0;U-251 MG: 3.6
GABPA	E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A	ENSG00000154727	GA binding protein transcription factor alpha subunit	21	25734570-25772460	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003258, CAB004411, HPA028791	Supported		Enhanced	Nucleoplasm	Renal cancer:3.97e-5 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 38.1	Expressed in all		
GATA1	ERYF1, GATA-1, GF1, NF-E1, NFE1	ENSG00000102145	GATA binding protein 1	X	48786554-48794311	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000232, HPA000233, CAB009195	Enhanced					Not detected	Tissue enriched	19	bone marrow: 33.2	testis: 1.7	Group enriched	12	HEL: 182.0;HMC-1: 176.5;K-562: 196.6
GATA2	NFE1B	ENSG00000179348	GATA binding protein 2	3	128479427-128493185	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005633, CAB024847	Approved		Supported	Nucleoplasm	Urothelial cancer:5.22e-5 (favourable), Renal cancer:2.04e-4 (favourable)	Expressed in all	Tissue enhanced		prostate: 62.7;seminal vesicle: 74.7	endometrium: 40.5	Cell line enhanced		BEWO: 272.0;HEL: 324.7;HMC-1: 165.0;SH-SY5Y: 347.2
GATA3	HDR	ENSG00000107485	GATA binding protein 3	10	8053604-8075198	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB016217, HPA029730	Enhanced		Supported	Nucleoplasm	Renal cancer:3.13e-4 (unfavourable)	Group enriched	Tissue enhanced		parathyroid gland: 235.0;skin: 148.9	placenta: 44.3	Cell line enhanced		BEWO: 172.2;MCF7: 354.3;RT4: 149.5;SH-SY5Y: 145.4;T-47d: 506.9
GATA4		ENSG00000136574	GATA binding protein 4	8	11676959-11760002	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB013125, HPA073899	Uncertain		Supported	Nuclear bodies		Tissue enhanced	Tissue enhanced		duodenum: 72.5;heart muscle: 59.0;ovary: 111.8	testis: 51.5	Cell line enhanced		HEK 293: 11.9;Hep G2: 21.2;HHSteC: 31.6;SH-SY5Y: 45.2
GATA5	bB379O24.1, GATAS	ENSG00000130700	GATA binding protein 5	20	62463497-62475970	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067583			Approved	Nucleoplasm<br>Cytosol		Tissue enhanced	Tissue enhanced		duodenum: 11.4;small intestine: 11.0;testis: 8.7	stomach: 7.5	Cell line enhanced		HEL: 2.6;K-562: 4.2;SiHa: 2.1;T-47d: 4.4
GATA6		ENSG00000141448	GATA binding protein 6	18	22169443-22202528	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB011581, HPA066629	Uncertain		Supported	Nucleus	Renal cancer:1.92e-9 (unfavourable)	Tissue enhanced	Mixed			adrenal gland: 50.8	Cell line enhanced		BEWO: 51.6;CACO-2: 55.5
GATAD1	FLJ22489, ODAG, RG083M05.2	ENSG00000157259	GATA zinc finger domain containing 1	7	92447453-92458836	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006105, HPA072785			Supported	Nucleus		Expressed in all	Expressed in all			thyroid gland: 42.3	Expressed in all		
GATAD2A	p66alpha	ENSG00000167491	GATA zinc finger domain containing 2A	19	19385826-19508931	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006759, HPA024373	Enhanced		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			testis: 64.1	Expressed in all		
GATAD2B	P66beta	ENSG00000143614	GATA zinc finger domain containing 2B	1	153789030-153923360	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA017015	Approved		Enhanced	Nucleoplasm	Colorectal cancer:1.30e-4 (unfavourable), Renal cancer:3.08e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 19.7	Expressed in all		
GBX1		ENSG00000164900	Gastrulation brain homeobox 1	7	151148589-151174745	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055783	Uncertain					Tissue enhanced	Group enriched	57	skeletal muscle: 4.4;testis: 6.9	all non-specific tissues: 0.0	Cell line enhanced		HMC-1: 1.4
GBX2		ENSG00000168505	Gastrulation brain homeobox 2	2	236165236-236168369	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067809			Approved	Nucleoplasm		Group enriched	Not detected			cerebral cortex: 0.6	Cell line enhanced		AF22: 47.4;PC-3: 13.2
GCM1	GCMA, hGCMa	ENSG00000137270	Glial cells missing homolog 1	6	53126964-53148829	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA011343	Enhanced		Approved	Vesicles		Not detected	Tissue enriched	21	placenta: 29.1	kidney: 1.3	Cell line enriched	25	BEWO: 38.0
GCM2	GCMB, hGCMb	ENSG00000124827	Glial cells missing homolog 2	6	10873223-10881941	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	997	parathyroid gland: 774.1	testis: 0.7	Not detected		
GFI1	GFI-1, GFI1A, ZNF163	ENSG00000162676	Growth factor independent 1 transcriptional repressor	1	92474762-92486876	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB011197	Uncertain				Colorectal cancer:5.68e-5 (favourable)	Mixed	Tissue enhanced		bone marrow: 34.8	lymph node: 8.1	Cell line enhanced		HL-60: 49.8;HMC-1: 42.0;THP-1: 86.5;U-937: 207.4
GFI1B	ZNF163B	ENSG00000165702	Growth factor independent 1B transcriptional repressor	9	132944000-132991687	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004420	Enhanced					Not detected	Tissue enriched	15	bone marrow: 23.8	testis: 1.5	Group enriched	6	HEL: 151.4;HMC-1: 92.4;K-562: 47.5
GLI1	GLI	ENSG00000111087	GLI family zinc finger 1	12	57460135-57472262	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009460, HPA065172, HPA068903	Uncertain		Enhanced	Nucleoplasm<br>Cytosol		Tissue enhanced	Tissue enhanced		cervix, uterine: 15.1;endometrium: 15.1	gallbladder: 8.5	Cell line enhanced		AN3-CA: 19.3;RH-30: 59.1
GLI2	HPE9, THP1, THP2	ENSG00000074047	GLI family zinc finger 2	2	120735623-120992653	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB008558, HPA074275	Approved		Supported	Nucleus<br>Nucleoli		Mixed	Tissue enhanced		ovary: 11.6	gallbladder: 6.0	Cell line enhanced		AF22: 30.8;U-2 OS: 33.2;WM-115: 27.2
GLI3	ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV	ENSG00000106571	GLI family zinc finger 3	7	41960950-42237870	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005534	Approved					Mixed	Mixed			endometrium: 15.9	Cell line enhanced		AF22: 44.3;WM-115: 32.9
GLI4	HKR4, ZNF928	ENSG00000250571	GLI family zinc finger 4	8	143267433-143276931	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023131	Uncertain		Approved	Nucleus<br>Cytokinetic bridge		Expressed in all	Expressed in all			spleen: 8.8	Expressed in all		
GLIS1	FLJ36155	ENSG00000174332	GLIS family zinc finger 1	1	53506237-53738106	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA001409	Uncertain					Tissue enhanced	Tissue enhanced		seminal vesicle: 11.0	prostate: 3.6	Cell line enhanced		BJ hTERT+: 3.7;PC-3: 6.7;U-138 MG: 5.0
GLIS2	NPHP7	ENSG00000126603	GLIS family zinc finger 2	16	4314761-4339597	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056976			Approved	Nucleoplasm<br>Plasma membrane<br>Cytosol	Renal cancer:8.06e-6 (favourable), Endometrial cancer:1.59e-5 (unfavourable)	Expressed in all	Mixed			gallbladder: 9.7	Cell line enhanced		U-2197: 35.6
GLIS3	MGC33662, ZNF515	ENSG00000107249	GLIS family zinc finger 3	9	3824127-4348392	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA056426	Approved		Supported	Nucleoplasm		Mixed	Tissue enhanced		thyroid gland: 34.9	fallopian tube: 16.6	Cell line enhanced		BJ hTERT+: 19.2;HSkMC: 25.2
GMEB1	P96PIF, PIF96	ENSG00000162419	Glucocorticoid modulatory element binding protein 1	1	28668732-28719353	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044811, HPA052975	Supported		Enhanced	Nucleoplasm	Liver cancer:8.91e-7 (unfavourable), Endometrial cancer:1.94e-4 (favourable)	Expressed in all	Mixed			bone marrow: 8.5	Expressed in all		
GMEB2	KIAA1269, P79PIF, PIF79	ENSG00000101216	Glucocorticoid modulatory element binding protein 2	20	63587602-63627041	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009706, HPA067455	Approved		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			testis: 12.8	Expressed in all		
GRHL1	LBP-32, MGR, TFCP2L2	ENSG00000134317	Grainyhead like transcription factor 1	2	9951693-10002277	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005798, HPA006420	Enhanced		Enhanced	Nucleus<br>Golgi apparatus<br>Vesicles		Mixed	Tissue enhanced		esophagus: 111.4;skin: 106.8	parathyroid gland: 50.3	Cell line enhanced		BEWO: 205.8;SK-BR-3: 84.4
GRHL2	BOM, DFNA28, FLJ13782, TFCP2L3	ENSG00000083307	Grainyhead like transcription factor 2	8	101492432-101669726	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004820, HPA062839	Uncertain		Supported	Nucleoplasm	Pancreatic cancer:6.27e-4 (unfavourable), Breast cancer:6.43e-4 (unfavourable)	Mixed	Mixed			prostate: 37.3	Cell line enhanced		A-431: 34.0;HaCaT: 40.9;RT4: 54.7;T-47d: 74.7
GRHL3	SOM, TFCP2L4	ENSG00000158055	Grainyhead like transcription factor 3	1	24319322-24364482	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA059960	Enhanced		Approved	Nucleoplasm		Tissue enhanced	Group enriched	11	esophagus: 85.1;skin: 50.1;tonsil: 22.6;urinary bladder: 28.1	testis: 4.3	Cell line enhanced		BEWO: 43.8;HaCaT: 32.1;MCF7: 43.8;RT4: 51.5
GSC		ENSG00000133937	Goosecoid homeobox	14	94768216-94770230	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA075650			Approved	Nucleus<br>Nuclear bodies		Mixed	Tissue enhanced		adipose tissue: 2.1	breast: 1.1	Cell line enhanced		HEK 293: 1.7;MCF7: 2.1;REH: 2.6;SH-SY5Y: 3.3;T-47d: 2.1;U-251 MG: 1.8
GSC2	GSCL	ENSG00000063515	Goosecoid homeobox 2	22	19148576-19150283	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA043011	Uncertain					Not detected	Tissue enriched	31	testis: 3.0	all non-specific tissues: 0.0	Not detected		
GSX1	Gsh-1, GSH1	ENSG00000169840	GS homeobox 1	13	27792643-27794768	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enriched	Not detected			cerebral cortex: 0.7	Not detected		
GSX2	Gsh2	ENSG00000180613	GS homeobox 2	4	54099523-54102505	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enriched	Not detected			testis: 0.4	Not detected		
GTF3A	AP2, TFIIIA	ENSG00000122034	General transcription factor IIIA	13	27424544-27435823	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007990	Supported		Supported	Nucleus	Renal cancer:3.43e-6 (unfavourable)	Expressed in all	Expressed in all			lymph node: 122.3	Expressed in all		
GZF1	dJ322G13.2, ZBTB23, ZNF336	ENSG00000125812	GDNF inducible zinc finger protein 1	20	23362182-23373063	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024520	Uncertain		Supported	Nucleus<br>Nucleoli	Liver cancer:9.81e-7 (unfavourable)	Expressed in all	Expressed in all			adrenal gland: 25.3	Expressed in all		
HAND1	bHLHa27, eHand, Hxt, Thing1	ENSG00000113196	Heart and neural crest derivatives expressed 1	5	154474972-154478264	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA040925	Approved		Uncertain	Nucleus<br>Nuclear membrane		Group enriched	Tissue enhanced		smooth muscle: 16.8	adrenal gland: 6.2	Cell line enriched	8	SH-SY5Y: 123.7
HAND2	bHLHa26, dHand, Hed, Thing2	ENSG00000164107	Heart and neural crest derivatives expressed 2	4	173524969-173530229	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA019591, CAB025576	Approved		Supported	Nucleoplasm<br>Vesicles		Tissue enhanced	Tissue enhanced		endometrium: 83.9	smooth muscle: 77.9	Cell line enriched	21	SH-SY5Y: 660.2
HBP1		ENSG00000105856	HMG-box transcription factor 1	7	107168961-107202529	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020225, CAB032824	Approved		Enhanced	Nuclear speckles	Renal cancer:7.70e-5 (favourable)	Expressed in all	Expressed in all			thyroid gland: 54.2	Expressed in all		
HDX	CXorf43, FLJ30678	ENSG00000165259	Highly divergent homeobox	X	84317874-84502479	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047189	Uncertain		Approved	Cytosol		Mixed	Mixed			cerebral cortex,endometrium: 3.8	Mixed		
HELT	bHLHb44, HCM1228, HESL, MEGANE, Mgn	ENSG00000187821	Helt bHLH transcription factor	4	185018841-185020804	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA036188, HPA036189	Uncertain					Not detected	Not detected			lung: 0.5	Cell line enhanced		HAP1: 1.4
HES1	bHLHb39, FLJ20408, HES-1, Hes1, HRY	ENSG00000114315	Hes family bHLH transcription factor 1	3	194136145-194138732	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA066929			Supported	Nucleus	Urothelial cancer:2.04e-5 (favourable)	Expressed in all	Mixed			thyroid gland: 97.8	Mixed		
HES2	bHLHb40	ENSG00000069812	Hes family bHLH transcription factor 2	1	6412418-6424670	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA039462	Uncertain					Mixed	Tissue enhanced		skin: 17.0	placenta: 9.8	Cell line enhanced		BEWO: 19.0;HaCaT: 33.0;HBEC3-KT: 23.1;TIME: 44.9
HES3	bHLHb43	ENSG00000173673	Hes family bHLH transcription factor 3	1	6244192-6245578	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA047927, HPA072697	Uncertain		Uncertain	Nucleus		Tissue enriched	Not detected			testis: 0.1	Cell line enriched	7	NTERA-2: 11.3
HES4	bHLHb42	ENSG00000188290	Hes family bHLH transcription factor 4	1	998962-1000172	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062465			Approved	Nucleoplasm<br>Vesicles<br>Cytosol	Liver cancer:2.99e-4 (unfavourable), Endometrial cancer:3.85e-4 (favourable), Renal cancer:6.27e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 7.5	Cell line enriched	8	HEK 293: 180.2
HES5	bHLHb38	ENSG00000197921	Hes family bHLH transcription factor 5	1	2528745-2530245	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA065458, HPA076164	Enhanced		Approved	Nucleoplasm<br>Nuclear speckles<br>Cytosol		Tissue enhanced	Tissue enhanced		cerebral cortex: 1.8	skin: 0.9	Cell line enhanced		HaCaT: 1.1
HES6	bHLHb41	ENSG00000144485	Hes family bHLH transcription factor 6	2	238238267-238240662	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA061763			Approved	Nucleus<br>Nucleoli<br>Nuclear bodies<br>Cytosol	Lung cancer:9.18e-5 (favourable), Liver cancer:2.79e-4 (unfavourable)	Expressed in all	Tissue enhanced		cerebral cortex: 76.8	fallopian tube: 22.3	Cell line enhanced		NB-4: 122.5;SCLC-21H: 144.1;SK-MEL-30: 141.7
HES7	bHLHb37	ENSG00000179111	Hes family bHLH transcription factor 7	17	8120590-8124092	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA072105	Uncertain		Approved	Nucleoplasm		Not detected	Tissue enhanced		placenta: 1.1	testis: 0.9	Cell line enhanced		HAP1: 8.4;HDLM-2: 6.2;HeLa: 8.1
HESX1	ANF, RPX	ENSG00000163666	HESX homeobox 1	3	57197843-57226521	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024187	Approved		Approved	Nucleus		Tissue enhanced	Tissue enhanced		testis: 12.4	skin: 5.4	Cell line enhanced		NTERA-2: 73.5;U-266/84: 17.0
HEY1	bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1	ENSG00000164683	Hes related family bHLH transcription factor with YRPW motif 1	8	79764010-79767863	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055599, HPA063472	Uncertain		Approved	Nucleoplasm<br>Nuclear membrane<br>Cytosol		Expressed in all	Tissue enhanced		cerebral cortex: 96.4	placenta: 28.8	Cell line enhanced		HEK 293: 120.1;SK-MEL-30: 70.9
HEY2	bHLHb32, HERP1, HESR2	ENSG00000135547	Hes related family bHLH transcription factor with YRPW motif 2	6	125747664-125761269	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030205, HPA074851	Approved		Approved	Nuclear bodies<br>Aggresome		Expressed in all	Mixed			fallopian tube: 21.6	Cell line enhanced		HEK 293: 6.3;SK-MEL-30: 5.0;TIME: 11.9;U-266/70: 13.2
HEYL	bHLHb33, HESR3, HEY3	ENSG00000163909	Hes related family bHLH transcription factor with YRPW motif-like	1	39624153-39639945	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001438, HPA076960	Approved		Approved	Mitochondria<br>Cytosol	Renal cancer:2.26e-6 (unfavourable), Urothelial cancer:2.63e-5 (unfavourable), Stomach cancer:3.57e-4 (unfavourable)	Expressed in all	Mixed			placenta: 44.4	Cell line enhanced		LHCN-M2: 18.5;RH-30: 26.3
HHEX	HEX, HOX11L-PEN, PRHX	ENSG00000152804	Hematopoietically expressed homeobox	10	92689951-92695646	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051894, HPA055460	Approved		Approved	Nucleoplasm<br>Mitochondria	Renal cancer:3.25e-5 (unfavourable), Cervical cancer:3.91e-5 (favourable), Liver cancer:6.23e-4 (unfavourable), Breast cancer:8.83e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 164.8	Cell line enhanced		HEL: 89.2;HMC-1: 92.9;HUVEC TERT2: 88.4;K-562: 137.7
HIC1	ZBTB29, ZNF901	ENSG00000177374	HIC ZBTB transcriptional repressor 1	17	2054154-2063241	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043372	Uncertain		Supported	Nucleoplasm<br>Cytosol	Renal cancer:9.36e-6 (unfavourable)	Expressed in all	Mixed			endometrium: 16.3	Cell line enhanced		BJ: 10.1;TIME: 10.1
HIC2	HRG22, KIAA1020, ZBTB30, ZNF907	ENSG00000169635	HIC ZBTB transcriptional repressor 2	22	21417404-21451463	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031884, HPA059399	Uncertain		Supported	Nucleus	Endometrial cancer:7.42e-5 (unfavourable)	Tissue enriched	Mixed			placenta: 8.4	Cell line enhanced		BEWO: 66.9;K-562: 113.3
HIF1A	bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8	ENSG00000100644	Hypoxia inducible factor 1 alpha subunit	14	61695513-61748259	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000907, HPA001275, CAB017442	Supported		Supported	Nucleoplasm<br>Nuclear bodies<br>Plasma membrane		Expressed in all	Expressed in all			bone marrow: 292.4	Mixed		
HIF3A	bHLHe17, IPAS, MOP7, PASD7	ENSG00000124440	Hypoxia inducible factor 3 alpha subunit	19	46297046-46343433	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041141	Approved		Supported	Nucleoplasm<br>Plasma membrane<br>Cytosol	Endometrial cancer:6.90e-9 (unfavourable)	Mixed	Tissue enhanced		placenta: 39.8	spleen: 19.9	Cell line enhanced		ASC TERT1: 6.5;HHSteC: 16.0;HSkMC: 12.2;TIME: 13.1
HINFP	DKFZP434F162, HiNF-P, MIZF, ZNF743	ENSG00000172273	Histone H4 transcription factor	11	119121587-119136044	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA061008	Uncertain				Liver cancer:4.44e-8 (unfavourable), Thyroid cancer:5.26e-4 (favourable)	Expressed in all	Expressed in all			testis: 11.9	Expressed in all		
HIVEP1	CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A	ENSG00000095951	Human immunodeficiency virus type I enhancer binding protein 1	6	12008762-12164999	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050724	Approved		Supported	Nucleoplasm<br>Nuclear bodies<br>Mitochondria		Expressed in all	Mixed			parathyroid gland: 25.7	Expressed in all		
HIVEP2	HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B	ENSG00000010818	Human immunodeficiency virus type I enhancer binding protein 2	6	142751467-142956698	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055954			Supported	Nucleoplasm		Expressed in all	Expressed in all			cerebral cortex: 31.1	Mixed		
HIVEP3	FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C	ENSG00000127124	Human immunodeficiency virus type I enhancer binding protein 3	1	41506365-42035925	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005728	Approved		Supported	Nucleoplasm		Mixed	Mixed			skin: 5.6	Cell line enhanced		HDLM-2: 17.9
HKR1	ZNF875	ENSG00000181666	HKR1, GLI-Kruppel zinc finger family member	19	37312837-37369365	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036126, HPA044855	Approved		Supported	Nucleoplasm<br>Golgi apparatus<br>Mitochondria	Prostate cancer:5.18e-5 (unfavourable), Pancreatic cancer:4.41e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 54.6	Expressed in all		
HLF	MGC33822	ENSG00000108924	HLF, PAR bZIP transcription factor	17	55265012-55325065	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA068156, HPA071210			Enhanced	Nucleus	Lung cancer:2.71e-7 (favourable), Renal cancer:3.55e-6 (favourable), Head and neck cancer:1.88e-4 (favourable)	Tissue enhanced	Mixed			cerebral cortex: 65.4	Group enriched	5	HDLM-2: 25.3;Hep G2: 110.7
HLX	HB24, HLX1	ENSG00000136630	H2.0 like homeobox	1	220879400-220885059	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005968	Uncertain		Approved	Nucleoplasm<br>Cytosol	Renal cancer:7.28e-6 (unfavourable)	Expressed in all	Tissue enhanced		bone marrow: 60.3	lung: 27.1	Cell line enhanced		THP-1: 72.2
HMBOX1	FLJ21616, HNF1LA, HOT1, PBHNF	ENSG00000147421	Homeobox containing 1	8	28890394-29064764	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055855, HPA058586, CAB070418	Enhanced		Enhanced	Nucleoplasm<br>Nuclear bodies<br>Cytosol		Expressed in all	Mixed			testis: 13.9	Expressed in all		
HMG20A	FLJ10739, HMGX1, HMGXB1	ENSG00000140382	High mobility group 20A	15	77420412-77485607	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008126	Supported		Approved	Nucleus		Expressed in all	Expressed in all			spleen: 49.0	Expressed in all		
HMG20B	BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL	ENSG00000064961	High mobility group 20B	19	3572777-3579088	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050220, HPA053157, HPA069832	Approved		Enhanced	Nucleoplasm	Endometrial cancer:1.72e-7 (favourable), Urothelial cancer:2.89e-5 (favourable)	Expressed in all	Expressed in all			prostate: 70.1	Expressed in all		
HMGA1	HMGIY	ENSG00000137309	High mobility group AT-hook 1	6	34236873-34246231	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB032200	Uncertain		Approved	Nucleus<br>Nucleoli	Liver cancer:1.29e-6 (unfavourable), Lung cancer:3.36e-4 (unfavourable), Endometrial cancer:7.13e-4 (unfavourable), Pancreatic cancer:8.71e-4 (unfavourable)	Expressed in all	Expressed in all			lymph node: 163.8	Expressed in all		
HMGA2	BABL, HMGIC, LIPO	ENSG00000149948	High mobility group AT-hook 2	12	65824131-65966295	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017809, HPA039076	Approved		Supported	Nucleus<br>Nucleoli	Urothelial cancer:2.86e-4 (unfavourable), Head and neck cancer:4.79e-4 (unfavourable)	Mixed	Tissue enhanced		testis: 3.7	bone marrow: 2.9	Cell line enhanced		AF22: 292.5
HMGXB3	HMGX3, KIAA0194, SMF	ENSG00000113716	HMG-box containing 3	5	150000046-150053142	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005967			Approved	Nucleoli	Liver cancer:3.37e-5 (unfavourable)	Expressed in all	Tissue enriched	10	parathyroid gland: 283.3	prostate: 27.4	Expressed in all		
HMGXB4	HMG2L1, THC211630	ENSG00000100281	HMG-box containing 4	22	35257452-35295807	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000725	Approved				Colorectal cancer:3.24e-5 (favourable), Pancreatic cancer:1.16e-4 (unfavourable), Liver cancer:4.79e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 18.8	Expressed in all		
HMX1	H6, NKX5-3	ENSG00000215612	H6 family homeobox 1	4	8846076-8871817	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Tissue enhanced		cerebral cortex: 1.1	testis: 0.9	Cell line enhanced		AN3-CA: 9.5;EFO-21: 5.6;HEK 293: 10.2;SH-SY5Y: 4.4
HMX2	NKX5-2	ENSG00000188816	H6 family homeobox 2	10	123148122-123150672	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA043379	Uncertain					Tissue enhanced	Tissue enriched	6	kidney: 1.2	duodenum,prostate,small intestine: 0.1	Cell line enriched	12	REH: 34.4
HMX3	NKX5-1	ENSG00000188620	H6 family homeobox 3	10	123135962-123137741	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA069659			Approved	Nucleus<br>Microtubule organizing center		Mixed	Not detected			adipose tissue: 0.3	Cell line enhanced		HEL: 4.7;K-562: 15.8;NB-4: 3.8;SiHa: 5.0
HNF1B	HNF1beta, LFB3, MODY5, TCF2, VHNF1	ENSG00000275410	HNF1 homeobox B	17	37686432-37745247	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002083, CAB068192	Enhanced		Supported	Nucleoplasm	Urothelial cancer:2.51e-6 (favourable), Renal cancer:6.00e-4 (favourable)	Tissue enhanced	Tissue enhanced		gallbladder: 21.5;kidney: 25.3	lung: 9.6	Cell line enhanced		A549: 16.8;CACO-2: 17.9;EFO-21: 26.2;RPTEC TERT1: 95.5
HNF4A	HNF4, MODY, MODY1, NR2A1, TCF14	ENSG00000101076	Hepatocyte nuclear factor 4 alpha	20	44355700-44434596	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004712, CAB019417	Enhanced		Supported	Nucleoplasm		Tissue enhanced	Group enriched	6	colon: 58.0;duodenum: 103.0;kidney: 44.7;liver: 51.0;rectum: 47.8;small intestine: 90.9;stomach: 21.9	gallbladder: 9.2	Group enriched	8	CACO-2: 126.0;Hep G2: 77.0
HNF4G	NR2A2	ENSG00000164749	Hepatocyte nuclear factor 4 gamma	8	75407914-75566843	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005438	Enhanced					Mixed	Group enriched	5	duodenum: 100.2;small intestine: 125.6	rectum: 21.0	Cell line enhanced		A549: 3.8;CAPAN-2: 13.9;PC-3: 4.4
HOMEZ	KIAA1443	ENSG00000215271	Homeobox and leucine zipper encoding	14	23272422-23299447	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036316, HPA036317	Approved		Supported	Nucleus<br>Nucleoli	Renal cancer:1.17e-11 (favourable), Ovarian cancer:2.41e-5 (favourable), Thyroid cancer:1.75e-4 (favourable)	Expressed in all	Expressed in all			testis: 41.7	Expressed in all		
HOPX	HOP, LAGY, NECC1, OB1, SMAP31	ENSG00000171476	HOP homeobox	4	56647988-56681899	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB018632, HPA030180	Enhanced					Mixed	Tissue enhanced		epididymis: 658.1;skin: 839.4	esophagus: 525.5	Cell line enhanced		HDLM-2: 28.9;HUVEC TERT2: 55.7;RT4: 40.2;TIME: 62.0
HOXA1	HOX1, HOX1F	ENSG00000105991	Homeobox A1	7	27092993-27095996	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Head and neck cancer:6.73e-5 (unfavourable)	Mixed	Tissue enhanced		urinary bladder: 8.4	parathyroid gland,skin: 2.7	Mixed		
HOXA10	HOX1, HOX1H	ENSG00000253293	Homeobox A10	7	27170591-27180261	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB019384	Approved		Supported	Nucleoplasm<br>Nuclear bodies		Mixed	Tissue enhanced		endometrium: 116.6;smooth muscle: 67.6	prostate: 42.2	Cell line enhanced		HEK 293: 164.0;U-937: 78.1
HOXA11	HOX1, HOX1I	ENSG00000005073	Homeobox A11	7	27181510-27185223	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006770, HPA035623	Enhanced		Supported	Nucleoplasm	Renal cancer:2.57e-5 (unfavourable)	Mixed	Tissue enhanced		endometrium: 96.3;smooth muscle: 68.5	cervix, uterine: 17.9	Cell line enhanced		HEK 293: 46.1;U-937: 37.5
HOXA13	HOX1, HOX1J	ENSG00000106031	Homeobox A13	7	27193503-27200106	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Tissue enhanced		cervix, uterine: 34.0;placenta: 24.5;prostate: 36.2;seminal vesicle: 32.5	rectum: 13.0	Cell line enhanced		HAP1: 27.6;HEK 293: 34.0;RT4: 33.4
HOXA2	HOX1K	ENSG00000105996	Homeobox A2	7	27100354-27102811	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA078220			Approved	Nucleus<br>Vesicles		Mixed	Tissue enhanced		parathyroid gland: 8.1	epididymis: 6.2	Cell line enhanced		AN3-CA: 13.4;HaCaT: 5.3
HOXA3	HOX1, HOX1E	ENSG00000105997	Homeobox A3	7	27106184-27152581	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029157	Uncertain		Supported	Nucleoplasm	Renal cancer:2.52e-6 (unfavourable)	Mixed	Mixed			fallopian tube: 16.2	Cell line enhanced		AN3-CA: 35.4;CAPAN-2: 58.4;HEK 293: 27.2;WM-115: 35.0
HOXA4	HOX1, HOX1D	ENSG00000197576	Homeobox A4	7	27128507-27130799	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060088	Approved		Enhanced	Nuclear bodies	Endometrial cancer:6.37e-4 (unfavourable)	Mixed	Tissue enhanced		fallopian tube: 37.3;parathyroid gland: 35.3	esophagus: 16.4	Cell line enhanced		AN3-CA: 26.9;WM-115: 28.7
HOXA5	HOX1, HOX1C	ENSG00000106004	Homeobox A5	7	27141052-27143668	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Endometrial cancer:2.28e-4 (unfavourable)	Mixed	Tissue enhanced		adrenal gland: 109.7;epididymis: 60.1	fallopian tube: 44.1	Cell line enhanced		AN3-CA: 86.9;HEK 293: 146.8
HOXA6	HOX1, HOX1B	ENSG00000106006	Homeobox A6	7	27145396-27150603	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA004203	Approved				Endometrial cancer:1.40e-4 (unfavourable), Renal cancer:2.03e-4 (favourable)	Mixed	Tissue enhanced		fallopian tube: 9.9	endometrium: 9.0	Group enriched	9	AN3-CA: 57.3;HEK 293: 77.5
HOXA7	HOX1, HOX1A	ENSG00000122592	Homeobox A7	7	27153716-27157936	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA074048			Approved	Nucleoplasm<br>Nuclear membrane	Renal cancer:1.15e-5 (favourable), Endometrial cancer:7.87e-5 (unfavourable)	Mixed	Mixed			epididymis: 21.6	Cell line enhanced		HAP1: 38.0;RPTEC TERT1: 34.0;SCLC-21H: 42.6
HOXA9	HOX1, HOX1G	ENSG00000078399	Homeobox A9	7	27162435-27175180	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA061982	Uncertain		Supported	Nucleus		Mixed	Mixed			kidney: 12.6	Cell line enhanced		HEK 293: 113.8;SCLC-21H: 133.7
HOXB1	HOX2, HOX2I	ENSG00000120094	Homeobox B1	17	48528526-48530997	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044576	Uncertain					Tissue enriched	Not detected			testis: 0.3	Not detected		
HOXB13		ENSG00000159184	Homeobox B13	17	48724763-48729178	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004438, HPA062852, HPA065019	Enhanced		Enhanced	Nucleoplasm		Tissue enriched	Tissue enhanced		prostate: 115.1;rectum: 39.0	colon: 21.4	Cell line enriched	13	PC-3: 139.6
HOXB2	HOX2, HOX2H	ENSG00000173917	Homeobox B2	17	48540894-48544989	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047857			Supported	Nucleus	Glioma:3.01e-4 (unfavourable)	Expressed in all	Tissue enhanced		epididymis: 56.6	cervix, uterine: 24.4	Cell line enhanced		AF22: 58.1;HEK 293: 59.6;HMC-1: 112.4;WM-115: 56.1
HOXB3	HOX2, HOX2G	ENSG00000120093	Homeobox B3	17	48548870-48604912	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009860	Approved				Urothelial cancer:8.45e-6 (favourable)	Mixed	Tissue enhanced		epididymis: 79.4	fallopian tube: 38.7	Cell line enhanced		CAPAN-2: 35.1;HEK 293: 38.6
HOXB4	HOX2, HOX2F	ENSG00000182742	Homeobox B4	17	48575513-48580111	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057432	Uncertain		Supported	Nucleus<br>Centrosome	Ovarian cancer:2.23e-4 (unfavourable)	Mixed	Tissue enhanced		epididymis: 16.1	fallopian tube: 12.5	Cell line enhanced		EFO-21: 30.9;HMC-1: 17.8
HOXB5	HOX2, HOX2A	ENSG00000120075	Homeobox B5	17	48591257-48593961	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043851, HPA074454			Enhanced	Nucleus	Urothelial cancer:8.59e-5 (favourable), Lung cancer:4.61e-4 (unfavourable), Endometrial cancer:6.28e-4 (favourable)	Tissue enhanced	Tissue enhanced		epididymis: 20.2	fallopian tube: 10.7	Cell line enhanced		HEK 293: 24.1;RPTEC TERT1: 14.7
HOXB6	HOX2, HOX2B	ENSG00000108511	Homeobox B6	17	48595751-48604992	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042063			Approved	Nucleus<br>Golgi apparatus	Endometrial cancer:2.46e-4 (favourable)	Tissue enhanced	Tissue enhanced		epididymis: 48.7;seminal vesicle: 30.1	cervix, uterine: 26.4	Cell line enhanced		HEK 293: 71.9;RPTEC TERT1: 39.9
HOXB7	HOX2, HOX2C	ENSG00000260027	Homeobox B7	17	48607227-48633572	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049940	Uncertain		Supported	Nucleoplasm<br>Nuclear bodies<br>Cytosol	Urothelial cancer:2.39e-4 (favourable)	Mixed	Tissue enriched	5	epididymis: 162.9	cervix, uterine: 32.1	Cell line enhanced		EFO-21: 76.4;SK-MEL-30: 62.0
HOXB8	HOX2, HOX2D	ENSG00000120068	Homeobox B8	17	48611377-48614939	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA075905			Supported	Nucleoplasm	Renal cancer:1.30e-7 (favourable)	Tissue enhanced	Tissue enhanced		epididymis: 68.0;seminal vesicle: 32.7	cervix, uterine: 16.9	Cell line enhanced		EFO-21: 33.5;HDLM-2: 15.7;HEK 293: 34.4;LHCN-M2: 15.9;RPTEC TERT1: 29.7
HOXB9	HOX2, HOX2E	ENSG00000170689	Homeobox B9	17	48621159-48626356	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031463			Approved	Nucleoplasm<br>Mitochondria	Head and neck cancer:6.64e-5 (unfavourable), Endometrial cancer:4.47e-4 (unfavourable)	Tissue enhanced	Tissue enhanced		epididymis: 107.2	colon: 26.1	Cell line enhanced		HDLM-2: 315.3;HEK 293: 116.2;HMC-1: 112.5;K-562: 130.4
HOXC10	HOX3I	ENSG00000180818	Homeobox C10	12	53985065-53990279	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053919	Uncertain		Supported	Nucleoplasm<br>Nuclear bodies		Mixed	Group enriched	9	kidney: 18.9;skeletal muscle: 40.3;skin: 8.4	breast: 2.5	Cell line enhanced		AN3-CA: 275.9;T-47d: 95.2
HOXC11	HOX3H	ENSG00000123388	Homeobox C11	12	53973126-53977643	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA038291	Uncertain		Supported	Nucleoplasm<br>Cytosol		Mixed	Tissue enhanced		skin: 2.2	testis: 1.1	Cell line enhanced		AN3-CA: 32.1;BJ hTERT+: 14.2;T-47d: 25.7
HOXC12	HOC3F, HOX3, HOX3F	ENSG00000123407	Homeobox C12	12	53954834-53958956	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055632	Uncertain					Mixed	Not detected			skin: 0.7	Group enriched	6	HaCaT: 20.3;K-562: 5.9;SiHa: 5.3
HOXC13	HOX3, HOX3G	ENSG00000123364	Homeobox C13	12	53938765-53946544	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051634	Supported					Mixed	Tissue enriched	8	skin: 4.6	breast,testis: 0.5	Cell line enhanced		AN3-CA: 28.1;HaCaT: 56.8;SK-BR-3: 26.3;T-47d: 25.6
HOXC4	HOX3, HOX3E	ENSG00000198353	Homeobox C4	12	54016931-54056030	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053910			Supported	Nucleus		Mixed	Tissue enhanced		fallopian tube: 33.9	kidney: 9.4	Cell line enhanced		HDLM-2: 29.1;HEK 293: 30.5;SH-SY5Y: 29.6
HOXC5	HOX3, HOX3D	ENSG00000172789	Homeobox C5	12	54032853-54035358	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026794	Uncertain		Supported	Nucleoplasm		Tissue enhanced	Tissue enhanced		fallopian tube: 6.0	ovary: 3.1	Cell line enhanced		AN3-CA: 5.6;SH-SY5Y: 7.0
HOXC6	HOX3, HOX3C	ENSG00000197757	Homeobox C6	12	53990624-54030823	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054981			Supported	Nucleoplasm<br>Cytosol	Renal cancer:3.55e-6 (unfavourable)	Mixed	Mixed			epididymis: 22.3	Cell line enhanced		AN3-CA: 85.1;HDLM-2: 73.7
HOXC8	HOX3, HOX3A	ENSG00000037965	Homeobox C8	12	54009106-54012362	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028911, CAB037020	Uncertain		Approved	Nucleoplasm<br>Microtubules	Renal cancer:1.47e-5 (unfavourable)	Mixed	Tissue enhanced		epididymis: 21.1;smooth muscle: 12.6	adrenal gland: 7.7	Cell line enhanced		ASC diff: 33.3;fHDF/TERT166: 46.1;HSkMC: 28.1;LHCN-M2: 36.5
HOXC9	HOX3, HOX3B	ENSG00000180806	Homeobox C9	12	53994895-54003337	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063965, HPA072160			Enhanced	Nucleoplasm		Mixed	Tissue enhanced		skeletal muscle: 6.2	adipose tissue: 3.3	Cell line enhanced		AN3-CA: 19.7;HDLM-2: 26.0;HEK 293: 30.3
HOXD1	HOX4, HOX4G	ENSG00000128645	Homeobox D1	2	176188579-176190907	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA040062, HPA056900			Supported	Nucleoplasm		Tissue enhanced	Tissue enhanced		epididymis: 8.7;fallopian tube: 7.3	lung: 4.5	Cell line enhanced		EFO-21: 5.9;RPTEC TERT1: 15.3;RT4: 12.7;SCLC-21H: 6.3
HOXD10	HOX4, HOX4D	ENSG00000128710	Homeobox D10	2	176108790-176119942	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA065871			Approved	Nucleoplasm<br>Cytosol<br>Cytoplasmic bodies	Renal cancer:1.92e-6 (unfavourable)	Mixed	Tissue enhanced		endometrium: 48.3;smooth muscle: 25.2	kidney: 12.7	Cell line enhanced		HEK 293: 36.4;RPTEC TERT1: 21.3;SCLC-21H: 12.9;SiHa: 17.8;U-251 MG: 11.0
HOXD11	HOX4, HOX4F	ENSG00000128713	Homeobox D11	2	176104216-176109754	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055155			Approved	Nucleoplasm		Mixed	Tissue enhanced		endometrium: 4.2	seminal vesicle: 1.3	Cell line enhanced		HEK 293: 18.4;SCLC-21H: 7.0;U-251 MG: 3.8
HOXD12	HOX4H	ENSG00000170178	Homeobox D12	2	176099730-176101193	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059444	Uncertain					Not detected	Tissue enhanced		colon: 1.0;rectum: 1.1;seminal vesicle: 1.8	prostate: 0.8	Cell line enhanced		REH: 2.3
HOXD13	HOX4I, SPD	ENSG00000128714	Homeobox D13	2	176092891-176095938	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064064			Supported	Nucleus	Colorectal cancer:6.95e-5 (unfavourable)	Mixed	Group enriched	8	cervix, uterine: 7.9;colon: 4.9;prostate: 16.9;rectum: 9.5;seminal vesicle: 24.5	urinary bladder: 1.5	Cell line enhanced		HAP1: 20.6;HEK 293: 52.3;HL-60: 52.4;NB-4: 24.7;SCLC-21H: 19.3
HOXD3	HOX1D, HOX4, HOX4A	ENSG00000128652	Homeobox D3	2	176136612-176173102	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051831, HPA063671			Enhanced	Nucleoplasm<br>Nuclear bodies		Tissue enhanced	Tissue enriched	6	epididymis: 46.7	fallopian tube: 8.0	Cell line enhanced		EFO-21: 7.4;HSkMC: 6.6;RPTEC TERT1: 7.3;SCLC-21H: 16.3;SH-SY5Y: 9.8
HOXD4	HOX4, HOX4B	ENSG00000170166	Homeobox D4	2	176151222-176153226	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054383, HPA070349	Approved		Enhanced	Nucleus<br>Cell Junctions		Tissue enhanced	Tissue enhanced		endometrium: 23.6;epididymis: 22.9	fallopian tube: 15.5	Cell line enhanced		EFO-21: 11.0;HEK 293: 25.9;RPTEC TERT1: 15.6
HOXD8	HOX4, HOX4E	ENSG00000175879	Homeobox D8	2	176129694-176132695	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Lung cancer:3.78e-4 (unfavourable)	Mixed	Tissue enhanced		epididymis: 122.0;kidney: 83.6	ovary: 43.1	Cell line enhanced		RPTEC TERT1: 56.9
HOXD9	HOX4, HOX4C	ENSG00000128709	Homeobox D9	2	176122720-176124937	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA068683			Supported	Nucleus<br>Nucleoli	Liver cancer:1.08e-5 (unfavourable), Colorectal cancer:8.25e-4 (unfavourable), Head and neck cancer:9.58e-4 (favourable)	Expressed in all	Tissue enhanced		endometrium: 45.4	smooth muscle: 23.7	Cell line enhanced		HEK 293: 14.8;RPTEC TERT1: 14.2;SH-SY5Y: 23.1;TIME: 13.8
HSF1	HSTF1	ENSG00000185122	Heat shock transcription factor 1	8	144291591-144314722	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004239, HPA008888	Supported		Supported	Nucleoplasm<br>Cytosol	Liver cancer:4.95e-4 (unfavourable), Endometrial cancer:8.93e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 127.1	Expressed in all		
HSF2		ENSG00000025156	Heat shock transcription factor 2	6	122399546-122433119	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB016067, HPA031455	Approved		Supported	Nucleoplasm	Liver cancer:1.51e-6 (unfavourable), Renal cancer:7.65e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 71.4	Expressed in all		
HSF4	CTM	ENSG00000102878	Heat shock transcription factor 4	16	67164681-67169945	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048584			Supported	Nuclear speckles	Renal cancer:2.19e-6 (unfavourable), Colorectal cancer:8.24e-5 (unfavourable)	Expressed in all	Mixed			adrenal gland: 14.8	Cell line enhanced		T-47d: 12.3;U-266/70: 18.1
HSF5	FLJ40311	ENSG00000176160	Heat shock transcription factor 5	17	58420167-58488384	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063613	Enhanced					Not detected	Tissue enriched	64	testis: 88.4	lymph node: 1.3	Not detected		
HSFX1	LW-1	ENSG00000171116	Heat shock transcription factor family, X-linked 1	X	149774068-149776867	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063040	Approved					Not detected	Mixed			ovary: 4.6	Mixed		
HSFX2		ENSG00000268738	Heat shock transcription factor family, X-linked 2	X	149592515-149594716	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063040	Supported					Not detected	Tissue enriched	8	testis: 9.3	seminal vesicle: 1.1	Not detected		
HSFY1	HSF2L, HSFY	ENSG00000172468	Heat shock transcription factor, Y-linked 1	Y	18546671-18588963	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	93	testis: 24.8	epididymis,kidney,skin: 0.2	Not detected		
HSFY2	FLJ25453	ENSG00000169953	Heat shock transcription factor, Y-linked 2	Y	18731440-18828662	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	200	testis: 24.7	kidney: 0.1	Not detected		
ID1	bHLHb24, dJ857M17.1.2	ENSG00000125968	Inhibitor of DNA binding 1, HLH protein	20	31605283-31606515	Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	CAB025915, HPA051456, HPA058518	Approved		Enhanced	Nucleoplasm<br>Golgi apparatus	Lung cancer:4.85e-4 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 213.9	Cell line enhanced		EFO-21: 475.3;PC-3: 474.7
ID2	bHLHb26, GIG8	ENSG00000115738	Inhibitor of DNA binding 2, HLH protein	2	8678845-8684453	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027612			Approved	Nucleoplasm<br>Nuclear bodies<br>Centrosome	Head and neck cancer:9.95e-4 (favourable)	Expressed in all	Tissue enriched	6	parathyroid gland: 1985.4	thyroid gland: 359.5	Cell line enhanced		HDLM-2: 675.4;HEK 293: 418.6
ID3	bHLHb25, HEIR-1	ENSG00000117318	Inhibitor of DNA binding 3, HLH protein	1	23557918-23559794	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB021353, HPA024677	Approved		Supported	Nucleoplasm	Endometrial cancer:1.27e-5 (favourable)	Expressed in all	Mixed			seminal vesicle: 91.4	Cell line enhanced		U-698: 261.7
ID4	bHLHb27	ENSG00000172201	Inhibitor of DNA binding 4, HLH protein	6	19837386-19840684	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060800			Supported	Nucleus	Pancreatic cancer:2.49e-4 (favourable)	Expressed in all	Tissue enhanced		thyroid gland: 626.0	fallopian tube: 128.5	Cell line enhanced		AF22: 57.9;AN3-CA: 71.8;EFO-21: 163.7;HEK 293: 91.1;SCLC-21H: 185.5
IKZF1	hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1	ENSG00000185811	IKAROS family zinc finger 1	7	50304124-50405101	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	CAB009247, HPA035221, HPA035222	Enhanced		Supported	Nucleoplasm	Cervical cancer:2.02e-4 (favourable), Breast cancer:4.28e-4 (favourable), Head and neck cancer:8.63e-4 (favourable)	Expressed in all	Tissue enhanced		lymph node: 83.0	tonsil: 55.9	Cell line enhanced		HDLM-2: 172.0;HMC-1: 152.5;MOLT-4: 116.9;REH: 122.5;U-698: 108.4
IKZF2	Helios, ZNFN1A2	ENSG00000030419	IKAROS family zinc finger 2	2	212999691-213152427	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059142	Approved		Approved	Nucleoplasm<br>Nuclear bodies<br>Cytosol		Mixed	Mixed			esophagus: 21.4	Cell line enhanced		MOLT-4: 24.8;RT4: 22.8
IKZF3	Aiolos, ZNFN1A3	ENSG00000161405	IKAROS family zinc finger 3	17	39757715-39864188	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017105, HPA024377	Enhanced		Uncertain	Plasma membrane<br>Cytosol	Cervical cancer:6.85e-6 (favourable), Head and neck cancer:4.16e-4 (favourable), Melanoma:5.42e-4 (favourable), Renal cancer:7.38e-4 (unfavourable)	Mixed	Tissue enhanced		lymph node: 44.7;spleen: 31.7;tonsil: 39.2	appendix: 25.5	Cell line enhanced		Daudi: 50.3;Karpas-707: 25.9;U-266/70: 32.8;U-266/84: 35.9;U-698: 78.2
IKZF4	Eos, ZNFN1A4	ENSG00000123411	IKAROS family zinc finger 4	12	56007659-56038435	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046270, HPA049016	Approved		Supported	Nucleoplasm<br>Nuclear bodies	Lung cancer:3.46e-4 (favourable), Pancreatic cancer:4.37e-4 (favourable)	Mixed	Mixed			parathyroid gland: 17.0	Cell line enhanced		HDLM-2: 33.6
IKZF5	FLJ22973, Pegasus, ZNFN1A5	ENSG00000095574	IKAROS family zinc finger 5	10	122990806-123008817	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015297, HPA051574			Supported	Nucleoplasm<br>Plasma membrane<br>Cytosol		Expressed in all	Expressed in all			bone marrow: 21.3	Expressed in all		
INSM1	IA-1, IA1	ENSG00000173404	INSM transcriptional repressor 1	20	20368121-20370949	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Tissue enhanced		adrenal gland: 9.3;stomach: 5.6	duodenum: 3.0	Cell line enriched	32	SCLC-21H: 438.4
INSM2	IA-6, Mlt1	ENSG00000168348	INSM transcriptional repressor 2	14	35534042-35537054	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044885, HPA051925	Uncertain		Approved	Nucleoplasm		Not detected	Tissue enhanced		cerebral cortex: 1.3	testis: 0.7	Cell line enriched	121	SH-SY5Y: 115.7
IRF1	MAR	ENSG00000125347	Interferon regulatory factor 1	5	132481609-132490798	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB011662, HPA063131	Supported		Supported	Nucleoplasm<br>Cytosol	Renal cancer:1.09e-7 (unfavourable)	Expressed in all	Expressed in all			spleen: 135.0	Expressed in all		
IRF2		ENSG00000168310	Interferon regulatory factor 2	4	184387713-184474580	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030813, CAB032306, HPA057327	Supported		Enhanced	Nucleoplasm<br>Cytosol	Breast cancer:6.95e-5 (favourable), Thyroid cancer:8.34e-5 (favourable)	Expressed in all	Expressed in all			spleen: 74.2	Expressed in all		
IRF3		ENSG00000126456	Interferon regulatory factor 3	19	49659569-49665875	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004895, CAB013018	Approved		Supported	Cytosol	Renal cancer:1.56e-7 (unfavourable), Urothelial cancer:3.61e-4 (favourable)	Expressed in all	Expressed in all			lymph node: 47.2	Expressed in all		
IRF4	LSIRF, MUM1	ENSG00000137265	Interferon regulatory factor 4	6	391739-411447	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002038, HPA002698, CAB013508	Enhanced		Supported	Nucleoplasm	Head and neck cancer:1.64e-6 (favourable), Breast cancer:6.44e-4 (favourable)	Tissue enriched	Tissue enhanced		lymph node: 27.1	tonsil: 24.1	Group enriched	5	HDLM-2: 204.2;Karpas-707: 141.1;RPMI-8226: 136.6;U-266/70: 134.4;U-266/84: 98.3;U-698: 40.9;WM-115: 106.9
IRF5		ENSG00000128604	Interferon regulatory factor 5	7	128937612-128950035	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046700	Enhanced					Expressed in all	Mixed			spleen: 23.9	Cell line enhanced		HDLM-2: 121.5;RPMI-8226: 65.7;U-937: 50.3
IRF6	LPS, OFC6, VWS, VWS1	ENSG00000117595	Interferon regulatory factor 6	1	209785623-209806175	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063121, HPA076162	Enhanced		Enhanced	Nucleus<br>Cytosol	Renal cancer:0.00e+0 (favourable)	Mixed	Mixed			skin: 84.0	Cell line enhanced		HaCaT: 216.2;HBEC3-KT: 62.1;hTCEpi: 129.2;hTERT-HME1: 67.4;RT4: 69.8
IRF7		ENSG00000185507	Interferon regulatory factor 7	11	612553-615999	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017694, HPA052757	Approved		Supported	Nucleoplasm<br>Cytosol	Renal cancer:1.71e-10 (unfavourable)	Expressed in all	Mixed			bone marrow: 1.8	Cell line enhanced		EFO-21: 3.4;Karpas-707: 4.6;SCLC-21H: 3.7
IRF8	ICSBP, ICSBP1, IRF-8	ENSG00000140968	Interferon regulatory factor 8	16	85898803-85922609	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002267, HPA002531, CAB013480	Enhanced		Enhanced	Nucleoplasm		Expressed in all	Tissue enhanced		lymph node: 297.7;spleen: 205.7;tonsil: 232.5	appendix: 118.0	Cell line enhanced		Daudi: 177.0;THP-1: 280.9;U-698: 672.1;U-937: 108.3
IRF9	ISGF3G	ENSG00000213928	Interferon regulatory factor 9	14	24161053-24166565	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001862	Approved		Supported	Cytosol	Renal cancer:7.58e-8 (unfavourable), Urothelial cancer:9.92e-4 (favourable)	Expressed in all	Expressed in all			spleen: 94.1	Expressed in all		
IRX1	IRX-5	ENSG00000170549	Iroquois homeobox 1	5	3596054-3601403	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043160	Uncertain		Approved	Nucleoplasm<br>Golgi apparatus		Group enriched	Tissue enhanced		breast: 7.7;kidney: 5.3;salivary gland: 5.7	lung: 3.6	Cell line enhanced		AF22: 9.8;REH: 38.0;U-251 MG: 13.8
IRX2		ENSG00000170561	Iroquois homeobox 2	5	2745845-2751662	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050895, HPA054669	Approved		Approved	Nucleus<br>Nucleoli	Pancreatic cancer:8.84e-4 (favourable)	Mixed	Tissue enhanced		breast: 29.6;lung: 28.0	skin: 19.5	Cell line enhanced		AF22: 100.0;BEWO: 58.5;hTCEpi: 47.9
IRX3	IRX-1	ENSG00000177508	Iroquois homeobox 3	16	54283304-54286763	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062522			Approved	Vesicles		Expressed in all	Tissue enhanced		breast: 96.6	skin: 70.5	Cell line enhanced		NB-4: 129.5;RPTEC TERT1: 178.7;T-47d: 115.6;THP-1: 136.2
IRX4		ENSG00000113430	Iroquois homeobox 4	5	1877413-1887236	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064094			Uncertain	Nucleus<br>Vesicles		Mixed	Tissue enhanced		prostate: 5.8;skin: 6.9	esophagus: 1.4	Cell line enhanced		BEWO: 43.3;HaCaT: 15.1;HBEC3-KT: 6.7
IRX5	IRX-2a	ENSG00000176842	Iroquois homeobox 5	16	54930862-54934485	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047130			Approved	Nuclear speckles<br>Microtubules<br>Cytosol	Lung cancer:4.59e-4 (favourable)	Tissue enhanced	Tissue enhanced		breast: 17.9;lung: 9.6;skin: 10.1	salivary gland: 4.6	Cell line enhanced		RPTEC TERT1: 20.1;T-47d: 34.4
IRX6	IRX-3, IRX7	ENSG00000159387	Iroquois homeobox 6	16	55323760-55330760	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA018332	Uncertain		Approved	Nucleus<br>Mitochondria	Lung cancer:3.34e-4 (favourable)	Tissue enhanced	Tissue enhanced		adipose tissue: 8.6;heart muscle: 4.9	skin: 3.3	Cell line enhanced		AF22: 1.3;HEK 293: 1.5;RPTEC TERT1: 4.5;SK-MEL-30: 3.0
ISL1	Isl-1, ISLET1	ENSG00000016082	ISL LIM homeobox 1	5	51383391-51394738	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057416	Approved		Enhanced	Nucleoplasm		Tissue enhanced	Group enriched	5	placenta: 10.7;prostate: 15.5;seminal vesicle: 25.9;stomach: 9.8	testis: 2.9	Cell line enriched	14	SH-SY5Y: 307.2
ISL2	FLJ10160	ENSG00000159556	ISL LIM homeobox 2	15	76336724-76342476	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA075192			Approved	Rods & Rings		Mixed	Not detected			prostate: 0.9	Cell line enhanced		HEK 293: 13.3
ISX	RAXLX	ENSG00000175329	Intestine specific homeobox	22	35066136-35087387	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060328	Approved		Supported	Nucleoplasm<br>Nuclear bodies		Tissue enhanced	Group enriched	36	colon: 27.4;duodenum: 37.5;rectum: 28.2;small intestine: 29.7	smooth muscle: 0.8	Group enriched	12	CACO-2: 1.3;Hep G2: 3.1
JARID2	JMJ	ENSG00000008083	Jumonji and AT-rich interaction domain containing 2	6	15246296-15522040	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063889, CAB069890	Uncertain		Supported	Nucleus<br>Mitochondria		Expressed in all	Mixed			bone marrow: 36.5	Expressed in all		
JDP2	JUNDM2	ENSG00000140044	Jun dimerization protein 2	14	75427716-75474111	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059511	Supported		Approved	Nucleoplasm<br>Nuclear speckles	Colorectal cancer:8.58e-5 (unfavourable)	Expressed in all	Expressed in all			spleen: 85.7	Cell line enhanced		HHSteC: 140.4
JUN	AP-1, c-Jun	ENSG00000177606	Jun proto-oncogene, AP-1 transcription factor subunit	1	58780788-58784327	Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB003801, CAB007780, HPA059474	Enhanced		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			thyroid gland: 314.6	Cell line enhanced		RH-30: 282.2
JUNB		ENSG00000171223	JunB proto-oncogene, AP-1 transcription factor subunit	19	12791496-12793315	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004464, HPA019149	Approved		Enhanced	Nucleoplasm	Renal cancer:1.05e-4 (unfavourable), Ovarian cancer:3.65e-4 (unfavourable)	Expressed in all	Expressed in all			adrenal gland: 320.7	Expressed in all		
JUND	AP-1	ENSG00000130522	JunD proto-oncogene, AP-1 transcription factor subunit	19	18279760-18281622	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005268, HPA063029	Supported		Supported	Nucleus	Breast cancer:6.15e-5 (favourable)	Expressed in all	Expressed in all			bone marrow: 277.7	Expressed in all		
KAT5	cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5	ENSG00000172977	Lysine acetyltransferase 5	11	65711996-65719604	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016953	Approved		Supported	Nucleoplasm	Renal cancer:1.10e-13 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 84.4	Expressed in all		
KAT6A	MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220	ENSG00000083168	Lysine acetyltransferase 6A	8	41929479-42051990	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017023, HPA063266, HPA065052	Supported		Approved	Nucleoli<br>Nuclear speckles<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 34.5	Expressed in all		
KAT6B	Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B	ENSG00000156650	Lysine acetyltransferase 6B	10	74825582-75032622	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006104	Supported		Approved	Nucleus<br>Nuclear bodies	Renal cancer:4.82e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 17.3	Expressed in all		
KAT7	HBO1, HBOA, MYST2, ZC2HC7	ENSG00000136504	Lysine acetyltransferase 7	17	49788555-49835030	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044470	Approved		Supported	Nucleoplasm		Expressed in all	Expressed in all			testis: 107.0	Expressed in all		
KAT8	FLJ14040, hMOF, MOF, MYST1, ZC2HC8	ENSG00000103510	Lysine acetyltransferase 8	16	31115754-31131393	Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA066324			Supported	Nucleoplasm	Lung cancer:6.34e-4 (favourable)	Expressed in all	Expressed in all			ovary: 61.6	Expressed in all		
KDM2A	CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA	ENSG00000173120	Lysine demethylase 2A	11	67119269-67258087	Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB012272, HPA044251	Supported		Approved	Nucleus		Expressed in all	Expressed in all			testis: 60.0	Expressed in all		
KDM5A	JARID1A, RBBP2	ENSG00000073614	Lysine demethylase 5A	12	280129-389454	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006201			Supported	Nuclear bodies<br>Cytosol		Expressed in all	Expressed in all			testis: 39.0	Expressed in all		
KDM5B	CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A	ENSG00000117139	Lysine demethylase 5B	1	202724491-202809470	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027179, HPA053723, CAB068193	Enhanced		Supported	Nucleus		Expressed in all	Tissue enriched	7	testis: 228.1	skin: 30.6	Mixed		
KDM5C	DXS1272E, JARID1C, MRX13, SMCX, XE169	ENSG00000126012	Lysine demethylase 5C	X	53191321-53225422	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038244, HPA046147			Enhanced	Nucleoplasm<br>Cytosol	Liver cancer:2.11e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 66.7	Expressed in all		
KDM5D	HY, HYA, JARID1D, KIAA0234, SMCY	ENSG00000012817	Lysine demethylase 5D	Y	19703865-19744939	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049086			Approved	Nucleoli fibrillar center	Head and neck cancer:3.58e-5 (favourable)	Mixed	Mixed			small intestine: 36.5	Cell line enhanced		HEL: 49.4;U-698: 32.8
KLF1	EKLF	ENSG00000105610	Kruppel like factor 1	19	12884423-12887181	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051850	Enhanced		Supported	Nucleoplasm		Not detected	Tissue enriched	24	bone marrow: 25.7	placenta: 1.0	Group enriched	33	HEL: 56.0;K-562: 136.3
KLF10	EGRA, TIEG, TIEG1	ENSG00000155090	Kruppel like factor 10	8	102648779-102655902	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Lung cancer:2.61e-5 (unfavourable)	Expressed in all	Expressed in all			lung: 100.0	Expressed in all		
KLF11	MODY7, TIEG2, Tieg3	ENSG00000172059	Kruppel like factor 11	2	10042849-10054836	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058276			Approved	Nucleoplasm<br>Focal adhesion sites<br>Cytosol		Expressed in all	Expressed in all			testis: 56.4	Mixed		
KLF12	AP-2rep, AP2REP, HSPC122	ENSG00000118922	Kruppel like factor 12	13	73686089-73995056	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064146			Approved	Nucleoplasm<br>Cytosol	Endometrial cancer:5.03e-6 (unfavourable)	Expressed in all	Mixed			epididymis: 13.7	Mixed		
KLF13	BTEB3, FKLF-2, NSLP1, RFLAT-1	ENSG00000169926	Kruppel like factor 13	15	31326855-31435665	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:2.37e-9 (favourable)	Expressed in all	Expressed in all			bone marrow: 37.8	Mixed		
KLF15	KKLF	ENSG00000163884	Kruppel like factor 15	3	126342635-126357442	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028866	Uncertain				Renal cancer:3.27e-7 (favourable)	Tissue enhanced	Tissue enhanced		ovary: 42.8	adipose tissue: 37.0	Cell line enhanced		ASC diff: 38.8;HHSteC: 28.8
KLF16	BTEB4, DRRF, NSLP2	ENSG00000129911	Kruppel like factor 16	19	1852399-1863568	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052481	Approved		Supported	Nucleus	Renal cancer:2.93e-5 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 17.5	Expressed in all		
KLF17	FLJ40160, Zfp393, ZNF393	ENSG00000171872	Kruppel like factor 17	1	44118850-44135140	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024629	Enhanced					Tissue enriched	Tissue enhanced		testis: 8.1	smooth muscle: 1.7	Cell line enhanced		BJ hTERT+ SV40 Large T+: 1.4;BJ hTERT+ SV40 Large T+ RasG12V: 1.2;HBF TERT88: 1.5;U-138 MG: 2.6
KLF2	LKLF	ENSG00000127528	Kruppel like factor 2	19	16324817-16327874	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055964	Approved		Approved	Nucleoplasm	Liver cancer:8.55e-4 (favourable)	Expressed in all	Expressed in all			adipose tissue: 115.9	Cell line enhanced		TIME: 57.5;U-266/70: 36.1;U-266/84: 34.1
KLF3	BKLF	ENSG00000109787	Kruppel like factor 3	4	38664196-38701042	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049512, HPA065054	Supported		Enhanced	Nucleoplasm	Renal cancer:4.36e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 63.1	Mixed		
KLF4	EZF, GKLF	ENSG00000136826	Kruppel like factor 4	9	107484852-107490482	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002926	Enhanced		Supported	Nucleoplasm	Renal cancer:3.93e-5 (favourable)	Expressed in all	Expressed in all			esophagus: 128.5	Cell line enhanced		hTCEpi: 66.2;U-2197: 130.0
KLF5	BTEB2, CKLF, IKLF	ENSG00000102554	Kruppel like factor 5	13	73054976-73077542	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA040398	Approved		Supported	Nucleoplasm<br>Golgi apparatus<br>Vesicles	Pancreatic cancer:2.55e-4 (unfavourable)	Expressed in all	Tissue enhanced		skin: 279.6	esophagus: 216.2	Cell line enhanced		HaCaT: 113.4;hTCEpi: 113.2;RT4: 108.4;SiHa: 121.1
KLF6	BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9	ENSG00000067082	Kruppel like factor 6	10	3775996-3785281	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB013529, HPA069585	Supported		Approved	Nucleus<br>Nucleoli fibrillar center<br>Vesicles<br>Cytosol	Renal cancer:2.28e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 323.6	Expressed in all		
KLF7	UKLF	ENSG00000118263	Kruppel like factor 7	2	207074137-207167267	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA030490	Approved		Approved	Golgi apparatus	Renal cancer:4.26e-4 (favourable)	Expressed in all	Expressed in all			smooth muscle: 30.5	Mixed		
KLF8	BKLF3, DXS741, ZNF741	ENSG00000102349	Kruppel like factor 8	X	56232421-56287889	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071740			Supported	Nucleoplasm	Head and neck cancer:3.32e-4 (favourable)	Mixed	Tissue enhanced		skin: 33.8	esophagus: 16.9	Cell line enhanced		hTCEpi: 9.9;RT4: 9.7;SK-BR-3: 7.9;T-47d: 18.2
KLF9	BTEB1	ENSG00000119138	Kruppel like factor 9	9	70384597-70414624	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029308			Approved	Nucleoplasm<br>Plasma membrane<br>Cytosol	Renal cancer:6.59e-6 (favourable)	Expressed in all	Expressed in all			smooth muscle: 88.4	Cell line enhanced		ASC TERT1: 58.2;HHSteC: 90.2
KMT2A	ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1	ENSG00000118058	Lysine methyltransferase 2A	11	118436490-118526832	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017794, CAB024270, HPA044910	Enhanced		Supported	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 31.0	Expressed in all		
KMT2B	CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7	ENSG00000272333	Lysine methyltransferase 2B	19	35718019-35738878	Cancer-related genes, Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006487			Approved	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			testis: 28.8	Expressed in all		
L3MBTL1	dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3	ENSG00000185513	L(3)mbt-like 1 (Drosophila)	20	43507680-43550950	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA068051			Supported	Nucleus		Mixed	Mixed			testis: 10.1	Cell line enhanced		BEWO: 7.9
LBX1	HPX6, LBX1H	ENSG00000138136	Ladybird homeobox 1	10	101226195-101229794	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA002016, HPA002086	Uncertain		Approved	Nucleoplasm<br>Nuclear bodies		Not detected	Tissue enriched	67	skeletal muscle: 9.1	lung: 0.1	Group enriched	8	HEK 293: 3.1;RH-30: 4.1;SCLC-21H: 10.7
LBX2		ENSG00000179528	Ladybird homeobox 2	2	74497517-74503316	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA044257	Uncertain		Approved	Nucleus<br>Midbody		Mixed	Tissue enhanced		duodenum: 5.3;small intestine: 5.3	stomach: 3.0	Cell line enhanced		Hep G2: 14.9
LEF1	TCF10, TCF1ALPHA, TCF7L3	ENSG00000138795	Lymphoid enhancer binding factor 1	4	108047545-108168956	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002087, CAB019405	Enhanced		Approved	Nucleoplasm	Renal cancer:2.47e-6 (unfavourable), Endometrial cancer:1.37e-5 (favourable)	Expressed in all	Tissue enhanced		lymph node: 41.7	tonsil: 28.3	Group enriched	6	MOLT-4: 512.4;REH: 443.8
LEUTX		ENSG00000213921	Leucine twenty homeobox	19	39776595-39786167	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA041498	Uncertain		Approved	Nucleus<br>Nucleoli		Not detected	Not detected			all non-specific tissues: 0.0	Not detected		
LHX1	LIM-1, LIM1	ENSG00000273706	LIM homeobox 1	17	36936785-36944612	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA073521	Enhanced				Endometrial cancer:3.63e-5 (unfavourable)	Tissue enhanced	Tissue enriched	6	kidney: 1.3	fallopian tube: 0.2	Cell line enhanced		HAP1: 3.9;WM-115: 6.9
LHX2	hLhx2, LH-2	ENSG00000106689	LIM homeobox 2	9	124001670-124033301	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA000838		Supported	Approved	Nucleoplasm	Cervical cancer:9.52e-4 (favourable)	Group enriched	Tissue enriched	11	cerebral cortex: 56.3	placenta: 5.1	Cell line enhanced		AN3-CA: 22.0;HAP1: 24.5;NTERA-2: 29.4
LHX3		ENSG00000107187	LIM homeobox 3	9	136196250-136205109	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Not detected			cerebral cortex: 0.4	Cell line enhanced		U-266/70: 1.0
LHX4	Gsh4	ENSG00000121454	LIM homeobox 4	1	180230286-180278982	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055705			Approved	Nuclear speckles		Not detected	Mixed			testis: 2.2	Cell line enhanced		BEWO: 10.3
LHX5		ENSG00000089116	LIM homeobox 5	12	113462034-113472280	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA053908	Uncertain					Mixed	Tissue enhanced		cerebral cortex: 1.4	stomach: 0.3	Cell line enhanced		HMC-1: 1.0
LHX6	LHX6.1	ENSG00000106852	LIM homeobox 6	9	122202577-122229626	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047854, HPA058319	Approved		Uncertain	Nucleoli fibrillar center<br>Plasma membrane		Mixed	Mixed			cerebral cortex: 8.1	Cell line enhanced		CACO-2: 10.9;NB-4: 11.6;PC-3: 11.4;U-87 MG: 9.4
LHX8	Lhx7	ENSG00000162624	LIM homeobox 8	1	75128434-75161533	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071806			Approved	Nucleus<br>Nucleoli<br>Cytosol		Not detected	Tissue enhanced		placenta: 1.8;testis: 1.3;tonsil: 1.5	gallbladder,urinary bladder: 1.0	Group enriched	6	SCLC-21H: 30.2;U-266/70: 6.6
LHX9		ENSG00000143355	LIM homeobox 9	1	197911902-197935478	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009695	Uncertain		Approved	Nucleus		Mixed	Tissue enhanced		ovary: 11.5;testis: 4.5	lung: 2.2	Cell line enriched	9	fHDF/TERT166: 213.5
LMX1A	LMX1, LMX1.1	ENSG00000162761	LIM homeobox transcription factor 1 alpha	1	165201867-165356715	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028051, HPA030088			Approved	Nucleoplasm<br>Golgi apparatus<br>Vesicles		Not detected	Tissue enhanced		duodenum: 1.0;testis: 2.2	adipose tissue,rectum,small intestine: 0.6	Cell line enriched	11	SCLC-21H: 1.0
LMX1B	NPS1	ENSG00000136944	LIM homeobox transcription factor 1 beta	9	126614443-126701032	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA073716			Approved	Nucleus		Tissue enriched	Tissue enhanced		breast: 5.8;salivary gland: 11.2	testis: 2.2	Cell line enhanced		MCF7: 13.7;T-47d: 10.1
LRRFIP1	FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP	ENSG00000124831	LRR binding FLII interacting protein 1	2	237627576-237813682	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006979	Approved		Supported	Cytosol		Expressed in all	Expressed in all			parathyroid gland: 125.3	Expressed in all		
LRRFIP2	HUFI-2	ENSG00000093167	LRR binding FLII interacting protein 2	3	37052656-37183689	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035956, HPA042023	Uncertain		Approved	Plasma membrane<br>Actin filaments	Cervical cancer:6.31e-4 (favourable)	Expressed in all	Expressed in all			testis: 130.8	Expressed in all		
LYAR	ZC2HC2, ZLYAR	ENSG00000145220	Ly1 antibody reactive	4	4267701-4290169	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035881	Enhanced		Supported	Nucleus<br>Nucleoli	Renal cancer:4.36e-10 (unfavourable), Liver cancer:3.20e-5 (unfavourable), Ovarian cancer:8.82e-4 (favourable)	Expressed in all	Tissue enriched	7	testis: 185.7	lymph node: 27.6	Expressed in all		
LYL1	bHLHa18	ENSG00000104903	LYL1, basic helix-loop-helix family member	19	13099033-13103161	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA075004			Approved	Golgi apparatus	Renal cancer:3.89e-4 (unfavourable)	Expressed in all	Tissue enhanced		bone marrow: 22.9;spleen: 20.7	appendix: 14.3	Cell line enhanced		HEL: 113.5;HMC-1: 179.8;K-562: 90.4;NB-4: 82.5;REH: 87.2
MAF	c-MAF	ENSG00000178573	MAF bZIP transcription factor	16	79585843-79600714	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB010296, HPA028289	Approved				Renal cancer:3.74e-4 (unfavourable)	Expressed in all	Tissue enhanced		parathyroid gland: 149.6	small intestine: 91.3	Group enriched	9	Karpas-707: 148.6;RPMI-8226: 242.2
MAFA	hMafA, RIPE3b1	ENSG00000182759	MAF bZIP transcription factor A	8	143419182-143430406	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Group enriched	11	skeletal muscle: 8.6;testis: 2.5	placenta: 0.5	Cell line enhanced		MCF7: 1.7;SCLC-21H: 3.7;T-47d: 2.8;U-2 OS: 2.1
MAFB	KRML	ENSG00000204103	MAF bZIP transcription factor B	20	40685848-40689240	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005653	Approved		Approved	Nucleus<br>Nucleoli<br>Golgi apparatus<br>Cytosol	Endometrial cancer:5.64e-4 (unfavourable)	Expressed in all	Tissue enriched	7	parathyroid gland: 689.3	spleen: 102.0	Cell line enhanced		HSkMC: 20.7;hTCEpi: 44.3;SCLC-21H: 19.6;SiHa: 16.5;U-138 MG: 16.2;U-2197: 22.6;U-87 MG: 15.7
MAFF	hMafF	ENSG00000185022	MAF bZIP transcription factor F	22	38200767-38216511	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB025341, HPA055371	Approved		Approved	Nucleus<br>Mitochondria	Breast cancer:4.32e-4 (favourable)	Expressed in all	Mixed			gallbladder: 66.3	Cell line enhanced		hTEC/SVTERT24-B: 79.2;SK-MEL-30: 75.4
MAFG	MGC13090, MGC20149	ENSG00000197063	MAF bZIP transcription factor G	17	81918270-81927714	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB025573	Approved				Liver cancer:1.90e-6 (unfavourable), Endometrial cancer:5.82e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 28.6	Expressed in all		
MAFK	NFE2U, P18	ENSG00000198517	MAF bZIP transcription factor K	7	1530714-1543043	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB026820, HPA060841	Approved		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			placenta: 36.8	Expressed in all		
MAX	bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8	ENSG00000125952	MYC associated factor X	14	65006174-65102695	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000328, HPA003474	Enhanced		Supported	Nucleoplasm<br>Golgi apparatus<br>Vesicles	Thyroid cancer:2.12e-4 (favourable), Renal cancer:5.57e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 78.8	Expressed in all		
MAZ	Pur-1, ZF87, Zif87, ZNF801	ENSG00000103495	MYC associated zinc finger protein	16	29806106-29811164	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA048315, HPA059495, HPA065930	Approved		Enhanced	Nucleus	Thyroid cancer:2.22e-4 (unfavourable), Renal cancer:5.15e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 197.0	Expressed in all		
MBD1	CXXC3, PCM1	ENSG00000141644	Methyl-CpG binding domain protein 1	18	50266882-50281774	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009017, CAB036003, HPA068850	Approved		Enhanced	Nucleoplasm<br>Vesicles	Prostate cancer:1.70e-6 (unfavourable), Liver cancer:5.08e-6 (unfavourable)	Expressed in all	Expressed in all			testis: 109.0	Expressed in all		
MECOM	EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3	ENSG00000085276	MDS1 and EVI1 complex locus	3	169083499-169663618	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046537	Supported		Supported	Nuclear speckles	Pancreatic cancer:2.59e-4 (unfavourable)	Mixed	Mixed			stomach: 67.3	Cell line enhanced		HUVEC TERT2: 48.0;RPTEC TERT1: 55.1;RT4: 94.4;TIME: 45.0
MEF2A	RSRFC4, RSRFC9	ENSG00000068305	Myocyte enhancer factor 2A	15	99565417-99716466	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004499, HPA046597	Approved		Supported	Nucleoplasm	Renal cancer:6.93e-4 (favourable), Stomach cancer:7.96e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 68.5	Expressed in all		
MEF2B	RSRFR2	ENSG00000213999	Myocyte enhancer factor 2B	19	19145568-19170289	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004734	Supported					Not detected	Group enriched	9	appendix: 17.6;lymph node: 45.7;tonsil: 27.2	spleen: 3.2	Group enriched	12	Daudi: 157.3;U-266/70: 161.9;U-698: 199.1
MEF2C		ENSG00000081189	Myocyte enhancer factor 2C	5	88717117-88904257	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005533, CAB068196, CAB068197	Enhanced		Supported	Nucleoplasm<br>Vesicles	Renal cancer:1.01e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 197.9	Cell line enhanced		HEL: 205.2;REH: 238.4;WM-115: 143.4
MEF2D		ENSG00000116604	Myocyte enhancer factor 2D	1	156463727-156500828	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004807, HPA007114	Enhanced		Enhanced	Nucleoplasm	Renal cancer:7.53e-4 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 55.5	Expressed in all		
MEIS1		ENSG00000143995	Meis homeobox 1	2	66433452-66573869	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	CAB011521, HPA056000, HPA058641	Approved		Supported	Nucleoplasm	Head and neck cancer:2.70e-5 (favourable), Renal cancer:1.69e-4 (unfavourable)	Tissue enhanced	Expressed in all			endometrium: 92.6	Cell line enhanced		BJ hTERT+: 37.0;SH-SY5Y: 30.4
MEIS2	HsT18361, MRG1	ENSG00000134138	Meis homeobox 2	15	36889204-37101299	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003256, CAB004999	Enhanced		Approved	Nucleoplasm<br>Cytosol	Renal cancer:2.64e-7 (unfavourable)	Mixed	Mixed			endometrium: 63.5	Cell line enhanced		fHDF/TERT166: 89.3;SH-SY5Y: 111.8
MEIS3	DKFZp547H236, MRG2	ENSG00000105419	Meis homeobox 3	19	47403124-47419523	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA046699	Uncertain		Approved	Nucleoplasm	Renal cancer:1.78e-6 (unfavourable)	Mixed	Tissue enhanced		endometrium: 82.4	cerebral cortex: 64.8	Cell line enhanced		AF22: 74.7
MEOX1	MOX1	ENSG00000005102	Mesenchyme homeobox 1	17	43640388-43661954	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045214	Uncertain		Uncertain	Nucleoli<br>Mitochondria		Mixed	Tissue enhanced		adipose tissue: 25.3	spleen: 16.4	Cell line enriched	10	HeLa: 16.8
MEOX2	GAX, MOX2	ENSG00000106511	Mesenchyme homeobox 2	7	15611212-15686812	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053793	Enhanced					Tissue enriched	Tissue enhanced		adipose tissue: 28.5;placenta: 57.7	lung: 10.8	Cell line enhanced		AN3-CA: 217.5;SCLC-21H: 37.0;U-138 MG: 58.7
MESP1	bHLHc5, MGC10676	ENSG00000166823	Mesoderm posterior bHLH transcription factor 1	15	89748661-89751310	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA069981			Supported	Nucleus<br>Nucleoli		Group enriched	Tissue enhanced		adipose tissue: 4.8;prostate: 4.8	cerebral cortex: 1.4	Cell line enhanced		A-431: 3.1;HDLM-2: 2.9;HEK 293: 2.7;PC-3: 5.2;SCLC-21H: 3.0
MESP2	bHLHc6, SCDO2	ENSG00000188095	Mesoderm posterior bHLH transcription factor 2	15	89760591-89778754	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Mixed			cervix, uterine: 1.2	Cell line enhanced		U-2197: 4.2
MGA	FLJ12634, KIAA0518, MAD5, MXD5	ENSG00000174197	MGA, MAX dimerization protein	15	41621224-41773081	Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA042278, HPA058183	Approved		Supported	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			testis: 16.2	Expressed in all		
MIER1	hMI-ER1, KIAA1610, MI-ER1	ENSG00000198160	MIER1 transcriptional regulator	1	66924895-66988619	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA019589, HPA050306	Enhanced		Enhanced	Nucleoplasm	Glioma:6.18e-8 (favourable), Colorectal cancer:4.96e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 63.1	Expressed in all		
MIER2	KIAA1193	ENSG00000105556	MIER family member 2	19	301444-344815	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041439	Uncertain		Approved	Nucleoplasm<br>Cytosol	Renal cancer:7.22e-6 (unfavourable), Endometrial cancer:1.72e-5 (favourable), Colorectal cancer:2.89e-4 (unfavourable)	Expressed in all	Mixed			testis: 12.8	Mixed		
MIER3	DKFZp686L09111, DKFZp781I1119, FLJ35954	ENSG00000155545	MIER family member 3	5	56919602-56971675	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058349, HPA065946	Uncertain		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			colon: 30.2	Expressed in all		
MITF	bHLHe32, MI, WS2, WS2A	ENSG00000187098	Melanogenesis associated transcription factor	3	69739435-69968337	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002578, HPA003259	Enhanced				Renal cancer:8.35e-10 (favourable)	Group enriched	Tissue enhanced		cervix, uterine: 80.9;endometrium: 79.3	smooth muscle: 69.5	Cell line enhanced		HMC-1: 78.7;SK-MEL-30: 205.7
MIXL1	MILD1, MIXL	ENSG00000185155	Mix paired-like homeobox	1	226223618-226227054	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005662			Approved	Nucleus		Tissue enriched	Tissue enhanced		tonsil: 3.0	lymph node: 2.8	Cell line enhanced		HAP1: 1.7;Hep G2: 5.7;U-698: 1.5
MKX	C10orf48, IRXL1, MGC39616	ENSG00000150051	Mohawk homeobox	10	27672875-27746060	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA006927	Uncertain		Approved	Nucleoplasm<br>Nuclear speckles		Mixed	Tissue enhanced		ovary: 13.6;prostate: 26.0	fallopian tube: 8.2	Cell line enhanced		BJ: 43.3;BJ hTERT+: 23.7;BJ hTERT+ SV40 Large T+: 30.7;fHDF/TERT166: 114.3
MLX	bHLHd13, MAD7, MXD7, TCFL4	ENSG00000108788	MLX, MAX dimerization protein	17	42567068-42573239	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB025329, HPA052766, HPA064438	Approved		Supported	Nucleoplasm<br>Nuclear membrane<br>Cytosol		Expressed in all	Expressed in all			duodenum: 46.3	Expressed in all		
MLXIP	bHLHe36, KIAA0867, MIR, MONDOA	ENSG00000175727	MLX interacting protein	12	122078722-122147347	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA023084	Approved				Liver cancer:2.28e-4 (unfavourable), Renal cancer:2.92e-4 (unfavourable)	Expressed in all	Expressed in all			rectum: 24.4	Expressed in all		
MLXIPL	bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH	ENSG00000009950	MLX interacting protein like	7	73593194-73624543	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA064640			Supported	Nucleus		Tissue enriched	Tissue enhanced		adipose tissue: 60.8;duodenum: 58.7	liver: 47.2	Cell line enhanced		Hep G2: 33.0;K-562: 13.2;SCLC-21H: 29.5;T-47d: 10.7
MNT	bHLHd3, MAD6, MXD6, ROX	ENSG00000070444	MAX network transcriptional repressor	17	2384060-2401118	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059532, HPA067578			Enhanced	Nucleoplasm		Expressed in all	Expressed in all			cerebral cortex: 15.2	Expressed in all		
MNX1	HB9, HLXB9, HOXHB9, SCRA1	ENSG00000130675	Motor neuron and pancreas homeobox 1	7	156994051-157010651	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071717			Approved	Nucleus<br>Nucleoli<br>Cytosol		Mixed	Tissue enhanced		duodenum: 7.3;small intestine: 6.7	colon: 3.7	Cell line enhanced		AN3-CA: 16.0;EFO-21: 15.3;RPMI-8226: 25.9;SCLC-21H: 22.6
MSC	ABF-1, bHLHa22	ENSG00000178860	Musculin	8	71841549-71844468	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062878			Supported	Nucleoplasm	Renal cancer:1.07e-13 (unfavourable), Liver cancer:4.83e-5 (unfavourable), Glioma:7.15e-4 (unfavourable)	Expressed in all	Mixed			placenta: 22.4	Cell line enriched	14	HDLM-2: 729.2
MSGN1	pMesogenin1	ENSG00000151379	Mesogenin 1	2	17816496-17817101	Predicted intracellular proteins, Transcription factors	No evidence							Not detected	Not detected			esophagus: 0.4	Not detected		
MSX1	HOX7, HYD1, OFC5	ENSG00000163132	Msh homeobox 1	4	4859666-4863936	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB026198, HPA063895, HPA073604	Enhanced		Supported	Nucleoplasm	Endometrial cancer:1.64e-7 (favourable), Renal cancer:1.18e-5 (unfavourable)	Tissue enriched	Group enriched	6	cervix, uterine: 61.1;endometrium: 23.7	adipose tissue: 6.6	Cell line enhanced		CACO-2: 39.5
MSX2	CRS2, FPP, HOX8, MSH, PFM, PFM1	ENSG00000120149	Msh homeobox 2	5	174724533-174730893	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005652	Uncertain		Supported	Nuclear speckles	Endometrial cancer:8.43e-5 (favourable), Lung cancer:6.93e-4 (unfavourable)	Mixed	Tissue enhanced		placenta: 47.8	parathyroid gland: 16.4	Cell line enriched	7	BEWO: 311.1
MTA1		ENSG00000182979	Metastasis associated 1	14	105419820-105470729	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004508, HPA005544	Supported		Enhanced	Nucleoplasm<br>Cytosol	Pancreatic cancer:9.48e-5 (favourable), Liver cancer:4.62e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 35.8	Expressed in all		
MTA2	MTA1-L1, MTA1L1	ENSG00000149480	Metastasis associated 1 family member 2	11	62593214-62601840	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005315, HPA006214, CAB017522	Enhanced		Enhanced	Nucleoplasm	Liver cancer:4.82e-5 (unfavourable)	Expressed in all	Expressed in all			skin: 88.3	Expressed in all		
MTA3	KIAA1266	ENSG00000057935	Metastasis associated 1 family member 3	2	42494569-42756947	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039433	Approved		Supported	Nucleus<br>Vesicles	Endometrial cancer:2.30e-4 (unfavourable), Liver cancer:4.69e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 52.4	Mixed		
MTF1		ENSG00000188786	Metal regulatory transcription factor 1	1	37809567-37859620	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028604, HPA028689	Uncertain		Enhanced	Nucleoplasm		Expressed in all	Mixed			bone marrow: 13.1	Expressed in all		
MXD1	bHLHc58, MAD, MAD1	ENSG00000059728	MAX dimerization protein 1	2	69897688-69942945	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001599	Enhanced		Uncertain	Nucleoplasm<br>Mitochondria<br>Cytosol	Endometrial cancer:8.14e-6 (unfavourable), Pancreatic cancer:8.50e-4 (unfavourable)	Expressed in all	Tissue enhanced		bone marrow: 113.8;esophagus: 101.9	appendix: 56.3	Mixed		
MXD3	bHLHc13, MAD3	ENSG00000213347	MAX dimerization protein 3	5	177301461-177312757	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA070111			Approved	Nucleus<br>Nucleoli	Liver cancer:3.60e-4 (unfavourable)	Expressed in all	Tissue enhanced		bone marrow: 24.2	skin: 12.6	Cell line enhanced		HDLM-2: 162.8
MXD4	bHLHc12, MAD4, MST149, MSTP149	ENSG00000123933	MAX dimerization protein 4	4	2247432-2262294	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053363			Supported	Cytosol	Pancreatic cancer:1.39e-5 (favourable), Head and neck cancer:2.21e-5 (favourable)	Expressed in all	Expressed in all			spleen: 41.3	Expressed in all		
MXI1	bHLHc11, MAD2, MXD2, MXI	ENSG00000119950	MAX interactor 1, dimerization protein	10	110207605-110287365	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035319, HPA056762	Approved		Supported	Nucleus<br>Nucleoli	Renal cancer:1.02e-5 (unfavourable), Prostate cancer:9.17e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 88.1	Expressed in all		
MYB	c-myb	ENSG00000118513	MYB proto-oncogene, transcription factor	6	135181315-135219173	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017704	Approved		Approved	Nucleus<br>Plasma membrane	Prostate cancer:9.65e-4 (favourable), Stomach cancer:9.87e-4 (favourable)	Tissue enhanced	Tissue enhanced		breast: 26.3;rectum: 29.1	colon: 25.2	Cell line enhanced		HL-60: 173.9;MOLT-4: 321.7;REH: 222.8;THP-1: 230.7;U-937: 145.8
MYBL1	A-myb, AMYB	ENSG00000185697	MYB proto-oncogene like 1	8	66562175-66614247	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008791	Uncertain				Renal cancer:2.03e-8 (unfavourable)	Mixed	Tissue enhanced		lymph node: 24.2;testis: 21.4	tonsil: 14.9	Cell line enhanced		BJ hTERT+ SV40 Large T+: 76.9;HBF TERT88: 109.4
MYBL2	B-MYB, BMYB	ENSG00000101057	MYB proto-oncogene like 2	20	43667019-43716496	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017114, HPA030530, HPA055416	Uncertain		Enhanced	Nucleoplasm<br>Cytosol	Renal cancer:0.00e+0 (unfavourable), Liver cancer:2.11e-7 (unfavourable), Endometrial cancer:9.73e-4 (unfavourable)	Tissue enriched	Tissue enhanced		bone marrow: 57.0;lymph node: 67.3;tonsil: 49.9	appendix: 32.7	Mixed		
MYC	bHLHe39, c-Myc, MYCC	ENSG00000136997	V-myc avian myelocytomatosis viral oncogene homolog	8	127735434-127741434	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000084, CAB010307, HPA055893, HPA066556	Supported		Enhanced	Nucleoplasm	Renal cancer:5.49e-8 (unfavourable), Urothelial cancer:4.96e-5 (unfavourable), Ovarian cancer:7.52e-4 (unfavourable)	Expressed in all	Expressed in all			adipose tissue: 151.6	Expressed in all		
MYCL	bHLHe38, LMYC, MYCL1	ENSG00000116990	V-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog	1	39895426-39902256	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063132			Supported	Nucleus	Lung cancer:4.49e-4 (favourable)	Expressed in all	Tissue enhanced		skin: 41.6	urinary bladder: 23.7	Group enriched	7	U-266/70: 372.1;U-266/84: 268.8
MYCN	bHLHe37, MYCNOT, N-myc, NMYC	ENSG00000134323	V-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	2	15940564-15947007	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057420			Approved	Nucleus<br>Nucleoli		Tissue enhanced	Tissue enhanced		placenta: 13.7	cerebral cortex: 7.2	Cell line enhanced		AF22: 43.5;BEWO: 230.1;HMC-1: 50.4;NTERA-2: 91.1;RH-30: 61.3
MYF5	bHLHc2	ENSG00000111049	Myogenic factor 5	12	80716912-80719673	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041691			Supported	Nucleoplasm		Not detected	Tissue enhanced		skeletal muscle: 1.9	prostate: 0.4	Cell line enriched	19	LHCN-M2: 398.0
MYF6	bHLHc4, MRF4	ENSG00000111046	Myogenic factor 6	12	80707498-80709474	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Head and neck cancer:2.05e-4 (unfavourable)	Group enriched	Tissue enriched	15	skeletal muscle: 99.2	prostate: 6.4	Cell line enriched	20	LHCN-M2: 19.4
MYNN	SBBIZ1, ZBTB31, ZNF902	ENSG00000085274	Myoneurin	3	169772831-169789716	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045149	Approved		Supported	Nucleus		Expressed in all	Expressed in all			testis: 18.2	Expressed in all		
MYOD1	bHLHc1, MYF3, MYOD, PUM	ENSG00000129152	Myogenic differentiation 1	11	17719568-17722131	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051362			Supported	Nucleoplasm<br>Nuclear bodies<br>Cytosol		Tissue enhanced	Tissue enriched	10	skeletal muscle: 9.0	prostate: 0.9	Cell line enriched	17	RH-30: 447.0
MYOG	bHLHc3, MYF4	ENSG00000122180	Myogenin	1	203083132-203086036	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028336, HPA038093	Approved		Supported	Nucleoplasm		Group enriched	Tissue enriched	9	skeletal muscle: 31.7	prostate: 3.3	Group enriched	197	HSkMC: 21.2;RH-30: 55.2
MYRF	C11orf9, MRF, Ndt80, pqn-47	ENSG00000124920	Myelin regulatory factor	11	61752642-61788518	Plasma proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA018310			Approved	Nucleoplasm<br>Cytosol	Renal cancer:2.01e-4 (unfavourable)	Mixed	Tissue enhanced		cerebral cortex: 67.4;stomach: 62.1	gallbladder: 38.3	Cell line enhanced		A549: 36.8;CACO-2: 56.7;CAPAN-2: 34.1;EFO-21: 48.7
MYT1	MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A	ENSG00000196132	Myelin transcription factor 1	20	64151791-64242253	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006303	Uncertain		Supported	Nucleoplasm<br>Cytosol		Tissue enhanced	Group enriched	7	adrenal gland: 2.5;cerebral cortex: 5.7	testis: 0.6	Cell line enhanced		REH: 3.3;SCLC-21H: 16.5;SH-SY5Y: 3.0
MYT1L	KIAA1106, NZF1, ZC2H2C2, ZC2HC4B	ENSG00000186487	Myelin transcription factor 1 like	2	1789113-2331260	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060245			Approved	Vesicles		Not detected	Tissue enriched	11	cerebral cortex: 60.0	testis: 5.3	Group enriched	12	SCLC-21H: 7.8;SH-SY5Y: 5.2
MZF1	MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6	ENSG00000099326	Myeloid zinc finger 1	19	58561931-58573575	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001757	Approved		Supported	Nucleus	Renal cancer:2.83e-8 (unfavourable), Urothelial cancer:4.09e-5 (favourable), Pancreatic cancer:7.97e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 14.6	Cell line enhanced		HEK 293: 39.4
NANOG	FLJ12581, FLJ40451	ENSG00000111704	Nanog homeobox	12	7787794-7799141	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB019380	Supported					Tissue enriched	Tissue enhanced		testis: 1.9	lung: 0.7	Cell line enriched	438	NTERA-2: 118.9
NANOGNB		ENSG00000205857	NANOG neighbor homeobox	12	7765216-7774121	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA060371	Uncertain					Tissue enriched	Not detected			testis: 0.5	Not detected		
NCOA1	bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1	ENSG00000084676	Nuclear receptor coactivator 1	2	24491914-24770702	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB019402, HPA070213, HPA070520	Enhanced		Enhanced	Nucleoplasm<br>Plasma membrane<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 59.0	Expressed in all		
NCOA2	bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2	ENSG00000140396	Nuclear receptor coactivator 2	8	70109762-70403805	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060243			Supported	Nucleoplasm<br>Nuclear bodies	Renal cancer:5.08e-4 (favourable)	Expressed in all	Expressed in all			epididymis: 36.0	Expressed in all		
NCOA3	ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1	ENSG00000124151	Nuclear receptor coactivator 3	20	47501902-47656877	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009800, HPA024210	Supported		Supported	Nucleoplasm<br>Cytosol	Liver cancer:8.09e-4 (unfavourable)	Expressed in all	Expressed in all			lymph node: 44.8	Expressed in all		
NCOR1	hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1	ENSG00000141027	Nuclear receptor corepressor 1	17	16029157-16218185	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043246, HPA050288, HPA051168, CAB072830	Enhanced		Enhanced	Nucleoplasm<br>Cytosol	Renal cancer:7.92e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 84.7	Expressed in all		
NCOR2	CTG26, SMRT, SMRTE, TNRC14, TRAC-1	ENSG00000196498	Nuclear receptor corepressor 2	12	124324415-124567589	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001928	Approved		Supported	Nucleoplasm		Expressed in all	Expressed in all			cerebral cortex: 81.2	Expressed in all		
NEUROD1	BETA2, BHF-1, bHLHa3, MODY6, NEUROD	ENSG00000162992	Neuronal differentiation 1	2	181673088-181680876	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003278, CAB022450	Approved				Glioma:6.83e-5 (favourable)	Tissue enhanced	Tissue enhanced		cerebral cortex: 5.9;duodenum: 6.0;small intestine: 4.4;stomach: 4.9	pancreas: 1.8	Cell line enriched	79	SCLC-21H: 331.4
NEUROD2	bHLHa1, NDRF	ENSG00000171532	Neuronal differentiation 2	17	39603536-39609777	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Tissue enriched	142	cerebral cortex: 14.9	stomach: 0.1	Cell line enriched	302	SCLC-21H: 30.2
NEUROD4	ATH-3, Atoh3, bHLHa4, MATH-3	ENSG00000123307	Neuronal differentiation 4	12	55019945-55030014	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015545	Supported					Not detected	Tissue enhanced		adrenal gland: 2.3	testis: 0.5	Group enriched	8	AF22: 1.3;SCLC-21H: 3.3
NEUROD6	Atoh2, bHLHa2, Math-2, Nex1, NEX1M	ENSG00000164600	Neuronal differentiation 6	7	31337461-31340894	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027046, HPA074530	Enhanced	Approved				Not detected	Tissue enriched	180	cerebral cortex: 18.0	all non-specific tissues: 0.0	Cell line enriched	71	SCLC-21H: 7.0
NEUROG1	AKA, bHLHa6, Math4C, NEUROD3, ngn1	ENSG00000181965	Neurogenin 1	5	135534282-135535949	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Not detected			all non-specific tissues: 0.0	Not detected		
NEUROG2	Atoh4, bHLHa8, Math4A, ngn-2, NGN2	ENSG00000178403	Neurogenin 2	4	112513516-112516172	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	CAB012342	Uncertain					Tissue enhanced	Tissue enhanced		testis: 1.5	cerebral cortex: 0.4	Cell line enriched	8	SH-SY5Y: 216.2
NEUROG3	Atoh5, bHLHa7, Math4B, ngn3	ENSG00000122859	Neurogenin 3	10	69571698-69573238	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039785	Uncertain					Tissue enhanced	Tissue enhanced		duodenum: 2.8;small intestine: 1.3	colon,rectum: 0.4	Group enriched	19	HMC-1: 1.7;THP-1: 7.1
NFAT5	KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP	ENSG00000102908	Nuclear factor of activated T-cells 5	16	69565094-69704666	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057304, HPA069711	Approved		Supported	Nucleus<br>Cytosol	Renal cancer:1.08e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 38.4	Expressed in all		
NFATC1	NF-ATC, NFAT2, NFATc	ENSG00000131196	Nuclear factor of activated T-cells 1	18	79395856-79529325	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004513, HPA071732	Enhanced		Supported	Nucleoplasm<br>Nuclear bodies		Expressed in all	Mixed			lymph node: 24.7	Cell line enhanced		U-698: 42.3
NFATC2	NF-ATP, NFAT1, NFATp	ENSG00000101096	Nuclear factor of activated T-cells 2	20	51386957-51562831	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008789, CAB018567, HPA024369	Enhanced		Supported	Nucleoplasm<br>Cytosol	Renal cancer:1.57e-4 (unfavourable)	Expressed in all	Expressed in all			gallbladder: 26.8	Cell line enhanced		HDLM-2: 22.7;HMC-1: 23.5;WM-115: 40.4
NFATC3	NFAT4, NFATX	ENSG00000072736	Nuclear factor of activated T-cells 3	16	68084751-68229259	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050665			Supported	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			testis: 50.0	Expressed in all		
NFATC4	NFAT3	ENSG00000100968	Nuclear factor of activated T-cells 4	14	24365673-24379604	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031641, CAB032859, HPA076526	Uncertain		Supported	Nuclear speckles<br>Cytosol	Renal cancer:1.81e-6 (unfavourable), Colorectal cancer:5.84e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 75.9	Cell line enhanced		BJ hTERT+: 80.5
NFE2	NF-E2	ENSG00000123405	Nuclear factor, erythroid 2	12	54292111-54301121	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001914	Enhanced		Approved	Nucleoplasm<br>Actin filaments		Mixed	Tissue enriched	6	bone marrow: 68.6	spleen: 11.9	Cell line enhanced		HEL: 328.8;K-562: 144.5;NB-4: 71.3
NFE2L1	FLJ00380, LCR-F1, NRF1, TCF11	ENSG00000082641	Nuclear factor, erythroid 2 like 1	17	48048329-48061487	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA063384, HPA065424	Approved		Approved	Nucleus<br>Cytosol	Renal cancer:5.79e-6 (favourable), Endometrial cancer:8.20e-5 (favourable), Head and neck cancer:2.73e-4 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 468.1	Expressed in all		
NFE2L2	NRF2	ENSG00000116044	Nuclear factor, erythroid 2 like 2	2	177227595-177392697	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002990, CAB020317, HPA043438	Enhanced		Approved	Nucleus<br>Plasma membrane<br>Cytosol	Renal cancer:2.26e-4 (favourable)	Expressed in all	Expressed in all			esophagus: 267.1	Expressed in all		
NFE2L3	Nrf3	ENSG00000050344	Nuclear factor, erythroid 2 like 3	7	26152240-26187125	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA055889	Enhanced		Approved	Nucleoplasm<br>Vesicles	Renal cancer:7.58e-12 (unfavourable), Pancreatic cancer:6.62e-5 (unfavourable), Stomach cancer:2.14e-4 (favourable)	Expressed in all	Tissue enhanced		placenta: 50.3	appendix: 14.3	Cell line enhanced		BEWO: 132.0;NTERA-2: 115.5
NFIA	KIAA1439, NFI-L	ENSG00000162599	Nuclear factor I A	1	60865259-61462793	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006111, HPA008884	Enhanced		Enhanced	Nucleoplasm	Urothelial cancer:2.03e-4 (unfavourable), Renal cancer:7.01e-4 (favourable), Head and neck cancer:7.30e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 53.8	Cell line enhanced		AN3-CA: 77.5
NFIB	NFI-RED, NFIB2, NFIB3	ENSG00000147862	Nuclear factor I B	9	14081843-14398983	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003956	Supported		Supported	Nucleus<br>Nucleoli fibrillar center	Renal cancer:3.53e-4 (favourable)	Expressed in all	Mixed			breast: 44.5	Cell line enhanced		AN3-CA: 151.3
NFIC	CTF, CTF5, NF-I, NFI	ENSG00000141905	Nuclear factor I C	19	3359563-3469217	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004300, CAB004674, HPA052625	Supported		Enhanced	Nucleus<br>Nucleoli fibrillar center	Endometrial cancer:1.52e-6 (favourable)	Expressed in all	Expressed in all			skeletal muscle: 68.9	Cell line enhanced		SiHa: 191.4
NFIL3	E4BP4, IL3BP1, NF-IL3A, NFIL3A	ENSG00000165030	Nuclear factor, interleukin 3 regulated	9	91409045-91423862	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003261	Approved		Approved	Nuclear bodies	Renal cancer:3.23e-6 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 137.2	Expressed in all		
NFIX	NF1A	ENSG00000008441	Nuclear factor I X	19	12995608-13098796	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007533	Supported		Supported	Nucleoplasm	Lung cancer:2.35e-4 (favourable), Liver cancer:4.66e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 191.5	Cell line enhanced		U-138 MG: 192.9;U-2197: 175.5
NFKB1	KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50	ENSG00000109320	Nuclear factor kappa B subunit 1	4	102501329-102617302	Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors	Evidence at protein level	CAB004031, HPA027305	Enhanced		Supported	Nucleoplasm<br>Cytosol	Renal cancer:1.76e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 56.9	Expressed in all		
NFKB2	LYT-10, NF-kB2, p105, p49/p100, p52	ENSG00000077150	Nuclear factor kappa B subunit 2	10	102394110-102402529	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008422, CAB022098, HPA023900	Enhanced		Approved	Nucleoplasm<br>Cytosol	Renal cancer:6.69e-12 (unfavourable), Melanoma:8.45e-5 (favourable), Colorectal cancer:3.86e-4 (unfavourable)	Expressed in all	Expressed in all			appendix: 70.7	Expressed in all		
NFKBIA	IkappaBalpha, IKBA, MAD-3, NFKBI	ENSG00000100906	NFKB inhibitor alpha	14	35401511-35404749	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB003815, HPA029207	Approved		Enhanced	Cytosol	Breast cancer:1.33e-5 (favourable)	Expressed in all	Expressed in all			bone marrow: 711.6	Expressed in all		
NFKBIB	IKBB, TRIP9	ENSG00000104825	NFKB inhibitor beta	19	38899700-38908893	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063734			Approved	Nucleoplasm<br>Centrosome<br>Cytosol		Expressed in all	Tissue enhanced		testis: 16.6	appendix: 7.1	Expressed in all		
NFKBID	IkappaBNS, TA-NFKBH	ENSG00000167604	NFKB inhibitor delta	19	35887653-35902303	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043573			Approved	Mitochondria	Urothelial cancer:8.34e-6 (favourable), Head and neck cancer:5.43e-4 (favourable), Breast cancer:6.01e-4 (favourable)	Expressed in all	Tissue enhanced		bone marrow: 9.8	appendix: 5.9	Mixed		
NFKBIE	IKBE	ENSG00000146232	NFKB inhibitor epsilon	6	44258166-44265788	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002692, HPA005941, CAB010272	Supported		Supported	Nucleus<br>Nucleoli fibrillar center<br>Cytosol	Renal cancer:1.37e-6 (unfavourable), Breast cancer:1.72e-5 (favourable), Liver cancer:3.50e-4 (unfavourable), Urothelial cancer:8.07e-4 (favourable)	Expressed in all	Mixed			spleen: 26.1	Expressed in all		
NFKBIL1	IKBL, NFKBIL	ENSG00000204498	NFKB inhibitor like 1	6	31546870-31558829	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Endometrial cancer:3.38e-4 (unfavourable)	Expressed in all	Mixed			fallopian tube: 4.2	Cell line enhanced		HEK 293: 22.4;U-266/70: 8.2;U-266/84: 6.7
NFKBIZ	FLJ34463, INAP, MAIL	ENSG00000144802	NFKB inhibitor zeta	3	101827991-101861022	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA010547, HPA075363	Enhanced		Supported	Nuclear speckles<br>Cytoplasmic bodies	Renal cancer:4.30e-8 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 268.5	Cell line enhanced		BJ hTERT+: 58.3
NFX1	MGC20369, NFX2, TEG-42, Tex42	ENSG00000086102	Nuclear transcription factor, X-box binding 1	9	33290511-33371157	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056310, HPA061382, HPA073519	Approved		Enhanced	Nucleus<br>Cytosol	Ovarian cancer:3.75e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 38.8	Expressed in all		
NFXL1	HOZFP	ENSG00000170448	Nuclear transcription factor, X-box binding like 1	4	47847233-47914667	Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA059132	Approved		Approved	Nucleoplasm	Liver cancer:9.28e-4 (unfavourable)	Expressed in all	Mixed			testis: 24.9	Expressed in all		
NFYA	CBF-B, HAP2, NF-YA	ENSG00000001167	Nuclear transcription factor Y subunit alpha	6	41072945-41099976	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009250, HPA050779	Enhanced		Enhanced	Nucleoplasm	Liver cancer:8.74e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 70.9	Expressed in all		
NFYB	CBF-A, HAP3, NF-YB	ENSG00000120837	Nuclear transcription factor Y subunit beta	12	104117077-104138289	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004211	Supported		Supported	Nucleoplasm	Renal cancer:9.28e-5 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 123.9	Expressed in all		
NFYC	CBF-C, NF-YC	ENSG00000066136	Nuclear transcription factor Y subunit gamma	1	40691648-40771603	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055011			Supported	Nucleoplasm	Renal cancer:1.24e-4 (favourable), Liver cancer:7.24e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 58.6	Expressed in all		
NHLH1	bHLHa35, HEN1, NSCL, NSCL1	ENSG00000171786	Nescient helix-loop-helix 1	1	160367067-160372848	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA017943, CAB033854	Uncertain		Approved	Golgi apparatus		Group enriched	Not detected			skin: 0.8	Cell line enriched	12	SCLC-21H: 30.9
NHLH2	bHLHa34, HEN2, NSCL2	ENSG00000177551	Nescient helix-loop-helix 2	1	115836377-115843917	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055238	Uncertain		Approved	Nucleoplasm<br>Nuclear bodies		Not detected	Tissue enhanced		skin: 3.9	cerebral cortex,testis: 0.8	Cell line enriched	11	SCLC-21H: 68.8
NKX1-1	HSPX153, SAX2	ENSG00000235608	NK1 homeobox 1	4	1402932-1406331	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA029367	Uncertain					Not detected	Not detected			testis: 0.1	Not detected		
NKX1-2	bB238F13.2, C10orf121	ENSG00000229544	NK1 homeobox 2	10	124445239-124450184	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA029367	Uncertain					Tissue enhanced	Not detected			cerebral cortex: 0.7	Cell line enhanced		HaCaT: 4.8;hTCEpi: 3.7;NTERA-2: 10.3;SCLC-21H: 5.3
NKX2-1	BCH, NKX2A, TITF1, TTF-1, TTF1	ENSG00000136352	NK2 homeobox 1	14	36516392-36521149	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000078, CAB053633, HPA074316	Enhanced		Uncertain	Golgi apparatus<br>Vesicles		Group enriched	Group enriched	177	lung: 101.3;thyroid gland: 103.5	stomach: 0.5	Cell line enriched	36	SCLC-21H: 119.8
NKX2-2	NKX2.2, NKX2B	ENSG00000125820	NK2 homeobox 2	20	21511010-21514026	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003468	Approved					Group enriched	Tissue enhanced		cerebral cortex: 9.9;stomach: 2.6	duodenum: 2.4	Cell line enhanced		HAP1: 4.3;T-47d: 4.6;U-138 MG: 17.1;U-2 OS: 3.7;WM-115: 7.0
NKX2-3	CSX3, NKX2.3, NKX2C, NKX4-3	ENSG00000119919	NK2 homeobox 3	10	99532933-99536524	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047561	Uncertain		Uncertain	Nucleoli<br>Cytosol		Tissue enhanced	Tissue enhanced		small intestine: 12.7;spleen: 29.6	duodenum: 11.5	Cell line enhanced		NB-4: 1.1;REH: 2.0
NKX2-4	NKX2.4, NKX2D	ENSG00000125816	NK2 homeobox 4	20	21395367-21398028	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA074996			Approved	Nuclear bodies		Not detected	Tissue enriched	20	testis: 2.0	all non-specific tissues: 0.0	Cell line enhanced		HAP1: 1.9;HEK 293: 3.6;SCLC-21H: 3.0;SK-MEL-30: 2.3
NKX2-5	CSX, CSX1, NKX2.5, NKX2E, NKX4-1	ENSG00000183072	NK2 homeobox 5	5	173232109-173235357	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA065034			Approved	Nucleoplasm<br>Cytosol		Mixed	Group enriched	126	heart muscle: 32.7;spleen: 14.5	breast,placenta,urinary bladder: 0.1	Cell line enhanced		HEK 293: 27.1;NTERA-2: 10.7;U-2 OS: 24.8;U-251 MG: 15.4
NKX2-6	CSX2, NKX4-2	ENSG00000180053	NK2 homeobox 6	8	23702451-23706598	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Not detected			all non-specific tissues: 0.0	Cell line enhanced		hTEC/SVTERT24-B: 3.6
NKX2-8	Nkx2-9, NKX2.8, NKX2H	ENSG00000136327	NK2 homeobox 8	14	36580579-36582607	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062879	Uncertain		Approved	Nucleoplasm<br>Plasma membrane		Mixed	Tissue enhanced		testis: 3.1	lung: 0.6	Cell line enhanced		HaCaT: 4.6;PC-3: 2.8;SiHa: 1.3
NKX3-1	BAPX2, NKX3.1, NKX3A	ENSG00000167034	NK3 homeobox 1	8	23678693-23682927	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA078571	Enhanced					Tissue enriched	Tissue enriched	11	prostate: 485.5	testis: 45.0	Cell line enhanced		SiHa: 27.8;U-138 MG: 25.5
NKX3-2	BAPX1, NKX3.2, NKX3B	ENSG00000109705	NK3 homeobox 2	4	13540830-13545050	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA027564	Approved		Approved	Nucleoplasm		Mixed	Tissue enhanced		spleen: 2.7	smooth muscle: 1.6	Cell line enhanced		HAP1: 3.6;NB-4: 6.2;NTERA-2: 5.3;THP-1: 3.9
NKX6-1	Nkx6.1, NKX6A	ENSG00000163623	NK6 homeobox 1	4	84491987-84498450	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036774, CAB070169	Supported		Supported	Nucleoplasm		Mixed	Tissue enhanced		esophagus: 6.9;thyroid gland: 2.9	testis: 1.4	Cell line enhanced		AF22: 4.0;HAP1: 6.0;HEK 293: 4.7;HMC-1: 3.4;U-2197: 5.9
NKX6-2	GTX, NKX6.1, NKX6B	ENSG00000148826	NK6 homeobox 2	10	132783179-132786052	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enriched	Group enriched	25	cerebral cortex: 15.7;stomach: 16.7	testis: 0.6	Not detected		
NKX6-3	FLJ25169	ENSG00000165066	NK6 homeobox 3	8	41645178-41650669	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA042790	Uncertain					Group enriched	Tissue enhanced		duodenum: 17.3;stomach: 50.6	parathyroid gland: 7.3	Group enriched	7	Daudi: 4.2;THP-1: 1.8
NOBOX	OG2, Og2x	ENSG00000106410	NOBOX oogenesis homeobox	7	144397240-144410227	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Not detected			testis: 0.7	Not detected		
NONO	NMT55, NRB54, P54, P54NRB, PPP1R114	ENSG00000147140	Non-POU domain containing, octamer-binding	X	71283192-71301168	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB022069, HPA054094, HPA054559	Enhanced		Enhanced	Nucleoplasm	Endometrial cancer:9.29e-4 (unfavourable)	Expressed in all	Expressed in all			ovary: 245.9	Expressed in all		
NOTO		ENSG00000214513	Notochord homeobox	2	73202258-73212513	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA034660	Uncertain					Not detected	Not detected			skin: 0.4	Not detected		
NPAS1	bHLHe11, MOP5, PASD5	ENSG00000130751	Neuronal PAS domain protein 1	19	47019820-47045775	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043364, HPA072259		Approved	Approved	Nucleoplasm		Tissue enhanced	Group enriched	5	cerebral cortex: 3.9;skin: 4.4;spleen: 1.8;stomach: 2.6	lymph node: 0.6	Cell line enhanced		HEK 293: 10.1;NB-4: 11.4
NPAS2	bHLHe9, MOP4, PASD4	ENSG00000170485	Neuronal PAS domain protein 2	2	100820152-100996829	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA019674	Uncertain	Supported	Approved	Nucleoplasm	Renal cancer:3.55e-7 (unfavourable), Liver cancer:2.07e-4 (unfavourable)	Expressed in all	Mixed			esophagus: 27.5	Cell line enhanced		PC-3: 102.3
NPAS3	bHLHe12, MOP6, PASD6	ENSG00000151322	Neuronal PAS domain protein 3	14	32934933-33804176	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002892	Enhanced		Approved	Nucleoplasm		Tissue enhanced	Tissue enhanced		cerebral cortex: 24.9	cervix, uterine: 10.1	Group enriched	8	AF22: 9.3;U-266/70: 17.8;U-266/84: 5.0
NPAS4	bHLHe79, Le-PAS, NXF, PASD10	ENSG00000174576	Neuronal PAS domain protein 4	11	66421004-66426707	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039255	Uncertain					Not detected	Tissue enhanced		cerebral cortex: 4.1;endometrium: 1.9	smooth muscle: 1.6	Not detected		
NR0B1	AHC, AHCH, DAX1, DSS	ENSG00000169297	Nuclear receptor subfamily 0 group B member 1	X	30304206-30309598	Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA061948, HPA067207			Supported	Nuclear speckles<br>Vesicles<br>Microtubule organizing center		Tissue enhanced	Group enriched	8	adrenal gland: 27.8;testis: 35.0	ovary: 4.1	Cell line enhanced		A549: 51.8;RT4: 14.5;U-87 MG: 7.9
NR0B2	SHP	ENSG00000131910	Nuclear receptor subfamily 0 group B member 2	1	26911489-26913966	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Group enriched	Tissue enhanced		duodenum: 78.6;liver: 48.8	small intestine: 28.9	Cell line enriched	19	Hep G2: 53.5
NR1D1	ear-1, hRev, Rev-ErbAalpha, THRA1, THRAL	ENSG00000126368	Nuclear receptor subfamily 1 group D member 1	17	40092787-40100725	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007935	Uncertain		Supported	Nuclear bodies	Melanoma:1.36e-4 (favourable), Colorectal cancer:1.94e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 37.4	Expressed in all		
NR1D2	BD73, EAR-1r, Hs.37288, HZF2, RVR	ENSG00000174738	Nuclear receptor subfamily 1 group D member 2	3	23945260-23980618	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053868, HPA054798	Approved		Approved	Nucleoplasm	Renal cancer:4.47e-7 (favourable)	Expressed in all	Expressed in all			thyroid gland: 90.4	Expressed in all		
NR1H2	LXR-b, NER, NER-I, RIP15, UNR	ENSG00000131408	Nuclear receptor subfamily 1 group H member 2	19	50329653-50382982	Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056838, HPA070212	Uncertain		Approved	Nucleoplasm	Colorectal cancer:9.86e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 87.6	Expressed in all		
NR1H3	LXR-a, RLD-1	ENSG00000025434	Nuclear receptor subfamily 1 group H member 3	11	47248300-47269032	Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036443, CAB037109	Approved				Renal cancer:1.40e-5 (unfavourable), Urothelial cancer:3.40e-4 (favourable), Endometrial cancer:5.05e-4 (favourable), Liver cancer:5.60e-4 (unfavourable)	Expressed in all	Expressed in all			adipose tissue: 55.2	Mixed		
NR1H4	FXR, HRR-1, HRR1, RIP14	ENSG00000012504	Nuclear receptor subfamily 1 group H member 4	12	100473708-100564413	Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters	Evidence at protein level	HPA047699			Approved	Nucleoplasm		Group enriched	Tissue enhanced		liver: 66.6;small intestine: 44.4	kidney: 29.9	Group enriched	26	Hep G2: 20.2;HHSteC: 14.1;RPTEC TERT1: 34.8
NR1I2	BXR, ONR1, PAR2, PXR, SXR	ENSG00000144852	Nuclear receptor subfamily 1 group I member 2	3	119780484-119818485	FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029309, HPA055121, HPA073926			Enhanced	Nucleoplasm		Group enriched	Group enriched	10	colon: 10.3;duodenum: 27.2;gallbladder: 6.4;liver: 20.0;rectum: 10.7;small intestine: 30.0	stomach: 1.7	Group enriched	7	Hep G2: 9.8;RH-30: 3.3
NR1I3	CAR, CAR1, MB67	ENSG00000143257	Nuclear receptor subfamily 1 group I member 3	1	161229666-161238302	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051365			Approved	Nucleoplasm		Tissue enriched	Tissue enriched	9	liver: 82.5	kidney: 9.4	Cell line enhanced		CACO-2: 3.7
NR2C1	TR2, TR2-11	ENSG00000120798	Nuclear receptor subfamily 2 group C member 1	12	95020229-95073703	Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035040, HPA035041, HPA067767	Enhanced		Supported	Nucleus<br>Cell Junctions<br>Cytosol	Renal cancer:1.03e-6 (unfavourable), Liver cancer:5.18e-5 (unfavourable), Urothelial cancer:5.62e-5 (favourable)	Expressed in all	Mixed			testis: 21.9	Expressed in all		
NR2C2	hTAK1, TAK1, TR2R1, TR4	ENSG00000177463	Nuclear receptor subfamily 2 group C member 2	3	14947584-15053600	Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006313	Approved		Enhanced	Nucleoplasm	Head and neck cancer:1.51e-5 (favourable)	Expressed in all	Expressed in all			testis: 38.6	Expressed in all		
NR2E1	TLL, TLX, XTLL	ENSG00000112333	Nuclear receptor subfamily 2 group E member 1	6	108166058-108188809	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036954, HPA055642	Enhanced		Approved	Nuclear bodies		Tissue enriched	Tissue enriched	46	cerebral cortex: 11.4	adrenal gland: 0.2	Cell line enhanced		BEWO: 2.9;U-251 MG: 3.3
NR2E3	PNR, rd7, RP37	ENSG00000278570	Nuclear receptor subfamily 2 group E member 3	15	71792638-71818259	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Not detected			prostate: 0.7	Not detected		
NR2F1	COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1	ENSG00000175745	Nuclear receptor subfamily 2 group F member 1	5	93583337-93594615	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB019281, HPA058974			Approved	Nucleoplasm<br>Cytosol	Urothelial cancer:1.47e-4 (unfavourable), Renal cancer:3.47e-4 (unfavourable)	Expressed in all	Mixed			placenta: 75.6	Cell line enhanced		AF22: 228.5;HHSteC: 146.5;PC-3: 180.1
NR2F2	ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2	ENSG00000185551	Nuclear receptor subfamily 2 group F member 2	15	96325938-96340263	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058974			Approved	Nucleoplasm<br>Cytosol		Expressed in all	Tissue enhanced		ovary: 360.7	endometrium: 187.1	Mixed		
NR2F6	EAR-2, ERBAL2	ENSG00000160113	Nuclear receptor subfamily 2 group F member 6	19	17231883-17245940	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Endometrial cancer:4.36e-4 (unfavourable)	Expressed in all	Mixed			duodenum: 30.9	Expressed in all		
NR3C1	GR, GRL	ENSG00000113580	Nuclear receptor subfamily 3 group C member 1	5	143277931-143435512	Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004248, CAB010435	Supported		Enhanced	Nucleoplasm<br>Mitochondria<br>Cytosol	Renal cancer:1.72e-6 (unfavourable), Endometrial cancer:3.64e-5 (unfavourable)	Expressed in all	Expressed in all			placenta: 67.0	Mixed		
NR3C2	MLR, MR	ENSG00000151623	Nuclear receptor subfamily 3 group C member 2	4	148078762-148444698	Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009155, HPA074979	Enhanced		Supported	Nucleoplasm	Renal cancer:3.10e-11 (favourable)	Mixed	Mixed			thyroid gland: 32.3	Cell line enhanced		HUVEC TERT2: 4.9;Karpas-707: 4.5;PC-3: 5.4;RPTEC TERT1: 5.9;TIME: 6.4
NR4A1	GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3	ENSG00000123358	Nuclear receptor subfamily 4 group A member 1	12	52022832-52059507	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059742, HPA070142	Approved		Supported	Nucleus<br>Cytosol	Renal cancer:6.99e-4 (favourable)	Expressed in all	Expressed in all			adrenal gland: 748.8	Cell line enhanced		MCF7: 67.2;SK-BR-3: 60.1;SK-MEL-30: 111.2
NR4A2	HZF-3, NOT, NURR1, RNR1, TINUR	ENSG00000153234	Nuclear receptor subfamily 4 group A member 2	2	156324432-156342348	Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000543, CAB010481	Uncertain		Supported	Nuclear speckles		Expressed in all	Tissue enhanced		adrenal gland: 174.3	ovary: 95.8	Cell line enhanced		HeLa: 10.1;HMC-1: 9.6;U-266/70: 11.3
NR4A3	CHN, CSMF, MINOR, NOR1	ENSG00000119508	Nuclear receptor subfamily 4 group A member 3	9	99821855-99866891	Cancer-related genes, Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043360	Uncertain				Breast cancer:5.97e-4 (favourable)	Mixed	Tissue enhanced		adrenal gland: 88.9	urinary bladder: 42.2	Cell line enhanced		BJ hTERT+: 21.0;SK-MEL-30: 14.0;U-266/70: 7.9
NR5A1	AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1	ENSG00000136931	Nuclear receptor subfamily 5 group A member 1	9	124481236-124507430	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Group enriched	Group enriched	6	adrenal gland: 137.7;ovary: 36.3;spleen: 151.6	testis: 19.6	Group enriched	31	HEL: 73.5;Hep G2: 36.2;K-562: 17.7
NR5A2	B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1	ENSG00000116833	Nuclear receptor subfamily 5 group A member 2	1	200027602-200177424	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005455, HPA017067	Supported		Uncertain	Nuclear speckles		Tissue enhanced	Mixed			liver: 19.5	Cell line enhanced		A549: 22.3;HAP1: 15.3;HUVEC TERT2: 17.0
NR6A1	CT150, GCNF, GCNF1, RTR	ENSG00000148200	Nuclear receptor subfamily 6 group A member 1	9	124517275-124771310	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031461, HPA045145			Supported	Nucleus		Tissue enriched	Tissue enriched	8	testis: 42.7	thyroid gland: 5.1	Cell line enhanced		BEWO: 107.1;K-562: 31.0;NTERA-2: 39.7
NRF1	ALPHA-PAL, EWG	ENSG00000106459	Nuclear respiratory factor 1	7	129611714-129757082	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029329	Approved		Supported	Nucleoplasm<br>Cytosol	Liver cancer:6.02e-4 (unfavourable)	Expressed in all	Expressed in all			fallopian tube: 20.9	Expressed in all		
NRL	D14S46E, NRL-MAF, RP27	ENSG00000129535	Neural retina leucine zipper	14	24080107-24115014	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB026066, HPA064599	Supported		Supported	Nucleoplasm<br>Cytosol		Mixed	Mixed			parathyroid gland: 4.6	Mixed		
NSD2	KMT3G, MMSET, WHSC1	ENSG00000109685	Nuclear receptor binding SET domain protein 2	4	1871424-1982207	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015801, CAB068246, CAB068247	Enhanced		Supported	Nucleus	Liver cancer:2.61e-4 (unfavourable), Renal cancer:7.19e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 66.6	Expressed in all		
OLIG1	BHLHB6, bHLHe21	ENSG00000184221	Oligodendrocyte transcription factor 1	21	33070144-33072420	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Tissue enriched	104	cerebral cortex: 142.6	kidney: 1.3	Cell line enhanced		NB-4: 24.7;RPMI-8226: 14.1;THP-1: 17.1;U-937: 22.7
OLIG2	BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17	ENSG00000205927	Oligodendrocyte transcription factor 2	21	33025845-33029196	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003254, CAB019381	Enhanced		Uncertain	Nucleoplasm<br>Plasma membrane		Tissue enriched	Tissue enriched	245	cerebral cortex: 91.0	duodenum: 0.3	Cell line enhanced		HMC-1: 46.5;NB-4: 25.3;THP-1: 23.2;WM-115: 10.9
OLIG3	Bhlhb7, bHLHe20	ENSG00000177468	Oligodendrocyte transcription factor 3	6	137492202-137494250	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018303, CAB024865	Uncertain					Not detected	Not detected			esophagus: 0.1	Cell line enhanced		NTERA-2: 1.2
ONECUT1	HNF-6, HNF6, HNF6A	ENSG00000169856	One cut homeobox 1	15	52756989-52791078	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003457	Enhanced					Group enriched	Group enriched	6	gallbladder: 8.4;liver: 5.9;pancreas: 2.3;testis: 1.8	bone marrow: 0.7	Cell line enhanced		MCF7: 1.7;WM-115: 1.5
ONECUT2	OC-2	ENSG00000119547	One cut homeobox 2	18	57435685-57491297	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057058	Enhanced		Supported	Nucleoplasm<br>Actin filaments		Group enriched	Tissue enhanced		duodenum: 10.4;gallbladder: 16.3	liver: 4.5	Cell line enhanced		HDLM-2: 19.1;HeLa: 8.5;SCLC-21H: 12.1
ONECUT3		ENSG00000205922	One cut homeobox 3	19	1752373-1780988	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059936			Supported	Nucleoplasm		Group enriched	Tissue enhanced		stomach: 4.0	gallbladder: 1.0	Group enriched	9	HaCaT: 6.2;PC-3: 14.4
OSR1	ODD	ENSG00000143867	Odd-skipped related transciption factor 1	2	19351485-19358653	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA015525	Uncertain					Mixed	Mixed			adipose tissue: 22.1	Cell line enriched	14	U-2197: 92.8
OSR2	FLJ90037	ENSG00000164920	Odd-skipped related transciption factor 2	8	98944403-98952104	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052425, HPA063486	Uncertain		Approved	Nucleus<br>Plasma membrane	Head and neck cancer:2.44e-5 (favourable)	Mixed	Tissue enhanced		endometrium: 205.3;fallopian tube: 144.6	ovary: 102.9	Cell line enriched	13	ASC diff: 372.1
OTP		ENSG00000171540	Orthopedia homeobox	5	77628712-77639688	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059342	Supported					Tissue enriched	Not detected			lung,testis: 0.1	Not detected		
OTX1		ENSG00000115507	Orthodenticle homeobox 1	2	63050057-63057836	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB012341, HPA052122	Approved		Uncertain	Nuclear speckles<br>Cytosol		Mixed	Tissue enhanced		cerebral cortex: 1.7;skin: 6.1	prostate: 1.0	Cell line enriched	6	THP-1: 35.9
OTX2		ENSG00000165588	Orthodenticle homeobox 2	14	56799905-56810479	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000633	Approved					Tissue enriched	Not detected			testis: 0.5	Group enriched	735	HAP1: 239.3;NTERA-2: 192.9
OVOL1	HOVO1	ENSG00000172818	Ovo like transcriptional repressor 1	11	65787022-65797219	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003984	Uncertain		Approved	Nucleus	Renal cancer:1.00e-13 (favourable), Endometrial cancer:1.87e-4 (unfavourable)	Mixed	Tissue enhanced		esophagus: 37.3;skin: 33.4;testis: 35.3	urinary bladder: 15.5	Cell line enhanced		A-431: 16.3;BEWO: 49.5;HaCaT: 27.3;RT4: 24.5;SK-BR-3: 17.8
OVOL2	bA504H3.3, CHED, CHED1, HOVO2, ZNF339	ENSG00000125850	Ovo like zinc finger 2	20	17956979-18059188	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038531	Uncertain		Approved	Nucleoplasm<br>Cytosol		Mixed	Tissue enhanced		stomach: 8.0	colon: 3.5	Cell line enhanced		A-431: 5.2;CAPAN-2: 6.7;HaCaT: 5.0;SCLC-21H: 10.2;SK-BR-3: 4.4
OVOL3	HOVO3	ENSG00000105261	Ovo like zinc finger 3	19	36111151-36113711	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Not detected	Group enriched	5	skin: 1.0;testis: 2.8	appendix: 0.3	Cell line enhanced		U-266/84: 2.1
PATZ1	dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG	ENSG00000100105	POZ/BTB and AT hook containing zinc finger 1	22	31325804-31346232	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047893, HPA048315	Approved		Supported	Nucleoplasm	Renal cancer:8.54e-8 (favourable), Urothelial cancer:7.79e-6 (favourable), Glioma:6.53e-5 (favourable), Lung cancer:8.71e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 40.4	Expressed in all		
PAX1		ENSG00000125813	Paired box 1	20	21705659-21718486	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Tissue enriched	11	parathyroid gland: 185.2	tonsil: 17.5	Cell line enriched	6	SCLC-21H: 1.6
PAX2		ENSG00000075891	Paired box 2	10	100735603-100829941	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	CAB013024, HPA047704, HPA070751	Enhanced		Supported	Nucleoli<br>Golgi apparatus	Endometrial cancer:4.56e-4 (unfavourable)	Group enriched	Group enriched	5	epididymis: 37.1;fallopian tube: 19.0;kidney: 25.3;seminal vesicle: 20.0	cervix, uterine: 4.9	Group enriched	8	AN3-CA: 16.6;EFO-21: 23.1;RPTEC TERT1: 13.3
PAX3	HUP2, WS1	ENSG00000135903	Paired box 3	2	222199888-222298996	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063659, HPA069000	Approved		Supported	Nucleoplasm		Tissue enriched	Group enriched	8	breast: 1.2;skeletal muscle: 1.1;skin: 3.2;testis: 2.4	prostate: 0.2	Cell line enhanced		BJ hTERT+ SV40 Large T+: 9.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.6;RH-30: 16.2;SK-MEL-30: 24.6
PAX4	MODY9	ENSG00000106331	Paired box 4	7	127610292-127618114	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enhanced		duodenum: 1.0;rectum: 1.1	small intestine,testis: 0.6	Cell line enriched	73	SCLC-21H: 15.3
PAX5	BSAP	ENSG00000196092	Paired box 5	9	36833275-37034185	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB026269, CAB026869, HPA056394, HPA068498	Enhanced		Approved	Nucleoplasm<br>Vesicles<br>Cytosol		Mixed	Tissue enhanced		lymph node: 48.5;spleen: 26.2;tonsil: 33.2	appendix: 19.5	Group enriched	6	Daudi: 48.5;REH: 181.0;U-698: 61.2
PAX6	AN, AN2, D11S812E, WAGR	ENSG00000007372	Paired box 6	11	31784779-31818062	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA030775, CAB034143	Supported		Enhanced	Nucleoplasm		Tissue enhanced	Group enriched	7	cerebral cortex: 22.3;stomach: 11.2	testis: 2.5	Cell line enhanced		AF22: 15.6;AN3-CA: 19.1;HEK 293: 17.3;U-251 MG: 14.4
PAX7	Hup1	ENSG00000009709	Paired box 7	1	18631006-18748866	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Group enriched	Group enriched	7	cerebral cortex: 1.3;skeletal muscle: 2.2	esophagus,testis: 0.2	Group enriched	7	A549: 1.3;CAPAN-2: 1.4;U-2 OS: 3.5
PAX8		ENSG00000125618	Paired box 8	2	113215997-113278950	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030062, CAB055097, CAB061888, HPA064554	Enhanced		Enhanced	Nucleoplasm	Endometrial cancer:1.75e-5 (unfavourable)	Group enriched	Tissue enriched	10	thyroid gland: 644.0	kidney: 65.2	Group enriched	8	EFO-21: 76.3;RPTEC TERT1: 144.9
PAX9		ENSG00000198807	Paired box 9	14	36657568-36679715	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038462	Enhanced		Approved	Nucleoplasm<br>Mitochondria	Cervical cancer:5.38e-4 (favourable)	Mixed	Group enriched	8	esophagus: 56.1;parathyroid gland: 102.3;salivary gland: 21.7	tonsil: 7.5	Cell line enhanced		HDLM-2: 44.7;PC-3: 18.6
PBRM1	BAF180, PB1	ENSG00000163939	Polybromo 1	3	52545352-52685917	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015629, HPA059373	Uncertain		Supported	Nucleoplasm		Expressed in all	Expressed in all			thyroid gland: 44.7	Expressed in all		
PBX1		ENSG00000185630	PBX homeobox 1	1	164555584-164899296	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003505, HPA003881, CAB018768	Supported		Enhanced	Nucleoplasm		Mixed	Expressed in all			endometrium: 248.2	Cell line enhanced		SK-BR-3: 173.0
PBX2	G17, HOX12, PBX2MHC	ENSG00000204304	PBX homeobox 2	6	32184741-32190186	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA061478	Enhanced		Approved	Nucleoplasm	Endometrial cancer:8.90e-5 (unfavourable), Ovarian cancer:6.84e-4 (favourable)	Expressed in all	Expressed in all			epididymis: 36.1	Mixed		
PBX3		ENSG00000167081	PBX homeobox 3	9	125747345-125967377	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003881	Supported		Approved	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 340.6	Mixed		
PBX4		ENSG00000105717	PBX homeobox 4	19	19561707-19618916	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049859, HPA056469	Enhanced		Enhanced	Vesicles	Urothelial cancer:5.94e-7 (favourable), Cervical cancer:8.69e-6 (favourable)	Mixed	Tissue enhanced		testis: 2.6;thyroid gland: 2.2	lymph node: 0.8	Cell line enhanced		PC-3: 1.5;RT4: 1.6
PDX1	IDX-1, IPF1, MODY4, PDX-1, STF-1	ENSG00000139515	Pancreatic and duodenal homeobox 1	13	27920020-27926231	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB025873, HPA059146	Enhanced		Supported	Nucleoplasm		Group enriched	Tissue enriched	7	duodenum: 43.6	stomach: 6.2	Group enriched	6	AN3-CA: 1.2;CACO-2: 1.0;CAPAN-2: 1.2;HDLM-2: 3.9;HEK 293: 2.2;HeLa: 4.1
PEG3	KIAA0287, ZKSCAN22, ZNF904, ZSCAN24	ENSG00000198300	Paternally expressed 3	19	56810083-56840728	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026070	Approved		Supported	Nucleoplasm	Thyroid cancer:1.56e-4 (unfavourable)	Tissue enhanced	Tissue enhanced		ovary: 340.4;placenta: 197.8	adrenal gland: 102.0	Cell line enhanced		BEWO: 100.6;Hep G2: 150.6;RH-30: 70.4
PGR	NR3C3, PR	ENSG00000082175	Progesterone receptor	11	101029624-101130524	Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000068, HPA004751, HPA008428, HPA017176, CAB055100	Enhanced				Endometrial cancer:5.76e-8 (favourable)	Group enriched	Group enriched	6	cervix, uterine: 96.2;endometrium: 172.3;fallopian tube: 53.3;smooth muscle: 114.9	ovary: 19.5	Cell line enriched	349	T-47d: 157.7
PHF5A	bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7	ENSG00000100410	PHD finger protein 5A	22	41459717-41468725	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028885	Supported		Enhanced	Nucleoplasm	Liver cancer:3.02e-8 (unfavourable)	Expressed in all	Expressed in all			lymph node: 39.8	Expressed in all		
PHOX2A	ARIX, CFEOM2, FEOM2, PMX2A	ENSG00000165462	Paired like homeobox 2a	11	72239077-72245664	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA065621, HPA078004	Enhanced		Approved	Nucleus<br>Nuclear membrane<br>Vesicles		Tissue enriched	Tissue enriched	14	adrenal gland: 26.4	appendix: 1.8	Cell line enriched	240	SH-SY5Y: 603.9
PHOX2B	NBPhox, Phox2b, PMX2B	ENSG00000109132	Paired like homeobox 2b	4	41744082-41748970	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA074325, HPA074941			Enhanced	Nucleoplasm		Not detected	Tissue enriched	8	adrenal gland: 10.3	small intestine: 1.2	Cell line enriched	92	SH-SY5Y: 130.2
PHTF1	PHTF	ENSG00000116793	Putative homeodomain transcription factor 1	1	113696831-113759489	Plasma proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA059486			Approved	Nucleoli<br>Nuclear bodies	Renal cancer:1.21e-6 (unfavourable)	Expressed in all	Tissue enhanced		testis: 54.4	parathyroid gland: 19.0	Mixed		
PHTF2	DKFZp434D166	ENSG00000006576	Putative homeodomain transcription factor 2	7	77798792-77957503	Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA012312	Uncertain		Approved	Nucleoplasm<br>Cytosol	Renal cancer:3.09e-7 (unfavourable), Thyroid cancer:2.78e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 62.0	Expressed in all		
PITX1	BFT, POTX, PTX1	ENSG00000069011	Paired like homeodomain 1	5	135027735-135034813	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008743	Approved		Supported	Nucleoli		Tissue enhanced	Tissue enriched	5	esophagus: 211.7	salivary gland: 38.5	Cell line enhanced		CACO-2: 116.7;K-562: 103.4;T-47d: 154.3
PITX2	ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS	ENSG00000164093	Paired like homeodomain 2	4	110617423-110642123	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050074, HPA062728			Enhanced	Nucleus		Mixed	Tissue enhanced		placenta: 72.2	skeletal muscle: 18.3	Cell line enhanced		CACO-2: 23.3;LHCN-M2: 25.4;RH-30: 24.6
PITX3	ASMD	ENSG00000107859	Paired like homeodomain 3	10	102230186-102241474	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Group enriched	11	adipose tissue: 1.2;skeletal muscle: 5.6	testis: 0.3	Cell line enriched	17	RH-30: 28.7
PKNOX1	PREP1	ENSG00000160199	PBX/knotted 1 homeobox 1	21	42974510-43033931	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004285, HPA057215, HPA065017	Approved		Enhanced	Nucleoplasm	Liver cancer:4.54e-8 (unfavourable), Pancreatic cancer:6.71e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 16.8	Expressed in all		
PKNOX2		ENSG00000165495	PBX/knotted 1 homeobox 2	11	125164687-125433389	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028867, CAB034342, HPA055368, HPA066962	Supported		Enhanced	Nucleus<br>Cytokinetic bridge		Tissue enhanced	Mixed			thyroid gland: 20.1	Cell line enhanced		AF22: 38.2;AN3-CA: 9.0;LHCN-M2: 9.6;WM-115: 21.0
PLAG1	ZNF912	ENSG00000181690	PLAG1 zinc finger	8	56160904-56211324	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA072290			Supported	Nuclear speckles		Mixed	Mixed			ovary: 5.9	Mixed		
PLAGL1	LOT1, ZAC	ENSG00000118495	PLAG1 like zinc finger 1	6	143940300-144064599	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055706			Supported	Nuclear bodies<br>Golgi apparatus<br>Vesicles	Renal cancer:4.94e-6 (unfavourable), Stomach cancer:6.61e-4 (unfavourable)	Mixed	Tissue enriched	5	placenta: 365.4	skin: 72.8	Cell line enhanced		AF22: 105.6;RH-30: 105.2
PLAGL2	ZNF900	ENSG00000126003	PLAG1 like zinc finger 2	20	32192503-32207791	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005900	Uncertain		Approved	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			testis: 25.8	Expressed in all		
POGZ	KIAA0461, ZNF280E, ZNF635m	ENSG00000143442	Pogo transposable element with ZNF domain	1	151402724-151459465	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006800, HPA008781	Enhanced		Enhanced	Nucleoplasm	Renal cancer:3.92e-5 (unfavourable), Urothelial cancer:4.40e-4 (favourable), Endometrial cancer:8.67e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 76.7	Expressed in all		
POU1F1	GHF-1, PIT1, POU1F1a	ENSG00000064835	POU class 1 homeobox 1	3	87259404-87276587	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041646, HPA050624	Enhanced					Not detected	Not detected			adrenal gland,cerebral cortex,gallbladder,skeletal muscle,spleen,thyroid gland: 0.1	Not detected		
POU2F1	OCT1, OTF1	ENSG00000143190	POU class 2 homeobox 1	1	167220829-167427345	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002608, HPA058559, HPA064323	Supported		Supported	Nucleoplasm<br>Endoplasmic reticulum<br>Vesicles	Renal cancer:2.98e-5 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 8.0	Mixed		
POU2F2	OCT2, OTF2	ENSG00000028277	POU class 2 homeobox 2	19	42086110-42196585	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002513, HPA049056, HPA062096, HPA064404	Enhanced		Enhanced	Nucleoplasm<br>Vesicles	Renal cancer:7.57e-11 (unfavourable)	Mixed	Tissue enhanced		lymph node: 62.3;tonsil: 44.4	appendix,spleen: 37.6	Cell line enhanced		BJ hTERT+: 42.5;Daudi: 81.0;hTEC/SVTERT24-B: 42.8;U-266/70: 57.7;U-266/84: 54.8;U-698: 61.5
POU2F3	Epoc-1, OCT11, PLA-1, Skn-1a	ENSG00000137709	POU class 2 homeobox 3	11	120236640-120319944	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA019652	Enhanced				Thyroid cancer:8.14e-4 (favourable)	Mixed	Group enriched	11	parathyroid gland: 15.5;skin: 72.3	seminal vesicle: 3.8	Cell line enhanced		CAPAN-2: 3.7;SK-BR-3: 2.2;T-47d: 5.2
POU3F1	OCT6, OTF6, SCIP	ENSG00000185668	POU class 3 homeobox 1	1	38044611-38046794	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055980, HPA073824			Enhanced	Nucleoplasm		Mixed	Tissue enriched	14	skin: 23.6	cerebral cortex: 1.6	Group enriched	9	AF22: 12.9;HDLM-2: 22.0;NTERA-2: 6.3;SCLC-21H: 5.3;SK-MEL-30: 15.0
POU3F2	BRN2, OCT7, OTF7, POUF3	ENSG00000184486	POU class 3 homeobox 2	6	98834592-98839470	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047081, HPA056261		Approved	Supported	Nucleus		Tissue enriched	Tissue enriched	70	cerebral cortex: 20.4	testis: 0.2	Cell line enhanced		AF22: 123.9;U-251 MG: 32.8;WM-115: 33.3
POU3F3	BRN1, OTF8	ENSG00000198914	POU class 3 homeobox 3	2	104855511-104858574	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052792, HPA056039, HPA067151	Approved		Enhanced	Nucleus	Endometrial cancer:4.26e-5 (unfavourable)	Group enriched	Group enriched	45	cerebral cortex: 43.9;epididymis: 46.3;kidney: 36.6;seminal vesicle: 23.2	skin: 0.8	Group enriched	5	AF22: 58.4;AN3-CA: 52.7;HEK 293: 20.3;RPTEC TERT1: 50.7;SH-SY5Y: 19.7
POU3F4	BRN4, DFN3, DFNX2, OTF9	ENSG00000196767	POU class 3 homeobox 4	X	83508250-83512127	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031984, HPA062295	Uncertain		Supported	Nucleus		Tissue enriched	Tissue enriched	11	cerebral cortex: 7.9	kidney: 0.7	Cell line enriched	96	AF22: 9.6
POU4F1	BRN3A, RDC-1	ENSG00000152192	POU class 4 homeobox 1	13	78598362-78603560	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA068024	Enhanced					Mixed	Tissue enhanced		testis: 1.8	tonsil: 0.7	Cell line enhanced		HEK 293: 12.9;HEL: 13.8;RH-30: 17.3;SCLC-21H: 20.1;U-266/70: 12.2
POU4F2	Brn-3b, BRN3B	ENSG00000151615	POU class 4 homeobox 2	4	146638893-146642474	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	18	testis: 1.8	all non-specific tissues: 0.0	Cell line enhanced		SCLC-21H: 2.1
POU4F3	BRN3C, DFNA15, DFNA42, DFNA52	ENSG00000091010	POU class 4 homeobox 3	5	146339024-146340520	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038215	Uncertain		Supported	Nucleoplasm		Tissue enhanced	Not detected			all non-specific tissues: 0.0	Not detected		
POU5F1	MGC22487, OCT3, Oct4, OTF3	ENSG00000204531	POU class 5 homeobox 1	6	31164337-31180731	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB025600, CAB026380, HPA058267	Approved		Supported	Nucleoplasm<br>Cytosol	Urothelial cancer:2.04e-5 (favourable)	Tissue enriched	Mixed			fallopian tube: 6.4	Group enriched	12	HAP1: 366.6;NTERA-2: 938.2
POU5F1B	OTF3C, OTF3P1, POU5F1P1	ENSG00000212993	POU class 5 homeobox 1B	8	127414290-127420069	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058267			Supported	Nucleoplasm		Tissue enhanced	Not detected			parathyroid gland: 0.7	Cell line enhanced		hTERT-HME1: 1.1
POU5F2	FLJ25680, SPRM-1	ENSG00000248483	POU domain class 5, transcription factor 2	5	93733220-93741637	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Not detected	Tissue enhanced		testis: 2.7	skin: 0.6	Cell line enriched	7	U-2 OS: 3.1
POU6F1	BRN5, MPOU, TCFB1	ENSG00000184271	POU class 6 homeobox 1	12	51186936-51217708	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047021, HPA050411	Enhanced		Supported	Nuclear bodies<br>Actin filaments	Pancreatic cancer:6.61e-4 (favourable)	Expressed in all	Mixed			cerebral cortex: 10.9	Mixed		
POU6F2	RPF-1	ENSG00000106536	POU class 6 homeobox 2	7	38977998-39493095	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Tissue enhanced		cerebral cortex: 3.1;placenta: 1.8	gallbladder,testis: 1.2	Cell line enhanced		EFO-21: 3.0;NTERA-2: 3.1;T-47d: 5.3;U-266/70: 4.7;U-266/84: 5.5
PPARA	hPPAR, NR1C1, PPAR	ENSG00000186951	Peroxisome proliferator activated receptor alpha	22	46150521-46243756	FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058901, HPA067049, CAB075701	Supported		Enhanced	Nucleus	Renal cancer:4.39e-9 (favourable)	Expressed in all	Expressed in all			kidney: 24.2	Mixed		
PPARD	FAAR, NR1C2, NUC1, NUCII	ENSG00000112033	Peroxisome proliferator activated receptor delta	6	35342558-35428191	FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017635	Approved				Liver cancer:4.57e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 40.2	Expressed in all		
PPARG	NR1C3, PPARG1, PPARG2, PPARgamma	ENSG00000132170	Peroxisome proliferator activated receptor gamma	3	12287368-12434356	Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004282, HPA051239, HPA063663	Approved		Enhanced	Nucleus<br>Vesicles	Renal cancer:1.59e-8 (favourable), Liver cancer:3.41e-5 (unfavourable), Urothelial cancer:5.52e-5 (favourable)	Expressed in all	Tissue enhanced		adipose tissue: 173.3	placenta: 59.2	Cell line enhanced		ASC diff: 131.6;BEWO: 223.4;RT4: 116.1
PPP1R13L	IASPP, RAI	ENSG00000104881	Protein phosphatase 1 regulatory subunit 13 like	19	45379634-45406349	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005016, HPA041231, HPA059883	Approved		Enhanced	Cytosol	Lung cancer:3.39e-5 (unfavourable), Ovarian cancer:5.40e-4 (unfavourable)	Expressed in all	Tissue enhanced		skin: 191.4	esophagus: 53.8	Cell line enhanced		hTCEpi: 138.6
PRDM1	BLIMP1, PRDI-BF1	ENSG00000057657	PR/SET domain 1	6	106086320-106109939	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030033	Approved		Approved	Nucleus<br>Nucleoli	Renal cancer:9.81e-5 (unfavourable)	Expressed in all	Tissue enhanced		esophagus: 61.0	endometrium: 30.1	Cell line enhanced		Karpas-707: 158.5;U-266/70: 62.6;U-266/84: 39.9
PRDM10	KIAA1231, MGC131802, PFM7	ENSG00000170325	PR/SET domain 10	11	129899706-130002835	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026997	Approved		Approved	Nucleoplasm<br>Nucleoli fibrillar center<br>Vesicles		Expressed in all	Mixed			parathyroid gland: 7.6	Expressed in all		
PRDM13		ENSG00000112238	PR/SET domain 13	6	99606730-99615578	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA070592	Uncertain					Not detected	Not detected			all non-specific tissues: 0.0	Not detected		
PRDM14		ENSG00000147596	PR/SET domain 14	8	70051651-70071693	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA019094, HPA057070	Uncertain		Uncertain	Nucleoplasm		Tissue enriched	Tissue enhanced		testis: 1.7	skin: 0.5	Cell line enriched	101	NTERA-2: 50.3
PRDM15	C21orf83, ZNF298	ENSG00000141956	PR/SET domain 15	21	41798225-41879482	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024268, HPA029255, HPA029256	Uncertain		Supported	Nucleoplasm<br>Nuclear bodies		Expressed in all	Mixed			lymph node: 8.8	Cell line enhanced		Daudi: 21.6;U-698: 37.6
PRDM16	KIAA1675, KMT8F, MEL1, MGC166915, PFM13	ENSG00000142611	PR/SET domain 16	1	3069168-3438621	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050343, HPA060467			Enhanced	Nucleoplasm	Thyroid cancer:4.70e-5 (unfavourable)	Mixed	Mixed			thyroid gland: 7.6	Cell line enhanced		AN3-CA: 1.4;CACO-2: 1.2;HAP1: 1.4;HEK 293: 1.6;HHSteC: 1.7;MCF7: 1.2
PRDM2	HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2	ENSG00000116731	PR/SET domain 2	1	13700198-13825079	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005809	Approved		Approved	Nucleus<br>Golgi apparatus		Expressed in all	Expressed in all			bone marrow: 51.2	Expressed in all		
PRDM4	PFM1	ENSG00000110851	PR/SET domain 4	12	107732866-107761272	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024322, HPA067437	Approved		Supported	Nucleoplasm	Renal cancer:3.15e-7 (favourable), Liver cancer:1.86e-4 (unfavourable), Melanoma:7.66e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 90.0	Expressed in all		
PRDM5	PFM2	ENSG00000138738	PR/SET domain 5	4	120684919-120922870	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051406	Enhanced		Supported	Nucleus<br>Nucleoli<br>Nuclear bodies		Mixed	Mixed			parathyroid gland: 20.7	Mixed		
PRDM6	KMT8C, PRISM	ENSG00000061455	PR/SET domain 6	5	123089121-123194266	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030322, HPA030324	Uncertain		Uncertain	Nucleoplasm		Mixed	Tissue enhanced		gallbladder: 5.2;placenta: 5.9	lung: 4.0	Cell line enhanced		BEWO: 3.5;HEK 293: 4.7
PRDM8	KMT8D	ENSG00000152784	PR/SET domain 8	4	80183879-80204329	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057253			Approved	Nuclear bodies		Tissue enhanced	Tissue enhanced		prostate: 40.8;seminal vesicle: 37.7	cerebral cortex: 23.2	Cell line enhanced		LHCN-M2: 34.7;NB-4: 30.5;SCLC-21H: 116.7
PRDM9	KMT8B, MSBP3, PFM6, ZNF899	ENSG00000164256	PR/SET domain 9	5	23443586-23528597	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059555	Uncertain					Not detected	Group enriched	7	epididymis: 1.7;testis: 7.1	bone marrow: 0.6	Cell line enriched	7	U-266/70: 5.0
PROP1		ENSG00000175325	PROP paired-like homeobox 1	5	177992235-177996242	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049839	Supported					Not detected	Not detected			all non-specific tissues: 0.0	Not detected		
PROX1		ENSG00000117707	Prospero homeobox 1	1	213983181-214041502	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000842, HPA001030			Supported	Nucleoplasm		Tissue enhanced	Tissue enhanced		liver: 45.3	adrenal gland: 13.3	Cell line enhanced		Hep G2: 21.7;RH-30: 15.7;SH-SY5Y: 83.1
PROX2	FLJ36749	ENSG00000119608	Prospero homeobox 2	14	74852871-74871940	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045057	Uncertain					Not detected	Mixed			skin: 2.4	Cell line enhanced		AF22: 1.8
PRRX1	PHOX1, PMX1	ENSG00000116132	Paired related homeobox 1	1	170662728-170739419	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051084, HPA063566	Uncertain		Supported	Nucleoplasm	Renal cancer:6.60e-10 (unfavourable)	Mixed	Mixed			cervix, uterine: 135.8	Cell line enhanced		ASC diff: 240.8;ASC TERT1: 194.6;BJ hTERT+: 165.0;U-138 MG: 137.1;U-2197: 125.0
PRRX2	PMX2, PRX2	ENSG00000167157	Paired related homeobox 2	9	129665641-129722674	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA006607, HPA026808	Approved		Approved	Nucleoplasm<br>Nuclear bodies		Mixed	Tissue enhanced		cervix, uterine: 9.9;skin: 10.7	testis: 6.3	Cell line enhanced		BJ: 24.1;BJ hTERT+: 16.5;fHDF/TERT166: 32.1;U-2197: 31.5
PSPC1	FLJ10955, PSP1	ENSG00000121390	Paraspeckle component 1	13	19674752-19783019	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038904	Supported		Approved	Nucleoplasm<br>Nucleoli fibrillar center	Thyroid cancer:1.46e-4 (favourable), Liver cancer:2.21e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 45.5	Expressed in all		
PTF1A	bHLHa29, PTF1-p48	ENSG00000168267	Pancreas specific transcription factor, 1a	10	23192327-23194252	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB022612			Approved	Nucleoplasm		Tissue enhanced	Tissue enriched	6	pancreas: 18.2	testis: 3.1	Cell line enriched	10	U-2 OS: 2.6
PURA	PUR-ALPHA, PUR1, PURALPHA	ENSG00000185129	Purine rich element binding protein A	5	140107777-140125619	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:4.77e-5 (favourable)	Expressed in all	Mixed			parathyroid gland: 26.9	Expressed in all		
PURB	PURBETA	ENSG00000146676	Purine rich element binding protein B	7	44876293-44885361	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048766			Supported	Nucleus		Expressed in all	Expressed in all			cerebral cortex: 24.5	Expressed in all		
PURG	PURG-A, PURG-B	ENSG00000172733	Purine rich element binding protein G	8	30995802-31033715	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047746	Uncertain		Approved	Nucleus<br>Nucleoli<br>Plasma membrane		Tissue enhanced	Tissue enhanced		cerebral cortex: 6.6;testis: 4.8	endometrium: 2.6	Cell line enhanced		AF22: 6.0;NTERA-2: 4.8;SH-SY5Y: 6.0
RARA	NR1B1, RAR	ENSG00000131759	Retinoic acid receptor alpha	17	40309192-40357643	Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058282			Supported	Nucleus<br>Cytosol	Endometrial cancer:2.60e-4 (favourable)	Expressed in all	Expressed in all			gallbladder: 68.6	Expressed in all		
RARB	HAP, NR1B2, RRB2	ENSG00000077092	Retinoic acid receptor beta	3	25174332-25597932	Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002617, HPA004174	Enhanced		Enhanced	Nucleoplasm	Renal cancer:3.43e-5 (favourable)	Expressed in all	Mixed			placenta: 20.6	Cell line enhanced		HEK 293: 14.7;HUVEC TERT2: 11.2;WM-115: 36.1
RARG	NR1B3, RARC	ENSG00000172819	Retinoic acid receptor gamma	12	53210567-53232980	Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053883	Supported		Supported	Nucleoplasm	Renal cancer:3.08e-6 (unfavourable), Endometrial cancer:3.68e-6 (unfavourable)	Expressed in all	Tissue enhanced		skin: 143.4	esophagus: 77.3	Mixed		
RAX	RX	ENSG00000134438	Retina and anterior neural fold homeobox	18	59267035-59274086	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Not detected			prostate: 0.2	Cell line enhanced		HMC-1: 1.6;SH-SY5Y: 1.0
RAX2	ARMD6, CORD11, MGC15631, RAXL1	ENSG00000173976	Retina and anterior neural fold homeobox 2	19	3769089-3772221	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052533	Uncertain					Not detected	Tissue enhanced		parathyroid gland: 1.2	fallopian tube: 0.7	Not detected		
RBAK	ZNF769	ENSG00000146587	RB associated KRAB zinc finger	7	5045821-5069488	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071231			Supported	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 14.8	Expressed in all		
RBPJ	CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH	ENSG00000168214	Recombination signal binding protein for immunoglobulin kappa J region	4	26163455-26435131	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060647			Supported	Nucleoplasm	Endometrial cancer:2.98e-4 (favourable)	Expressed in all	Expressed in all			placenta: 77.2	Expressed in all		
RBPJL	RBP-L, RBPSUHL, SUH, SUHL	ENSG00000124232	Recombination signal binding protein for immunoglobulin kappa J region like	20	45306851-45317824	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB006846	Enhanced					Group enriched	Tissue enriched	151	pancreas: 205.8	stomach: 1.3	Not detected		
RC3H2	FLJ20301, FLJ20713, MNAB, RNF164	ENSG00000056586	Ring finger and CCCH-type domains 2	9	122844556-122905341	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042863, HPA062144	Approved		Supported	Vesicles	Renal cancer:5.50e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 25.5	Expressed in all		
RCOR2		ENSG00000167771	REST corepressor 2	11	63911221-63916844	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021638	Uncertain		Approved	Nucleus<br>Vesicles<br>Midbody		Mixed	Tissue enhanced		cerebral cortex: 13.2	testis: 3.7	Cell line enhanced		AF22: 39.9;NTERA-2: 52.3;SCLC-21H: 95.8;SH-SY5Y: 57.5
RCOR3	FLJ10876	ENSG00000117625	REST corepressor 3	1	211258377-211316385	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007413, HPA071997	Enhanced		Approved	Nucleus<br>Nucleoli	Glioma:1.92e-5 (favourable), Lung cancer:5.75e-5 (favourable)	Expressed in all	Expressed in all			testis: 66.3	Expressed in all		
REL	c-Rel, I-Rel	ENSG00000162924	REL proto-oncogene, NF-kB subunit	2	60881521-60931610	Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors	Evidence at protein level	CAB004404	Uncertain					Mixed	Mixed			bone marrow: 29.8	Expressed in all		
RELA	NFKB3, p65	ENSG00000173039	RELA proto-oncogene, NF-kB subunit	11	65653596-65663094	Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors	Evidence at protein level	CAB004264, CAB005030, HPA063461	Supported		Enhanced	Cytosol	Renal cancer:5.66e-4 (unfavourable), Liver cancer:9.18e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 62.5	Expressed in all		
RELB	REL-B	ENSG00000104856	RELB proto-oncogene, NF-kB subunit	19	45001430-45038198	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB007753, HPA040506	Approved		Approved	Nucleoplasm<br>Cytosol	Renal cancer:2.99e-6 (unfavourable), Breast cancer:1.55e-4 (favourable)	Expressed in all	Expressed in all			appendix: 25.1	Cell line enhanced		HDLM-2: 73.5
RERE	ARG, ARP, ATN1L, DNB1, KIAA0458	ENSG00000142599	Arginine-glutamic acid dipeptide repeats	1	8352397-8817643	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024093	Uncertain					Expressed in all	Expressed in all			endometrium: 93.2	Expressed in all		
REST	NRSF, XBR	ENSG00000084093	RE1 silencing transcription factor	4	56907876-56966678	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006079, CAB068222	Supported		Approved	Nucleoplasm<br>Cytosol	Renal cancer:9.50e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 32.2	Mixed		
RFX1	EF-C	ENSG00000132005	Regulatory factor X1	19	13961538-14007039	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048722	Approved		Supported	Nucleoplasm	Head and neck cancer:2.42e-4 (favourable), Pancreatic cancer:4.92e-4 (favourable)	Expressed in all	Expressed in all			testis: 16.8	Expressed in all		
RFX2	FLJ14226	ENSG00000087903	Regulatory factor X2	19	5993164-6199572	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048969	Enhanced		Approved	Nucleoplasm<br>Golgi apparatus<br>Cytosol	Endometrial cancer:2.67e-4 (favourable), Cervical cancer:2.80e-4 (favourable), Pancreatic cancer:7.36e-4 (favourable)	Mixed	Tissue enhanced		testis: 93.1	fallopian tube: 32.8	Cell line enhanced		SCLC-21H: 27.7
RFX3		ENSG00000080298	Regulatory factor X3	9	3218297-3526004	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035689	Enhanced		Approved	Nucleoplasm<br>Vesicles	Breast cancer:1.47e-4 (favourable)	Mixed	Tissue enhanced		testis: 38.6	fallopian tube: 18.3	Cell line enhanced		AF22: 26.0;SCLC-21H: 16.6
RFX4		ENSG00000111783	Regulatory factor X4	12	106582907-106762803	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050527	Enhanced		Approved	Nucleus		Tissue enriched	Group enriched	236	cerebral cortex: 30.8;testis: 135.8	prostate: 0.3	Cell line enriched	13	AF22: 47.1
RFX5		ENSG00000143390	Regulatory factor X5	1	151340640-151347357	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018519	Supported					Expressed in all	Expressed in all			lymph node: 85.6	Expressed in all		
RFX6	dJ955L16.1, MGC33442, RFXDC1	ENSG00000185002	Regulatory factor X6	6	116877212-116932163	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA037696, HPA037697	Approved		Supported	Nucleus<br>Nucleoli	Pancreatic cancer:3.59e-4 (favourable)	Tissue enhanced	Tissue enhanced		adrenal gland: 5.9;stomach: 7.2	duodenum: 2.3	Cell line enhanced		HEK 293: 1.2
RFX7	FLJ12994, RFXDC2	ENSG00000181827	Regulatory factor X7	15	56087280-56243266	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035462	Supported		Approved	Nucleus<br>Nuclear membrane	Renal cancer:1.12e-5 (unfavourable)	Expressed in all	Mixed			testis: 8.2	Expressed in all		
RFX8	FLJ42986	ENSG00000196460	RFX family member 8, lacking RFX DNA binding domain	2	101397361-101474703	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059745			Approved	Nucleoplasm<br>Nuclear bodies		Mixed	Tissue enhanced		bone marrow: 2.6	testis: 1.3	Cell line enhanced		hTEC/SVTERT24-B: 13.4;LHCN-M2: 5.8;U-87 MG: 8.3
RFXANK	ANKRA1, BLS, F14150_1, MGC138628, RFX-B	ENSG00000064490	Regulatory factor X associated ankyrin containing protein	19	19192229-19201869	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049157, HPA053330	Approved		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			fallopian tube: 50.1	Expressed in all		
RFXAP		ENSG00000133111	Regulatory factor X associated protein	13	36819224-36829104	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA032035			Approved	Nuclear speckles	Lung cancer:2.26e-5 (favourable), Pancreatic cancer:4.18e-4 (favourable), Stomach cancer:4.91e-4 (favourable)	Expressed in all	Mixed			testis: 12.2	Expressed in all		
RHOXF1	OTEX, PEPP1	ENSG00000101883	Rhox homeobox family member 1	X	120109053-120115937	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056506	Approved					Mixed	Tissue enriched	9	testis: 15.5	adipose tissue: 1.6	Not detected		
RHOXF2	CT107, PEPP-2, PEPP2, THG1	ENSG00000131721	Rhox homeobox family member 2	X	120158561-120165630	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003314, CAB020794	Enhanced					Tissue enhanced	Tissue enriched	184	testis: 20.8	skin: 0.1	Cell line enhanced		K-562: 209.3;NB-4: 108.3;THP-1: 42.9;U-266/84: 73.5
RHOXF2B		ENSG00000203989	Rhox homeobox family member 2B	X	120070672-120077705	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003314	Supported					Not detected	Tissue enriched	19	testis: 2.7	ovary,skin,spleen: 0.1	Group enriched	341	HL-60: 168.7;K-562: 191.8;NB-4: 216.8
RLF	Zn-15L, ZNF292L	ENSG00000117000	Rearranged L-myc fusion	1	40161373-40240921	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054653, HPA057300	Uncertain		Approved	Nucleus	Renal cancer:7.68e-6 (unfavourable), Liver cancer:1.75e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 20.8	Expressed in all		
RORA	NR1F1, ROR1, ROR2, ROR3, RZRA	ENSG00000069667	RAR related orphan receptor A	15	60488284-61229319	Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009861	Approved				Renal cancer:5.42e-6 (favourable)	Mixed	Expressed in all			skin: 76.3	Cell line enhanced		Karpas-707: 52.5;U-266/70: 31.7;U-266/84: 43.2
RORB	NR1F2, ROR-BETA, RZRB	ENSG00000198963	RAR related orphan receptor B	9	74497365-74693177	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008393	Uncertain		Approved	Nucleus		Group enriched	Tissue enhanced		cerebral cortex: 12.6;cervix, uterine: 14.1	prostate: 7.4	Cell line enhanced		HHSteC: 18.9;HSkMC: 9.0;MOLT-4: 5.5;SH-SY5Y: 14.3
RORC	NR1F3, RORG, RZRG, TOR	ENSG00000143365	RAR related orphan receptor C	1	151806071-151831872	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA065620			Supported	Nuclear bodies	Renal cancer:2.94e-5 (favourable), Colorectal cancer:1.83e-4 (favourable)	Mixed	Mixed			thyroid gland: 50.4	Cell line enhanced		HDLM-2: 24.3;Karpas-707: 9.4;MOLT-4: 5.6;T-47d: 10.0
RREB1	HNT	ENSG00000124782	Ras responsive element binding protein 1	6	7107597-7251980	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001756, HPA034843	Approved		Supported	Nucleoli fibrillar center<br>Nuclear speckles	Renal cancer:1.41e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 23.1	Mixed		
RUNX1	AML1, AMLCR1, CBFA2, PEBP2A2	ENSG00000159216	Runt related transcription factor 1	21	34787801-36004667	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004176, HPA037912	Enhanced		Enhanced	Nucleoplasm<br>Vesicles	Renal cancer:3.44e-15 (unfavourable)	Expressed in all	Mixed			breast: 34.0	Cell line enhanced		HEL: 225.2
RUNX2	AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1	ENSG00000124813	Runt related transcription factor 2	6	45328157-45664349	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB008374, HPA022040, CAB062561, CAB068226	Enhanced		Enhanced	Nucleoplasm	Renal cancer:3.97e-9 (unfavourable), Urothelial cancer:6.66e-5 (unfavourable), Stomach cancer:2.24e-4 (unfavourable)	Mixed	Mixed			cervix, uterine: 10.6	Cell line enhanced		Karpas-707: 54.6;RH-30: 54.1;U-698: 41.3
RUNX3	AML2, CBFA3, PEBP2A3	ENSG00000020633	Runt related transcription factor 3	1	24899511-24965121	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004195, CAB025416, HPA059006	Enhanced		Supported	Nucleus<br>Cytosol	Renal cancer:5.59e-5 (unfavourable), Colorectal cancer:8.71e-4 (unfavourable)	Expressed in all	Tissue enhanced		spleen: 50.5	bone marrow: 45.2	Cell line enhanced		HDLM-2: 125.1;Karpas-707: 125.3;SK-MEL-30: 77.0
RXRA	NR2B1	ENSG00000186350	Retinoid X receptor alpha	9	134317098-134440585	Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004565, CAB005352	Supported		Supported	Nucleus<br>Golgi apparatus	Renal cancer:5.58e-4 (unfavourable), Pancreatic cancer:7.02e-4 (favourable)	Expressed in all	Mixed			esophagus: 25.8	Mixed		
RXRB	H-2RIIBP, NR2B2, RCoR-1	ENSG00000204231	Retinoid X receptor beta	6	33193588-33200688	Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002003, HPA063653	Supported		Supported	Nucleus		Expressed in all	Mixed			epididymis: 15.7	Cell line enhanced		RH-30: 8.5;T-47d: 8.2
RXRG	NR2B3	ENSG00000143171	Retinoid X receptor gamma	1	165400917-165445355	Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002615, HPA012933	Uncertain		Supported	Nucleoplasm<br>Nuclear bodies	Thyroid cancer:9.40e-5 (favourable)	Group enriched	Tissue enhanced		skeletal muscle: 16.7	cervix, uterine: 4.7	Cell line enriched	6	SK-MEL-30: 29.1
SALL1	Hsal1, TBS, ZNF794	ENSG00000103449	Spalt like transcription factor 1	16	51135975-51151367	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049829	Uncertain		Approved	Nucleus<br>Cytosol	Renal cancer:1.91e-7 (favourable), Endometrial cancer:1.28e-4 (favourable)	Group enriched	Tissue enhanced		thyroid gland: 40.1	cerebral cortex: 30.3	Cell line enhanced		AF22: 29.2;NTERA-2: 48.0;RPTEC TERT1: 30.7;U-87 MG: 45.3
SALL2	Hsal2, KIAA0360, ZNF795	ENSG00000165821	Spalt like transcription factor 2	14	21521081-21537216	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004162	Approved		Approved	Nucleus<br>Vesicles	Pancreatic cancer:1.23e-4 (favourable), Endometrial cancer:3.97e-4 (unfavourable)	Mixed	Tissue enhanced		parathyroid gland: 67.9	cerebral cortex: 42.4	Cell line enhanced		AF22: 123.9;NTERA-2: 95.1;SCLC-21H: 50.0
SALL3	ZNF796	ENSG00000256463	Spalt like transcription factor 3	18	78980275-79002677	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016656	Uncertain					Tissue enriched	Tissue enhanced		cerebral cortex: 4.1;prostate: 2.0	kidney: 0.9	Group enriched	29	HAP1: 4.8;HEK 293: 2.5;NTERA-2: 9.5
SALL4	dJ1112F19.1, ZNF797	ENSG00000101115	Spalt like transcription factor 4	20	51782331-51802520	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015291, HPA015791	Enhanced		Enhanced	Nucleoplasm		Tissue enriched	Group enriched	7	parathyroid gland: 6.7;prostate: 1.4;testis: 5.8;thyroid gland: 3.5	urinary bladder: 0.6	Cell line enhanced		AF22: 24.7;AN3-CA: 16.2;BEWO: 32.0;NTERA-2: 60.1;SiHa: 16.5
SATB1		ENSG00000182568	SATB homeobox 1	3	18345387-18445588	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA051769, CAB056144	Supported		Supported	Nucleoplasm<br>Nuclear bodies	Renal cancer:1.96e-7 (favourable), Pancreatic cancer:8.97e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 76.6	Cell line enhanced		HDLM-2: 421.9;REH: 115.4;THP-1: 129.6
SATB2	FLJ21474, KIAA1034	ENSG00000119042	SATB homeobox 2	2	199269500-199471266	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231	Enhanced		Supported	Nucleoplasm	Renal cancer:5.37e-8 (favourable)	Tissue enhanced	Group enriched	5	cerebral cortex: 22.7;colon: 34.1;rectum: 43.2	small intestine: 6.3	Mixed		
SCRT1	DKFZp547F072, ZNF898	ENSG00000261678	Scratch family transcriptional repressor 1	8	144330565-144336281	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045265	Uncertain		Supported	Nuclear bodies		Tissue enhanced	Tissue enriched	7	cerebral cortex: 10.9	adrenal gland: 1.5	Group enriched	12	SCLC-21H: 11.4;SH-SY5Y: 2.3
SCRT2	ZNF898B	ENSG00000215397	Scratch family transcriptional repressor 2	20	661596-676179	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA067697			Approved	Nucleoplasm		Tissue enriched	Not detected			cerebral cortex: 0.6	Group enriched	5	Karpas-707: 1.4;NTERA-2: 1.8;RPMI-8226: 2.8;SCLC-21H: 2.2;SH-SY5Y: 2.1
SCX	bHLHa41, bHLHa48, SCXA, SCXB	ENSG00000260428	Scleraxis bHLH transcription factor	8	144266560-144268481	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA043183	Uncertain				Glioma:2.46e-4 (unfavourable)	Group enriched	Tissue enhanced		skeletal muscle: 5.3	parathyroid gland: 2.9	Cell line enhanced		BEWO: 4.9;HaCaT: 5.0
SFPQ	PPP1R140, PSF	ENSG00000116560	Splicing factor proline and glutamine rich	1	35176378-35193148	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009886, HPA047513, HPA054689	Enhanced		Enhanced	Nucleoplasm	Liver cancer:7.91e-13 (unfavourable), Breast cancer:9.56e-5 (favourable)	Expressed in all	Expressed in all			bone marrow: 135.5	Expressed in all		
SHOX	GCFX, PHOG, SHOXY, SS	ENSG00000185960	Short stature homeobox	X	624344-659411	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035141, HPA060931			Enhanced	Nucleoplasm<br>Vesicles		Not detected	Mixed			spleen: 1.0	Cell line enhanced		BJ: 19.3;BJ hTERT+: 9.5
SHOX2	OG12, OG12X, SHOT	ENSG00000168779	Short stature homeobox 2	3	158095954-158106503	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Tissue enhanced		adipose tissue: 4.1;testis: 3.3	cervix, uterine: 2.8	Cell line enhanced		SH-SY5Y: 26.1;THP-1: 28.6
SIM1	bHLHe14	ENSG00000112246	Single-minded family bHLH transcription factor 1	6	100385015-100464929	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA024385			Approved	Nuclear speckles	Renal cancer:5.32e-7 (favourable)	Tissue enhanced	Tissue enhanced		epididymis: 3.5;kidney: 11.2;seminal vesicle: 3.2	skeletal muscle: 1.2	Cell line enhanced		BJ: 13.9;BJ hTERT+: 19.3;RPTEC TERT1: 13.9
SIM2	bHLHe15, MGC119447, SIM	ENSG00000159263	Single-minded family bHLH transcription factor 2	21	36699133-36749917	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029295	Approved		Supported	Nucleoplasm<br>Nuclear bodies	Endometrial cancer:2.10e-4 (unfavourable), Urothelial cancer:2.88e-4 (favourable)	Tissue enhanced	Tissue enhanced		esophagus: 22.8;kidney: 13.0;prostate: 10.3	stomach: 5.1	Cell line enhanced		PC-3: 40.7;RPTEC TERT1: 41.3;RT4: 26.9
SIX1	DFNA23	ENSG00000126778	SIX homeobox 1	14	60643415-60658259	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001893, CAB058690	Enhanced		Supported	Nucleus<br>Nucleoli	Endometrial cancer:8.92e-6 (unfavourable), Lung cancer:3.94e-4 (favourable)	Mixed	Group enriched	6	cervix, uterine: 21.9;parathyroid gland: 53.5;prostate: 21.2;salivary gland: 21.6;skeletal muscle: 41.5	adipose tissue: 5.6	Cell line enhanced		LHCN-M2: 118.6;RH-30: 69.5
SIX2		ENSG00000170577	SIX homeobox 2	2	45005161-45009430	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056958			Supported	Nucleoplasm<br>Nuclear membrane		Mixed	Group enriched	5	cervix, uterine: 18.7;parathyroid gland: 8.6;prostate: 6.3;salivary gland: 9.4;skeletal muscle: 6.7	adipose tissue: 1.9	Cell line enhanced		ASC TERT1: 34.1;LHCN-M2: 39.0;RH-30: 30.9;SCLC-21H: 63.8;U-2197: 32.8;U-698: 29.5
SIX3	HPE2	ENSG00000138083	SIX homeobox 3	2	44941898-44946077	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067988			Approved	Nucleoplasm		Mixed	Tissue enriched	31	parathyroid gland: 39.3	cervix, uterine: 1.2	Cell line enhanced		HAP1: 12.7;SCLC-21H: 77.1;SH-SY5Y: 27.8
SIX4	AREC3	ENSG00000100625	SIX homeobox 4	14	60709528-60724348	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031794	Uncertain		Approved	Nucleoplasm		Mixed	Tissue enriched	5	parathyroid gland: 23.9	skeletal muscle: 4.7	Cell line enhanced		A-431: 29.3;RH-30: 31.5
SIX5	DMAHP	ENSG00000177045	SIX homeobox 5	19	45764785-45769226	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042068	Approved					Expressed in all	Mixed			ovary: 33.7	Mixed		
SIX6	OPTX2, Six9	ENSG00000184302	SIX homeobox 6	14	60508951-60512850	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001403	Approved		Approved	Nucleoplasm		Tissue enriched	Not detected			testis: 0.1	Cell line enriched	14	MOLT-4: 33.0
SMAD1	JV4-1, MADH1, MADR1	ENSG00000170365	SMAD family member 1	4	145481194-145558079	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005389	Approved		Supported	Nucleus<br>Plasma membrane<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 67.4	Cell line enhanced		HUVEC TERT2: 94.6
SMAD2	JV18-1, MADH2, MADR2	ENSG00000175387	SMAD family member 2	18	47808957-47931146	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	CAB025507, HPA067203, CAB073546	Approved		Supported	Nucleus<br>Nucleoli<br>Cytosol	Liver cancer:9.44e-5 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 126.7	Expressed in all		
SMAD3	HsT17436, JV15-2, MADH3	ENSG00000166949	SMAD family member 3	15	67063763-67195195	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB008094, HPA046386, HPA067203, CAB069409	Approved		Enhanced	Nucleoplasm<br>Cytosol	Pancreatic cancer:2.48e-4 (unfavourable)	Expressed in all	Expressed in all			esophagus: 54.2	Expressed in all		
SMAD4	DPC4, MADH4	ENSG00000141646	SMAD family member 4	18	51028394-51085045	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA019154	Approved		Supported	Nucleoplasm<br>Centrosome<br>Cytosol	Renal cancer:1.92e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 39.3	Expressed in all		
SMAD5	Dwfc, JV5-1, MADH5	ENSG00000113658	SMAD family member 5	5	136132845-136188747	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058931	Approved		Supported	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			endometrium: 43.1	Expressed in all		
SMAD6	HsT17432, MADH6, MADH7	ENSG00000137834	SMAD family member 6	15	66702228-66782848	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA061917			Supported	Nucleus<br>Nuclear bodies<br>Golgi apparatus	Urothelial cancer:5.45e-5 (favourable)	Expressed in all	Tissue enhanced		lung: 16.8	placenta: 10.7	Cell line enhanced		EFO-21: 28.0
SMAD7	MADH7, MADH8	ENSG00000101665	SMAD family member 7	18	48919853-48950711	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB026212, HPA028897	Approved		Supported	Nucleoplasm<br>Cytosol	Endometrial cancer:5.61e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 42.0	Mixed		
SMAD9	MADH6, MADH9, SMAD8, SMAD8/9	ENSG00000120693	SMAD family member 9	13	36844831-36920765	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009119, HPA031162	Approved		Supported	Nucleoplasm<br>Cytosol	Glioma:4.39e-4 (favourable), Thyroid cancer:4.92e-4 (unfavourable)	Mixed	Tissue enhanced		thyroid gland: 62.8	prostate: 22.2	Cell line enhanced		SH-SY5Y: 41.4
SMARCA1	hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI	ENSG00000102038	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1	X	129446501-129523500	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003335, HPA064712	Uncertain		Supported	Nucleoplasm<br>Vesicles	Pancreatic cancer:3.03e-4 (favourable), Renal cancer:5.09e-4 (favourable)	Expressed in all	Mixed			testis: 113.1	Mixed		
SMARCA5	hISWI, hSNF2H, ISWI	ENSG00000153147	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	4	143513463-143557486	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005227, HPA008751	Supported		Supported	Nucleus<br>Nucleoli fibrillar center	Liver cancer:1.61e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 59.1	Expressed in all		
SMARCC1	BAF155, CRACC1, Rsc8, SRG3	ENSG00000173473	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1	3	47585272-47782106	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB011576, CAB016336, HPA024352, HPA026853	Enhanced		Enhanced	Nucleoplasm	Colorectal cancer:3.34e-4 (favourable), Liver cancer:3.37e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 36.1	Expressed in all		
SMARCC2	BAF170, CRACC2, Rsc8	ENSG00000139613	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2	12	56162983-56189567	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004321, HPA021213, HPA061788	Supported		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			cerebral cortex: 76.8	Expressed in all		
SMARCE1	BAF57	ENSG00000073584	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1	17	40624962-40648508	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003916, CAB037318	Enhanced		Supported	Nucleoplasm		Expressed in all	Expressed in all			endometrium: 74.3	Expressed in all		
SNAI1	SLUGH2, SNA, SNAH, SNAIL, SNAIL1	ENSG00000124216	Snail family transcriptional repressor 1	20	49982999-49988886	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005883, HPA056831, HPA069985, CAB078687	Supported		Supported	Nucleus<br>Cytosol	Renal cancer:2.63e-7 (unfavourable), Thyroid cancer:8.82e-7 (unfavourable), Lung cancer:1.61e-5 (unfavourable), Colorectal cancer:4.76e-4 (unfavourable)	Expressed in all	Tissue enhanced		gallbladder: 26.2	thyroid gland: 13.4	Cell line enhanced		SiHa: 30.1;TIME: 32.4;WM-115: 25.0
SNAI2	SLUG, SLUGH, SLUGH1, SNAIL2	ENSG00000019549	Snail family transcriptional repressor 2	8	48917768-48921740	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB011671	Supported		Approved	Nucleus	Renal cancer:4.69e-8 (unfavourable), Urothelial cancer:7.16e-4 (unfavourable), Pancreatic cancer:7.83e-4 (unfavourable)	Expressed in all	Mixed			cervix, uterine: 71.0	Cell line enhanced		ASC diff: 194.2;ASC TERT1: 202.4;LHCN-M2: 229.9;U-138 MG: 243.9
SNAI3	SMUC, Zfp293, ZNF293	ENSG00000185669	Snail family transcriptional repressor 3	16	88677682-88686493	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA071127			Approved	Nucleoplasm	Cervical cancer:1.39e-4 (favourable), Pancreatic cancer:3.58e-4 (favourable)	Mixed	Tissue enhanced		skeletal muscle: 10.9	lymph node: 4.3	Cell line enhanced		NB-4: 11.5;RPMI-8226: 19.9
SNAPC4	FLJ13451, PTFalpha, SNAP190	ENSG00000165684	Small nuclear RNA activating complex polypeptide 4	9	136375577-136400168	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046627, HPA073243	Uncertain		Approved	Nucleoplasm<br>Nuclear membrane	Pancreatic cancer:4.52e-5 (favourable)	Expressed in all	Expressed in all			testis: 20.6	Expressed in all		
SOHLH1	bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2	ENSG00000165643	Spermatogenesis and oogenesis specific basic helix-loop-helix 1	9	135693407-135699528	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059439			Approved	Nuclear speckles		Mixed	Group enriched	27	cerebral cortex: 6.3;testis: 13.4	skin: 0.3	Group enriched	36	CACO-2: 14.6;U-266/84: 19.8
SOHLH2	bHLHe81, FLJ20449, SPATA28, TEB1	ENSG00000120669	Spermatogenesis and oogenesis specific basic helix-loop-helix 2	13	36168208-36214615	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA029182						Mixed	Tissue enriched	15	testis: 46.2	prostate: 3.0	Cell line enhanced		A-431: 7.0;HL-60: 8.5;Karpas-707: 8.3;NB-4: 9.8;U-266/84: 11.1
SOX1		ENSG00000182968	SRY-box 1	13	112067647-112070488	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Group enriched	Group enriched	8	cerebral cortex: 3.6;testis: 1.5	skin: 0.3	Group enriched	6	AF22: 44.0;SCLC-21H: 10.1
SOX10	DOM, WS2E, WS4	ENSG00000100146	SRY-box 10	22	37970686-37987422	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB003171, HPA068898	Enhanced		Supported	Nucleoplasm		Not detected	Tissue enhanced		cerebral cortex: 56.6;salivary gland: 50.5	breast: 24.0	Group enriched	686	SK-MEL-30: 236.8;WM-115: 425.1
SOX11		ENSG00000176887	SRY-box 11	2	5692667-5701385	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000536, CAB056152, CAB056153	Approved					Group enriched	Tissue enriched	15	cerebral cortex: 5.4	smooth muscle: 0.3	Group enriched	7	AF22: 48.1;NTERA-2: 23.8;REH: 16.5;RH-30: 18.0;SCLC-21H: 35.0;SH-SY5Y: 47.7;WM-115: 11.2
SOX12	SOX22	ENSG00000177732	SRY-box 12	20	325595-330224	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055052, HPA061627			Supported	Nucleoplasm	Liver cancer:6.64e-5 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 10.7	Mixed		
SOX13	ICA12, MGC117216, Sox-13	ENSG00000143842	SRY-box 13	1	204073115-204127743	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051790, HPA054843			Enhanced	Nucleoplasm	Colorectal cancer:6.49e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 53.8	Cell line enhanced		SK-BR-3: 103.3
SOX14	SOX28	ENSG00000168875	SRY-box 14	3	137764284-137766338	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Group enriched	19	placenta: 2.4;prostate: 1.2	all non-specific tissues: 0.0	Not detected		
SOX15	SOX20, SOX26, SOX27	ENSG00000129194	SRY-box 15	17	7588178-7590170	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067196, HPA074049	Enhanced		Supported	Nucleus<br>Nucleoli<br>Golgi apparatus<br>Vesicles		Tissue enhanced	Tissue enhanced		skin: 40.5	esophagus: 17.5	Group enriched	8	A-431: 108.6;HaCaT: 120.2;HBEC3-KT: 39.0;hTCEpi: 38.2
SOX17		ENSG00000164736	SRY-box 17	8	54457935-54460888	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB025594, HPA068399	Enhanced		Approved	Nucleoplasm	Endometrial cancer:2.76e-4 (favourable)	Group enriched	Tissue enhanced		cervix, uterine: 30.2;endometrium: 32.2;fallopian tube: 30.1	adipose tissue: 14.7	Cell line enriched	8	EFO-21: 102.6
SOX18		ENSG00000203883	SRY-box 18	20	64047582-64049641	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA073703			Approved	Nucleus		Expressed in all	Tissue enhanced		adipose tissue: 32.9	lung: 12.0	Cell line enhanced		HUVEC TERT2: 17.4;NB-4: 22.5;REH: 7.7;TIME: 7.8
SOX2		ENSG00000181449	SRY-box 2	3	181711924-181714436	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB010648, HPA045725, HPA071379	Approved	Supported	Supported	Nucleoplasm		Tissue enhanced	Tissue enriched	8	cerebral cortex: 117.9	esophagus: 14.8	Cell line enhanced		AF22: 273.3;HAP1: 122.7;NTERA-2: 226.0
SOX21	SOX25	ENSG00000125285	SRY-box 21	13	94709622-94712399	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA048337, HPA064084	Approved		Approved	Nucleus	Glioma:1.34e-4 (favourable), Cervical cancer:7.60e-4 (favourable)	Tissue enhanced	Group enriched	6	cerebral cortex: 17.9;esophagus: 6.9;skin: 19.4;stomach: 33.4	tonsil: 3.1	Cell line enhanced		AF22: 80.6;HAP1: 12.8;NTERA-2: 22.0;PC-3: 11.6
SOX3	PHP	ENSG00000134595	SRY-box 3	X	140502985-140505116	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054720, HPA075003			Enhanced	Nucleoplasm		Tissue enhanced	Tissue enriched	7	fallopian tube: 14.2	testis: 2.0	Group enriched	11	AF22: 7.2;HEK 293: 7.2;NTERA-2: 17.4
SOX30		ENSG00000039600	SRY-box 30	5	157625679-157671480	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006159, CAB009382	Enhanced					Mixed	Tissue enriched	94	testis: 144.4	fallopian tube: 1.5	Cell line enhanced		A-431: 1.7;CACO-2: 1.0;HDLM-2: 3.8
SOX4		ENSG00000124766	SRY-box 4	6	21592768-21598619	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029901	Approved		Supported	Nucleoplasm<br>Mitochondria	Liver cancer:2.57e-5 (unfavourable)	Expressed in all	Expressed in all			endometrium: 80.5	Cell line enhanced		AN3-CA: 194.4;MOLT-4: 151.8;SH-SY5Y: 123.8
SOX5	L-SOX5, MGC35153	ENSG00000134532	SRY-box 5	12	23529500-23951032	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060499			Supported	Nucleoplasm		Mixed	Tissue enhanced		testis: 58.4	cerebral cortex: 11.7	Cell line enhanced		AF22: 14.4;HDLM-2: 25.3;K-562: 15.1;WM-115: 13.9
SOX6		ENSG00000110693	SRY-box 6	11	15966449-16739591	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001923, HPA003908	Enhanced		Approved	Nucleoplasm	Renal cancer:6.47e-12 (favourable)	Mixed	Tissue enhanced		testis: 25.9	bone marrow: 16.5	Cell line enhanced		WM-115: 20.4
SOX7		ENSG00000171056	SRY-box 7	8	10723768-10730512	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009065	Approved		Approved	Nuclear speckles<br>Golgi apparatus		Expressed in all	Tissue enhanced		placenta: 49.6	lung: 18.7	Cell line enhanced		HaCaT: 21.1;HUVEC TERT2: 46.6;TIME: 36.3
SOX8		ENSG00000005513	SRY-box 8	16	981808-986979	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041640, HPA058665	Enhanced		Supported	Nucleus		Tissue enriched	Tissue enriched	29	cerebral cortex: 109.9	salivary gland: 3.8	Cell line enriched	5	RH-30: 112.8
SOX9	CMD1, CMPD1, SRA1	ENSG00000125398	SRY-box 9	17	72121020-72126420	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001758, CAB022456, CAB068240	Enhanced		Enhanced	Nucleoplasm	Lung cancer:2.07e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 61.3	Cell line enhanced		AN3-CA: 72.2;Hep G2: 65.5;U-251 MG: 54.6
SP1		ENSG00000185591	Sp1 transcription factor	12	53380176-53416446	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000330, HPA001853, HPA012292	Supported		Enhanced	Nucleoplasm	Pancreatic cancer:1.43e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 54.3	Expressed in all		
SP100		ENSG00000067066	SP100 nuclear antigen	2	230415942-230544090	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016707, HPA017384	Enhanced		Supported	Nucleus<br>Nuclear bodies	Renal cancer:1.61e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 139.6	Cell line enhanced		BJ hTERT+ SV40 Large T+ RasG12V: 274.7
SP110	IFI41, IFI75	ENSG00000135899	SP110 nuclear body protein	2	230167293-230225729	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047036, HPA058554	Approved		Supported	Nucleus	Renal cancer:1.17e-5 (unfavourable)	Expressed in all	Expressed in all			spleen: 66.3	Cell line enhanced		BJ hTERT+ SV40 Large T+ RasG12V: 94.0
SP140	LYSP100-A, LYSP100-B	ENSG00000079263	SP140 nuclear body protein	2	230203110-230313215	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006162, HPA067493	Enhanced		Approved	Nucleoli fibrillar center<br>Mitochondria		Mixed	Group enriched	6	appendix: 32.8;lymph node: 64.4;spleen: 38.3;tonsil: 50.7	urinary bladder: 7.6	Cell line enhanced		Daudi: 22.1;HDLM-2: 48.5;Karpas-707: 18.0;RPMI-8226: 11.2
SP140L		ENSG00000185404	SP140 nuclear body protein like	2	230327184-230403732	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055864	Uncertain		Approved	Nucleoplasm	Renal cancer:5.09e-10 (unfavourable)	Expressed in all	Mixed			spleen: 28.7	Mixed		
SP2	KIAA0048	ENSG00000167182	Sp2 transcription factor	17	47896150-47928957	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003357, CAB010245	Supported		Enhanced	Nucleoplasm<br>Vesicles	Renal cancer:1.82e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 40.3	Expressed in all		
SP3	SPR-2	ENSG00000172845	Sp3 transcription factor	2	173906459-173965702	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004580, HPA032145, HPA032146	Supported	Supported			Renal cancer:2.46e-5 (unfavourable)	Expressed in all	Expressed in all			cervix, uterine: 91.7	Expressed in all		
SP4	HF1B, MGC130008, MGC130009, SPR-1	ENSG00000105866	Sp4 transcription factor	7	21428034-21514822	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB010246, HPA040395	Uncertain		Enhanced	Nucleoplasm<br>Cytosol		Expressed in all	Mixed			parathyroid gland: 14.9	Cell line enhanced		REH: 24.6
SP5		ENSG00000204335	Sp5 transcription factor	2	170715351-170718078	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA074123			Approved	Nucleus<br>Nucleoli		Mixed	Tissue enhanced		endometrium: 3.9	stomach: 2.3	Group enriched	12	CACO-2: 23.0;Hep G2: 83.0
SP6	Epfn, KLF14	ENSG00000189120	Sp6 transcription factor	17	47844908-47855874	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024516, HPA044469			Supported	Nucleoplasm<br>Mitotic spindle<br>Centrosome	Lung cancer:2.11e-6 (unfavourable), Urothelial cancer:5.72e-4 (favourable), Stomach cancer:6.39e-4 (favourable)	Mixed	Tissue enhanced		placenta: 32.5;seminal vesicle: 14.7	skin: 7.2	Cell line enriched	5	BEWO: 88.4
SP7	osterix, OSX	ENSG00000170374	Sp7 transcription factor	12	53326575-53345315	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029964, HPA063202	Enhanced	Approved				Not detected	Tissue enhanced		testis: 1.3	parathyroid gland,thyroid gland: 0.4	Not detected		
SP8		ENSG00000164651	Sp8 transcription factor	7	20782283-20786886	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054006	Uncertain		Approved	Nucleus		Tissue enhanced	Tissue enriched	12	prostate: 10.5	skin: 0.8	Cell line enhanced		HUVEC TERT2: 5.3;NTERA-2: 13.0;PC-3: 20.5
SP9	ZNF990	ENSG00000217236	Sp9 transcription factor	2	174334946-174338492	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA062616	Uncertain		Approved	Mitochondria		Mixed	Tissue enhanced		fallopian tube: 1.4	skin: 0.9	Cell line enhanced		A549: 6.5;fHDF/TERT166: 4.2;THP-1: 7.8
SPDEF	bA375E1.3, PDEF	ENSG00000124664	SAM pointed domain containing ETS transcription factor	6	34537802-34556333	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055707			Supported	Nucleus<br>Nucleoli	Endometrial cancer:9.26e-9 (favourable)	Group enriched	Tissue enhanced		prostate: 172.4	breast: 42.6	Cell line enhanced		MCF7: 221.8;SK-BR-3: 144.8;T-47d: 145.8
SPI1	OF, PU.1, SFPI1, SPI-1, SPI-A	ENSG00000066336	Spi-1 proto-oncogene	11	47354860-47378576	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	CAB004079, HPA044653	Enhanced		Supported	Nucleoplasm	Renal cancer:2.07e-5 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 212.5	Cell line enhanced		HL-60: 125.6;HMC-1: 245.7;NB-4: 167.8;THP-1: 137.9;U-937: 90.6
SPIB	SPI-B	ENSG00000269404	Spi-B transcription factor	19	50418938-50431313	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018523	Uncertain				Head and neck cancer:2.14e-5 (favourable), Breast cancer:4.76e-5 (favourable)	Mixed	Tissue enhanced		appendix: 53.9;lymph node: 103.3;tonsil: 91.1	spleen: 39.2	Group enriched	10	Daudi: 119.1;HDLM-2: 99.4;Karpas-707: 37.4;U-698: 159.1
SPIC	MGC40611, SPI-C	ENSG00000166211	Spi-C transcription factor	12	101475421-101486997	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Tissue enriched	12	spleen: 46.7	lymph node: 3.9	Not detected		
SREBF1	bHLHd1, SREBP-1c, SREBP1, SREBP1a	ENSG00000072310	Sterol regulatory element binding transcription factor 1	17	17810399-17837002	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	CAB005406, HPA043343, HPA043878	Uncertain		Supported	Golgi apparatus<br>Cytosol	Endometrial cancer:2.66e-4 (favourable), Pancreatic cancer:9.05e-4 (favourable)	Expressed in all	Expressed in all			adrenal gland: 92.4	Expressed in all		
SREBF2	bHLHd2, SREBP2	ENSG00000198911	Sterol regulatory element binding transcription factor 2	22	41833079-41907308	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA031962, HPA031963	Approved		Supported	Nucleoplasm<br>Vesicles<br>Mitochondria	Renal cancer:1.37e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 118.4	Expressed in all		
SRF	MCM1	ENSG00000112658	Serum response factor	6	43171299-43181507	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001819, CAB005416	Supported		Supported	Nucleus	Renal cancer:2.01e-5 (unfavourable)	Expressed in all	Expressed in all			smooth muscle: 70.2	Expressed in all		
SRY	TDF	ENSG00000184895	Sex determining region Y	Y	2786855-2787699	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enhanced	Tissue enhanced		skin: 1.0;testis: 2.8	esophagus: 0.7	Cell line enhanced		RT4: 1.7
SSRP1	FACT80	ENSG00000149136	Structure specific recognition protein 1	11	57325985-57335877	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002697	Approved		Approved	Nucleus<br>Cytosol	Liver cancer:4.03e-7 (unfavourable), Pancreatic cancer:1.40e-4 (unfavourable), Renal cancer:5.63e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 124.9	Expressed in all		
ST18	KIAA0535, NZF3, ZC2H2C3, ZC2HC10, ZNF387	ENSG00000147488	ST18, C2H2C-type zinc finger	8	52110839-52460959	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044919	Uncertain					Tissue enhanced	Tissue enriched	7	cerebral cortex: 11.6	stomach: 1.5	Cell line enhanced		HAP1: 2.8;SCLC-21H: 11.3;U-87 MG: 1.5
STAT1	ISGF-3, STAT91	ENSG00000115415	Signal transducer and activator of transcription 1	2	190964358-191020960	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000931, HPA000982, CAB004049	Approved		Enhanced	Nucleoplasm<br>Cytosol	Renal cancer:1.22e-5 (unfavourable), Ovarian cancer:1.75e-4 (favourable), Pancreatic cancer:4.23e-4 (unfavourable)	Expressed in all	Expressed in all			lymph node: 193.8	Expressed in all		
STAT2	STAT113	ENSG00000170581	Signal transducer and activator of transcription 2	12	56341597-56360155	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB003858, HPA018888	Approved		Supported	Plasma membrane<br>Cytosol	Renal cancer:4.78e-13 (unfavourable), Endometrial cancer:4.75e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 47.9	Expressed in all		
STAT3	APRF	ENSG00000168610	Signal transducer and activator of transcription 3	17	42313324-42388568	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001671, CAB003859, HPA058603, CAB068241, CAB068242	Supported		Supported	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			gallbladder: 127.5	Mixed		
STAT4		ENSG00000138378	Signal transducer and activator of transcription 4	2	191029576-191151596	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001860, CAB013108	Enhanced				Renal cancer:1.07e-8 (unfavourable), Pancreatic cancer:5.88e-4 (favourable)	Mixed	Tissue enhanced		testis: 50.5	spleen: 18.5	Group enriched	7	Karpas-707: 34.1;U-266/70: 20.1;U-266/84: 6.9
STAT5A	MGF, STAT5	ENSG00000126561	Signal transducer and activator of transcription 5A	17	42287547-42311943	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB003860, HPA027873, HPA042128, HPA049883, HPA051156	Approved		Enhanced	Nucleoplasm<br>Cytosol	Breast cancer:5.87e-4 (favourable)	Expressed in all	Expressed in all			adipose tissue: 90.3	Cell line enhanced		HDLM-2: 100.4;HEL: 145.8;K-562: 246.3;MOLT-4: 160.1
STAT5B		ENSG00000173757	Signal transducer and activator of transcription 5B	17	42199168-42276707	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004298, HPA042128, HPA049883, HPA051156	Approved				Renal cancer:2.39e-5 (favourable), Pancreatic cancer:1.63e-4 (favourable), Endometrial cancer:9.37e-4 (favourable)	Expressed in all	Expressed in all			endometrium: 71.3	Cell line enhanced		HDLM-2: 112.6
STAT6	D12S1644, IL-4-STAT	ENSG00000166888	Signal transducer and activator of transcription 6	12	57095408-57132139	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001861	Approved		Enhanced	Nucleoplasm<br>Cytosol	Urothelial cancer:1.14e-4 (favourable), Endometrial cancer:1.69e-4 (favourable), Thyroid cancer:7.76e-4 (favourable)	Expressed in all	Expressed in all			skin: 163.9	Mixed		
T		ENSG00000164458	T brachyury transcription factor	6	166157656-166168700	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003322	Uncertain		Supported	Nucleus		Tissue enriched	Tissue enriched	20	parathyroid gland: 8.7	testis: 0.4	Group enriched	6	HeLa: 10.3;SCLC-21H: 4.2
TADA2B	MGC21874	ENSG00000173011	Transcriptional adaptor 2B	4	7041899-7057952	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035770	Approved		Approved	Nuclear speckles	Renal cancer:7.17e-11 (favourable), Urothelial cancer:1.59e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 27.4	Expressed in all		
TAF1	BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250	ENSG00000147133	TATA-box binding protein associated factor 1	X	71366239-71532374	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001075, CAB016283	Supported		Enhanced	Nucleoplasm	Renal cancer:6.03e-4 (unfavourable), Lung cancer:6.54e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 26.2	Expressed in all		
TAL1	bHLHa17, SCL, TCL5	ENSG00000162367	TAL bHLH transcription factor 1, erythroid differentiation factor	1	47216290-47232220	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB017805, HPA047866, HPA073983	Approved		Supported	Nucleus		Mixed	Tissue enhanced		bone marrow: 17.7	placenta: 10.0	Cell line enhanced		HEL: 137.6;HMC-1: 62.0;K-562: 43.6;TIME: 28.0
TAL2	bHLHa19	ENSG00000186051	TAL bHLH transcription factor 2	9	105662457-105663112	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030886	Uncertain		Approved	Cytosol	Renal cancer:2.69e-4 (favourable)	Tissue enhanced	Group enriched	5	kidney: 3.5;skeletal muscle: 4.8	epididymis: 0.8	Cell line enhanced		HAP1: 3.1;K-562: 7.5
TBP	GTF2D1, SCA17, TFIID	ENSG00000112592	TATA-box binding protein	6	170554302-170572870	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009442, HPA049805	Approved		Supported	Nucleoplasm	Liver cancer:1.51e-7 (unfavourable)	Expressed in all	Expressed in all			testis: 61.8	Expressed in all		
TBPL1	STUD, TLF, TLP, TRF2	ENSG00000028839	TATA-box binding protein like 1	6	133952170-133990432	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071810, HPA071813	Enhanced		Enhanced	Nucleoplasm<br>Nucleoli	Liver cancer:7.91e-5 (unfavourable), Renal cancer:4.14e-4 (unfavourable), Glioma:4.67e-4 (favourable), Pancreatic cancer:7.23e-4 (favourable)	Expressed in all	Tissue enriched	8	testis: 227.4	thyroid gland: 28.2	Expressed in all		
TBPL2	TBP2, TRF3	ENSG00000182521	TATA-box binding protein like 2	14	55413541-55456726	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA056241	Uncertain					Tissue enriched	Mixed			skin: 2.0	Cell line enhanced		HDLM-2: 5.4;U-2 OS: 3.1;U-937: 3.1
TBR1		ENSG00000136535	T-box, brain 1	2	161416094-161425870	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051256, HPA078644, HPA078657	Enhanced	Approved				Not detected	Tissue enriched	30	cerebral cortex: 30.6	testis: 1.0	Not detected		
TBX1	CATCH22, VCF	ENSG00000184058	T-box 1	22	19756703-19783593	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029330			Approved	Nuclear bodies<br>Cytoplasmic bodies	Urothelial cancer:8.90e-4 (favourable)	Mixed	Tissue enhanced		skeletal muscle: 23.0	testis: 10.5	Cell line enhanced		K-562: 107.3;TIME: 35.1
TBX10	TBX13, TBX7	ENSG00000167800	T-box 10	11	67631303-67639560	Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA047881	Uncertain					Group enriched	Group enriched	27	colon: 8.8;duodenum: 5.8;rectum: 8.6;small intestine: 10.6	appendix: 0.3	Cell line enhanced		NTERA-2: 5.3;RPMI-8226: 2.5;SK-BR-3: 9.3;U-2 OS: 2.7
TBX15	TBX14	ENSG00000092607	T-box 15	1	118883046-118989556	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052245, HPA053713	Uncertain		Approved	Nucleoplasm<br>Centrosome	Renal cancer:5.57e-8 (unfavourable)	Mixed	Group enriched	7	adipose tissue: 17.0;breast: 8.9;liver: 24.1;skeletal muscle: 42.2	lymph node: 3.1	Cell line enhanced		ASC diff: 36.8;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;fHDF/TERT166: 22.5;HSkMC: 28.3;RH-30: 29.4;U-2197: 26.3
TBX18		ENSG00000112837	T-box 18	6	84687351-84764519	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Mixed			adipose tissue: 6.1	Cell line enhanced		A549: 52.2
TBX19	dj747L4.1, TPIT	ENSG00000143178	T-box 19	1	168281040-168314426	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005800, HPA072686	Supported		Approved	Nuclear speckles	Renal cancer:4.55e-9 (unfavourable)	Expressed in all	Mixed			endometrium: 5.4	Cell line enhanced		HaCaT: 4.8
TBX2		ENSG00000121068	T-box 2	17	61399896-61409466	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008586, CAB013636	Approved		Approved	Nucleoplasm<br>Cytosol		Expressed in all	Tissue enhanced		lung: 50.0	seminal vesicle: 40.0	Cell line enhanced		AN3-CA: 124.2;MCF7: 62.0;SH-SY5Y: 65.7;WM-115: 44.0
TBX20		ENSG00000164532	T-box 20	7	35202430-35254147	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enhanced		adrenal gland: 5.6;heart muscle: 22.2	placenta: 5.0	Cell line enhanced		SH-SY5Y: 7.5;WM-115: 4.2
TBX21	T-bet, TBLYM	ENSG00000073861	T-box 21	17	47733244-47746119	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB009524, CAB030043	Enhanced					Mixed	Tissue enhanced		lymph node: 8.5;spleen: 11.1	bone marrow: 6.4	Cell line enriched	152	HDLM-2: 15.1
TBX22	CLPA, CPX	ENSG00000122145	T-box 22	X	80014756-80031769	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Group enriched	19	testis: 10.4;thyroid gland: 3.5	seminal vesicle: 0.3	Cell line enriched	6	HDLM-2: 1.6
TBX3	TBX3-ISO, UMS, XHL	ENSG00000135111	T-box 3	12	114670254-114684164	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005799			Approved	Nucleoplasm<br>Cytosol	Urothelial cancer:3.28e-4 (favourable)	Expressed in all	Tissue enhanced		adrenal gland: 200.0	prostate: 119.8	Cell line enhanced		BJ: 87.5;BJ hTERT+: 80.2;RT4: 103.3
TBX4		ENSG00000121075	T-box 4	17	61452404-61485110	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB032413, HPA044457	Uncertain		Approved	Vesicles		Mixed	Group enriched	6	lung: 43.6;placenta: 29.8;prostate: 14.9	urinary bladder: 4.8	Cell line enhanced		BJ: 2.4;THP-1: 3.9
TBX5	HOS	ENSG00000089225	T-box 5	12	114353931-114408442	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008786, HPA064683	Uncertain		Approved	Nucleoplasm		Mixed	Group enriched	6	heart muscle: 40.0;lung: 18.0;placenta: 46.8	prostate: 6.2	Cell line enhanced		BJ: 17.0;BJ hTERT+: 36.2;BJ hTERT+ SV40 Large T+: 9.5;BJ hTERT+ SV40 Large T+ RasG12V: 12.1;HAP1: 18.0
TBX6		ENSG00000149922	T-box 6	16	30085793-30091887	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062498			Approved	Nucleus		Mixed	Mixed			stomach: 4.4	Cell line enhanced		RT4: 5.5;U-266/70: 5.4
TCF12	bHLHb20, HEB, HsT17266, HTF4	ENSG00000140262	Transcription factor 12	15	56918623-57299281	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	CAB004432, HPA065827	Approved		Supported	Nucleoplasm<br>Nuclear speckles	Renal cancer:5.24e-5 (unfavourable), Melanoma:8.89e-4 (unfavourable)	Expressed in all	Expressed in all			cervix, uterine: 116.2	Expressed in all		
TCF15	bHLHa40, EC2, PARAXIS	ENSG00000125878	Transcription factor 15 (basic helix-loop-helix)	20	603797-610398	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050998, HPA060221	Uncertain		Supported	Nuclear speckles	Ovarian cancer:3.25e-4 (unfavourable)	Mixed	Group enriched	5	adipose tissue: 6.3;heart muscle: 3.4;placenta: 4.8;skeletal muscle: 4.6;testis: 1.3	lung: 0.7	Cell line enhanced		HEL: 9.5;HMC-1: 14.7
TCF21	bHLHa23, POD1	ENSG00000118526	Transcription factor 21	6	133889138-133895553	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA013189	Uncertain					Mixed	Tissue enhanced		placenta: 62.4;spleen: 46.9	ovary: 32.1	Cell line enriched	10	HHSteC: 13.5
TCF23	bHLHa24, OUT	ENSG00000163792	Transcription factor 23	2	27149004-27156974	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Tissue enhanced		endometrium: 33.8;ovary: 22.7;smooth muscle: 30.8	fallopian tube: 13.9	Cell line enriched	7	THP-1: 2.3
TCF25	KIAA1049, Nulp1	ENSG00000141002	Transcription factor 25	16	89873570-89913627	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041699, HPA041786	Enhanced				Endometrial cancer:6.95e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 123.7	Expressed in all		
TCF3	bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR	ENSG00000071564	Transcription factor 3	19	1609290-1652605	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB018351, HPA049808, HPA062476	Approved		Enhanced	Nucleoplasm	Renal cancer:1.53e-4 (unfavourable), Liver cancer:2.46e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 103.3	Expressed in all		
TCF4	bHLHb19, E2-2, ITF2, SEF2-1B	ENSG00000196628	Transcription factor 4	18	55222331-55664787	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB020722, HPA025958	Approved		Supported	Nucleoplasm<br>Cytosol	Renal cancer:7.24e-5 (unfavourable), Urothelial cancer:9.95e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex,cervix, uterine: 44.9	Cell line enhanced		HDLM-2: 128.1;SH-SY5Y: 177.9
TCF7	TCF-1	ENSG00000081059	Transcription factor 7 (T-cell specific, HMG-box)	5	134114711-134151865	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB019403, HPA058863, HPA070505	Enhanced		Enhanced	Nucleoplasm		Expressed in all	Tissue enhanced		lymph node: 110.1	appendix: 71.7	Cell line enriched	13	MOLT-4: 1060.4
TCF7L1	TCF3	ENSG00000152284	Transcription factor 7 like 1	2	85133410-85310388	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071298			Supported	Nucleoplasm<br>Cytosol	Liver cancer:6.16e-5 (unfavourable), Endometrial cancer:1.70e-4 (unfavourable), Renal cancer:2.06e-4 (unfavourable), Stomach cancer:2.72e-4 (unfavourable), Urothelial cancer:5.38e-4 (unfavourable)	Expressed in all	Mixed			adipose tissue,endometrium,thyroid gland: 22.5	Cell line enhanced		NTERA-2: 99.6;RH-30: 43.7;T-47d: 41.9
TCF7L2	TCF-4, TCF4	ENSG00000148737	Transcription factor 7 like 2	10	112950250-113167678	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB013535, HPA038800	Supported	Approved	Supported	Nucleoplasm<br>Nuclear bodies		Expressed in all	Expressed in all			endometrium: 30.9	Mixed		
TCFL5	bHLHe82, CHA, E2BP-1, Figlb	ENSG00000101190	Transcription factor like 5	20	62841115-62861763	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055223	Approved		Supported	Nucleoplasm	Endometrial cancer:3.24e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 144.4	Expressed in all		
TEAD1	AA, TCF13, TEF-1	ENSG00000187079	TEA domain transcription factor 1	11	12674591-12944483	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057339, HPA062471			Enhanced	Nucleoplasm		Expressed in all	Mixed			parathyroid gland: 88.3	Mixed		
TEAD2	ETF, TEF-4, TEF4	ENSG00000074219	TEA domain transcription factor 2	19	49340595-49362457	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA066292, HPA069963			Enhanced	Nucleoplasm	Liver cancer:8.66e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 58.9	Cell line enhanced		AF22: 134.1;AN3-CA: 137.1
TEAD3	ETFR-1, TEAD5, TEF-5	ENSG00000007866	TEA domain transcription factor 3	6	35473597-35497076	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028906	Uncertain				Renal cancer:1.01e-7 (unfavourable), Endometrial cancer:5.09e-4 (unfavourable)	Expressed in all	Mixed			smooth muscle: 80.5	Cell line enhanced		BEWO: 114.2
TEAD4	EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1	ENSG00000197905	TEA domain transcription factor 4	12	2959330-3040673	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056896	Uncertain		Supported	Nucleoplasm	Renal cancer:9.78e-9 (unfavourable)	Tissue enriched	Tissue enhanced		skeletal muscle: 38.8	thyroid gland: 17.8	Cell line enhanced		HBEC3-KT: 263.0
TEF	KIAA1655	ENSG00000167074	TEF, PAR bZIP transcription factor	22	41367333-41399326	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:3.47e-11 (favourable)	Expressed in all	Mixed			parathyroid gland: 58.6	Expressed in all		
TET1	bA119F7.1, CXXC6, KIAA1676, LCX	ENSG00000138336	Tet methylcytosine dioxygenase 1	10	68560656-68694482	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA019032, HPA057273			Supported	Nucleus<br>Nuclear membrane		Tissue enriched	Mixed			parathyroid gland: 2.4	Cell line enhanced		BEWO: 17.6;HAP1: 21.7;K-562: 11.0;NTERA-2: 12.2
TFAM	TCF6, TCF6L2	ENSG00000108064	Transcription factor A, mitochondrial	10	58385022-58399221	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA040648, HPA063684	Supported		Enhanced	Mitochondria	Renal cancer:2.22e-5 (favourable), Ovarian cancer:2.74e-4 (favourable), Endometrial cancer:8.73e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 62.3	Expressed in all		
TFAP2A	AP-2, AP2TF, TFAP2	ENSG00000137203	Transcription factor AP-2 alpha	6	10393186-10419659	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000326, HPA028850, HPA056871	Enhanced		Enhanced	Nucleoplasm	Lung cancer:1.09e-4 (unfavourable)	Tissue enhanced	Tissue enhanced		breast: 40.0;placenta: 42.3;skin: 76.1	epididymis: 24.9	Cell line enhanced		HDLM-2: 103.3
TFAP2B	AP2-B	ENSG00000008196	Transcription factor AP-2 beta	6	50818723-50847613	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034683, HPA062942	Supported		Approved	Nucleoplasm		Tissue enriched	Tissue enhanced		epididymis: 39.4	breast: 9.6	Group enriched	5	AF22: 94.8;SH-SY5Y: 188.6
TFAP2C	AP2-GAMMA, ERF1, hAP-2g, TFAP2G	ENSG00000087510	Transcription factor AP-2 gamma	20	56629302-56639283	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB016061, CAB016079, HPA055179, HPA057076	Enhanced		Supported	Nucleoplasm	Cervical cancer:6.90e-4 (favourable)	Tissue enhanced	Tissue enhanced		skin: 63.0	breast: 31.6	Cell line enhanced		BEWO: 183.4;MCF7: 128.7;SK-BR-3: 231.1;WM-115: 112.9
TFAP2D	TFAP2BL1	ENSG00000008197	Transcription factor AP-2 delta	6	50713828-50772988	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048962	Uncertain					Tissue enriched	Not detected			cerebral cortex: 0.1	Cell line enhanced		HAP1: 1.3
TFAP2E	AP2E	ENSG00000116819	Transcription factor AP-2 epsilon	1	35573370-35595328	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Tissue enhanced		skin: 7.2	lymph node: 2.1	Cell line enhanced		NB-4: 4.5;U-937: 4.6
TFAP4	AP-4, bHLHc41	ENSG00000090447	Transcription factor AP-4	16	4257186-4273075	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001912	Supported		Supported	Nucleoplasm<br>Mitochondria	Renal cancer:4.31e-6 (unfavourable), Liver cancer:3.32e-4 (unfavourable)	Expressed in all	Expressed in all			ovary: 12.0	Expressed in all		
TFCP2	CP2, LBP-1C, LSF, TFCP2C	ENSG00000135457	Transcription factor CP2	12	51093663-51173134	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA070247			Supported	Nucleoplasm<br>Cytosol	Melanoma:1.18e-4 (unfavourable), Liver cancer:1.83e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 44.3	Mixed		
TFCP2L1	CRTR1, LBP-9	ENSG00000115112	Transcription factor CP2 like 1	2	121216587-121285207	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029708	Uncertain		Supported	Nucleoli fibrillar center	Renal cancer:7.72e-6 (favourable)	Mixed	Tissue enhanced		kidney: 49.0	thyroid gland: 45.7	Cell line enhanced		BEWO: 17.6;HEL: 14.0;hTCEpi: 12.5;RPTEC TERT1: 32.4;RT4: 25.3;SCLC-21H: 15.6
TFDP1	DILC, Dp-1, DP1, DRTF1	ENSG00000198176	Transcription factor Dp-1	13	113584721-113641470	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB033605, HPA044754, HPA068909	Enhanced		Supported	Nucleoplasm<br>Cytosol	Liver cancer:1.03e-4 (unfavourable), Stomach cancer:6.17e-4 (favourable), Renal cancer:7.57e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 99.9	Expressed in all		
TFDP2	Dp-2	ENSG00000114126	Transcription factor Dp-2	3	141944428-142149544	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB018396	Supported		Supported	Nucleus<br>Vesicles	Cervical cancer:6.32e-4 (favourable), Renal cancer:9.84e-4 (favourable)	Expressed in all	Expressed in all			testis: 127.5	Expressed in all		
TFE3	bHLHe33, TFEA	ENSG00000068323	Transcription factor binding to IGHM enhancer 3	X	49028726-49043486	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023881	Approved		Supported	Nucleoplasm<br>Cytosol	Renal cancer:2.19e-8 (unfavourable), Liver cancer:6.03e-5 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 24.4	Expressed in all		
TFEB	bHLHe35, TCFEB	ENSG00000112561	Transcription factor EB	6	41683978-41736259	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049532			Supported	Nucleoplasm	Renal cancer:1.06e-5 (favourable), Pancreatic cancer:4.77e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 54.3	Cell line enhanced		BEWO: 65.1;U-698: 44.9
TFEC	bHLHe34, TCFEC, TFECL	ENSG00000105967	Transcription factor EC	7	115935148-116159896	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB032260, HPA063577	Approved		Supported	Nucleoplasm		Tissue enhanced	Mixed			appendix: 26.3	Cell line enhanced		HEL: 14.6;HUVEC TERT2: 9.2;THP-1: 14.4;TIME: 10.2;U-937: 19.1
TGIF1	HPE4, TGIF	ENSG00000177426	TGFB induced factor homeobox 1	18	3411608-3459978	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062160			Supported	Nucleoplasm	Pancreatic cancer:6.47e-4 (unfavourable)	Expressed in all	Expressed in all			epididymis: 162.4	Mixed		
TGIF2		ENSG00000118707	TGFB induced factor homeobox 2	20	36573488-36593950	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053786			Supported	Nucleoplasm		Expressed in all	Mixed			fallopian tube: 38.3	Mixed		
TGIF2LX		ENSG00000153779	TGFB induced factor homeobox 2 like, X-linked	X	89921882-89922883	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034543	Supported		Approved	Nucleoplasm		Tissue enhanced	Tissue enriched	134	testis: 13.3	all non-specific tissues: 0.0	Group enriched	10	SH-SY5Y: 11.2;U-2 OS: 12.7;U-266/84: 14.3
TGIF2LY		ENSG00000176679	TGFB induced factor homeobox 2 like, Y-linked	Y	3579041-3580041	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	74	testis: 7.3	all non-specific tissues: 0.0	Not detected		
THAP1	4833431A01Rik, DYT6, FLJ10477	ENSG00000131931	THAP domain containing 1	8	42836674-42843325	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071310			Supported	Nucleus		Expressed in all	Mixed			testis: 17.6	Expressed in all		
THAP10		ENSG00000129028	THAP domain containing 10	15	70881342-70892785	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041416	Uncertain		Approved	Nucleoplasm<br>Cytosol	Renal cancer:3.05e-5 (favourable)	Expressed in all	Mixed			cerebral cortex: 10.0	Cell line enhanced		U-2197: 36.6
THAP11	CTG-B43a, CTG-B45d, HRIHFB2206	ENSG00000168286	THAP domain containing 11	16	67842082-67844195	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041434, HPA042189	Supported		Enhanced	Nucleoplasm<br>Cytokinetic bridge		Expressed in all	Expressed in all			fallopian tube: 25.4	Expressed in all		
THAP12	DAP4, P52rIPK, PRKRIR, THAP0	ENSG00000137492	THAP domain containing 12	11	76349956-76380971	Plasma proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA008758	Approved		Approved	Nucleoplasm		Expressed in all	Expressed in all			endometrium: 42.8	Expressed in all		
THAP2	DKFZP564I0422	ENSG00000173451	THAP domain containing 2	12	71663009-71680639	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039790	Approved		Approved	Nucleoplasm<br>Golgi apparatus		Expressed in all	Mixed			adrenal gland: 35.2	Expressed in all		
THAP3		ENSG00000041988	THAP domain containing 3	1	6624866-6635586	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067114	Approved		Approved	Nucleus	Colorectal cancer:1.33e-4 (unfavourable)	Expressed in all	Expressed in all			ovary: 18.0	Expressed in all		
THAP4	CGI-36	ENSG00000176946	THAP domain containing 4	2	241584405-241637449	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA044982, HPA053448	Uncertain		Approved	Nucleoplasm<br>Nuclear speckles	Renal cancer:1.46e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 83.1	Expressed in all		
THAP5	DKFZp313O1132	ENSG00000177683	THAP domain containing 5	7	108554543-108569750	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043170, HPA051488	Approved		Enhanced	Nucleus	Renal cancer:8.99e-4 (favourable)	Expressed in all	Expressed in all			testis: 46.7	Expressed in all		
THAP6	MGC30052	ENSG00000174796	THAP domain containing 6	4	75513946-75550473	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035767	Uncertain		Approved	Nucleus<br>Centrosome		Expressed in all	Expressed in all			testis: 43.6	Expressed in all		
THAP7	MGC10963	ENSG00000184436	THAP domain containing 7	22	20999104-21002196	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003083	Approved		Approved	Nucleus<br>Vesicles		Expressed in all	Expressed in all			testis: 20.4	Expressed in all		
THAP8	FLJ32891	ENSG00000161277	THAP domain containing 8	19	36034985-36054762	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064056, HPA070139			Enhanced	Nucleoplasm	Liver cancer:1.32e-4 (unfavourable), Pancreatic cancer:3.19e-4 (favourable)	Expressed in all	Mixed			testis: 9.0	Mixed		
THAP9	FLJ34093	ENSG00000168152	THAP domain containing 9	4	82900684-82919969	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA037420, HPA037421	Uncertain		Approved	Mitochondria	Renal cancer:3.50e-5 (favourable)	Expressed in all	Mixed			testis: 11.4	Mixed		
THRA	AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3	ENSG00000126351	Thyroid hormone receptor, alpha	17	40058290-40093867	Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009654, CAB023349	Uncertain		Supported	Cytosol	Renal cancer:6.05e-8 (favourable), Lung cancer:1.84e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 238.9	Expressed in all		
THRB	ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2	ENSG00000151090	Thyroid hormone receptor beta	3	24117160-24495282	Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002008, CAB002009, HPA061035	Approved		Supported	Nuclear bodies	Renal cancer:9.46e-8 (favourable)	Mixed	Mixed			cerebral cortex: 36.3	Cell line enhanced		K-562: 43.8;RT4: 28.1
TLX1	HOX11, TCL3	ENSG00000107807	T-cell leukemia homeobox 1	10	101130505-101137789	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Colorectal cancer:7.32e-4 (unfavourable)	Mixed	Tissue enriched	5	spleen: 31.3	salivary gland: 6.0	Cell line enhanced		HAP1: 4.1;K-562: 10.7;SH-SY5Y: 2.9
TLX2	Enx, HOX11L1, NCX, Tlx2	ENSG00000115297	T-cell leukemia homeobox 2	2	74513463-74517147	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA040969, HPA062254	Uncertain		Approved	Nucleoplasm		Mixed	Tissue enhanced		adrenal gland: 2.7	testis: 0.8	Cell line enriched	17	SH-SY5Y: 68.4
TLX3	HOX11L2, RNX	ENSG00000164438	T-cell leukemia homeobox 3	5	171309284-171312134	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030504, HPA060957, HPA069359	Approved		Supported	Nucleoplasm		Tissue enhanced	Not detected			all non-specific tissues: 0.0	Cell line enriched	6	SH-SY5Y: 28.2
TONSL	IKBR, NFKBIL2	ENSG00000160949	Tonsoku-like, DNA repair protein	8	144428775-144444444	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024679, HPA046494	Uncertain		Enhanced	Nucleoplasm<br>Nuclear bodies	Renal cancer:2.62e-7 (unfavourable), Liver cancer:2.84e-4 (unfavourable)	Expressed in all	Mixed			bone marrow: 5.4	Mixed		
TOX	KIAA0808, TOX1	ENSG00000198846	Thymocyte selection associated high mobility group box	8	58805418-59119208	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018322, HPA073241	Enhanced		Approved	Nucleus<br>Nucleoli fibrillar center	Renal cancer:1.90e-7 (unfavourable), Lung cancer:5.20e-4 (favourable)	Expressed in all	Mixed			lymph node: 21.1	Cell line enhanced		MOLT-4: 117.4;SH-SY5Y: 46.0
TOX2	C20orf100, dJ1108D11.2, GCX-1	ENSG00000124191	TOX high mobility group box family member 2	20	43914864-44069616	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049900, HPA058396	Approved		Supported	Nucleoplasm	Renal cancer:7.45e-8 (unfavourable), Endometrial cancer:2.60e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 19.8	Cell line enhanced		HHSteC: 99.2;U-266/70: 59.6
TOX3	CAGF9, TNRC9	ENSG00000103460	TOX high mobility group box family member 3	16	52438005-52547802	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA040376	Enhanced		Approved	Nucleoplasm	Renal cancer:3.08e-12 (favourable), Urothelial cancer:3.95e-4 (favourable)	Mixed	Mixed			stomach: 18.0	Cell line enhanced		AF22: 39.9;HAP1: 20.6;RT4: 62.7;SCLC-21H: 31.8
TOX4	C14orf92, KIAA0737, LCP1	ENSG00000092203	TOX high mobility group box family member 4	14	21476597-21499175	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA017880, HPA027551	Approved		Approved	Nucleus<br>Nucleoli<br>Vesicles	Renal cancer:8.38e-5 (favourable), Liver cancer:3.46e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 35.4	Expressed in all		
TP53	LFS1, p53	ENSG00000141510	Tumor protein p53	17	7661779-7687550	Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters	Evidence at protein level	CAB002973, CAB039238, CAB039239, HPA051244, CAB072876	Enhanced		Enhanced	Nucleoplasm	Endometrial cancer:1.35e-4 (favourable), Prostate cancer:5.01e-4 (unfavourable)	Expressed in all	Expressed in all			fallopian tube: 50.3	Expressed in all		
TP63	EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L	ENSG00000073282	Tumor protein p63	3	189631416-189897279	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000083, HPA006288, HPA007010	Enhanced		Enhanced	Nucleoplasm<br>Golgi apparatus<br>Cytosol	Breast cancer:1.07e-4 (favourable)	Group enriched	Tissue enhanced		esophagus: 60.9;skin: 164.1	urinary bladder: 28.8	Group enriched	5	HaCaT: 77.1;HBEC3-KT: 119.9;hTCEpi: 89.8;hTERT-HME1: 90.5;RT4: 147.6
TP73	P73	ENSG00000078900	Tumor protein p73	1	3652520-3736201	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB002514, CAB003022, HPA027314, HPA044516	Enhanced		Supported	Nucleoplasm<br>Golgi apparatus	Endometrial cancer:1.82e-4 (favourable), Cervical cancer:2.98e-4 (favourable), Head and neck cancer:9.50e-4 (favourable)	Mixed	Group enriched	5	fallopian tube: 10.8;skin: 7.7	prostate: 1.8	Cell line enhanced		SCLC-21H: 21.2
TPRX1	FLJ40321	ENSG00000178928	Tetrapeptide repeat homeobox 1	19	47801243-47819051	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA044922	Uncertain					Not detected	Tissue enriched	13	testis: 1.3	endometrium: 0.1	Not detected		
TRERF1	BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132	ENSG00000124496	Transcriptional regulating factor 1	6	42224931-42452051	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027771, HPA051273, HPA059943	Enhanced		Enhanced	Nucleoplasm<br>Cytosol	Renal cancer:3.67e-5 (unfavourable)	Mixed	Mixed			testis: 10.9	Cell line enhanced		HDLM-2: 133.6
TRPS1	GC79, LGCR	ENSG00000104447	Transcriptional repressor GATA binding 1	8	115408496-115809673	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060380, HPA071767	Enhanced		Supported	Nucleoplasm	Pancreatic cancer:3.16e-4 (unfavourable), Head and neck cancer:9.42e-4 (favourable)	Tissue enriched	Tissue enhanced		breast: 75.9	testis: 22.6	Cell line enhanced		SK-BR-3: 58.4;T-47d: 230.2
TSC22D1	MGC17597, TGFB1I4, TSC22	ENSG00000102804	TSC22 domain family member 1	13	44432143-44577147	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA077414			Approved	Nucleoplasm<br>Nuclear bodies	Renal cancer:4.54e-4 (favourable), Ovarian cancer:7.97e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 269.2	Cell line enhanced		HEL: 221.4
TSC22D2	KIAA0669, TILZ4a, TILZ4b, TILZ4c	ENSG00000196428	TSC22 domain family member 2	3	150408335-150466431	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004926	Approved		Approved	Cytosol	Endometrial cancer:2.74e-4 (unfavourable), Renal cancer:5.80e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium,smooth muscle: 38.2	Expressed in all		
TSC22D3	DIP, DSIPI, GILZ, hDIP, TSC-22R	ENSG00000157514	TSC22 domain family member 3	X	107713221-107777342	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001916, CAB034364	Approved		Approved	Nuclear speckles<br>Golgi apparatus<br>Cytosol	Endometrial cancer:2.43e-4 (unfavourable)	Expressed in all	Expressed in all			breast: 548.3	Cell line enhanced		ASC diff: 261.1;HHSteC: 527.6;hTCEpi: 413.6;Karpas-707: 261.7
TSC22D4	THG-1, TILZ2	ENSG00000166925	TSC22 domain family member 4	7	100463359-100479279	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA006757	Uncertain		Approved	Cytosol	Colorectal cancer:2.66e-4 (unfavourable), Liver cancer:9.45e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 278.2	Expressed in all		
TSHZ1	NY-CO-33, SDCCAG33, TSH1	ENSG00000179981	Teashirt zinc finger homeobox 1	18	75210755-75289950	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006982	Approved		Approved	Nucleoplasm	Thyroid cancer:1.71e-5 (unfavourable)	Expressed in all	Expressed in all			ovary: 46.4	Cell line enhanced		HDLM-2: 45.8
TSHZ2	C20orf17, OVC10-2, TSH2, ZABC2, ZNF218	ENSG00000182463	Teashirt zinc finger homeobox 2	20	52972407-53495330	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038123	Uncertain		Approved	Nucleoplasm<br>Golgi apparatus		Mixed	Mixed			ovary: 21.7	Cell line enhanced		AN3-CA: 24.7;HeLa: 15.8;SiHa: 16.3;U-2197: 12.7
TSHZ3	KIAA1474, TSH3, ZNF537	ENSG00000121297	Teashirt zinc finger homeobox 3	19	31274945-31349547	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008834	Approved		Supported	Nucleoplasm	Renal cancer:2.92e-4 (unfavourable)	Mixed	Mixed			ovary: 37.5	Cell line enhanced		RH-30: 44.3;U-138 MG: 31.7
TWIST1	ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST	ENSG00000122691	Twist family bHLH transcription factor 1	7	19020991-19117672	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Tissue enhanced		adipose tissue: 22.7;endometrium: 30.7	placenta: 17.3	Cell line enriched	6	SH-SY5Y: 272.1
TWIST2	bHLHa39, Dermo-1, DERMO1	ENSG00000233608	Twist family bHLH transcription factor 2	2	238848032-238910543	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062870			Supported	Nucleus<br>Nucleoli		Mixed	Tissue enhanced		cervix, uterine: 40.1	adipose tissue: 27.3	Cell line enhanced		ASC diff: 104.1;BJ: 108.5;BJ hTERT+: 326.5;fHDF/TERT166: 143.5;U-2197: 143.4
UBP1	LBP-1a	ENSG00000153560	Upstream binding protein 1 (LBP-1a)	3	33388336-33441371	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003967			Supported	Nucleoplasm	Colorectal cancer:1.81e-4 (favourable), Liver cancer:9.45e-4 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 54.5	Expressed in all		
UBTF	NOR-90, UBF, UBF1, UBF2	ENSG00000108312	Upstream binding transcription factor, RNA polymerase I	17	44205033-44221626	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB004611, HPA006385	Enhanced	Supported	Enhanced	Nucleoli fibrillar center		Expressed in all	Expressed in all			parathyroid gland: 81.5	Expressed in all		
UBTFL1	C11orf27	ENSG00000255009	Upstream binding transcription factor, RNA polymerase I-like 1	11	90085950-90087131	Predicted intracellular proteins, Transcription factors	No evidence							Not detected	Not detected			all non-specific tissues: 0.0	Not detected		
UNCX	Uncx4.1	ENSG00000164853	UNC homeobox	7	1232907-1237318	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA063294			Approved	Nucleoplasm		Not detected	Not detected			kidney: 0.4	Cell line enriched	16	NB-4: 63.3
USF1	bHLHb11, MLTFI, UEF	ENSG00000158773	Upstream transcription factor 1	1	161039251-161045977	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB001480, HPA036233, HPA036535	Supported		Enhanced	Nucleoplasm	Renal cancer:6.01e-12 (unfavourable), Urothelial cancer:1.95e-5 (favourable), Head and neck cancer:8.70e-4 (favourable)	Expressed in all	Expressed in all			spleen: 34.8	Expressed in all		
USF2	bHLHb12, FIP	ENSG00000105698	Upstream transcription factor 2, c-fos interacting	19	35268978-35279821	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029764, HPA046567			Supported	Nucleoplasm<br>Vesicles	Pancreatic cancer:5.12e-5 (favourable), Urothelial cancer:3.28e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 215.5	Expressed in all		
UTF1		ENSG00000171794	Undifferentiated embryonic cell transcription factor 1	10	133230274-133231558	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Tissue enriched	11	testis: 1.4	spleen: 0.1	Group enriched	18	NTERA-2: 5.7;RPMI-8226: 1.4
VAX1		ENSG00000148704	Ventral anterior homeobox 1	10	117128521-117138301	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028946	Uncertain		Approved	Nucleus<br>Nucleoli		Not detected	Tissue enhanced		cerebral cortex: 1.4	testis: 0.4	Group enriched	8	A-431: 2.9;WM-115: 2.4
VAX2	DRES93	ENSG00000116035	Ventral anterior homeobox 2	2	70900590-70933446	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009708			Approved	Nuclear speckles		Mixed	Tissue enhanced		cerebral cortex: 3.2	adipose tissue,adrenal gland,breast,endometrium: 0.7	Cell line enhanced		SH-SY5Y: 7.0
VDR	NR1I1, PPP1R163	ENSG00000111424	Vitamin D (1,25- dihydroxyvitamin D3) receptor	12	47841537-47943048	Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters	Evidence at protein level	CAB004617, HPA047740			Enhanced	Nucleoplasm	Renal cancer:4.89e-6 (favourable)	Expressed in all	Tissue enhanced		parathyroid gland: 175.9	small intestine: 57.9	Cell line enhanced		HDLM-2: 73.7;U-937: 60.2
VENTX	HPX42B, VENTX2	ENSG00000151650	VENT homeobox	10	133237404-133241929	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050955	Uncertain		Uncertain	Nucleoli fibrillar center<br>Cytosol		Tissue enriched	Mixed			appendix: 4.7	Group enriched	22	NB-4: 10.5;NTERA-2: 9.2
VEZF1	DB1, ZNF161	ENSG00000136451	Vascular endothelial zinc finger 1	17	57971547-57988259	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027520, HPA048315	Uncertain		Enhanced	Nucleoplasm	Colorectal cancer:6.14e-5 (favourable), Liver cancer:6.46e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 82.1	Expressed in all		
VSX1	PPCD, PPCD1, PPD	ENSG00000100987	Visual system homeobox 1	20	25070885-25082365	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enhanced		ovary: 1.7	cerebral cortex: 1.4	Cell line enriched	5	Karpas-707: 3.1
VSX2	CHX10, HOX10, RET1	ENSG00000119614	Visual system homeobox 2	14	74239472-74262738	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003436	Supported					Tissue enriched	Not detected			testis: 0.2	Not detected		
WIZ	ZNF803	ENSG00000011451	Widely interspaced zinc finger motifs	19	15419980-15449951	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA022923, HPA023774	Supported		Enhanced	Nucleoplasm<br>Midbody	Endometrial cancer:5.12e-5 (unfavourable)	Expressed in all	Expressed in all			testis: 31.1	Expressed in all		
WT1	AWT1, GUD, NPHS4, WAGR, WIT-2	ENSG00000184937	Wilms tumor 1	11	32387775-32435630	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB000327, HPA035717, HPA053848	Enhanced		Supported	Nucleoplasm		Tissue enriched	Tissue enhanced		endometrium: 112.9;fallopian tube: 126.5;smooth muscle: 80.2	testis: 55.1	Cell line enhanced		HEL: 23.8;HMC-1: 28.7;K-562: 21.7;NB-4: 40.6;THP-1: 20.5
XBP1	XBP2	ENSG00000100219	X-box binding protein 1	22	28794555-28800597	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level							Not detected	Expressed in all			breast: 918.6	Expressed in all		
YBX1	BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1	ENSG00000065978	Y-box binding protein 1	1	42682427-42702349	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005875, HPA040304, HPA057159	Supported		Enhanced	Vesicles<br>Cytosol	Liver cancer:9.87e-10 (unfavourable), Renal cancer:3.59e-7 (unfavourable)	Expressed in all	Expressed in all			testis: 1542.9	Expressed in all		
YBX2	Contrin, CSDA3, MSY2	ENSG00000006047	Y-box binding protein 2	17	7288252-7294615	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB012332, HPA053904, HPA056744	Enhanced		Supported	Nucleoli fibrillar center	Endometrial cancer:6.50e-5 (unfavourable)	Mixed	Tissue enriched	64	testis: 385.4	adipose tissue: 6.0	Cell line enhanced		CACO-2: 8.7;MCF7: 14.2;T-47d: 25.9
YBX3	CSDA, CSDA1, dbpA, ZONAB	ENSG00000060138	Y-box binding protein 3	12	10699089-10723312	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034838	Approved		Supported	Cytosol	Renal cancer:6.17e-13 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 1300.9	Mixed		
YY1	DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1	ENSG00000100811	YY1 transcription factor	14	100238298-100282792	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001119, CAB009392	Supported		Supported	Nucleoplasm<br>Nucleoli fibrillar center<br>Vesicles	Liver cancer:3.44e-4 (unfavourable), Endometrial cancer:6.13e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 65.8	Expressed in all		
YY2	ZNF631	ENSG00000230797	YY2 transcription factor	X	21855987-21858727	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001119, HPA030335	Enhanced		Approved	Nuclear bodies		Mixed	Tissue enhanced		testis: 10.9	endometrium: 2.8	Mixed		
ZBED1	ALTE, DREF, hDREF, KIAA0785, TRAMP	ENSG00000214717	Zinc finger BED-type containing 1	X	2486414-2500967	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:3.13e-4 (unfavourable)	Expressed in all	Expressed in all			cervix, uterine: 24.6	Cell line enhanced		BEWO: 87.7
ZBED2	MGC10796	ENSG00000177494	Zinc finger BED-type containing 2	3	111592900-111595443	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029786			Approved	Nuclear bodies<br>Mitochondria<br>Cytosol	Pancreatic cancer:8.83e-4 (unfavourable)	Tissue enriched	Tissue enhanced		fallopian tube: 30.3;thyroid gland: 113.1	lung: 14.9	Cell line enhanced		CAPAN-2: 45.9;EFO-21: 33.6;HaCaT: 44.7;HBEC3-KT: 81.4;RPTEC TERT1: 56.1
ZBED3	MGC15435	ENSG00000132846	Zinc finger BED-type containing 3	5	77072072-77087323	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055995	Approved		Approved	Nucleoplasm<br>Plasma membrane	Renal cancer:1.68e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 18.8	Mixed		
ZBED4	KIAA0637	ENSG00000100426	Zinc finger BED-type containing 4	22	49853842-49890078	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045341	Approved		Supported	Nucleoplasm		Expressed in all	Expressed in all			lymph node: 7.7	Expressed in all		
ZBED5	Buster1	ENSG00000236287	Zinc finger BED-type containing 5	11	10812074-10858796	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048472, HPA050994	Uncertain		Approved	Nucleus<br>Nucleoli fibrillar center<br>Golgi apparatus	Liver cancer:2.19e-5 (unfavourable), Urothelial cancer:3.87e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 90.6	Expressed in all		
ZBED6		ENSG00000257315	Zinc finger BED-type containing 6	1	203795714-203854999	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026439, HPA028490, HPA028526, HPA068807	Approved		Approved	Nucleoplasm<br>Microtubule organizing center		Expressed in all	Mixed			cervix, uterine: 14.3	Mixed		
ZBTB1	KIAA0997, ZNF909	ENSG00000126804	Zinc finger and BTB domain containing 1	14	64503712-64533690	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050516	Approved		Supported	Nucleoplasm<br>Nuclear membrane	Head and neck cancer:4.92e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 53.5	Expressed in all		
ZBTB11	ZNF-U69274, ZNF913	ENSG00000066422	Zinc finger and BTB domain containing 11	3	101648889-101677495	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA015328, HPA024138	Approved		Enhanced	Nucleoplasm	Endometrial cancer:7.49e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 23.4	Expressed in all		
ZBTB12	C6orf46, D6S59E, G10, NG35	ENSG00000204366	Zinc finger and BTB domain containing 12	6	31899607-31901992	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047161	Approved				Renal cancer:1.52e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 1.7	Mixed		
ZBTB14	ZFP161, ZNF478	ENSG00000198081	Zinc finger and BTB domain containing 14	18	5289019-5297053	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050758, HPA070819	Uncertain		Enhanced	Nucleus<br>Nucleoli<br>Cytosol		Expressed in all	Expressed in all			lymph node: 28.9	Expressed in all		
ZBTB16	PLZF, ZNF145	ENSG00000109906	Zinc finger and BTB domain containing 16	11	114059593-114250676	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001499, CAB004540	Uncertain				Renal cancer:2.21e-4 (favourable)	Tissue enhanced	Mixed			ovary: 59.5	Cell line enhanced		ASC diff: 40.2;ASC TERT1: 23.6;HEL: 33.4;HHSteC: 21.2;HSkMC: 19.6;hTCEpi: 18.6;hTERT-HME1: 17.2
ZBTB17	MIZ1, pHZ-67, ZNF151, ZNF60	ENSG00000116809	Zinc finger and BTB domain containing 17	1	15941869-15976132	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005789	Approved				Liver cancer:2.38e-6 (unfavourable), Renal cancer:3.27e-5 (unfavourable), Urothelial cancer:2.04e-4 (favourable)	Expressed in all	Expressed in all			testis: 21.9	Expressed in all		
ZBTB18	C2H2-171, RP58, TAZ-1, ZNF238	ENSG00000179456	Zinc finger and BTB domain containing 18	1	244048939-244057476	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Urothelial cancer:6.78e-6 (favourable), Endometrial cancer:1.34e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 76.3	Mixed		
ZBTB2	bA351K16.2, KIAA1483, ZNF437	ENSG00000181472	Zinc finger and BTB domain containing 2	6	151364117-151391548	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023136, HPA023137, HPA023458, HPA023487	Approved		Supported	Nucleoplasm<br>Cytosol	Renal cancer:9.36e-6 (unfavourable), Liver cancer:1.21e-5 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 50.0	Expressed in all		
ZBTB20	DKFZp566F123, DPZF, ODA-8S, ZNF288	ENSG00000181722	Zinc finger and BTB domain containing 20	3	114314501-115147271	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015551, HPA016815	Approved		Supported	Nucleoplasm<br>Nuclear bodies		Tissue enhanced	Mixed			testis: 17.4	Mixed		
ZBTB21	KIAA1227, ZNF295	ENSG00000173276	Zinc finger and BTB domain containing 21	21	41986831-42010387	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024655, HPA031757, HPA031758	Enhanced		Enhanced	Nucleus		Expressed in all	Mixed			adrenal gland: 47.6	Expressed in all		
ZBTB22	BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A	ENSG00000236104	Zinc finger and BTB domain containing 22	6	33314406-33317942	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043848			Approved	Nucleoplasm		Expressed in all	Tissue enhanced		parathyroid gland: 28.9	epididymis: 11.8	Mixed		
ZBTB24	BIF1, KIAA0441, PATZ2, ZNF450	ENSG00000112365	Zinc finger and BTB domain containing 24	6	109462594-109483237	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA017872, HPA049003	Uncertain		Approved	Nucleus<br>Cytokinetic bridge<br>Centrosome	Liver cancer:3.15e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 13.9	Expressed in all		
ZBTB25	C14orf51, KUP, ZNF46	ENSG00000089775	Zinc finger and BTB domain containing 25	14	64449106-64505213	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054699	Uncertain		Enhanced	Nucleoplasm	Renal cancer:3.56e-6 (unfavourable)	Expressed in all	Mixed			thyroid gland: 14.8	Expressed in all		
ZBTB26	ZNF481	ENSG00000171448	Zinc finger and BTB domain containing 26	9	122915566-122931500	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021444	Uncertain					Expressed in all	Mixed			testis: 18.2	Expressed in all		
ZBTB32	FAXF, FAZF, Rog, TZFP, ZNF538	ENSG00000011590	Zinc finger and BTB domain containing 32	19	35704527-35717038	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA076730	Enhanced					Mixed	Tissue enriched	11	testis: 43.3	lymph node: 3.9	Cell line enhanced		HDLM-2: 3.9;hTEC/SVTERT24-B: 2.0
ZBTB33	kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348	ENSG00000177485	Zinc finger and BTB domain containing 33	X	120250752-120258398	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000755, CAB001980, HPA005732	Approved		Enhanced	Nucleus<br>Plasma membrane<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 23.4	Expressed in all		
ZBTB34	KIAA1993, MGC24652, ZNF918	ENSG00000177125	Zinc finger and BTB domain containing 34	9	126860665-126885878	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023893	Approved		Supported	Nucleoplasm		Expressed in all	Mixed			placenta: 9.6	Expressed in all		
ZBTB37	MGC2629, ZNF908	ENSG00000185278	Zinc finger and BTB domain containing 37	1	173868082-173903549	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023438	Approved		Approved	Nucleus<br>Nucleoli fibrillar center<br>Cytosol		Mixed	Tissue enhanced		testis: 17.0	spleen: 5.3	Mixed		
ZBTB38	CIBZ, FLJ35036, PPP1R171, ZNF921	ENSG00000177311	Zinc finger and BTB domain containing 38	3	141324213-141449792	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA014865, HPA059378			Enhanced	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 126.8	Cell line enhanced		RPMI-8226: 273.3
ZBTB39	KIAA0352, ZNF922	ENSG00000166860	Zinc finger and BTB domain containing 39	12	56998834-57006446	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016866, HPA020306	Uncertain		Approved	Vesicles		Expressed in all	Mixed			testis: 13.4	Expressed in all		
ZBTB4	KAISO-L1, KIAA1538, ZNF903	ENSG00000174282	Zinc finger and BTB domain containing 4	17	7459366-7484263	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB008980, HPA064763	Supported		Supported	Nucleoplasm<br>Nuclear bodies<br>Cytosol	Renal cancer:1.65e-9 (favourable), Pancreatic cancer:2.53e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 84.8	Mixed		
ZBTB40	KIAA0478, ZNF923	ENSG00000184677	Zinc finger and BTB domain containing 40	1	22451851-22531157	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042386			Approved	Nucleus	Liver cancer:7.78e-8 (unfavourable), Pancreatic cancer:4.12e-5 (favourable), Head and neck cancer:2.01e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 20.8	Mixed		
ZBTB41	DKFZp686C06120, FLJ36199, FRBZ1, ZNF924	ENSG00000177888	Zinc finger and BTB domain containing 41	1	197153680-197200542	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034841, HPA034842	Uncertain		Approved	Nucleus<br>Nuclear membrane<br>Cytosol	Liver cancer:5.86e-4 (unfavourable)	Expressed in all	Mixed			thyroid gland: 12.7	Expressed in all		
ZBTB42	ZNF925	ENSG00000179627	Zinc finger and BTB domain containing 42	14	104800596-104804712	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000703, HPA066961	Uncertain		Supported	Nucleus	Renal cancer:2.30e-9 (favourable)	Expressed in all	Mixed			prostate: 8.9	Cell line enhanced		HDLM-2: 17.6;MCF7: 24.3;T-47d: 24.0
ZBTB43	FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B	ENSG00000169155	Zinc finger and BTB domain containing 43	9	126805006-126838210	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016825	Approved		Approved	Nucleus<br>Nucleoli	Renal cancer:8.73e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 38.8	Expressed in all		
ZBTB44	BTBD15, HSPC063, ZNF851	ENSG00000196323	Zinc finger and BTB domain containing 44	11	130226677-130314686	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052589	Approved		Approved	Nucleoplasm		Expressed in all	Expressed in all			testis: 75.4	Expressed in all		
ZBTB45	FLJ14486, ZNF499	ENSG00000119574	Zinc finger and BTB domain containing 45	19	58513530-58538911	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA035754	Uncertain		Approved	Cytosol	Renal cancer:5.38e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 10.5	Expressed in all		
ZBTB46	BTBD4, BZEL, FLJ13502, RINZF, ZNF340	ENSG00000130584	Zinc finger and BTB domain containing 46	20	63743666-63831244	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA013997	Uncertain		Approved	Nucleus	Pancreatic cancer:2.17e-4 (favourable)	Expressed in all	Mixed			spleen: 13.3	Mixed		
ZBTB47	DKFZp434N0615, KIAA1190, ZNF651	ENSG00000114853	Zinc finger and BTB domain containing 47	3	42653684-42665854	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA074057			Approved	Nucleoplasm	Renal cancer:7.96e-5 (favourable)	Expressed in all	Expressed in all			heart muscle: 50.0	Cell line enhanced		ASC diff: 42.2
ZBTB48	HKR3, ZNF855	ENSG00000204859	Zinc finger and BTB domain containing 48	1	6580001-6589280	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030417	Uncertain		Approved	Nucleoplasm<br>Cytosol	Pancreatic cancer:5.19e-6 (favourable), Cervical cancer:1.04e-4 (favourable)	Expressed in all	Expressed in all			testis: 32.9	Expressed in all		
ZBTB49	FLJ38559, ZNF509	ENSG00000168826	Zinc finger and BTB domain containing 49	4	4290251-4321786	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024450	Approved		Approved	Nucleoplasm<br>Microtubules<br>Cytosol	Urothelial cancer:2.88e-5 (favourable), Pancreatic cancer:1.76e-4 (favourable), Head and neck cancer:5.24e-4 (favourable)	Expressed in all	Mixed			testis: 7.4	Expressed in all		
ZBTB5	KIAA0354	ENSG00000168795	Zinc finger and BTB domain containing 5	9	37438114-37465399	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021521	Approved		Approved	Nucleoplasm<br>Nuclear bodies<br>Golgi apparatus		Expressed in all	Expressed in all			thyroid gland: 17.6	Expressed in all		
ZBTB6	ZID, ZNF482	ENSG00000186130	Zinc finger and BTB domain containing 6	9	122908056-122913330	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054111, HPA076894	Approved		Approved	Nucleoplasm<br>Mitochondria	Glioma:9.75e-6 (favourable), Renal cancer:5.08e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 12.6	Expressed in all		
ZBTB7A	DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A	ENSG00000178951	Zinc finger and BTB domain containing 7A	19	4044364-4066945	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB037214, CAB037285, HPA046387	Enhanced		Approved	Nucleoplasm	Renal cancer:1.34e-6 (favourable), Endometrial cancer:6.50e-6 (favourable), Stomach cancer:1.79e-4 (favourable), Pancreatic cancer:2.99e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 23.9	Expressed in all		
ZBTB7B	c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B	ENSG00000160685	Zinc finger and BTB domain containing 7B	1	155002630-155018522	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006811, HPA025820	Enhanced		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			skin: 89.4	Mixed		
ZBTB7C	ZBTB36, ZNF857C	ENSG00000184828	Zinc finger and BTB domain containing 7C	18	48026673-48410752	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Colorectal cancer:1.59e-4 (favourable)	Mixed	Mixed			esophagus: 31.7	Cell line enhanced		RPMI-8226: 6.7;RT4: 34.0;SCLC-21H: 6.5;SH-SY5Y: 7.3
ZBTB8B	DKFZp547H154, RP1-27O5.1, ZNF916B	ENSG00000273274	Zinc finger and BTB domain containing 8B	1	32465069-32496686	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055553	Approved					Tissue enhanced	Not detected			cerebral cortex: 0.6	Cell line enhanced		SCLC-21H: 1.1
ZC3H4	C19orf7, KIAA1064	ENSG00000130749	Zinc finger CCCH-type containing 4	19	47064187-47113752	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA040934, HPA041068	Supported		Enhanced	Nucleoplasm<br>Cytosol	Urothelial cancer:2.23e-4 (favourable)	Expressed in all	Expressed in all			spleen: 13.5	Expressed in all		
ZC3H6	FLJ41410, FLJ45877, KIAA2035, ZC3HDC6	ENSG00000188177	Zinc finger CCCH-type containing 6	2	112275594-112340063	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036019, HPA036020, HPA076065	Uncertain		Approved	Nucleoplasm<br>Golgi apparatus		Expressed in all	Mixed			ovary: 7.6	Mixed		
ZC3H8	Fliz1, ZC3HDC8	ENSG00000144161	Zinc finger CCCH-type containing 8	2	112211525-112255136	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034803, HPA034804	Approved		Supported	Nucleoplasm<br>Nuclear bodies	Endometrial cancer:1.12e-6 (unfavourable), Renal cancer:1.89e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 16.2	Expressed in all		
ZEB1	AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a	ENSG00000148516	Zinc finger E-box binding homeobox 1	10	31318495-31529814	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027524, CAB058686	Enhanced		Supported	Nucleoplasm	Renal cancer:7.34e-6 (unfavourable)	Expressed in all	Mixed			smooth muscle: 79.9	Cell line enhanced		ASC TERT1: 102.9
ZEB2	KIAA0569, SIP-1, SIP1, ZFHX1B	ENSG00000169554	Zinc finger E-box binding homeobox 2	2	144364364-144524583	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003456	Approved		Approved	Nucleus<br>Nucleoli<br>Cytosol	Renal cancer:6.04e-5 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 99.9	Mixed		
ZFAT	KIAA1485, ZFAT1, ZNF406	ENSG00000066827	Zinc finger and AT-hook domain containing	8	134477788-134713049	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020989, HPA063592	Enhanced		Approved	Nucleoplasm<br>Nuclear bodies		Expressed in all	Group enriched	6	kidney: 10.5;placenta: 44.3	testis: 4.3	Mixed		
ZFHX2	KIAA1056, KIAA1762, ZFH-5, ZNF409	ENSG00000136367	Zinc finger homeobox 2	14	23520855-23556192	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000720, HPA005146	Uncertain		Approved	Nucleus<br>Nucleoli fibrillar center		Mixed	Tissue enhanced		testis: 13.0	parathyroid gland: 4.0	Cell line enhanced		AN3-CA: 4.5
ZFHX3	ATBF1, ZNF927	ENSG00000140836	Zinc finger homeobox 3	16	72782885-73059698	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059353	Uncertain				Renal cancer:1.37e-5 (favourable), Breast cancer:1.55e-4 (unfavourable)	Expressed in all	Tissue enhanced		parathyroid gland: 28.3	thyroid gland: 12.4	Mixed		
ZFHX4	FLJ20980, ZFH4	ENSG00000091656	Zinc finger homeobox 4	8	76681219-76867285	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023837	Uncertain		Approved	Nucleoplasm<br>Nucleoli fibrillar center		Mixed	Tissue enhanced		seminal vesicle: 8.0;testis: 12.1	cerebral cortex: 5.0	Cell line enhanced		TIME: 35.2
ZFP1	FLJ34243, ZNF475	ENSG00000184517	ZFP1 zinc finger protein	16	75148492-75172236	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044916, HPA062910	Uncertain		Approved	Nucleus	Glioma:5.81e-5 (favourable), Stomach cancer:9.80e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 25.0	Expressed in all		
ZFP14	KIAA1559, ZNF531	ENSG00000142065	ZFP14 zinc finger protein	19	36334453-36379199	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA030637	Uncertain		Approved	Nuclear speckles	Urothelial cancer:2.75e-5 (favourable)	Expressed in all	Mixed			parathyroid gland: 8.4	Mixed		
ZFP2	FLJ21628, ZNF751	ENSG00000198939	ZFP2 zinc finger protein	5	178895894-178933212	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023364	Uncertain					Mixed	Mixed			testis: 7.8	Cell line enhanced		AN3-CA: 5.1;HAP1: 2.7
ZFP28	KIAA1431, mkr5	ENSG00000196867	ZFP28 zinc finger protein	19	56538948-56556810	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028879	Uncertain		Approved	Nucleoplasm<br>Cytosol		Mixed	Mixed			ovary: 13.0	Mixed		
ZFP3	FLJ30726, ZNF752	ENSG00000180787	ZFP3 zinc finger protein	17	5078248-5096374	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053085, HPA057290	Approved		Approved	Nucleoplasm<br>Cytosol	Renal cancer:7.69e-7 (favourable), Pancreatic cancer:1.07e-4 (favourable), Lung cancer:1.38e-4 (favourable), Cervical cancer:5.68e-4 (favourable)	Mixed	Mixed			parathyroid gland: 13.1	Cell line enhanced		SH-SY5Y: 6.1
ZFP30	KIAA0961, ZNF745	ENSG00000120784	ZFP30 zinc finger protein	19	37613749-37692337	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030606	Uncertain		Approved	Cytosol	Renal cancer:3.86e-4 (favourable)	Expressed in all	Mixed			testis: 14.0	Cell line enhanced		U-2 OS: 34.4
ZFP37	ZNF906	ENSG00000136866	ZFP37 zinc finger protein	9	113038380-113056759	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA049112	Uncertain		Approved	Nucleus<br>Vesicles	Glioma:9.22e-5 (favourable)	Mixed	Mixed			ovary: 8.8	Mixed		
ZFP42	REX1, ZNF754	ENSG00000179059	ZFP42 zinc finger protein	4	187995771-188005050	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB025557	Uncertain					Tissue enriched	Tissue enhanced		testis: 3.1	placenta: 1.0	Cell line enriched	17	BEWO: 113.6
ZFP57	bA145L22, bA145L22.2, C6orf40, ZNF698	ENSG00000204644	ZFP57 zinc finger protein	6	29672392-29681110	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047172	Uncertain				Pancreatic cancer:1.95e-4 (favourable)	Tissue enriched	Not detected			cerebral cortex,heart muscle: 0.4	Cell line enriched	25	BEWO: 6.2
ZFP62	FLJ34231, ZET, ZNF755	ENSG00000196670	ZFP62 zinc finger protein	5	180847611-180861285	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048629	Approved		Approved	Nucleoplasm<br>Actin filaments		Expressed in all	Expressed in all			thyroid gland: 39.6	Expressed in all		
ZFP64	dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338	ENSG00000020256	ZFP64 zinc finger protein	20	52051663-52204308	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035112, HPA058387	Uncertain		Approved	Nucleus	Liver cancer:9.86e-7 (unfavourable)	Expressed in all	Expressed in all			skin: 13.8	Expressed in all		
ZFP69	FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A	ENSG00000187815	ZFP69 zinc finger protein	1	40477215-40496343	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027808, HPA054942	Uncertain		Approved	Nucleus	Renal cancer:5.00e-6 (unfavourable), Head and neck cancer:9.31e-4 (favourable)	Expressed in all	Mixed			testis: 6.7	Cell line enhanced		THP-1: 39.0
ZFP69B	FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B	ENSG00000187801	ZFP69 zinc finger protein B	1	40450102-40463718	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044289	Uncertain		Approved	Nucleus<br>Cytosol		Mixed	Mixed			cerebral cortex: 3.7	Mixed		
ZFP82	KIAA1948, MGC45380, ZNF545	ENSG00000181007	ZFP82 zinc finger protein	19	36383120-36418656	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA051669, HPA060470	Uncertain		Approved	Nucleoplasm<br>Nuclear membrane<br>Cytosol		Mixed	Mixed			thyroid gland: 8.8	Mixed		
ZFP90	KIAA1954, NK10, ZNF756	ENSG00000184939	ZFP90 zinc finger protein	16	68530090-68576072	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029017	Uncertain		Supported	Vesicles<br>Plasma membrane<br>Centrosome	Renal cancer:1.78e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 31.7	Mixed		
ZFP91	PZF, ZNF757	ENSG00000186660	ZFP91 zinc finger protein	11	58579111-58621042	Enzymes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024037, CAB025417, HPA065325	Approved		Supported	Nucleus<br>Nucleoli	Pancreatic cancer:3.74e-6 (unfavourable)	Expressed in all	Expressed in all			testis: 175.7	Expressed in all		
ZFP92	ZNF897	ENSG00000189420	ZFP92 zinc finger protein	X	153418322-153426481	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA003030	Uncertain					Tissue enhanced	Mixed			fallopian tube: 5.3	Cell line enhanced		HDLM-2: 3.5;HMC-1: 3.1;U-937: 4.8
ZFPM1	FOG, FOG1, ZC2HC11A, ZNF89A	ENSG00000179588	Zinc finger protein, FOG family member 1	16	88453317-88537016	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046603	Enhanced		Approved	Nucleoplasm<br>Cytosol	Urothelial cancer:4.24e-4 (favourable)	Expressed in all	Mixed			stomach: 13.7	Cell line enhanced		K-562: 26.0
ZFPM2	FOG2, hFOG-2, ZC2HC11B, ZNF89B	ENSG00000169946	Zinc finger protein, FOG family member 2	8	104590733-105804532	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004094	Approved		Supported	Nucleoplasm		Mixed	Tissue enhanced		ovary: 41.0	smooth muscle: 26.3	Cell line enhanced		AF22: 6.4;BJ hTERT+: 11.5;HHSteC: 8.3;HUVEC TERT2: 9.0
ZFX	ZNF926	ENSG00000005889	Zinc finger protein, X-linked	X	24149173-24216255	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001748, HPA003877, HPA071863	Supported		Approved	Nucleoplasm<br>Nucleoli		Expressed in all	Expressed in all			parathyroid gland: 33.2	Expressed in all		
ZFY	ZNF911	ENSG00000067646	Zinc finger protein, Y-linked	Y	2935281-2982506	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001748, HPA071863	Uncertain		Approved	Nucleoplasm<br>Nucleoli	Head and neck cancer:3.58e-5 (favourable)	Mixed	Mixed			testis: 12.8	Mixed		
ZGLP1	GATAD3, GLP-1, GLP1	ENSG00000220201	Zinc finger, GATA-like protein 1	19	10304803-10309880	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049855	Uncertain		Approved	Nucleus<br>Vesicles		Mixed	Mixed			testis: 3.1	Cell line enhanced		NB-4: 20.8
ZGPAT	dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP	ENSG00000197114	Zinc finger CCCH-type and G-patch domain containing	20	63707465-63736142	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056705			Supported	Nucleus<br>Plasma membrane	Head and neck cancer:6.17e-5 (favourable)	Expressed in all	Expressed in all			liver: 27.5	Expressed in all		
ZHX1		ENSG00000165156	Zinc fingers and homeoboxes 1	8	123248451-123275541	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055357, HPA060251			Enhanced	Nucleoplasm	Endometrial cancer:6.09e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 62.9	Expressed in all		
ZHX2	KIAA0854	ENSG00000178764	Zinc fingers and homeoboxes 2	8	122781394-122974512	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006769, HPA006996	Enhanced		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			ovary: 32.8	Cell line enhanced		REH: 47.1
ZHX3	KIAA0395, TIX1	ENSG00000174306	Zinc fingers and homeoboxes 3	20	41178448-41317672	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046498			Supported	Nucleoplasm	Urothelial cancer:1.84e-5 (unfavourable), Renal cancer:2.53e-5 (favourable), Endometrial cancer:1.62e-4 (unfavourable), Thyroid cancer:7.52e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 43.5	Expressed in all		
ZIC1	ZIC, ZNF201	ENSG00000152977	Zic family member 1	3	147393422-147510293	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004098	Supported		Supported	Nucleoplasm		Tissue enhanced	Tissue enriched	9	cerebral cortex: 23.8	skin: 2.5	Cell line enriched	5	AF22: 171.9
ZIC2	HPE5	ENSG00000043355	Zic family member 2	13	99981772-99986773	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055031			Supported	Nuclear bodies	Cervical cancer:2.64e-4 (favourable), Liver cancer:2.91e-4 (unfavourable)	Mixed	Tissue enriched	6	cerebral cortex: 7.3	testis: 1.2	Cell line enhanced		AF22: 84.4;HEK 293: 60.2;NTERA-2: 79.9;SCLC-21H: 209.9
ZIC3	HTX, HTX1, ZNF203	ENSG00000156925	Zic family member 3	X	137566142-137577691	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052936, HPA069523	Approved		Supported	Nucleoplasm		Tissue enriched	Group enriched	12	cerebral cortex: 1.6;testis: 1.3	bone marrow,skin: 0.1	Group enriched	38	AF22: 39.4;NTERA-2: 44.7
ZIC4		ENSG00000174963	Zic family member 4	3	147386046-147406860	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at transcript level	HPA030194	Uncertain		Approved	Nucleus<br>Cytosol		Mixed	Group enriched	6	cerebral cortex: 4.3;skin: 1.4	skeletal muscle: 0.5	Cell line enhanced		AF22: 17.0;SH-SY5Y: 5.5
ZIC5		ENSG00000139800	Zic family member 5	13	99962964-99971909	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA074045			Uncertain	Nucleoplasm<br>Vesicles		Mixed	Group enriched	45	cerebral cortex: 2.3;testis: 6.6	all non-specific tissues: 0.0	Cell line enhanced		AF22: 21.7;NTERA-2: 15.0;SCLC-21H: 100.6
ZIK1	ZNF762	ENSG00000171649	Zinc finger protein interacting with K protein 1	19	57578456-57593777	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA059975	Uncertain		Approved	Intermediate filaments		Mixed	Mixed			parathyroid gland: 12.2	Cell line enhanced		HEK 293: 26.5;NTERA-2: 34.3
ZIM2	ZNF656	ENSG00000269699	Zinc finger imprinted 2	19	56774552-56840729	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071856			Approved	Nuclear speckles<br>Cytosol		Not detected	Group enriched	7	adrenal gland: 5.8;cerebral cortex: 5.1;ovary: 9.9;placenta: 6.8;testis: 7.7	endometrium: 1.0	Cell line enhanced		BEWO: 4.7;Hep G2: 4.0;NTERA-2: 1.6;RH-30: 1.6;U-2 OS: 1.2
ZIM3	ZNF657	ENSG00000141946	Zinc finger imprinted 3	19	57134096-57145202	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA034575	Uncertain					Not detected	Not detected			testis: 0.7	Not detected		
ZKSCAN1	KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33	ENSG00000106261	Zinc finger with KRAB and SCAN domains 1	7	100015572-100041689	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006672	Uncertain		Approved	Nucleus<br>Nuclear bodies<br>Mitochondria		Expressed in all	Expressed in all			skin: 38.9	Expressed in all		
ZKSCAN2	FLJ23199, ZNF694, ZSCAN34	ENSG00000155592	Zinc finger with KRAB and SCAN domains 2	16	25236001-25257931	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049141	Uncertain		Approved	Nucleoplasm<br>Nucleoli fibrillar center<br>Golgi apparatus	Renal cancer:1.70e-6 (favourable)	Expressed in all	Mixed			testis: 7.6	Mixed		
ZKSCAN3	ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35	ENSG00000189298	Zinc finger with KRAB and SCAN domains 3	6	28349914-28369177	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009637, HPA060116	Approved		Enhanced	Nucleoplasm	Glioma:6.55e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 10.1	Mixed		
ZKSCAN4	FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36	ENSG00000187626	Zinc finger with KRAB and SCAN domains 4	6	28244623-28252224	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009637	Approved		Approved	Nucleoplasm<br>Cytosol	Liver cancer:1.90e-6 (unfavourable), Lung cancer:5.04e-4 (favourable)	Expressed in all	Mixed			testis: 18.3	Expressed in all		
ZKSCAN5	ZFP95, ZNF914, ZSCAN37	ENSG00000196652	Zinc finger with KRAB and SCAN domains 5	7	99504651-99534700	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003201	Uncertain		Approved	Intermediate filaments	Liver cancer:7.59e-6 (unfavourable), Thyroid cancer:1.13e-4 (unfavourable)	Expressed in all	Mixed			testis: 15.1	Expressed in all		
ZKSCAN7	FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39	ENSG00000196345	Zinc finger with KRAB and SCAN domains 7	3	44555193-44594173	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048312, HPA049906, HPA071850	Uncertain		Enhanced	Cytosol		Mixed	Mixed			ovary: 4.1	Cell line enhanced		AN3-CA: 3.9;SH-SY5Y: 5.2
ZKSCAN8	LD5-1, ZNF192, ZSCAN40	ENSG00000198315	Zinc finger with KRAB and SCAN domains 8	6	28141910-28159472	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003483	Approved		Approved	Nucleus<br>Cytosol	Endometrial cancer:1.33e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 25.0	Expressed in all		
ZNF10	KOX1	ENSG00000256223	Zinc finger protein 10	12	133130575-133159465	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003204	Uncertain		Approved	Nucleus<br>Vesicles<br>Plasma membrane		Expressed in all	Expressed in all			parathyroid gland: 40.9	Mixed		
ZNF100		ENSG00000197020	Zinc finger protein 100	19	21722766-21767628	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059135	Uncertain				Urothelial cancer:5.47e-4 (favourable)	Mixed	Mixed			testis: 11.6	Cell line enhanced		MOLT-4: 24.6
ZNF101	DKFZp570I0164, HZF12	ENSG00000181896	Zinc finger protein 101	19	19668796-19683509	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023449, HPA055486	Uncertain				Cervical cancer:5.76e-5 (favourable), Stomach cancer:1.11e-4 (favourable), Head and neck cancer:2.15e-4 (favourable), Ovarian cancer:2.26e-4 (favourable), Urothelial cancer:4.37e-4 (favourable), Lung cancer:6.65e-4 (favourable)	Expressed in all	Tissue enhanced		lymph node: 31.4	tonsil: 22.3	Expressed in all		
ZNF107	smap-7, ZFD25, ZNF588	ENSG00000196247	Zinc finger protein 107	7	64666083-64711582	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:2.62e-4 (unfavourable)	Expressed in all	Mixed			lymph node: 19.4	Expressed in all		
ZNF112	ZFP112, ZNF228	ENSG00000062370	Zinc finger protein 112	19	44326555-44367217	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA023856	Approved		Approved	Centrosome	Renal cancer:1.54e-5 (favourable)	Mixed	Mixed			testis: 13.8	Cell line enhanced		U-2197: 16.1
ZNF114	MGC17986	ENSG00000178150	Zinc finger protein 114	19	48270102-48287608	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA025019, HPA029553	Uncertain		Approved	Nucleus<br>Cytosol	Head and neck cancer:3.29e-4 (unfavourable)	Mixed	Tissue enhanced		thyroid gland: 10.3	parathyroid gland: 3.6	Cell line enhanced		BEWO: 21.9;Hep G2: 18.9
ZNF117	H-plk, HPF9	ENSG00000152926	Zinc finger protein 117	7	64971776-65006684	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031148			Approved	Nucleoli fibrillar center<br>Cytosol	Renal cancer:2.17e-11 (unfavourable)	Expressed in all	Mixed			adrenal gland: 25.2	Mixed		
ZNF121	D19S204, ZHC32, ZNF20	ENSG00000197961	Zinc finger protein 121	19	9560353-9584533	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054961	Uncertain		Uncertain	Nucleoplasm<br>Nucleoli<br>Centrosome	Urothelial cancer:5.75e-5 (favourable), Ovarian cancer:6.59e-5 (favourable), Renal cancer:1.01e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 23.1	Expressed in all		
ZNF124	HZF-16, HZF16	ENSG00000196418	Zinc finger protein 124	1	247121975-247172016	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031127	Uncertain		Approved	Nucleus<br>Nuclear membrane	Urothelial cancer:1.03e-4 (favourable)	Expressed in all	Mixed			salivary gland: 16.8	Mixed		
ZNF131	pHZ-10, ZBTB35	ENSG00000172262	Zinc finger protein 131	5	43065176-43192021	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007023, HPA027748, HPA074630	Approved		Enhanced	Nucleoplasm<br>Intermediate filaments	Liver cancer:1.56e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 59.4	Expressed in all		
ZNF132	pHZ-12	ENSG00000131849	Zinc finger protein 132	19	58432814-58440222	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA008726	Uncertain		Approved	Vesicles<br>Intermediate filaments	Renal cancer:7.26e-13 (favourable), Pancreatic cancer:1.92e-4 (favourable)	Mixed	Mixed			parathyroid gland: 11.6	Mixed		
ZNF133	pHZ-13, pHZ-66, ZNF150	ENSG00000125846	Zinc finger protein 133	20	18288283-18316996	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001493	Enhanced		Approved	Nucleus<br>Vesicles	Liver cancer:4.46e-6 (unfavourable), Renal cancer:2.20e-5 (unfavourable)	Expressed in all	Expressed in all			epididymis: 20.1	Mixed		
ZNF134	pHZ-15	ENSG00000213762	Zinc finger protein 134	19	57614233-57624723	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009064	Supported		Approved	Nucleoplasm	Cervical cancer:1.03e-4 (unfavourable), Renal cancer:2.61e-4 (favourable), Head and neck cancer:5.21e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 20.9	Mixed		
ZNF135	pHZ-17, ZNF61, ZNF78L1	ENSG00000176293	Zinc finger protein 135	19	58059239-58086310	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006961	Approved		Approved	Cytosol	Renal cancer:3.93e-5 (favourable)	Mixed	Mixed			parathyroid gland: 25.0	Cell line enhanced		T-47d: 6.6
ZNF136	pHZ-20	ENSG00000196646	Zinc finger protein 136	19	12163064-12189881	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054120			Approved	Nucleoli	Renal cancer:4.75e-5 (favourable)	Expressed in all	Mixed			thyroid gland: 14.5	Mixed		
ZNF138	pHZ-32	ENSG00000197008	Zinc finger protein 138	7	64794388-64833681	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA077435			Uncertain	Cytosol		Expressed in all	Mixed			cerebral cortex: 9.1	Expressed in all		
ZNF14	GIOT-4, KOX6	ENSG00000105708	Zinc finger protein 14	19	19710471-19733097	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049863	Uncertain		Approved	Nucleus<br>Cytosol	Renal cancer:8.09e-6 (favourable), Lung cancer:7.96e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 13.3	Mixed		
ZNF140	pHZ-39	ENSG00000196387	Zinc finger protein 140	12	133079838-133107544	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048332	Uncertain					Expressed in all	Expressed in all			thyroid gland: 16.3	Mixed		
ZNF141	D4S90, pHZ-44	ENSG00000131127	Zinc finger protein 141	4	337814-384864	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Urothelial cancer:4.76e-4 (favourable)	Expressed in all	Mixed			adrenal gland,thyroid gland: 14.9	Mixed		
ZNF142	KIAA0236, pHZ-49	ENSG00000115568	Zinc finger protein 142	2	218637916-218659655	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049594	Uncertain		Approved	Nucleus<br>Nucleoli fibrillar center	Liver cancer:1.35e-5 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 14.9	Expressed in all		
ZNF143	pHZ-1, SBF, STAF	ENSG00000166478	Zinc finger protein 143	11	9460319-9528524	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003263, HPA074818	Supported		Approved	Nucleoplasm<br>Nuclear bodies<br>Vesicles	Liver cancer:1.76e-5 (unfavourable), Renal cancer:6.78e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 31.1	Expressed in all		
ZNF146	OZF	ENSG00000167635	Zinc finger protein 146	19	36214602-36238774	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003358	Supported		Supported	Nucleoli		Expressed in all	Expressed in all			parathyroid gland: 63.2	Expressed in all		
ZNF148	BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148	ENSG00000163848	Zinc finger protein 148	3	125225561-125375354	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001656, CAB017486	Supported		Supported	Nucleus<br>Golgi apparatus	Pancreatic cancer:2.88e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 50.4	Expressed in all		
ZNF154	pHZ-92	ENSG00000179909	Zinc finger protein 154	19	57697367-57709194	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Mixed			parathyroid gland: 9.5	Cell line enhanced		AF22: 5.2;MOLT-4: 3.6;NTERA-2: 2.9
ZNF155	pHZ-96	ENSG00000204920	Zinc finger protein 155	19	43967862-43998325	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003220	Uncertain		Approved	Nucleoplasm<br>Cytosol		Mixed	Mixed			parathyroid gland: 14.5	Mixed		
ZNF157	HZF22	ENSG00000147117	Zinc finger protein 157	X	47370583-47414305	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA003319	Uncertain					Tissue enhanced	Mixed			fallopian tube: 2.1	Cell line enhanced		U-266/84: 1.6
ZNF16	KOX9	ENSG00000170631	Zinc finger protein 16	8	144930358-144950888	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035782, HPA061835	Uncertain		Supported	Nucleus<br>Nucleoli	Head and neck cancer:2.39e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 16.1	Expressed in all		
ZNF160	F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18	ENSG00000170949	Zinc finger protein 160	19	53066606-53103436	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA023599	Uncertain		Approved	Nuclear speckles<br>Cytosol	Urothelial cancer:2.67e-5 (favourable)	Expressed in all	Expressed in all			spleen: 37.4	Mixed		
ZNF165	CT53, ZSCAN7	ENSG00000197279	Zinc finger protein 165	6	28080975-28089563	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007247			Approved	Nuclear speckles<br>Microtubules	Renal cancer:1.19e-5 (favourable), Urothelial cancer:9.82e-5 (favourable), Ovarian cancer:2.10e-4 (favourable)	Mixed	Tissue enhanced		testis: 35.8	epididymis: 7.5	Cell line enhanced		BEWO: 23.4
ZNF169	MGC51961	ENSG00000175787	Zinc finger protein 169	9	94259311-94301454	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041769	Uncertain		Approved	Nuclear speckles<br>Cytosol		Mixed	Mixed			spleen: 7.7	Mixed		
ZNF17	FLJ40864, FLJ46058, FLJ46615, HPF3, KIAA1947, KOX10	ENSG00000186272	Zinc finger protein 17	19	57411163-57421939	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Pancreatic cancer:6.03e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 9.3	Expressed in all		
ZNF174	ZSCAN8	ENSG00000103343	Zinc finger protein 174	16	3401235-3409370	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA009656	Approved		Supported	Nucleoplasm<br>Actin filaments<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 28.3	Expressed in all		
ZNF175	OTK18	ENSG00000105497	Zinc finger protein 175	19	51571298-51592508	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002717	Uncertain		Supported	Nucleoplasm<br>Intermediate filaments<br>Cytosol	Thyroid cancer:6.64e-4 (unfavourable)	Mixed	Mixed			parathyroid gland: 19.7	Cell line enhanced		HEL: 45.3
ZNF177		ENSG00000188629	Zinc finger protein 177	19	9363020-9382617	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003141	Uncertain					Not detected	Tissue enhanced		testis: 14.3	epididymis: 8.7	Mixed		
ZNF18	HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38	ENSG00000154957	Zinc finger protein 18	17	11977439-11997510	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006144	Uncertain		Approved	Nucleoplasm<br>Golgi apparatus<br>Plasma membrane<br>Cytosol	Renal cancer:3.06e-6 (unfavourable), Pancreatic cancer:5.12e-6 (favourable), Cervical cancer:6.32e-4 (favourable)	Expressed in all	Expressed in all			testis: 22.3	Expressed in all		
ZNF180	HHZ168	ENSG00000167384	Zinc finger protein 180	19	44474428-44500524	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028979, HPA028980	Uncertain		Approved	Nucleoplasm		Expressed in all	Mixed			parathyroid gland: 12.3	Mixed		
ZNF181	HHZ181, MGC44316	ENSG00000197841	Zinc finger protein 181	19	34734155-34745378	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043701, HPA062305	Uncertain		Approved	Nucleus	Pancreatic cancer:1.05e-4 (favourable), Melanoma:2.60e-4 (unfavourable), Urothelial cancer:5.45e-4 (favourable)	Expressed in all	Expressed in all			ovary: 21.5	Mixed		
ZNF182	HHZ150, KOX14, Zfp182, ZNF21	ENSG00000147118	Zinc finger protein 182	X	47974851-48003978	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA059574	Uncertain		Approved	Nucleus	Urothelial cancer:1.55e-7 (favourable), Renal cancer:2.42e-5 (unfavourable), Liver cancer:3.73e-4 (unfavourable)	Expressed in all	Mixed			thyroid gland: 9.2	Expressed in all		
ZNF184		ENSG00000096654	Zinc finger protein 184	6	27450743-27473118	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003226, HPA064793	Uncertain		Supported	Nucleus	Ovarian cancer:4.41e-5 (favourable)	Expressed in all	Mixed			testis: 15.2	Expressed in all		
ZNF189		ENSG00000136870	Zinc finger protein 189	9	101398873-101410660	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034814	Uncertain		Approved	Intermediate filaments	Renal cancer:5.32e-4 (favourable)	Expressed in all	Expressed in all			epididymis: 104.7	Expressed in all		
ZNF19	KOX12, MGC51021	ENSG00000157429	Zinc finger protein 19	16	71464555-71565089	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA063685	Approved		Approved	Mitochondria		Mixed	Expressed in all			testis: 29.2	Mixed		
ZNF195		ENSG00000005801	Zinc finger protein 195	11	3339261-3379222	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030605	Uncertain		Approved	Nucleus<br>Cytosol	Urothelial cancer:4.79e-7 (favourable), Liver cancer:3.53e-5 (unfavourable), Renal cancer:7.89e-5 (unfavourable), Prostate cancer:4.24e-4 (unfavourable)	Expressed in all	Expressed in all			epididymis: 21.3	Expressed in all		
ZNF197	D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41	ENSG00000186448	Zinc finger protein 197	3	44584888-44648471	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054567	Uncertain		Approved	Nucleoplasm	Prostate cancer:6.78e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 9.2	Mixed		
ZNF2	A1-5, Zfp661, ZNF661	ENSG00000275111	Zinc finger protein 2	2	95165432-95184317	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041358	Uncertain		Approved	Nucleoplasm<br>Plasma membrane<br>Cytosol	Lung cancer:4.69e-5 (favourable)	Expressed in all	Mixed			parathyroid gland: 6.4	Expressed in all		
ZNF20	KOX13	ENSG00000132010	Zinc finger protein 20	19	12092843-12140407	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020887	Uncertain		Approved	Nucleoplasm<br>Plasma membrane		Not detected	Mixed			testis: 9.3	Mixed		
ZNF200		ENSG00000010539	Zinc finger protein 200	16	3222325-3236221	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018981, HPA059310	Uncertain		Approved	Mitochondria		Expressed in all	Tissue enhanced		testis: 31.6	placenta: 8.8	Expressed in all		
ZNF202	ZKSCAN10, ZSCAN42	ENSG00000166261	Zinc finger protein 202	11	123724177-123741675	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:9.93e-7 (unfavourable), Liver cancer:2.52e-6 (unfavourable)	Expressed in all	Expressed in all			testis: 16.7	Expressed in all		
ZNF205	Zfp13, ZNF210	ENSG00000122386	Zinc finger protein 205	16	3112560-3120517	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001791	Uncertain		Approved	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 14.6	Mixed		
ZNF208	PMIDP, ZNF95	ENSG00000160321	Zinc finger protein 208	19	21932958-22010949	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Mixed			testis: 16.5	Group enriched	10	NTERA-2: 33.9;U-266/84: 7.7
ZNF211	CH2H2-25, ZNF-25	ENSG00000121417	Zinc finger protein 211	19	57630395-57642779	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA011340, HPA049967	Approved		Approved	Mitochondria<br>Rods & Rings		Expressed in all	Expressed in all			parathyroid gland: 32.7	Mixed		
ZNF212	C2H2-150	ENSG00000170260	Zinc finger protein 212	7	149239651-149255609	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049807, HPA054178	Uncertain		Supported	Nucleus		Expressed in all	Expressed in all			testis: 15.1	Expressed in all		
ZNF213	CR53, ZKSCAN21, ZSCAN53	ENSG00000085644	Zinc finger protein 213	16	3129777-3142805	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA035000, HPA056750	Uncertain		Approved	Nucleus<br>Nuclear membrane<br>Vesicles<br>Cytosol	Liver cancer:6.74e-4 (unfavourable)	Expressed in all	Mixed			testis: 16.3	Expressed in all		
ZNF214		ENSG00000149050	Zinc finger protein 214	11	6999318-7020368	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055391	Uncertain					Mixed	Mixed			fallopian tube: 6.9	Mixed		
ZNF215	ZKSCAN11, ZSCAN43	ENSG00000149054	Zinc finger protein 215	11	6926404-7001004	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047243, HPA051010	Enhanced		Approved	Nucleoplasm<br>Vesicles		Mixed	Mixed			lymph node: 4.5	Cell line enhanced		U-698: 14.5
ZNF217	ZABC1	ENSG00000171940	Zinc finger protein 217	20	53567065-53609907	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051857	Approved		Enhanced	Nuclear speckles		Expressed in all	Mixed			testis: 41.2	Expressed in all		
ZNF219		ENSG00000165804	Zinc finger protein 219	14	21090046-21104722	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030761, HPA056168	Approved		Supported	Nucleus		Expressed in all	Expressed in all			skin: 44.0	Expressed in all		
ZNF22	HKR-T1, KOX15, Zfp422, ZNF422	ENSG00000165512	Zinc finger protein 22	10	45000475-45005326	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016736, HPA054893	Approved		Enhanced	Nucleus	Renal cancer:1.11e-5 (unfavourable), Stomach cancer:8.06e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 46.7	Mixed		
ZNF222		ENSG00000159885	Zinc finger protein 222	19	44025342-44033112	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004086	Approved		Approved	Nucleoplasm<br>Nuclear bodies	Pancreatic cancer:5.56e-7 (favourable)	Expressed in all	Mixed			testis: 16.9	Mixed		
ZNF223		ENSG00000178386	Zinc finger protein 223	19	44051367-44067991	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067823			Approved	Nucleus<br>Mitochondria		Mixed	Mixed			prostate,thyroid gland: 10.6	Cell line enhanced		RT4: 18.6
ZNF224	BMZF-2, KOX22, ZNF255, ZNF27	ENSG00000267680	Zinc finger protein 224	19	44094339-44109886	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054045	Approved		Supported	Nucleus<br>Nuclear membrane	Urothelial cancer:1.53e-7 (favourable), Renal cancer:5.32e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 35.7	Expressed in all		
ZNF225		ENSG00000256294	Zinc finger protein 225	19	44112181-44134816	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA073778			Approved	Nucleoplasm		Mixed	Tissue enhanced		testis: 22.8	breast: 10.6	Mixed		
ZNF226		ENSG00000167380	Zinc finger protein 226	19	44165073-44178381	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006145, CAB034353	Uncertain		Approved	Nuclear bodies	Urothelial cancer:2.37e-5 (favourable), Pancreatic cancer:8.34e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 39.9	Expressed in all		
ZNF227		ENSG00000131115	Zinc finger protein 227	19	44207547-44237268	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030573	Uncertain		Approved	Plasma membrane	Urothelial cancer:2.64e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 18.7	Mixed		
ZNF229		ENSG00000278318	Zinc finger protein 229	19	44417519-44448578	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA001494	Uncertain		Approved	Vesicles<br>Plasma membrane	Renal cancer:8.43e-5 (favourable)	Mixed	Tissue enhanced		parathyroid gland: 6.7	fallopian tube,thyroid gland: 3.1	Mixed		
ZNF23	KOX16, Zfp612, ZNF359, ZNF612	ENSG00000167377	Zinc finger protein 23	16	71447597-71463095	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023534	Uncertain		Approved	Cytosol		Not detected	Mixed			cerebral cortex: 12.0	Expressed in all		
ZNF230	FDZF2	ENSG00000159882	Zinc finger protein 230	19	44002948-44013926	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006172			Approved	Mitochondria		Mixed	Mixed			ovary: 5.2	Mixed		
ZNF232	ZSCAN11	ENSG00000167840	Zinc finger protein 232	17	5105541-5123116	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027309, HPA028611	Uncertain		Supported	Nucleus<br>Vesicles<br>Cytosol	Liver cancer:4.66e-4 (unfavourable), Pancreatic cancer:6.55e-4 (favourable)	Expressed in all	Mixed			ovary: 4.3	Mixed		
ZNF233	FLJ38032	ENSG00000159915	Zinc finger protein 233	19	44259880-44275317	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA020975	Uncertain		Approved	Nucleoplasm		Mixed	Tissue enhanced		testis: 26.1	cerebral cortex: 5.8	Mixed		
ZNF234	HZF4, ZNF269	ENSG00000263002	Zinc finger protein 234	19	44141557-44160309	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001664	Approved		Approved	Nuclear bodies	Urothelial cancer:4.34e-5 (favourable)	Expressed in all	Mixed			parathyroid gland: 9.1	Mixed		
ZNF235	ANF270, HZF6, ZFP93, ZNF270	ENSG00000159917	Zinc finger protein 235	19	44228729-44305046	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045582	Uncertain		Supported	Nucleoplasm		Mixed	Mixed			parathyroid gland: 5.1	Mixed		
ZNF236		ENSG00000130856	Zinc finger protein 236	18	76822607-76970727	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008600	Uncertain					Expressed in all	Mixed			testis: 13.3	Mixed		
ZNF239	HOK-2, MOK2	ENSG00000196793	Zinc finger protein 239	10	43556344-43574618	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030843, HPA046679	Uncertain		Approved	Nucleus<br>Nuclear bodies	Renal cancer:4.70e-7 (unfavourable)	Expressed in all	Mixed			testis: 14.7	Cell line enhanced		NTERA-2: 24.4
ZNF24	KOX17, Zfp191, ZNF191, ZSCAN3	ENSG00000172466	Zinc finger protein 24	18	35332212-35345482	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024062, CAB025642	Supported		Supported	Nucleus	Renal cancer:1.44e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 56.6	Expressed in all		
ZNF248	bA162G10.3	ENSG00000198105	Zinc finger protein 248	10	37776526-37858106	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018237, HPA018287, HPA018455	Uncertain		Approved	Nucleoplasm	Lung cancer:1.04e-4 (favourable), Pancreatic cancer:1.22e-4 (favourable), Renal cancer:2.25e-4 (unfavourable), Prostate cancer:6.71e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 25.9	Expressed in all		
ZNF25	FLJ31890, KOX19, Zfp9	ENSG00000175395	Zinc finger protein 25	10	37949572-37976633	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA030190	Uncertain		Approved	Nucleoplasm<br>Golgi apparatus		Expressed in all	Mixed			cerebral cortex: 26.9	Mixed		
ZNF250	MGC9718, ZFP647, ZNF647	ENSG00000196150	Zinc finger protein 250	8	144876497-144902168	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020853	Uncertain		Supported	Nuclear speckles	Renal cancer:2.43e-7 (favourable), Urothelial cancer:8.26e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 20.1	Expressed in all		
ZNF251		ENSG00000198169	Zinc finger protein 251	8	144720907-144756417	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA018290	Approved		Approved	Nucleoplasm	Renal cancer:1.42e-9 (unfavourable)	Expressed in all	Mixed			thyroid gland: 13.8	Mixed		
ZNF253	BMZF-1, FLJ90391, ZNF411	ENSG00000256771	Zinc finger protein 253	19	19865886-19894674	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:9.69e-5 (favourable), Glioma:1.11e-4 (favourable), Ovarian cancer:2.19e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 25.9	Mixed		
ZNF254	BMZF-5, HD-ZNF1, ZNF539, ZNF91L	ENSG00000213096	Zinc finger protein 254	19	24033405-24129961	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Lung cancer:8.60e-4 (favourable), Urothelial cancer:9.96e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 29.3	Mixed		
ZNF256	BMZF-3	ENSG00000152454	Zinc finger protein 256	19	57940833-57947675	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055390	Uncertain		Supported	Nucleus		Expressed in all	Mixed			testis: 7.9	Cell line enhanced		HEK 293: 30.4
ZNF257	BMZF-4	ENSG00000197134	Zinc finger protein 257	19	22052452-22091480	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Ovarian cancer:2.05e-4 (favourable)	Tissue enhanced	Mixed			testis: 4.2	Cell line enhanced		NTERA-2: 11.0;RH-30: 5.6
ZNF26	FLJ20755, KOX20	ENSG00000198393	Zinc finger protein 26	12	132986365-133032952	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA018329, HPA042406	Uncertain		Approved	Nuclear bodies<br>Mitochondria		Mixed	Mixed			epididymis: 6.9	Mixed		
ZNF260	ozrf1, Zfp260	ENSG00000254004	Zinc finger protein 260	19	36510695-36528660	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028806	Approved		Supported	Nucleoplasm<br>Cytosol	Renal cancer:1.44e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 20.5	Mixed		
ZNF263	FPM315, ZKSCAN12, ZSCAN44	ENSG00000006194	Zinc finger protein 263	16	3263800-3301401	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035085, HPA035086	Approved		Supported	Nucleoplasm<br>Mitotic spindle<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 58.2	Expressed in all		
ZNF264	KIAA0412	ENSG00000083844	Zinc finger protein 264	19	57191500-57222846	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057665	Uncertain					Expressed in all	Expressed in all			testis: 18.3	Mixed		
ZNF266	HZF1	ENSG00000174652	Zinc finger protein 266	19	9412598-9435578	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026836, HPA054110	Uncertain		Enhanced	Nucleus<br>Vesicles<br>Rods & Rings	Head and neck cancer:3.94e-6 (favourable), Pancreatic cancer:3.03e-5 (favourable), Urothelial cancer:9.15e-5 (favourable), Cervical cancer:1.41e-4 (favourable), Renal cancer:1.82e-4 (unfavourable), Lung cancer:4.47e-4 (favourable)	Expressed in all	Expressed in all			epididymis: 117.7	Mixed		
ZNF267	HZF2	ENSG00000185947	Zinc finger protein 267	16	31873758-31917357	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003866	Approved		Approved	Nucleoplasm	Renal cancer:1.58e-6 (unfavourable)	Expressed in all	Mixed			appendix: 24.9	Expressed in all		
ZNF268	HZF3	ENSG00000090612	Zinc finger protein 268	12	133181409-133214831	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001794	Approved		Approved	Actin filaments<br>Cytosol		Expressed in all	Mixed			parathyroid gland: 23.5	Mixed		
ZNF273	HZF9	ENSG00000198039	Zinc finger protein 273	7	64870172-64930966	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA077549			Approved	Nucleoplasm		Mixed	Mixed			testis: 2.9	Mixed		
ZNF274	ZKSCAN19, ZSCAN51	ENSG00000171606	Zinc finger protein 274	19	58183029-58213562	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028880	Uncertain		Supported	Nucleus<br>Centrosome	Prostate cancer:1.75e-4 (unfavourable), Glioma:4.26e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 40.2	Expressed in all		
ZNF275		ENSG00000063587	Zinc finger protein 275	X	153334155-153360110	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA000566	Approved		Approved	Nucleoli		Expressed in all	Expressed in all			adrenal gland: 79.3	Cell line enhanced		U-266/70: 46.8
ZNF276	CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477	ENSG00000158805	Zinc finger protein 276	16	89720400-89740903	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021309, HPA022255	Uncertain		Approved	Nucleus<br>Nucleoli<br>Plasma membrane<br>Cytosol	Renal cancer:3.37e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 22.9	Expressed in all		
ZNF277	NRIF4, ZNF277P	ENSG00000198839	Zinc finger protein 277	7	112206588-112343096	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027307	Uncertain		Approved	Nucleoplasm<br>Plasma membrane	Renal cancer:9.47e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 33.4	Expressed in all		
ZNF28	DKFZp781D0275, KOX24	ENSG00000198538	Zinc finger protein 28	19	52797409-52857600	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Breast cancer:9.29e-4 (unfavourable)	Expressed in all	Mixed			thyroid gland: 17.9	Mixed		
ZNF280A	3'OY11.1, SUHW1, ZNF280, ZNF636	ENSG00000169548	Zinc finger protein 280A	22	22513736-22520270	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA044475	Uncertain		Uncertain	Nucleoplasm		Tissue enhanced	Not detected			adrenal gland: 0.3	Cell line enhanced		BEWO: 1.8;K-562: 7.3;SK-MEL-30: 1.6
ZNF280B	5'OY11.1, SUHW2, ZNF279, ZNF632	ENSG00000275004	Zinc finger protein 280B	22	22484421-22509154	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059519	Uncertain		Approved	Nucleoplasm		Mixed	Tissue enriched	7	testis: 12.6	cerebral cortex: 1.8	Cell line enhanced		K-562: 8.3;U-2 OS: 4.7
ZNF280C	FLJ20095, SUHW3, ZNF633	ENSG00000056277	Zinc finger protein 280C	X	130202711-130268899	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051494, HPA055788	Enhanced		Approved	Nucleus<br>Nucleoli fibrillar center		Expressed in all	Tissue enhanced		testis: 17.5	epididymis: 6.3	Mixed		
ZNF280D	FLJ20086, SUHW4, ZNF634	ENSG00000137871	Zinc finger protein 280D	15	56630181-56918571	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030233	Approved		Approved	Nucleoplasm<br>Golgi apparatus<br>Centrosome<br>Cytosol		Expressed in all	Expressed in all			endometrium: 31.8	Mixed		
ZNF281	ZBP-99	ENSG00000162702	Zinc finger protein 281	1	200404940-200410056	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051228	Uncertain		Enhanced	Nucleoplasm	Renal cancer:2.60e-5 (unfavourable), Cervical cancer:1.16e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 21.5	Expressed in all		
ZNF282	HUB1	ENSG00000170265	Zinc finger protein 282	7	149195485-149226248	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024374	Supported		Approved	Nucleoplasm<br>Cytosol	Liver cancer:3.03e-5 (unfavourable)	Expressed in all	Expressed in all			cervix, uterine,fallopian tube: 14.9	Expressed in all		
ZNF283		ENSG00000167637	Zinc finger protein 283	19	43827292-43852017	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA072977			Approved	Nucleoplasm		Mixed	Mixed			parathyroid gland: 10.2	Cell line enhanced		U-2 OS: 25.1
ZNF284	DKFZp781F1775	ENSG00000186026	Zinc finger protein 284	19	44072144-44089613	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Mixed			skin: 3.6	Mixed		
ZNF285	ZNF285A	ENSG00000267508	Zinc finger protein 285	19	44382298-44401608	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046100, HPA049212	Uncertain					Mixed	Mixed			ovary: 7.9	Mixed		
ZNF286A	KIAA1874, ZNF286	ENSG00000187607	Zinc finger protein 286A	17	15699577-15720787	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021594			Approved	Nucleoli		Mixed	Mixed			ovary: 21.8	Mixed		
ZNF286B	ZNF286C, ZNF286L, ZNF590	ENSG00000249459	Zinc finger protein 286B	17	18658429-18682262	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA068125	Uncertain		Approved	Nuclear speckles<br>Cytosol		Mixed	Mixed			ovary: 2.6	Mixed		
ZNF287	ZKSCAN13, ZSCAN45	ENSG00000141040	Zinc finger protein 287	17	16551387-16569206	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029290	Uncertain		Approved	Golgi apparatus	Renal cancer:5.28e-5 (favourable)	Mixed	Mixed			parathyroid gland: 13.0	Mixed		
ZNF292	bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16	ENSG00000188994	Zinc finger protein 292	6	87152833-87264196	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA032154, HPA050618	Uncertain		Approved	Nucleus<br>Nuclear membrane		Expressed in all	Expressed in all			endometrium: 17.1	Expressed in all		
ZNF296	ZNF342	ENSG00000170684	Zinc finger protein 296	19	45071500-45076588	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046940, HPA049576	Uncertain		Approved	Nucleoplasm<br>Centrosome	Head and neck cancer:5.24e-4 (favourable)	Expressed in all	Mixed			spleen: 3.7	Cell line enhanced		Daudi: 16.2;U-698: 18.2
ZNF3	A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113	ENSG00000166526	Zinc finger protein 3	7	100064033-100082548	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003719	Supported	Approved	Approved	Nucleoplasm	Melanoma:1.59e-4 (unfavourable), Urothelial cancer:2.20e-4 (favourable), Lung cancer:5.73e-4 (favourable)	Expressed in all	Expressed in all			fallopian tube: 56.8	Expressed in all		
ZNF30	DKFZp686N19164, FLJ20562, KOX28	ENSG00000168661	Zinc finger protein 30	19	34926903-34945170	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA030400	Uncertain		Approved	Nucleoplasm<br>Cytosol	Pancreatic cancer:1.16e-4 (favourable)	Expressed in all	Mixed			fallopian tube: 5.0	Mixed		
ZNF300		ENSG00000145908	Zinc finger protein 300	5	150894392-150904983	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028975, HPA051777	Uncertain		Supported	Nucleoplasm<br>Nucleoli	Renal cancer:3.21e-6 (unfavourable)	Expressed in all	Mixed			ovary: 12.4	Mixed		
ZNF302	ZNF135L, ZNF140L, ZNF327	ENSG00000089335	Zinc finger protein 302	19	34677639-34686397	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059503			Approved	Vesicles<br>Cytokinetic bridge	Endometrial cancer:2.03e-5 (unfavourable), Urothelial cancer:9.85e-5 (favourable), Renal cancer:5.41e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 42.1	Mixed		
ZNF304		ENSG00000131845	Zinc finger protein 304	19	57351307-57359898	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050531	Approved		Approved	Nuclear speckles	Renal cancer:1.52e-7 (favourable), Melanoma:4.95e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 15.9	Mixed		
ZNF311		ENSG00000197935	Zinc finger protein 311	6	28994785-29005316	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA050541	Uncertain					Mixed	Not detected			fallopian tube: 0.4	Not detected		
ZNF316	ENST00000305834, MZF-3	ENSG00000205903	Zinc finger protein 316	7	6637322-6656432	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Pancreatic cancer:6.03e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 50.8	Expressed in all		
ZNF317		ENSG00000130803	Zinc finger protein 317	19	9140380-9163424	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042075, HPA048625	Approved		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 20.7	Expressed in all		
ZNF319	KIAA1388, Zfp319	ENSG00000166188	Zinc finger protein 319	16	57994668-58000453	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052584	Uncertain		Approved	Nucleus	Pancreatic cancer:5.87e-5 (favourable), Liver cancer:1.90e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 13.9	Expressed in all		
ZNF32	KOX30	ENSG00000169740	Zinc finger protein 32	10	43643859-43648856	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039148, HPA059640			Supported	Nucleoplasm<br>Nuclear bodies	Pancreatic cancer:3.02e-4 (favourable), Liver cancer:7.08e-4 (unfavourable)	Expressed in all	Expressed in all			epididymis: 71.8	Mixed		
ZNF320	DKFZp686G16228, ZFPL	ENSG00000182986	Zinc finger protein 320	19	52863790-52897693	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043696, HPA062474	Uncertain		Approved	Nucleoplasm<br>Cytoplasmic bodies		Expressed in all	Mixed			parathyroid gland: 22.5	Cell line enhanced		RT4: 70.3
ZNF322	bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489	ENSG00000181315	Zinc finger protein 322	6	26634383-26659752	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043161, HPA046692	Approved		Supported	Nucleus<br>Centrosome<br>Cytosol	Glioma:1.75e-4 (favourable), Lung cancer:8.57e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 29.2	Mixed		
ZNF324	ZF5128, ZNF324A	ENSG00000083812	Zinc finger protein 324	19	58467045-58475436	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039774	Uncertain		Approved	Nucleus<br>Nuclear membrane<br>Cytosol	Renal cancer:1.34e-7 (favourable), Pancreatic cancer:4.74e-5 (favourable), Thyroid cancer:6.99e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 8.6	Expressed in all		
ZNF324B	FLJ45850	ENSG00000249471	Zinc finger protein 324B	19	58451604-58457833	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023400	Uncertain		Approved	Nucleoli<br>Cytosol	Pancreatic cancer:2.83e-4 (favourable)	Expressed in all	Mixed			spleen: 4.7	Cell line enhanced		HEK 293: 35.2
ZNF329	FLJ12586	ENSG00000181894	Zinc finger protein 329	19	58126252-58155110	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044373	Uncertain		Approved	Nucleoplasm<br>Nuclear membrane	Renal cancer:8.58e-9 (favourable)	Expressed in all	Mixed			parathyroid gland: 16.9	Mixed		
ZNF331	RITA, ZNF361, ZNF463	ENSG00000130844	Zinc finger protein 331	19	53520981-53580269	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063157			Approved	Nucleoplasm	Stomach cancer:4.79e-4 (unfavourable), Thyroid cancer:7.43e-4 (unfavourable)	Expressed in all	Expressed in all			adrenal gland: 208.6	Cell line enhanced		HEK 293: 73.6
ZNF333	KIAA1806	ENSG00000160961	Zinc finger protein 333	19	14689801-14733746	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA043973, HPA054680	Uncertain		Approved	Nucleoplasm		Mixed	Mixed			endometrium: 11.1	Mixed		
ZNF334	bA179N14.1	ENSG00000198185	Zinc finger protein 334	20	46499630-46513559	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050022	Uncertain		Approved	Nucleus<br>Cytosol		Mixed	Mixed			ovary: 19.4	Cell line enhanced		AF22: 15.3;BEWO: 18.7;NTERA-2: 10.4;SCLC-21H: 15.2
ZNF335	bA465L10.2, NIF-1	ENSG00000198026	Zinc finger protein 335	20	45948653-45972172	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063999, HPA071230			Enhanced	Nucleoplasm	Renal cancer:2.77e-5 (unfavourable), Liver cancer:1.59e-4 (unfavourable), Head and neck cancer:4.48e-4 (favourable), Prostate cancer:7.04e-4 (unfavourable)	Expressed in all	Expressed in all			skin: 24.6	Expressed in all		
ZNF337	dJ694B14.1	ENSG00000130684	Zinc finger protein 337	20	25674215-25696841	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044303, HPA064219	Approved		Approved	Nuclear speckles<br>Plasma membrane	Renal cancer:2.87e-6 (unfavourable)	Mixed	Expressed in all			parathyroid gland: 27.9	Expressed in all		
ZNF33A	FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK	ENSG00000189180	Zinc finger protein 33A	10	38010650-38065088	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056638	Approved					Expressed in all	Expressed in all			parathyroid gland: 35.1	Expressed in all		
ZNF33B	KOX2, KOX31, ZNF11B	ENSG00000196693	Zinc finger protein 33B	10	42574185-42638568	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056638	Approved					Expressed in all	Expressed in all			parathyroid gland: 32.1	Mixed		
ZNF34	KOX32	ENSG00000196378	Zinc finger protein 34	8	144773114-144787345	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA053925, HPA060755, HPA066805	Uncertain		Enhanced	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			ovary: 12.8	Mixed		
ZNF341	dJ553F4.3	ENSG00000131061	Zinc finger protein 341	20	33731657-33792269	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023240, HPA024607, HPA067108	Uncertain		Approved	Nucleoplasm<br>Vesicles	Liver cancer:1.87e-4 (unfavourable), Head and neck cancer:3.93e-4 (favourable)	Expressed in all	Mixed			testis: 2.3	Mixed		
ZNF343	MGC10715	ENSG00000088876	Zinc finger protein 343	20	2481817-2524702	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030587, HPA052438	Approved		Approved	Nucleoplasm	Liver cancer:1.38e-6 (unfavourable), Renal cancer:4.53e-5 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 15.6	Expressed in all		
ZNF345	HZF10	ENSG00000251247	Zinc finger protein 345	19	36850361-36913029	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA025816	Uncertain					Mixed	Mixed			testis: 17.7	Mixed		
ZNF347	ZNF1111	ENSG00000197937	Zinc finger protein 347	19	53124072-53159075	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023448	Uncertain		Approved	Microtubules		Mixed	Expressed in all			spleen: 13.3	Mixed		
ZNF35	HF.10, HF10, Zfp105	ENSG00000169981	Zinc finger protein 35	3	44648727-44660791	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051859, HPA054738	Uncertain		Approved	Nucleoplasm		Expressed in all	Mixed			testis: 9.2	Mixed		
ZNF350	ZBRK1, ZFQR	ENSG00000256683	Zinc finger protein 350	19	51964343-51986856	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001521	Uncertain		Supported	Nucleoplasm<br>Nuclear bodies	Urothelial cancer:2.54e-4 (favourable)	Expressed in all	Mixed			prostate: 45.0	Mixed		
ZNF354A	EZNF, HKL1, KID-1, KID1, TCF17	ENSG00000169131	Zinc finger protein 354A	5	178694605-178730702	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052043	Approved		Supported	Nucleus<br>Nucleoli<br>Cytosol	Renal cancer:3.45e-6 (unfavourable), Ovarian cancer:8.28e-4 (favourable)	Expressed in all	Expressed in all			testis: 15.7	Mixed		
ZNF354B	FLJ25008, KID2	ENSG00000178338	Zinc finger protein 354B	5	178859953-178888122	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA029056	Approved		Approved	Nucleoplasm	Renal cancer:1.30e-5 (unfavourable), Head and neck cancer:9.52e-4 (favourable)	Expressed in all	Expressed in all			placenta: 19.9	Mixed		
ZNF354C	KID3	ENSG00000177932	Zinc finger protein 354C	5	179060415-179083537	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030904	Uncertain		Supported	Nuclear membrane<br>Cytosol		Mixed	Mixed			ovary: 9.2	Cell line enhanced		AN3-CA: 17.5
ZNF358	FLJ10390, ZFEND	ENSG00000198816	Zinc finger protein 358	19	7515292-7521026	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030887, HPA063624	Approved		Approved	Nucleus	Pancreatic cancer:2.50e-4 (favourable)	Expressed in all	Expressed in all			ovary: 84.0	Mixed		
ZNF362	FLJ25476, lin-29, RN	ENSG00000160094	Zinc finger protein 362	1	33256545-33300719	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059239	Uncertain		Approved	Nucleus<br>Nucleoli		Expressed in all	Expressed in all			spleen: 22.1	Expressed in all		
ZNF366	FLJ39796	ENSG00000178175	Zinc finger protein 366	5	72442652-72507727	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023128, HPA023526	Uncertain					Mixed	Mixed			placenta: 10.2	Cell line enhanced		HUVEC TERT2: 1.0;TIME: 1.1
ZNF37A	KOX21, ZNF37	ENSG00000075407	Zinc finger protein 37A	10	38094334-38150293	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003172	Approved		Approved	Vesicles	Renal cancer:2.31e-4 (unfavourable), Liver cancer:2.83e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 18.1	Expressed in all		
ZNF382	FLJ14686, KS1	ENSG00000161298	Zinc finger protein 382	19	36604817-36634113	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049259	Approved		Approved	Nuclear speckles		Mixed	Mixed			cerebral cortex: 10.9	Mixed		
ZNF383	FLJ35863	ENSG00000188283	Zinc finger protein 383	19	37217926-37248738	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063945	Approved		Supported	Nucleus<br>Nuclear membrane	Urothelial cancer:3.71e-4 (favourable), Pancreatic cancer:9.97e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 9.2	Mixed		
ZNF384	CAGH1A, CIZ, NMP4, NP, TNRC1	ENSG00000126746	Zinc finger protein 384	12	6666477-6689572	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004051	Supported		Supported	Nucleoplasm		Expressed in all	Expressed in all			endometrium: 66.0	Expressed in all		
ZNF391	dJ153G14.3	ENSG00000124613	Zinc finger protein 391	6	27374615-27403904	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA050886	Uncertain				Ovarian cancer:1.89e-4 (favourable)	Mixed	Mixed			testis: 9.0	Mixed		
ZNF394	FLJ12298, ZKSCAN14, ZSCAN46	ENSG00000160908	Zinc finger protein 394	7	99486519-99500324	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051421, HPA054639	Uncertain		Approved	Nucleoplasm<br>Cytosol	Urothelial cancer:1.09e-4 (favourable), Lung cancer:2.11e-4 (favourable), Breast cancer:3.56e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 62.0	Expressed in all		
ZNF396	FLJ31213, ZSCAN14	ENSG00000186496	Zinc finger protein 396	18	35366697-35377337	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006686	Uncertain					Mixed	Mixed			thyroid gland: 14.3	Mixed		
ZNF397	MGC13250, ZNF47, ZSCAN15	ENSG00000186812	Zinc finger protein 397	18	35241030-35267133	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026087	Uncertain		Approved	Nucleoli<br>Plasma membrane<br>Microtubules<br>Cytosol	Pancreatic cancer:9.44e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 30.8	Mixed		
ZNF398	KIAA1339, P51, P71, ZER6	ENSG00000197024	Zinc finger protein 398	7	149126416-149182802	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA071533			Approved	Nucleoplasm<br>Mitochondria		Expressed in all	Expressed in all			testis: 16.1	Expressed in all		
ZNF404		ENSG00000176222	Zinc finger protein 404	19	43872363-43901385	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA032014, HPA063607	Uncertain		Approved	Nucleoli<br>Intermediate filaments		Mixed	Mixed			epididymis: 11.7	Cell line enriched	6	U-2 OS: 45.7
ZNF407	FLJ13839, FLJ20307, KIAA1703	ENSG00000215421	Zinc finger protein 407	18	74597870-75065671	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028255, HPA041673	Uncertain		Approved	Nucleoplasm<br>Plasma membrane	Renal cancer:9.79e-5 (favourable)	Expressed in all	Mixed			parathyroid gland: 9.0	Mixed		
ZNF408	FLJ12827	ENSG00000175213	Zinc finger protein 408	11	46700818-46705912	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA017892	Uncertain		Approved	Microtubule organizing center<br>Cytosol	Liver cancer:6.59e-5 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 8.3	Expressed in all		
ZNF41	MGC8941, MRX89	ENSG00000147124	Zinc finger protein 41	X	47445879-47482946	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA069102	Enhanced		Approved	Nucleoplasm	Renal cancer:6.95e-4 (favourable), Head and neck cancer:8.32e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 19.4	Expressed in all		
ZNF410	APA-1, APA1	ENSG00000119725	Zinc finger protein 410	14	73886617-73932511	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002871			Approved	Nuclear bodies		Mixed	Expressed in all			testis: 81.3	Expressed in all		
ZNF414	MGC15716, Zfp414	ENSG00000133250	Zinc finger protein 414	19	8509678-8514164	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053769	Approved		Approved	Nucleus<br>Cytosol	Head and neck cancer:1.67e-6 (favourable), Endometrial cancer:4.17e-4 (favourable), Pancreatic cancer:4.59e-4 (favourable), Urothelial cancer:8.71e-4 (favourable)	Expressed in all	Expressed in all			spleen: 12.3	Mixed		
ZNF415		ENSG00000170954	Zinc finger protein 415	19	53107879-53133077	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005553	Approved		Approved	Nucleoli fibrillar center<br>Microtubules		Mixed	Mixed			testis: 39.6	Cell line enhanced		RT4: 17.7
ZNF416	FLJ20557	ENSG00000083817	Zinc finger protein 416	19	57571566-57578927	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA063318			Approved	Nuclear bodies<br>Cytosol	Renal cancer:1.20e-5 (favourable)	Expressed in all	Mixed			testis: 7.8	Mixed		
ZNF417	MGC34079	ENSG00000173480	Zinc finger protein 417	19	57900296-57916610	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042125, HPA043288, HPA056213	Uncertain		Uncertain	Nucleoplasm	Urothelial cancer:3.48e-4 (favourable)	Expressed in all	Expressed in all			epididymis: 59.9	Mixed		
ZNF418	FLJ31551, KIAA1956	ENSG00000196724	Zinc finger protein 418	19	57921884-57935393	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043800, HPA053762, HPA072145	Approved		Uncertain	Nucleus	Prostate cancer:1.72e-4 (unfavourable)	Mixed	Mixed			parathyroid gland: 14.8	Cell line enhanced		AF22: 11.0
ZNF419	ZAPHIR, ZNF419A	ENSG00000105136	Zinc finger protein 419	19	57487711-57496097	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA003152, HPA003274	Uncertain		Supported	Nucleus<br>Nucleoli fibrillar center	Urothelial cancer:2.53e-5 (favourable), Prostate cancer:6.47e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 16.2	Mixed		
ZNF420	FLJ32191	ENSG00000197050	Zinc finger protein 420	19	37007857-37130314	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059675	Approved		Approved	Nucleoplasm	Glioma:4.88e-5 (favourable), Renal cancer:1.83e-4 (favourable)	Expressed in all	Mixed			testis: 18.5	Mixed		
ZNF423	Ebfaz, JBTS19, KIAA0760, NPHP14, OAZ, Roaz, Zfp104	ENSG00000102935	Zinc finger protein 423	16	49487524-49857919	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015258, HPA065820	Uncertain		Enhanced	Nucleus		Mixed	Mixed			fallopian tube: 15.4	Cell line enhanced		AF22: 53.5;NTERA-2: 27.7;REH: 22.3;SCLC-21H: 34.3;SH-SY5Y: 92.6
ZNF425		ENSG00000204947	Zinc finger protein 425	7	149102784-149126346	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020087	Uncertain		Supported	Nucleus		Mixed	Mixed			parathyroid gland: 5.5	Mixed		
ZNF426	MGC2663	ENSG00000130818	Zinc finger protein 426	19	9523224-9538645	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029342	Approved		Approved	Nucleoplasm	Renal cancer:2.57e-6 (favourable), Urothelial cancer:1.81e-4 (favourable), Head and neck cancer:3.74e-4 (favourable)	Expressed in all	Mixed			esophagus: 22.7	Mixed		
ZNF429		ENSG00000197013	Zinc finger protein 429	19	21496682-21556270	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004139			Approved	Nucleus	Ovarian cancer:1.96e-8 (favourable), Pancreatic cancer:7.30e-4 (favourable)	Mixed	Mixed			thyroid gland: 16.3	Mixed		
ZNF43	HTF6, KOX27, ZNF39L1	ENSG00000198521	Zinc finger protein 43	19	21804949-21852125	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA050271	Uncertain				Ovarian cancer:3.16e-5 (favourable)	Mixed	Mixed			testis: 16.2	Cell line enhanced		MOLT-4: 31.1
ZNF430	FLJ13659	ENSG00000118620	Zinc finger protein 430	19	21020620-21060050	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059135	Uncertain					Mixed	Mixed			ovary: 15.8	Mixed		
ZNF431	KIAA1969	ENSG00000196705	Zinc finger protein 431	19	21142024-21196053	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059135	Uncertain					Mixed	Mixed			ovary: 26.8	Mixed		
ZNF432	KIAA0798	ENSG00000256087	Zinc finger protein 432	19	52031379-52095738	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052082, HPA060274, HPA065606	Uncertain		Supported	Nucleoplasm	Urothelial cancer:4.11e-5 (favourable), Renal cancer:6.47e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 21.1	Mixed		
ZNF433	FLJ40981	ENSG00000197647	Zinc finger protein 433	19	12014732-12035741	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA073724	Uncertain		Approved	Nuclear bodies	Renal cancer:8.33e-15 (favourable)	Expressed in all	Expressed in all			testis: 51.5	Mixed		
ZNF436	KIAA1710, Zfp46	ENSG00000125945	Zinc finger protein 436	1	23359448-23369442	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043817	Enhanced		Supported	Nucleoplasm<br>Cytosol		Expressed in all	Mixed			ovary: 12.4	Cell line enhanced		HSkMC: 26.4
ZNF438	bA330O11.1	ENSG00000183621	Zinc finger protein 438	10	30820207-31031937	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA039843	Uncertain		Supported	Nucleoplasm<br>Cytosol		Expressed in all	Mixed			thyroid gland: 16.2	Cell line enhanced		U-937: 19.8
ZNF439	DKFZp571K0837	ENSG00000171291	Zinc finger protein 439	19	11848726-11883750	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047845	Uncertain		Uncertain	Nucleus		Mixed	Mixed			parathyroid gland: 25.5	Cell line enhanced		U-138 MG: 15.4
ZNF44	KOX7, ZNF504, ZNF55, ZNF58	ENSG00000197857	Zinc finger protein 44	19	12224686-12294887	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003146	Supported		Approved	Nucleoplasm<br>Microtubules<br>Cytosol	Urothelial cancer:9.21e-6 (favourable), Lung cancer:7.54e-4 (favourable), Head and neck cancer:8.74e-4 (favourable)	Expressed in all	Mixed			skin: 8.6	Mixed		
ZNF440	FLJ37933	ENSG00000171295	Zinc finger protein 440	19	11814284-11835201	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047845	Uncertain		Uncertain	Nucleus	Renal cancer:1.18e-4 (favourable), Prostate cancer:3.57e-4 (unfavourable), Urothelial cancer:9.88e-4 (favourable)	Expressed in all	Mixed			fallopian tube: 23.2	Mixed		
ZNF441	FLJ38637	ENSG00000197044	Zinc finger protein 441	19	11767000-11784078	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA063338			Approved	Nuclear speckles		Expressed in all	Mixed			thyroid gland: 12.1	Mixed		
ZNF442	FLJ14356	ENSG00000198342	Zinc finger protein 442	19	12345949-12365905	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA045738, HPA053407	Uncertain		Approved	Nuclear membrane<br>Vesicles		Mixed	Mixed			ovary: 6.0	Mixed		
ZNF443	ZK1	ENSG00000180855	Zinc finger protein 443	19	12429707-12441112	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003150, HPA018683	Supported		Uncertain	Nucleoplasm<br>Microtubule organizing center	Renal cancer:2.74e-7 (favourable), Urothelial cancer:3.91e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 7.0	Mixed		
ZNF444	EZF2, FLJ11137, ZSCAN17	ENSG00000167685	Zinc finger protein 444	19	56132599-56160893	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056895, HPA065203	Approved		Supported	Nucleus<br>Nucleoli	Urothelial cancer:1.87e-4 (favourable), Renal cancer:2.61e-4 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 27.8	Expressed in all		
ZNF445	ZKSCAN15, ZNF168, ZSCAN47	ENSG00000185219	Zinc finger protein 445	3	44431720-44477670	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006678	Uncertain		Approved	Nucleus<br>Mitochondria<br>Cytosol		Expressed in all	Mixed			parathyroid gland: 7.2	Mixed		
ZNF446	FLJ20626, ZKSCAN20, ZSCAN52	ENSG00000083838	Zinc finger protein 446	19	58474017-58481230	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052786			Approved	Nuclear speckles	Pancreatic cancer:1.32e-4 (favourable)	Expressed in all	Mixed			fallopian tube: 11.6	Expressed in all		
ZNF449	FLJ23614, ZSCAN19	ENSG00000173275	Zinc finger protein 449	X	135344796-135363152	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA018079	Uncertain		Approved	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 12.3	Mixed		
ZNF45	ZNF13	ENSG00000124459	Zinc finger protein 45	19	43912629-43935278	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038611, HPA075124	Uncertain		Supported	Nucleoplasm		Expressed in all	Mixed			parathyroid gland: 18.3	Expressed in all		
ZNF451	COASTER, dJ417I1.1, KIAA0576, KIAA1702	ENSG00000112200	Zinc finger protein 451	6	57086844-57170307	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028838			Approved	Nucleus		Expressed in all	Expressed in all			testis: 51.2	Expressed in all		
ZNF454	FLJ37444	ENSG00000178187	Zinc finger protein 454	5	178941191-178966433	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA024556	Uncertain					Mixed	Mixed			testis: 4.0	Cell line enhanced		AF22: 1.0;EFO-21: 1.9;HHSteC: 1.3;HSkMC: 1.3;NTERA-2: 1.5;SH-SY5Y: 1.1
ZNF460	HZF8, ZNF272	ENSG00000197714	Zinc finger protein 460	19	57280051-57293569	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053004, HPA066506	Uncertain		Approved	Nucleoplasm		Mixed	Mixed			adrenal gland: 6.3	Cell line enhanced		Karpas-707: 9.7
ZNF461	GIOT-1, MGC33911	ENSG00000197808	Zinc finger protein 461	19	36637192-36666853	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA021139	Uncertain		Approved	Nucleus<br>Nucleoli<br>Golgi apparatus	Endometrial cancer:3.64e-4 (unfavourable)	Expressed in all	Mixed			thyroid gland: 6.2	Mixed		
ZNF462	DKFZP762N2316, KIAA1803, Zfp462	ENSG00000148143	Zinc finger protein 462	9	106863097-107013634	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA022283	Uncertain		Approved	Nucleoplasm	Renal cancer:6.19e-4 (favourable)	Mixed	Mixed			parathyroid gland: 15.9	Mixed		
ZNF467	EZI, Zfp467	ENSG00000181444	Zinc finger protein 467	7	149764182-149773479	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042907	Uncertain		Approved	Mitochondria	Pancreatic cancer:4.56e-4 (favourable)	Expressed in all	Mixed			spleen: 14.1	Cell line enhanced		AN3-CA: 30.3;HMC-1: 16.5;T-47d: 17.2
ZNF468		ENSG00000204604	Zinc finger protein 468	19	52838008-52857649	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:3.94e-7 (favourable), Breast cancer:6.87e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 20.4	Mixed		
ZNF469	KIAA1858	ENSG00000225614	Zinc finger protein 469	16	88427471-88440757	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA069784			Approved	Vesicles		Mixed	Mixed			cervix, uterine: 2.2	Cell line enhanced		SiHa: 5.3;THP-1: 4.3
ZNF470	CZF-1, FLJ26175	ENSG00000197016	Zinc finger protein 470	19	56567511-56588911	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029000	Uncertain		Supported	Nucleoplasm<br>Nuclear bodies		Mixed	Mixed			cerebral cortex,testis: 5.8	Cell line enhanced		HEK 293: 10.0
ZNF471	KIAA1396, Z1971	ENSG00000196263	Zinc finger protein 471	19	56507843-56530221	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA066695	Uncertain		Supported	Nucleus	Renal cancer:2.37e-4 (favourable)	Mixed	Mixed			ovary: 27.4	Mixed		
ZNF479	KR19	ENSG00000185177	Zinc finger protein 479	7	57119614-57139864	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Not detected	Tissue enriched	42	testis: 4.1	all non-specific tissues: 0.0	Not detected		
ZNF48	DKFZp762K013, FLJ31751, MGC43952, ZNF553	ENSG00000180035	Zinc finger protein 48	16	30378106-30400108	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023806	Uncertain		Supported	Mitochondria	Pancreatic cancer:1.20e-6 (favourable), Renal cancer:7.50e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 14.0	Expressed in all		
ZNF480	MGC32104	ENSG00000198464	Zinc finger protein 480	19	52297177-52325922	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042218	Uncertain		Supported	Nucleoplasm	Melanoma:1.65e-4 (unfavourable), Renal cancer:2.03e-4 (favourable)	Expressed in all	Mixed			lymph node: 14.8	Mixed		
ZNF483	KIAA1962, ZKSCAN16, ZSCAN48	ENSG00000173258	Zinc finger protein 483	9	111525159-111577844	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055041	Uncertain		Approved	Nucleoli		Tissue enhanced	Mixed			cerebral cortex: 13.0	Cell line enhanced		NTERA-2: 7.5;SCLC-21H: 5.1
ZNF484	BA526D8.4, FLJ33884	ENSG00000127081	Zinc finger protein 484	9	92845031-92878038	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028973	Uncertain		Approved	Nucleoplasm<br>Nuclear membrane<br>Cytosol		Mixed	Mixed			parathyroid gland: 6.9	Mixed		
ZNF485		ENSG00000198298	Zinc finger protein 485	10	43606407-43617903	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA059356	Uncertain				Breast cancer:5.24e-4 (unfavourable)	Expressed in all	Mixed			testis: 7.2	Mixed		
ZNF487	KRBO1, ZNF487P	ENSG00000243660	Zinc finger protein 487	10	43436841-43483179	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA037820			Approved	Nucleoplasm<br>Nuclear membrane<br>Cytosol		Mixed	Tissue enriched	5	testis: 51.4	fallopian tube: 9.9	Mixed		
ZNF490	KIAA1198	ENSG00000188033	Zinc finger protein 490	19	12577961-12640098	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005576	Uncertain					Mixed	Mixed			thyroid gland: 2.8	Mixed		
ZNF491	FLJ34791	ENSG00000177599	Zinc finger protein 491	19	11797667-11809622	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Mixed			parathyroid gland: 3.6	Mixed		
ZNF492	KIAA1473, ZNF115	ENSG00000229676	Zinc finger protein 492	19	22634324-22667670	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Group enriched	Tissue enhanced		testis: 3.6	bone marrow: 1.6	Cell line enhanced		BEWO: 5.4;NTERA-2: 4.1;U-2197: 3.7
ZNF493	FLJ36504	ENSG00000196268	Zinc finger protein 493	19	21397119-21427573	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Expressed in all			thyroid gland: 34.6	Mixed		
ZNF496	MGC15548, ZKSCAN17, ZSCAN49	ENSG00000162714	Zinc finger protein 496	1	247297412-247331846	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055834			Uncertain	Golgi apparatus		Expressed in all	Expressed in all			fallopian tube: 24.2	Expressed in all		
ZNF497	FLJ44773	ENSG00000174586	Zinc finger protein 497	19	58354357-58362848	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047872	Uncertain		Approved	Nucleus<br>Cell Junctions		Mixed	Mixed			fallopian tube: 8.1	Cell line enhanced		HEK 293: 18.3
ZNF500	KIAA0557, ZKSCAN18, ZSCAN50	ENSG00000103199	Zinc finger protein 500	16	4748239-4767624	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035498, HPA057963	Supported		Enhanced	Nucleoplasm<br>Cytosol	Stomach cancer:3.41e-4 (favourable)	Expressed in all	Mixed			spleen: 5.6	Expressed in all		
ZNF501	MGC21738, ZNF52	ENSG00000186446	Zinc finger protein 501	3	44729596-44737083	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044161	Uncertain		Approved	Endoplasmic reticulum		Mixed	Mixed			prostate,testis: 2.7	Mixed		
ZNF502	FLJ12515, FLJ14855	ENSG00000196653	Zinc finger protein 502	3	44712643-44723831	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024761, HPA029557	Uncertain				Renal cancer:4.51e-5 (favourable), Urothelial cancer:2.06e-4 (favourable)	Expressed in all	Mixed			testis: 5.0	Mixed		
ZNF506	DKFZp761G1812	ENSG00000081665	Zinc finger protein 506	19	19785839-19821751	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Expressed in all	Expressed in all			thyroid gland: 16.2	Mixed		
ZNF507	KIAA1084	ENSG00000168813	Zinc finger protein 507	19	32345594-32387667	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030964, HPA049728	Uncertain		Supported	Nucleoli<br>Cytosol		Expressed in all	Expressed in all			testis: 35.0	Expressed in all		
ZNF510	KIAA0972	ENSG00000081386	Zinc finger protein 510	9	96755865-96778129	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049139	Uncertain		Approved	Nucleoplasm<br>Plasma membrane	Renal cancer:5.94e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 12.5	Expressed in all		
ZNF511	MGC30006	ENSG00000198546	Zinc finger protein 511	10	133308475-133313162	Predicted membrane proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA035360	Uncertain				Renal cancer:1.13e-4 (unfavourable)	Expressed in all	Expressed in all			ovary: 12.2	Expressed in all		
ZNF512	KIAA1805	ENSG00000243943	Zinc finger protein 512	2	27582969-27623215	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031430	Approved		Enhanced	Nucleus	Lung cancer:5.08e-9 (favourable), Endometrial cancer:5.10e-4 (unfavourable), Pancreatic cancer:5.19e-4 (favourable), Breast cancer:9.79e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 45.7	Mixed		
ZNF512B	GM632, MGC149845, MGC149846	ENSG00000196700	Zinc finger protein 512B	20	63956702-63969865	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006688	Approved		Approved	Nucleoplasm		Expressed in all	Expressed in all			cerebral cortex,parathyroid gland: 16.9	Mixed		
ZNF513	FLJ32203, RP58	ENSG00000163795	Zinc finger protein 513	2	27377231-27380790	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051493	Uncertain				Liver cancer:6.21e-5 (unfavourable)	Expressed in all	Expressed in all			testis: 25.9	Expressed in all		
ZNF514	FLJ14457	ENSG00000144026	Zinc finger protein 514	2	95147330-95165413	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA028974	Approved		Approved	Nucleoplasm<br>Nuclear bodies		Expressed in all	Expressed in all			epididymis: 32.8	Expressed in all		
ZNF516	HsT287, KIAA0222	ENSG00000101493	Zinc finger protein 516	18	76358190-76495190	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015792	Uncertain		Approved	Nucleoplasm<br>Cytosol	Renal cancer:1.21e-4 (favourable), Liver cancer:2.79e-4 (unfavourable), Breast cancer:7.09e-4 (favourable), Pancreatic cancer:7.96e-4 (favourable)	Expressed in all	Expressed in all			endometrium: 54.4	Mixed		
ZNF517		ENSG00000197363	Zinc finger protein 517	8	144798876-144811169	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055337			Approved	Nucleoplasm	Pancreatic cancer:1.66e-4 (favourable)	Expressed in all	Mixed			skin: 7.5	Mixed		
ZNF518A	KIAA0335, ZNF518	ENSG00000177853	Zinc finger protein 518A	10	96129715-96205288	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029049			Approved	Nucleus		Expressed in all	Mixed			testis: 30.1	Mixed		
ZNF518B	KIAA1729	ENSG00000178163	Zinc finger protein 518B	4	10439874-10457410	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031215, HPA031216	Approved		Approved	Nucleus		Mixed	Mixed			testis: 16.9	Mixed		
ZNF519	FLJ36809, HsT2362	ENSG00000175322	Zinc finger protein 519	18	14057457-14132490	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028982	Uncertain		Approved	Nucleoli		Mixed	Mixed			endometrium: 4.0	Mixed		
ZNF521	EHZF, Evi3	ENSG00000198795	Zinc finger protein 521	18	25061926-25352190	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023056, HPA023849	Enhanced		Approved	Nucleoplasm		Mixed	Mixed			spleen: 29.0	Cell line enhanced		AF22: 66.8;HUVEC TERT2: 39.1
ZNF524	MGC23143	ENSG00000171443	Zinc finger protein 524	19	55600022-55603138	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050981	Uncertain		Approved	Nucleus	Urothelial cancer:4.98e-8 (favourable)	Expressed in all	Expressed in all			spleen: 15.7	Mixed		
ZNF526	KIAA1951, MGC4267	ENSG00000167625	Zinc finger protein 526	19	42220271-42228201	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023070, HPA056609	Uncertain		Approved	Nucleus<br>Golgi apparatus<br>Vesicles		Expressed in all	Mixed			skin: 6.2	Expressed in all		
ZNF527	KIAA1829	ENSG00000189164	Zinc finger protein 527	19	37371061-37393066	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA037740, HPA037741	Uncertain		Approved	Nuclear speckles<br>Golgi apparatus		Mixed	Mixed			parathyroid gland: 4.8	Mixed		
ZNF528	KIAA1827	ENSG00000167555	Zinc finger protein 528	19	52397849-52418412	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA065435			Approved	Nuclear speckles<br>Cytosol		Expressed in all	Expressed in all			thyroid gland: 31.1	Mixed		
ZNF529	KIAA1615	ENSG00000186020	Zinc finger protein 529	19	36534774-36605276	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA031311	Uncertain		Approved	Nucleoplasm	Urothelial cancer:1.39e-5 (favourable)	Expressed in all	Mixed			testis: 17.4	Mixed		
ZNF530	KIAA1508	ENSG00000183647	Zinc finger protein 530	19	57599885-57612722	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045868	Uncertain		Approved	Vesicles		Mixed	Mixed			spleen: 3.1	Cell line enhanced		HEK 293: 68.7;U-266/84: 40.3
ZNF532	FLJ10697	ENSG00000074657	Zinc finger protein 532	18	58862600-58986480	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA015322	Approved		Approved	Nucleoplasm<br>Golgi apparatus	Endometrial cancer:6.46e-5 (unfavourable), Urothelial cancer:5.76e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 104.4	Cell line enhanced		AF22: 113.9
ZNF534	FLJ25344, KRBO3	ENSG00000198633	Zinc finger protein 534	19	52429187-52452315	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enriched	Tissue enhanced		testis: 2.4	cerebral cortex: 0.9	Not detected		
ZNF536	KIAA0390	ENSG00000198597	Zinc finger protein 536	19	30228290-30713538	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA077341			Approved	Nucleus<br>Cell Junctions		Mixed	Tissue enhanced		cerebral cortex: 19.0	thyroid gland: 5.3	Cell line enhanced		HAP1: 11.4;SH-SY5Y: 31.3;WM-115: 12.5
ZNF540	DKFZp547B0714	ENSG00000171817	Zinc finger protein 540	19	37551406-37614097	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003444	Supported		Supported	Nucleoplasm<br>Vesicles<br>Cytosol		Mixed	Mixed			thyroid gland: 13.3	Mixed		
ZNF541	DKFZp434I1930	ENSG00000118156	Zinc finger protein 541	19	47520685-47555856	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058541, HPA076453	Enhanced		Approved	Nucleoplasm<br>Cytosol	Cervical cancer:2.94e-4 (favourable)	Tissue enhanced	Tissue enriched	11	testis: 19.2	ovary: 1.7	Group enriched	6	HEL: 1.4;SiHa: 5.3;U-87 MG: 1.6
ZNF543	DKFZp434H055	ENSG00000178229	Zinc finger protein 543	19	57320509-57330776	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029736, HPA057665	Uncertain		Approved	Nuclear speckles<br>Cytosol	Renal cancer:2.03e-5 (favourable)	Expressed in all	Mixed			ovary: 6.0	Mixed		
ZNF544	AF020591	ENSG00000198131	Zinc finger protein 544	19	58228594-58277495	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA002732	Approved		Approved	Nucleoplasm	Liver cancer:1.04e-5 (unfavourable), Melanoma:3.65e-5 (unfavourable)	Expressed in all	Expressed in all			epididymis: 48.6	Cell line enhanced		HEK 293: 153.3
ZNF546	MGC43537, ZNF49	ENSG00000187187	Zinc finger protein 546	19	39984134-40021041	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030838			Approved	Nucleus<br>Cytosol		Mixed	Tissue enhanced		testis: 14.4	parathyroid gland,thyroid gland: 3.2	Mixed		
ZNF547	FLJ31100	ENSG00000152433	Zinc finger protein 547	19	57363477-57379565	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA056001	Uncertain					Mixed	Mixed			thyroid gland: 5.2	Mixed		
ZNF548	FLJ32932	ENSG00000188785	Zinc finger protein 548	19	57389850-57402992	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA066042	Uncertain		Approved	Nucleus	Breast cancer:7.85e-4 (favourable)	Expressed in all	Expressed in all			lymph node: 32.6	Mixed		
ZNF549	FLJ34917	ENSG00000121406	Zinc finger protein 549	19	57527325-57557542	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039511	Uncertain		Approved	Nucleoplasm<br>Cytosol		Mixed	Mixed			parathyroid gland: 10.2	Mixed		
ZNF550	MGC41917	ENSG00000251369	Zinc finger protein 550	19	57535257-57559863	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003251	Uncertain		Approved	Vesicles<br>Microtubules	Prostate cancer:2.21e-4 (unfavourable)	Expressed in all	Mixed			ovary: 12.7	Mixed		
ZNF551	DKFZp686H1038	ENSG00000204519	Zinc finger protein 551	19	57681969-57717301	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA038187			Approved	Nucleoplasm<br>Nuclear speckles	Melanoma:7.68e-5 (unfavourable), Renal cancer:1.32e-4 (favourable)	Expressed in all	Mixed			testis: 8.0	Mixed		
ZNF552	FLJ21603	ENSG00000178935	Zinc finger protein 552	19	57803841-57814913	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043800, HPA053762, HPA072145	Uncertain		Uncertain	Nucleus	Colorectal cancer:2.66e-4 (favourable), Breast cancer:4.57e-4 (favourable), Head and neck cancer:9.96e-4 (favourable)	Expressed in all	Mixed			breast: 33.9	Expressed in all		
ZNF554	FLJ34817	ENSG00000172006	Zinc finger protein 554	19	2819874-2835773	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060247, HPA063358	Uncertain		Supported	Nucleoplasm<br>Nucleoli	Renal cancer:1.99e-5 (favourable), Pancreatic cancer:4.69e-4 (favourable), Urothelial cancer:5.00e-4 (favourable), Lung cancer:9.31e-4 (favourable)	Expressed in all	Mixed			cerebral cortex: 7.5	Mixed		
ZNF555	MGC26707	ENSG00000186300	Zinc finger protein 555	19	2841435-2860484	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA053956, HPA055430	Uncertain					Mixed	Mixed			testis: 10.4	Mixed		
ZNF556	FLJ11637	ENSG00000172000	Zinc finger protein 556	19	2867335-2883445	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA060593			Approved	Nucleus		Mixed	Tissue enhanced		fallopian tube: 3.3;ovary: 6.5	testis: 1.3	Cell line enhanced		Hep G2: 9.1;RH-30: 18.6
ZNF557	MGC4054	ENSG00000130544	Zinc finger protein 557	19	7069444-7087968	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003151, HPA029291	Uncertain		Approved	Nucleus<br>Intermediate filaments<br>Cytosol	Head and neck cancer:3.67e-6 (favourable), Pancreatic cancer:1.51e-4 (favourable), Lung cancer:2.62e-4 (favourable), Endometrial cancer:5.70e-4 (favourable)	Expressed in all	Mixed			testis: 5.4	Expressed in all		
ZNF558	FLJ30932	ENSG00000167785	Zinc finger protein 558	19	8806170-8832328	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA003151	Uncertain				Renal cancer:1.23e-6 (unfavourable), Urothelial cancer:9.30e-5 (favourable), Head and neck cancer:1.04e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 19.0	Mixed		
ZNF559	MGC13105	ENSG00000188321	Zinc finger protein 559	19	9323772-9351162	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059632, HPA065485	Approved		Supported	Nucleoplasm<br>Cytosol	Ovarian cancer:6.99e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 40.8	Mixed		
ZNF560	FLJ31986	ENSG00000198028	Zinc finger protein 560	19	9466507-9498607	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045439, HPA063209			Supported	Nucleoplasm<br>Plasma membrane		Tissue enriched	Tissue enriched	9	testis: 11.9	placenta: 1.2	Cell line enhanced		HEL: 19.1;NTERA-2: 20.6
ZNF561	MGC45408	ENSG00000171469	Zinc finger protein 561	19	9604680-9621399	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055332, HPA062397	Uncertain		Approved	Nucleoplasm	Renal cancer:1.16e-4 (favourable), Ovarian cancer:1.31e-4 (favourable)	Expressed in all	Expressed in all			smooth muscle: 38.2	Mixed		
ZNF562	FLJ20079	ENSG00000171466	Zinc finger protein 562	19	9641808-9675086	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055332, HPA062397	Uncertain		Approved	Nucleoplasm	Head and neck cancer:4.17e-4 (favourable)	Expressed in all	Expressed in all			esophagus: 18.7	Expressed in all		
ZNF563	FLJ34797	ENSG00000188868	Zinc finger protein 563	19	12317477-12333720	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042136	Uncertain					Expressed in all	Tissue enhanced		testis: 25.7	thyroid gland: 8.5	Mixed		
ZNF564	MGC26914	ENSG00000249709	Zinc finger protein 564	19	12525370-12551542	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043998	Uncertain		Approved	Golgi apparatus		Not detected	Mixed			thyroid gland: 10.5	Mixed		
ZNF565	FLJ36991	ENSG00000196357	Zinc finger protein 565	19	36182060-36246257	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044123	Uncertain		Approved	Nucleoplasm<br>Nuclear bodies		Expressed in all	Mixed			testis: 11.6	Mixed		
ZNF566	FLJ14779, MGC12515	ENSG00000186017	Zinc finger protein 566	19	36445119-36489902	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023456	Uncertain		Approved	Nucleus	Endometrial cancer:1.86e-4 (unfavourable)	Expressed in all	Mixed			thyroid gland: 8.0	Mixed		
ZNF567	MGC45586	ENSG00000189042	Zinc finger protein 567	19	36687612-36727701	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023937	Uncertain		Approved	Nucleoplasm<br>Cytosol		Expressed in all	Mixed			testis: 16.1	Mixed		
ZNF568	DKFZp686B0797	ENSG00000198453	Zinc finger protein 568	19	36916329-36998700	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052061	Uncertain					Mixed	Mixed			parathyroid gland: 14.3	Mixed		
ZNF569	FLJ32053, ZAP1	ENSG00000196437	Zinc finger protein 569	19	37411155-37469275	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052994	Uncertain		Approved	Nucleoplasm<br>Golgi apparatus<br>Vesicles		Mixed	Mixed			testis: 20.5	Mixed		
ZNF57	ZNF424	ENSG00000171970	Zinc finger protein 57	19	2900898-2918476	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA061915			Approved	Nucleoli	Renal cancer:4.11e-9 (favourable), Lung cancer:6.26e-4 (favourable), Pancreatic cancer:7.72e-4 (favourable)	Expressed in all	Tissue enhanced		testis: 47.3	skin: 11.5	Mixed		
ZNF570	FLJ30791	ENSG00000171827	Zinc finger protein 570	19	37467585-37488652	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at transcript level	HPA028881	Uncertain		Approved	Nucleoplasm	Renal cancer:4.06e-5 (favourable)	Expressed in all	Mixed			testis: 10.7	Mixed		
ZNF571	HSPC059	ENSG00000180479	Zinc finger protein 571	19	37554782-37594790	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA054762			Approved	Nucleus<br>Nucleoli<br>Plasma membrane		Mixed	Tissue enriched	6	thyroid gland: 130.6	parathyroid gland: 21.6	Mixed		
ZNF572	FLJ38002	ENSG00000180938	Zinc finger protein 572	8	124973298-124979389	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA066838	Enhanced		Approved	Nuclear speckles		Expressed in all	Mixed			testis: 6.7	Mixed		
ZNF573	FLJ30921	ENSG00000189144	Zinc finger protein 573	19	37735833-37817300	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA042776	Uncertain		Approved	Intermediate filaments<br>Cytosol		Mixed	Mixed			thyroid gland: 4.2	Mixed		
ZNF574	FLJ22059	ENSG00000105732	Zinc finger protein 574	19	42068477-42081549	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023196, HPA057274	Approved		Supported	Nucleoplasm		Expressed in all	Expressed in all			testis: 36.5	Expressed in all		
ZNF575	FLJ32567	ENSG00000176472	Zinc finger protein 575	19	43525497-43536130	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051865	Approved		Approved	Nucleus<br>Nucleoli fibrillar center<br>Cytosol		Expressed in all	Mixed			colon: 4.3	Cell line enhanced		MOLT-4: 6.2
ZNF576	MGC2508	ENSG00000124444	Zinc finger protein 576	19	43596392-43601157	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA050064	Uncertain		Approved	Nucleoplasm<br>Golgi apparatus	Liver cancer:1.29e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 15.4	Expressed in all		
ZNF577	MGC4400	ENSG00000161551	Zinc finger protein 577	19	51804816-51890950	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041499, HPA046761	Uncertain		Supported	Nucleus<br>Nucleoli	Urothelial cancer:2.03e-4 (favourable)	Mixed	Mixed			ovary: 28.9	Mixed		
ZNF578	FLJ31384	ENSG00000258405	Zinc finger protein 578	19	52453576-52512154	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Tissue enriched	5	testis: 14.0	thyroid gland: 2.6	Cell line enhanced		NTERA-2: 4.2;U-266/84: 6.8
ZNF579	FLJ35453	ENSG00000218891	Zinc finger protein 579	19	55576770-55580845	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062812	Approved		Approved	Nucleus	Renal cancer:1.00e-5 (unfavourable)	Expressed in all	Expressed in all			gallbladder: 13.0	Expressed in all		
ZNF580		ENSG00000213015	Zinc finger protein 580	19	55635016-55643469	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054058	Approved		Approved	Nucleus	Renal cancer:5.79e-6 (unfavourable), Pancreatic cancer:2.36e-5 (favourable), Liver cancer:5.63e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 38.1	Expressed in all		
ZNF581	FLJ22550, HSPC189	ENSG00000171425	Zinc finger protein 581	19	55635459-55645622	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059657	Uncertain				Liver cancer:5.74e-5 (unfavourable)	Expressed in all	Expressed in all			ovary: 21.7	Expressed in all		
ZNF582	FLJ30927	ENSG00000018869	Zinc finger protein 582	19	56375846-56393545	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA028858	Uncertain		Approved	Nucleoplasm<br>Cytosol		Mixed	Mixed			thyroid gland: 12.4	Cell line enhanced		HEK 293: 26.0
ZNF583	FLJ31030	ENSG00000198440	Zinc finger protein 583	19	56397966-56436035	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023805, HPA023957	Uncertain		Approved	Nucleoli<br>Cytosol		Mixed	Mixed			testis: 13.7	Mixed		
ZNF584	FLJ39899	ENSG00000171574	Zinc finger protein 584	19	58401504-58418327	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at transcript level	HPA043408, HPA048075	Uncertain		Approved	Nuclear speckles		Expressed in all	Mixed			fallopian tube: 10.1	Mixed		
ZNF585A	FLJ23765	ENSG00000196967	Zinc finger protein 585A	19	37106734-37172741	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Expressed in all			thyroid gland: 17.9	Mixed		
ZNF585B	FLJ14928, SZFP41	ENSG00000245680	Zinc finger protein 585B	19	37181579-37218153	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA075556			Approved	Nucleoplasm<br>Cytoplasmic bodies		Expressed in all	Mixed			parathyroid gland: 19.7	Mixed		
ZNF586	FLJ20070	ENSG00000083828	Zinc finger protein 586	19	57769655-57819939	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030306, HPA060782	Approved		Approved	Nucleoli fibrillar center<br>Vesicles	Breast cancer:9.83e-5 (favourable), Urothelial cancer:5.36e-4 (favourable)	Expressed in all	Expressed in all			bone marrow: 16.3	Mixed		
ZNF587	FLJ14710, FLJ20813, UBF-fl, ZF6	ENSG00000198466	Zinc finger protein 587	19	57849857-57865112	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042125, HPA043288, HPA056213	Uncertain		Uncertain	Nucleoplasm	Renal cancer:7.98e-4 (unfavourable)	Expressed in all	Mixed			rectum: 17.0	Expressed in all		
ZNF589	SZF1	ENSG00000164048	Zinc finger protein 589	3	48241100-48299253	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003145	Uncertain		Approved	Nucleoplasm	Lung cancer:6.45e-5 (favourable), Pancreatic cancer:1.21e-4 (favourable), Head and neck cancer:1.71e-4 (favourable), Cervical cancer:2.50e-4 (favourable)	Expressed in all	Mixed			prostate: 28.0	Expressed in all		
ZNF592	CAMOS, KIAA0211, SCAR5	ENSG00000166716	Zinc finger protein 592	15	84748635-84806432	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020332, HPA021600	Approved		Approved	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 16.7	Expressed in all		
ZNF594	KIAA1871	ENSG00000180626	Zinc finger protein 594	17	5179536-5191883	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA060283, HPA067178, HPA069360			Enhanced	Nucleus		Mixed	Mixed			ovary,parathyroid gland: 13.9	Mixed		
ZNF596		ENSG00000172748	Zinc finger protein 596	8	232137-264703	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055463	Uncertain		Approved	Nucleoli<br>Mitochondria		Mixed	Tissue enhanced		testis: 27.8	parathyroid gland: 12.9	Mixed		
ZNF597	FLJ33071, HIT-4	ENSG00000167981	Zinc finger protein 597	16	3432422-3443542	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA001556	Approved		Approved	Nucleus<br>Nucleoli		Expressed in all	Mixed			testis: 7.2	Mixed		
ZNF599	FLJ30663	ENSG00000153896	Zinc finger protein 599	19	34758076-34773229	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA014701	Uncertain		Approved	Nucleoplasm<br>Plasma membrane<br>Cytosol		Mixed	Mixed			epididymis: 14.6	Mixed		
ZNF600	DKFZp686F06123, KR-ZNF1	ENSG00000189190	Zinc finger protein 600	19	52764195-52786791	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:4.98e-7 (unfavourable), Urothelial cancer:1.11e-5 (favourable)	Expressed in all	Mixed			spleen: 7.8	Cell line enhanced		RT4: 17.0
ZNF605		ENSG00000196458	Zinc finger protein 605	12	132918308-132956306	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA061970, HPA062655	Uncertain		Approved	Nucleoplasm<br>Vesicles		Expressed in all	Mixed			parathyroid gland: 11.3	Mixed		
ZNF606	FLJ14260, KIAA1852, ZNF328	ENSG00000166704	Zinc finger protein 606	19	57977053-58003349	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041712, HPA043584	Uncertain		Supported	Nucleoplasm	Urothelial cancer:4.75e-6 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 18.9	Cell line enhanced		HEK 293: 21.5
ZNF607	FLJ14802, MGC13071	ENSG00000198182	Zinc finger protein 607	19	37696363-37719790	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049465, HPA055018	Uncertain		Approved	Nucleoplasm	Urothelial cancer:5.23e-5 (favourable)	Expressed in all	Mixed			parathyroid gland: 9.6	Mixed		
ZNF610	FLJ36040	ENSG00000167554	Zinc finger protein 610	19	52336245-52367778	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055771, HPA078134	Enhanced		Approved	Nucleus	Renal cancer:1.05e-7 (favourable), Ovarian cancer:3.38e-4 (favourable)	Mixed	Tissue enhanced		testis: 22.0	ovary: 10.4	Mixed		
ZNF611	MGC5384	ENSG00000213020	Zinc finger protein 611	19	52702813-52735073	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:3.33e-4 (favourable)	Mixed	Mixed			fallopian tube: 11.1	Mixed		
ZNF613	FLJ13590	ENSG00000176024	Zinc finger protein 613	19	51927147-51948759	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA026833	Uncertain		Approved	Nucleoplasm<br>Vesicles	Urothelial cancer:1.92e-6 (favourable)	Expressed in all	Tissue enhanced		prostate: 32.4	placenta: 9.8	Mixed		
ZNF614	FLJ21941	ENSG00000142556	Zinc finger protein 614	19	52012765-52030240	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021197	Uncertain		Approved	Nucleoplasm<br>Vesicles<br>Cytosol		Expressed in all	Mixed			prostate: 14.0	Expressed in all		
ZNF615	FLJ33710	ENSG00000197619	Zinc finger protein 615	19	51991332-52008230	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA052422	Uncertain		Approved	Nucleoli<br>Mitochondria	Urothelial cancer:2.98e-4 (favourable)	Expressed in all	Mixed			prostate: 28.7	Mixed		
ZNF616	MGC45556	ENSG00000204611	Zinc finger protein 616	19	52113091-52139922	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062639, HPA071539	Approved		Approved	Centrosome		Expressed in all	Expressed in all			adrenal gland: 17.2	Mixed		
ZNF618	KIAA1952, NEDD10	ENSG00000157657	Zinc finger protein 618	9	113876282-114056591	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023116, HPA061732	Uncertain		Approved	Nucleoplasm	Renal cancer:5.22e-7 (favourable), Glioma:8.34e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 16.5	Mixed		
ZNF619	FLJ90764	ENSG00000177873	Zinc finger protein 619	3	40477113-40490236	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA045094	Uncertain		Approved	Nucleoplasm<br>Intermediate filaments		Expressed in all	Mixed			parathyroid gland: 7.7	Mixed		
ZNF620	MGC50836	ENSG00000177842	Zinc finger protein 620	3	40505992-40518736	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031452, HPA059383	Uncertain		Approved	Centrosome		Mixed	Mixed			thyroid gland: 6.0	Mixed		
ZNF621	FLJ45246	ENSG00000172888	Zinc finger protein 621	3	40524878-40574685	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA065518, HPA071440			Supported	Nuclear speckles		Expressed in all	Expressed in all			parathyroid gland: 22.6	Expressed in all		
ZNF623	KIAA0628	ENSG00000183309	Zinc finger protein 623	8	143636013-143656418	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA044372	Uncertain		Approved	Nucleus	Endometrial cancer:2.94e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 6.2	Cell line enhanced		SiHa: 24.6
ZNF624	KIAA1349	ENSG00000197566	Zinc finger protein 624	17	16620737-16653856	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023157, HPA023244	Uncertain		Approved	Vesicles		Mixed	Mixed			testis: 9.0	Mixed		
ZNF625		ENSG00000257591	Zinc finger protein 625	19	12142090-12156729	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA074014			Approved	Nucleus<br>Mitochondria		Mixed	Mixed			thyroid gland: 4.7	Mixed		
ZNF626		ENSG00000188171	Zinc finger protein 626	19	20620061-20661596	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA045631	Uncertain		Approved	Nucleoplasm<br>Nuclear membrane<br>Vesicles		Mixed	Expressed in all			parathyroid gland: 52.8	Mixed		
ZNF627	FLJ90365	ENSG00000198551	Zinc finger protein 627	19	11559374-11619135	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049770, HPA073463	Uncertain		Approved	Nucleus<br>Nucleoli	Renal cancer:6.93e-7 (favourable), Head and neck cancer:8.12e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 20.7	Expressed in all		
ZNF628	ZEC, Zfp628	ENSG00000197483	Zinc finger protein 628	19	55476332-55484487	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044451	Uncertain		Approved	Nucleoplasm		Expressed in all	Tissue enhanced		testis: 7.2	spleen: 2.7	Mixed		
ZNF629	KIAA0326, ZNF65	ENSG00000102870	Zinc finger protein 629	16	30778449-30787202	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA019550, HPA056051	Uncertain		Supported	Nucleus<br>Golgi apparatus	Renal cancer:4.57e-10 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 27.8	Mixed		
ZNF639	ANC-2H01, ZASC1	ENSG00000121864	Zinc finger protein 639	3	179322991-179338583	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049023, HPA052163	Uncertain		Supported	Nucleoplasm	Glioma:7.36e-5 (favourable), Liver cancer:2.13e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 69.0	Expressed in all		
ZNF641	FLJ31295	ENSG00000167528	Zinc finger protein 641	12	48337180-48351414	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035189	Uncertain		Supported	Nucleoplasm	Pancreatic cancer:8.30e-5 (favourable), Ovarian cancer:3.91e-4 (favourable)	Expressed in all	Expressed in all			adrenal gland: 28.8	Expressed in all		
ZNF644	BM-005, KIAA1221, MGC60165, MGC70410	ENSG00000122482	Zinc finger protein 644	1	90915298-91022272	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057795	Uncertain		Uncertain	Vesicles	Colorectal cancer:4.27e-4 (favourable), Endometrial cancer:8.39e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 31.0	Expressed in all		
ZNF646	KIAA0296	ENSG00000167395	Zinc finger protein 646	16	31074422-31084196	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042364, HPA066468	Uncertain		Approved	Nucleoplasm<br>Plasma membrane<br>Cytosol	Liver cancer:1.28e-6 (unfavourable)	Expressed in all	Tissue enhanced		testis: 34.3	spleen: 10.8	Expressed in all		
ZNF648	FLJ46813	ENSG00000179930	Zinc finger protein 648	1	182054570-182061712	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA053897	Uncertain					Not detected	Not detected			ovary,testis: 0.6	Cell line enriched	87	HMC-1: 31.7
ZNF649	FLJ12644	ENSG00000198093	Zinc finger protein 649	19	51889224-51905040	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA026541	Uncertain				Renal cancer:4.60e-5 (favourable), Melanoma:7.44e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 33.8	Mixed		
ZNF652	KIAA0924	ENSG00000198740	Zinc finger protein 652	17	49289206-49362473	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044408	Uncertain		Approved	Nucleus	Endometrial cancer:1.35e-4 (favourable)	Expressed in all	Mixed			breast: 7.2	Mixed		
ZNF653	Zip67	ENSG00000161914	Zinc finger protein 653	19	11483427-11505923	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023631, HPA023635	Uncertain		Supported	Nucleus	Endometrial cancer:4.15e-4 (favourable), Colorectal cancer:8.37e-4 (unfavourable), Urothelial cancer:8.74e-4 (favourable)	Expressed in all	Mixed			testis: 19.0	Expressed in all		
ZNF654	FLJ10997, FLJ21142	ENSG00000175105	Zinc finger protein 654	3	88059274-88144665	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA036172, HPA036173, HPA049262, HPA077939	Uncertain		Supported	Nucleoplasm<br>Microtubules	Prostate cancer:9.97e-6 (unfavourable)	Expressed in all	Mixed			testis: 11.8	Expressed in all		
ZNF655	VIK, VIK-1	ENSG00000197343	Zinc finger protein 655	7	99558406-99576453	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029534, HPA050750	Uncertain		Supported	Nucleoplasm<br>Plasma membrane	Breast cancer:7.12e-4 (favourable), Melanoma:7.24e-4 (unfavourable)	Expressed in all	Expressed in all			lymph node: 21.2	Mixed		
ZNF658	DKFZp572C163, FLJ32813, MGC35232	ENSG00000274349	Zinc finger protein 658	9	66856426-66932141	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047730, HPA048668	Uncertain		Approved	Nucleoplasm		Mixed	Mixed			skin: 9.7	Mixed		
ZNF66	FLJ16537, ZNF66P	ENSG00000160229	Zinc finger protein 66	19	20776304-20807322	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at transcript level							Mixed	Tissue enhanced		ovary: 9.5	thyroid gland: 4.2	Cell line enhanced		RT4: 11.8
ZNF660	FLJ36870	ENSG00000144792	Zinc finger protein 660	3	44578223-44599694	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029705	Uncertain		Uncertain	Nucleoli fibrillar center<br>Cytosol		Mixed	Mixed			ovary: 3.1	Cell line enhanced		AF22: 3.3;HEL: 3.1;NTERA-2: 5.2;RH-30: 3.3
ZNF662	FLJ45880	ENSG00000182983	Zinc finger protein 662	3	42905731-42917641	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA039116, HPA040377	Uncertain					Mixed	Mixed			skin: 13.3	Cell line enhanced		SH-SY5Y: 3.6;U-2 OS: 4.9
ZNF664	DKFZp761B128, ZFOC1, ZNF176	ENSG00000179195	Zinc finger protein 664	12	123971845-124015439	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA047846			Approved	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 236.1	Expressed in all		
ZNF665	FLJ14345	ENSG00000197497	Zinc finger protein 665	19	53159213-53193386	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA023437	Uncertain		Approved	Nuclear membrane		Mixed	Mixed			ovary: 3.7	Mixed		
ZNF667	FLJ14011	ENSG00000198046	Zinc finger protein 667	19	56439325-56478065	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030731, HPA046673	Uncertain		Approved	Nucleus		Mixed	Mixed			cerebral cortex: 18.3	Cell line enhanced		HEL: 11.0;U-138 MG: 14.5
ZNF668	FLJ13479	ENSG00000167394	Zinc finger protein 668	16	31060843-31074320	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043048	Uncertain		Approved	Nucleus<br>Nucleoli	Prostate cancer:6.24e-4 (unfavourable)	Expressed in all	Mixed			testis: 6.9	Expressed in all		
ZNF669	FLJ12606	ENSG00000188295	Zinc finger protein 669	1	247099962-247104372	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044043	Uncertain		Approved	Nucleoli	Renal cancer:4.59e-7 (favourable)	Expressed in all	Mixed			testis: 8.7	Mixed		
ZNF670	MGC12466	ENSG00000277462	Zinc finger protein 670	1	247036784-247078755	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003142	Uncertain		Approved	Nucleus<br>Cytosol		Expressed in all	Mixed			testis: 6.1	Expressed in all		
ZNF671	FLJ23506	ENSG00000083814	Zinc finger protein 671	19	57719751-57727624	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046099	Uncertain		Approved	Nucleoplasm	Breast cancer:2.20e-4 (favourable), Pancreatic cancer:3.57e-4 (favourable)	Mixed	Mixed			parathyroid gland: 16.6	Mixed		
ZNF672	FLJ22301	ENSG00000171161	Zinc finger protein 672	1	248838210-248849517	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055779, HPA062506	Approved		Enhanced	Nucleoplasm	Urothelial cancer:1.79e-5 (favourable), Pancreatic cancer:7.51e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 24.8	Expressed in all		
ZNF674	MRX92, ZNF673B	ENSG00000251192	Zinc finger protein 674	X	46497727-46545457	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031026, HPA065295	Uncertain					Mixed	Mixed			prostate: 3.3	Mixed		
ZNF675	TBZF, TIZ	ENSG00000197372	Zinc finger protein 675	19	23525631-23687220	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Mixed	Expressed in all			testis: 25.1	Cell line enhanced		HDLM-2: 56.3
ZNF676		ENSG00000196109	Zinc finger protein 676	19	22179091-22196951	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enriched	Tissue enhanced		parathyroid gland: 4.4;testis: 4.0	thyroid gland: 3.0	Cell line enriched	9	NTERA-2: 7.0
ZNF677	MGC48625	ENSG00000197928	Zinc finger protein 677	19	53235381-53254898	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023106, HPA024796	Approved		Approved	Nucleus<br>Centrosome		Mixed	Expressed in all			testis: 71.1	Cell line enhanced		NTERA-2: 30.7
ZNF678	MGC42493	ENSG00000181450	Zinc finger protein 678	1	227563543-227677443	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA028507	Uncertain		Approved	Nucleoli<br>Mitochondria<br>Cytosol		Expressed in all	Mixed			thyroid gland: 8.9	Expressed in all		
ZNF679	MGC42415	ENSG00000197123	Zinc finger protein 679	7	64228474-64266931	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Tissue enriched	17	testis: 1.6	all non-specific tissues: 0.0	Not detected		
ZNF680	FLJ90430	ENSG00000173041	Zinc finger protein 680	7	64519884-64563106	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA003173			Approved	Nucleus		Expressed in all	Expressed in all			thyroid gland: 42.5	Mixed		
ZNF681	FLJ31526	ENSG00000196172	Zinc finger protein 681	19	23739195-23758891	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Mixed			testis: 4.6	Cell line enhanced		HDLM-2: 15.0
ZNF682	BC39498_3	ENSG00000197124	Zinc finger protein 682	19	19997058-20039506	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA055998	Uncertain		Uncertain	Golgi apparatus	Urothelial cancer:3.51e-4 (favourable)	Tissue enhanced	Mixed			thyroid gland: 13.3	Cell line enhanced		AN3-CA: 20.2
ZNF683	Hobit, MGC33414	ENSG00000176083	Zinc finger protein 683	1	26361634-26374522	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023865	Uncertain				Endometrial cancer:2.90e-5 (favourable), Urothelial cancer:3.45e-5 (favourable)	Mixed	Tissue enriched	11	testis: 78.7	lung: 7.1	Cell line enhanced		NB-4: 1.4
ZNF684	MGC27466	ENSG00000117010	Zinc finger protein 684	1	40531561-40548169	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA059153	Uncertain		Approved	Nucleus<br>Cytosol	Renal cancer:4.89e-10 (favourable)	Expressed in all	Mixed			kidney: 6.8	Cell line enhanced		THP-1: 23.3
ZNF687	KIAA1441	ENSG00000143373	Zinc finger protein 687	1	151281618-151292180	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021193, HPA023948	Approved		Enhanced	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 26.0	Expressed in all		
ZNF689	FLJ90415	ENSG00000156853	Zinc finger protein 689	16	30602558-30624012	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054095, HPA055385	Approved		Approved	Nucleus<br>Nucleoli fibrillar center	Pancreatic cancer:9.89e-4 (favourable)	Expressed in all	Expressed in all			testis: 35.4	Expressed in all		
ZNF69	Cos5	ENSG00000198429	Zinc finger protein 69	19	11887784-11914329	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA047845	Uncertain		Uncertain	Nucleus	Endometrial cancer:1.55e-4 (favourable)	Mixed	Tissue enhanced		parathyroid gland: 24.9	kidney: 10.3	Cell line enhanced		AF22: 13.8
ZNF691	Zfp691	ENSG00000164011	Zinc finger protein 691	1	42846573-42852477	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA062527	Approved		Approved	Nucleus<br>Nucleoli<br>Vesicles	Liver cancer:7.33e-6 (unfavourable), Pancreatic cancer:6.25e-5 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 21.5	Expressed in all		
ZNF692	AREBP, FLJ20531, Zfp692	ENSG00000171163	Zinc finger protein 692	1	248850006-248859144	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059337, HPA062792	Uncertain		Enhanced	Nucleus<br>Nucleoli	Renal cancer:7.72e-9 (unfavourable), Urothelial cancer:8.35e-5 (favourable), Pancreatic cancer:4.09e-4 (favourable)	Expressed in all	Expressed in all			testis: 26.8	Expressed in all		
ZNF695	SBZF3	ENSG00000197472	Zinc finger protein 695	1	246945547-247008093	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024743	Uncertain		Approved	Nuclear speckles		Mixed	Tissue enhanced		testis: 1.2	small intestine: 0.6	Mixed		
ZNF696	FLJ14129	ENSG00000185730	Zinc finger protein 696	8	143289676-143298061	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA057855, HPA072473	Uncertain		Approved	Nucleus<br>Nucleoli	Endometrial cancer:3.52e-5 (unfavourable), Cervical cancer:6.63e-5 (unfavourable), Pancreatic cancer:1.41e-4 (favourable)	Expressed in all	Mixed			cerebral cortex: 9.8	Mixed		
ZNF697	MGC45731	ENSG00000143067	Zinc finger protein 697	1	119619422-119647773	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049933	Uncertain		Approved	Nucleoplasm	Renal cancer:6.20e-5 (favourable)	Expressed in all	Mixed			placenta: 10.9	Cell line enhanced		SK-MEL-30: 35.9;WM-115: 45.9
ZNF699	FLJ38144, hang	ENSG00000196110	Zinc finger protein 699	19	9294275-9309838	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA058287	Uncertain					Mixed	Mixed			parathyroid gland: 4.9	Cell line enhanced		U-138 MG: 14.3
ZNF7	HF.16, KOX4	ENSG00000147789	Zinc finger protein 7	8	144827464-144847509	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030296, HPA059090	Uncertain		Approved	Mitochondria	Renal cancer:8.46e-8 (unfavourable)	Expressed in all	Expressed in all			testis: 31.3	Expressed in all		
ZNF70	Cos17, MGC48959	ENSG00000187792	Zinc finger protein 70	22	23738678-23751092	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018821	Uncertain		Supported	Cytosol		Mixed	Mixed			ovary: 4.9	Mixed		
ZNF700	DKFZp434I1610	ENSG00000196757	Zinc finger protein 700	19	11925068-11950773	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA047845	Uncertain		Uncertain	Nucleus	Renal cancer:2.01e-5 (unfavourable), Urothelial cancer:2.53e-5 (favourable), Head and neck cancer:1.27e-4 (favourable), Prostate cancer:1.75e-4 (unfavourable), Melanoma:2.58e-4 (unfavourable)	Expressed in all	Expressed in all			skin: 19.1	Mixed		
ZNF701	FLJ10891	ENSG00000167562	Zinc finger protein 701	19	52555457-52587174	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005532	Uncertain		Approved	Nucleoplasm<br>Microtubule organizing center	Urothelial cancer:4.89e-5 (favourable)	Mixed	Expressed in all			thyroid gland: 16.2	Mixed		
ZNF705A	FLJ16353	ENSG00000196946	Zinc finger protein 705A	12	8157034-8188537	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Not detected	Mixed			cerebral cortex: 8.9	Cell line enhanced		AN3-CA: 5.3;BJ hTERT+: 5.5;HDLM-2: 5.4;NTERA-2: 6.4
ZNF705D		ENSG00000215343	Zinc finger protein 705D	8	12104389-12115516	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Not detected	Tissue enriched	6	epididymis: 4.5	testis: 0.7	Not detected		
ZNF705G		ENSG00000215372	Zinc finger protein 705G	8	7355517-7385558	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Not detected	Not detected			testis: 0.9	Not detected		
ZNF707		ENSG00000181135	Zinc finger protein 707	8	143684452-143713898	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044991	Approved		Enhanced	Nucleoplasm	Endometrial cancer:6.79e-4 (unfavourable)	Expressed in all	Mixed			skin: 4.9	Mixed		
ZNF708	KOX8, ZNF15, ZNF15L1	ENSG00000182141	Zinc finger protein 708	19	21291160-21329425	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Ovarian cancer:3.53e-4 (favourable), Glioma:6.32e-4 (favourable)	Expressed in all	Mixed			cerebral cortex: 17.7	Mixed		
ZNF709	FLJ38281	ENSG00000242852	Zinc finger protein 709	19	12461184-12513854	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA045573, HPA053153	Uncertain		Approved	Nucleoplasm		Not detected	Tissue enhanced		testis: 14.0	thyroid gland: 4.8	Mixed		
ZNF71	Cos26, EZFIT	ENSG00000197951	Zinc finger protein 71	19	56595264-56626481	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA018124	Uncertain		Approved	Nucleus<br>Nucleoli		Expressed in all	Mixed			cerebral cortex: 5.3	Mixed		
ZNF710	DKFZp547K1113, FLJ00306, FLJ37393	ENSG00000140548	Zinc finger protein 710	15	90001392-90082206	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030226, HPA030227, HPA030228	Enhanced		Approved	Nucleoplasm<br>Mitochondria		Expressed in all	Expressed in all			appendix: 20.4	Expressed in all		
ZNF711	CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6	ENSG00000147180	Zinc finger protein 711	X	85244032-85273362	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030654	Enhanced		Approved	Nucleoplasm		Mixed	Tissue enhanced		testis: 69.8	cerebral cortex: 32.7	Cell line enhanced		AF22: 34.0;HAP1: 51.8;HEK 293: 42.5;RH-30: 40.6
ZNF713	FLJ39963	ENSG00000178665	Zinc finger protein 713	7	55887475-55942225	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059425, HPA062887	Uncertain		Approved	Nucleoli		Mixed	Mixed			testis: 8.4	Cell line enhanced		SH-SY5Y: 7.3
ZNF716	FLJ46189	ENSG00000182111	Zinc finger protein 716	7	57450177-57473546	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enriched	Not detected			testis: 0.9	Not detected		
ZNF721	KIAA1982	ENSG00000182903	Zinc finger protein 721	4	425815-499156	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA065313			Approved	Microtubule organizing center<br>Cytosol	Urothelial cancer:2.76e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 30.8	Expressed in all		
ZNF724	ZNF724P	ENSG00000196081	Zinc finger protein 724	19	23221599-23250390	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Mixed			esophagus: 2.9	Mixed		
ZNF726		ENSG00000213967	Zinc finger protein 726	19	23914876-23945159	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Mixed			epididymis: 6.3	Mixed		
ZNF727	ZNF727P	ENSG00000214652	Zinc finger protein 727	7	64045443-64078549	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051027, HPA061215	Uncertain		Uncertain	Nucleoplasm		Tissue enhanced	Mixed			thyroid gland: 5.8	Cell line enriched	7	T-47d: 7.1
ZNF729		ENSG00000196350	Zinc finger protein 729	19	22286408-22317176	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Tissue enriched	22	testis: 3.8	breast,cerebral cortex,endometrium,parathyroid gland: 0.1	Cell line enhanced		NTERA-2: 2.6
ZNF730		ENSG00000183850	Zinc finger protein 730	19	23075210-23147219	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Tissue enhanced		testis: 9.3	ovary: 3.1	Cell line enhanced		NTERA-2: 23.2;REH: 19.3
ZNF732	FLJ59067	ENSG00000186777	Zinc finger protein 732	4	270675-305321	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Tissue enhanced		testis: 2.6	skin: 0.8	Cell line enhanced		NTERA-2: 7.2;SH-SY5Y: 1.7
ZNF735	ZNF735P	ENSG00000223614	Zinc finger protein 735	7	64207090-64220508	Predicted intracellular proteins, Transcription factors	Evidence at protein level							Not detected	Not detected			testis: 0.1	Not detected		
ZNF736		ENSG00000234444	Zinc finger protein 736	7	64307459-64354860	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051027, HPA061215	Uncertain		Uncertain	Nucleoplasm	Endometrial cancer:3.03e-4 (unfavourable), Prostate cancer:5.01e-4 (unfavourable), Urothelial cancer:8.65e-4 (favourable)	Mixed	Mixed			testis: 15.1	Mixed		
ZNF737	ZNF102	ENSG00000237440	Zinc finger protein 737	19	20535825-20565809	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Mixed	Mixed			thyroid gland: 66.9	Cell line enhanced		MOLT-4: 22.1;RT4: 22.5
ZNF74	Cos52, Zfp520, ZNF520	ENSG00000185252	Zinc finger protein 74	22	20394115-20408461	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003354	Approved		Supported	Nucleoplasm<br>Actin filaments		Expressed in all	Mixed			ovary: 4.8	Cell line enhanced		K-562: 37.4
ZNF740	Zfp740	ENSG00000139651	Zinc finger protein 740	12	53180700-53195141	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035691	Approved		Approved	Nucleus	Melanoma:4.55e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 14.3	Expressed in all		
ZNF746	FLJ31413, PARIS	ENSG00000181220	Zinc finger protein 746	7	149472794-149497817	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA020272	Approved				Renal cancer:7.47e-6 (unfavourable), Liver cancer:2.32e-5 (unfavourable), Pancreatic cancer:4.22e-4 (favourable)	Expressed in all	Expressed in all			testis: 23.0	Expressed in all		
ZNF749	FLJ16360	ENSG00000186230	Zinc finger protein 749	19	57435329-57445485	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042082, HPA042091, HPA056001	Uncertain		Approved	Nucleoplasm<br>Nuclear membrane		Expressed in all	Mixed			parathyroid gland: 4.2	Expressed in all		
ZNF75A	FLJ31529	ENSG00000162086	Zinc finger protein 75a	16	3305406-3318852	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA001665	Uncertain		Approved	Nucleoplasm<br>Nucleoli fibrillar center		Expressed in all	Expressed in all			parathyroid gland: 46.7	Mixed		
ZNF75D	D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28	ENSG00000186376	Zinc finger protein 75D	X	135248920-135344087	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004705	Supported		Approved	Nucleoplasm<br>Golgi apparatus	Urothelial cancer:7.42e-5 (favourable), Renal cancer:1.31e-4 (favourable)	Expressed in all	Expressed in all			prostate: 15.8	Mixed		
ZNF76	D6S229E, Zfp523, ZNF523	ENSG00000065029	Zinc finger protein 76	6	35258909-35295985	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030090, HPA030091	Approved		Approved	Nucleoplasm<br>Cytosol	Ovarian cancer:1.18e-4 (favourable), Pancreatic cancer:5.09e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 34.7	Expressed in all		
ZNF763	ZNF440L	ENSG00000197054	Zinc finger protein 763	19	11965037-11980381	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA047845	Uncertain		Uncertain	Nucleus		Mixed	Mixed			parathyroid gland: 11.5	Cell line enhanced		BEWO: 5.9
ZNF764	MGC13138	ENSG00000169951	Zinc finger protein 764	16	30553764-30558498	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003203	Uncertain		Approved	Cytosol	Endometrial cancer:6.84e-4 (favourable)	Expressed in all	Mixed			testis: 6.0	Expressed in all		
ZNF765		ENSG00000196417	Zinc finger protein 765	19	53389793-53430413	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Breast cancer:9.11e-4 (unfavourable)	Mixed	Mixed			parathyroid gland: 13.0	Mixed		
ZNF766		ENSG00000196214	Zinc finger protein 766	19	52269571-52296046	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044882, HPA063496	Uncertain		Supported	Centrosome		Expressed in all	Expressed in all			testis: 43.6	Expressed in all		
ZNF768	FLJ23436	ENSG00000169957	Zinc finger protein 768	16	30524001-30526821	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024630, HPA066512	Supported		Approved	Nucleus<br>Vesicles	Renal cancer:9.30e-6 (favourable), Urothelial cancer:6.46e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 55.9	Expressed in all		
ZNF77	pT1	ENSG00000175691	Zinc finger protein 77	19	2933218-2944971	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA023397	Uncertain		Approved	Nucleus<br>Nucleoli	Lung cancer:6.79e-6 (favourable), Endometrial cancer:6.65e-5 (favourable), Cervical cancer:8.49e-4 (favourable)	Expressed in all	Mixed			breast: 5.8	Mixed		
ZNF770	FLJ20582, PRO1914	ENSG00000198146	Zinc finger protein 770	15	34978341-34988287	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA024518	Approved					Expressed in all	Expressed in all			thyroid gland: 73.6	Expressed in all		
ZNF771	DSC43	ENSG00000179965	Zinc finger protein 771	16	30407297-30431108	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030730, HPA046672, HPA059398	Uncertain		Approved	Nucleus<br>Nucleoli		Expressed in all	Mixed			cerebral cortex: 7.0	Expressed in all		
ZNF772	DKFZp686I1569	ENSG00000197128	Zinc finger protein 772	19	57466663-57477570	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031312	Uncertain		Approved	Cytosol	Renal cancer:1.02e-6 (favourable)	Mixed	Mixed			parathyroid gland: 20.0	Cell line enhanced		BJ hTERT+ SV40 Large T+ RasG12V: 28.4
ZNF773	MGC4728, ZNF419B	ENSG00000152439	Zinc finger protein 773	19	57499915-57518404	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA003152	Uncertain		Approved	Nucleus<br>Nucleoli fibrillar center		Mixed	Mixed			parathyroid gland: 13.1	Mixed		
ZNF774	MGC75360	ENSG00000196391	Zinc finger protein 774	15	90352245-90369146	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030839, HPA030840	Uncertain		Supported	Intermediate filaments<br>Cytosol		Mixed	Mixed			cerebral cortex: 8.1	Mixed		
ZNF775	MGC33584	ENSG00000196456	Zinc finger protein 775	7	150379335-150398631	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Pancreatic cancer:1.35e-5 (favourable), Renal cancer:2.84e-4 (favourable), Head and neck cancer:3.48e-4 (favourable)	Expressed in all	Mixed			cerebral cortex: 7.1	Mixed		
ZNF776	FLJ38288	ENSG00000152443	Zinc finger protein 776	19	57746796-57758159	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046653, HPA068553	Uncertain		Approved	Nucleus<br>Cytosol	Cervical cancer:9.74e-4 (unfavourable)	Expressed in all	Mixed			epididymis: 26.3	Mixed		
ZNF777	KIAA1285	ENSG00000196453	Zinc finger protein 777	7	149431363-149461123	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003252	Approved		Approved	Nucleus		Expressed in all	Expressed in all			cerebral cortex: 10.4	Mixed		
ZNF778	FLJ31875	ENSG00000170100	Zinc finger protein 778	16	89217703-89237071	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA052057, HPA057151	Uncertain		Supported	Nucleus<br>Nuclear bodies		Mixed	Mixed			parathyroid gland: 15.1	Mixed		
ZNF780A	ZNF780	ENSG00000197782	Zinc finger protein 780A	19	40069152-40090938	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003311	Uncertain		Approved	Nucleus<br>Centrosome	Urothelial cancer:9.30e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 8.4	Expressed in all		
ZNF780B	ZNF779	ENSG00000128000	Zinc finger protein 780B	19	40028260-40056209	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003311	Uncertain		Approved	Nucleus<br>Centrosome		Expressed in all	Mixed			thyroid gland: 8.0	Mixed		
ZNF781	FLJ37549	ENSG00000196381	Zinc finger protein 781	19	37667751-37692322	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA062512	Uncertain		Approved	Nucleoplasm		Mixed	Mixed			smooth muscle: 3.7	Cell line enhanced		AN3-CA: 2.1;SH-SY5Y: 2.4;U-266/84: 2.0
ZNF782	FLJ16636	ENSG00000196597	Zinc finger protein 782	9	96816472-96875623	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA011013	Approved		Approved	Nucleus<br>Mitochondria		Expressed in all	Mixed			testis: 10.4	Mixed		
ZNF784	MGC75238	ENSG00000179922	Zinc finger protein 784	19	55620742-55624601	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059676	Uncertain		Approved	Nucleus	Urothelial cancer:1.02e-4 (favourable)	Expressed in all	Expressed in all			skeletal muscle: 14.7	Expressed in all		
ZNF785	FLJ32130	ENSG00000197162	Zinc finger protein 785	16	30573740-30585771	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA030510			Approved	Nucleoplasm<br>Plasma membrane	Pancreatic cancer:2.03e-5 (favourable), Lung cancer:8.99e-4 (favourable)	Expressed in all	Expressed in all			endometrium: 11.7	Mixed		
ZNF786	DKFZp762I137	ENSG00000197362	Zinc finger protein 786	7	149069643-149090782	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021518, HPA053459	Uncertain		Approved	Nucleoplasm<br>Nuclear speckles	Liver cancer:1.09e-4 (unfavourable), Pancreatic cancer:2.01e-4 (favourable)	Expressed in all	Mixed			skin: 7.2	Expressed in all		
ZNF789		ENSG00000198556	Zinc finger protein 789	7	99472841-99503650	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA029500, HPA050793	Uncertain		Enhanced	Nucleoplasm	Urothelial cancer:5.31e-6 (favourable), Renal cancer:3.56e-4 (unfavourable), Pancreatic cancer:7.14e-4 (favourable)	Expressed in all	Mixed			prostate: 13.9	Expressed in all		
ZNF79	pT7	ENSG00000196152	Zinc finger protein 79	9	127424374-127445372	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028977	Uncertain		Approved	Nucleoplasm<br>Plasma membrane<br>Cytosol	Renal cancer:6.04e-7 (favourable), Pancreatic cancer:5.42e-5 (favourable), Endometrial cancer:6.83e-5 (favourable), Lung cancer:5.96e-4 (favourable)	Expressed in all	Mixed			testis: 11.4	Expressed in all		
ZNF790	FLJ20350, MGC62100	ENSG00000197863	Zinc finger protein 790	19	36817428-36850787	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA056134, HPA060288	Uncertain		Approved	Nucleoli	Endometrial cancer:7.66e-4 (unfavourable)	Expressed in all	Mixed			testis: 20.5	Mixed		
ZNF791	FLJ90396	ENSG00000173875	Zinc finger protein 791	19	12610918-12633840	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021537	Uncertain		Approved	Nucleus	Urothelial cancer:1.39e-5 (favourable), Lung cancer:9.07e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 25.1	Expressed in all		
ZNF792	FLJ38451	ENSG00000180884	Zinc finger protein 792	19	34956354-34964049	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035157, HPA035158	Supported		Approved	Nucleoplasm<br>Nuclear bodies	Colorectal cancer:2.72e-4 (favourable)	Expressed in all	Mixed			lung: 6.2	Cell line enhanced		HEL: 11.5;HMC-1: 14.3;SH-SY5Y: 11.1
ZNF793		ENSG00000188227	Zinc finger protein 793	19	37506939-37548762	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA034781	Uncertain		Approved	Nucleus<br>Nucleoli<br>Cytosol		Mixed	Mixed			parathyroid gland: 15.7	Cell line enhanced		AN3-CA: 12.6;U-266/70: 15.1
ZNF799	HIT-40, MGC71805, ZNF842	ENSG00000196466	Zinc finger protein 799	19	12390016-12401271	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003150, HPA018683	Supported		Uncertain	Nucleoplasm<br>Microtubule organizing center	Endometrial cancer:2.39e-4 (favourable)	Mixed	Mixed			placenta: 6.9	Mixed		
ZNF8	HF.18, Zfp128	ENSG00000278129	Zinc finger protein 8	19	58278951-58302805	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034797, HPA034798	Uncertain		Approved	Nucleoplasm<br>Nuclear bodies		Mixed	Mixed			parathyroid gland: 4.5	Mixed		
ZNF80	pT17	ENSG00000174255	Zinc finger protein 80	3	114234631-114237578	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA065484	Uncertain					Not detected	Tissue enhanced		breast: 6.4	lymph node: 2.7	Cell line enhanced		MCF7: 1.2
ZNF800		ENSG00000048405	Zinc finger protein 800	7	127346790-127431924	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023090, HPA052194	Approved		Supported	Nucleoli<br>Cytosol		Expressed in all	Expressed in all			bone marrow: 47.9	Expressed in all		
ZNF805		ENSG00000204524	Zinc finger protein 805	19	57240685-57255135	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA057665, HPA058895	Uncertain					Mixed	Mixed			parathyroid gland: 5.1	Mixed		
ZNF808		ENSG00000198482	Zinc finger protein 808	19	52527652-52564464	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Urothelial cancer:3.88e-4 (favourable), Thyroid cancer:7.82e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 8.8	Mixed		
ZNF81	HFZ20, MRX45	ENSG00000197779	Zinc finger protein 81	X	47836902-48002561	Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA001689	Approved					Mixed	Mixed			parathyroid gland: 9.9	Mixed		
ZNF813	FLJ16542	ENSG00000198346	Zinc finger protein 813	19	53467735-53496255	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056406	Uncertain		Approved	Vesicles		Expressed in all	Mixed			prostate: 8.1	Cell line enhanced		RT4: 14.6
ZNF814		ENSG00000204514	Zinc finger protein 814	19	57848731-57889074	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043800, HPA053762, HPA072145	Approved		Uncertain	Nucleus		Mixed	Mixed			thyroid gland: 18.2	Cell line enhanced		NTERA-2: 34.7
ZNF816	ZNF816A	ENSG00000180257	Zinc finger protein 816	19	52949379-52962911	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Evidence at protein level	HPA042466	Uncertain		Uncertain	Nucleoli		Expressed in all	Mixed			prostate: 20.8	Cell line enhanced		RT4: 42.8
ZNF823	HSZFP36	ENSG00000197933	Zinc finger protein 823	19	11721265-11739009	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Head and neck cancer:6.76e-5 (favourable), Renal cancer:4.49e-4 (favourable), Stomach cancer:5.05e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 12.5	Mixed		
ZNF827		ENSG00000151612	Zinc finger protein 827	4	145757627-145938635	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA021166	Uncertain		Approved	Nucleoplasm		Mixed	Mixed			prostate: 37.4	Cell line enhanced		WM-115: 67.4
ZNF829	DKFZp779O175	ENSG00000185869	Zinc finger protein 829	19	36888124-36916291	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA073073			Approved	Nucleus<br>Nuclear bodies		Mixed	Tissue enriched	5	testis: 18.3	ovary: 3.4	Mixed		
ZNF83	FLJ11015, HPF1, ZNF816B	ENSG00000167766	Zinc finger protein 83	19	52594060-52690496	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA025970	Approved		Approved	Nucleoplasm	Urothelial cancer:6.92e-6 (favourable), Renal cancer:3.13e-5 (unfavourable), Head and neck cancer:3.83e-4 (favourable), Ovarian cancer:9.06e-4 (favourable), Melanoma:9.20e-4 (unfavourable)	Expressed in all	Expressed in all			epididymis: 111.9	Mixed		
ZNF835	BC37295_3	ENSG00000127903	Zinc finger protein 835	19	56661981-56671783	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA051136	Uncertain		Approved	Microtubules		Mixed	Mixed			ovary: 5.3	Cell line enhanced		BEWO: 2.3;EFO-21: 1.9;NTERA-2: 4.7;SH-SY5Y: 2.6;U-266/84: 2.8
ZNF836	FLJ16287	ENSG00000196267	Zinc finger protein 836	19	52153864-52171643	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:3.77e-4 (favourable), Cervical cancer:5.11e-4 (favourable)	Expressed in all	Mixed			adrenal gland: 34.6	Mixed		
ZNF837		ENSG00000152475	Zinc finger protein 837	19	58367618-58381060	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA042833	Uncertain		Approved	Nucleoli	Renal cancer:1.76e-5 (favourable), Endometrial cancer:1.27e-4 (favourable)	Expressed in all	Mixed			skin,spleen: 1.4	Cell line enhanced		HEK 293: 8.6
ZNF84	HPF2	ENSG00000198040	Zinc finger protein 84	12	133037292-133063304	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA028860	Approved		Supported	Nucleoplasm	Liver cancer:1.59e-4 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 33.1	Mixed		
ZNF841	LOC284371	ENSG00000197608	Zinc finger protein 841	19	52064466-52095765	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:3.56e-6 (unfavourable), Urothelial cancer:8.92e-5 (favourable), Head and neck cancer:2.93e-4 (favourable)	Expressed in all	Mixed			prostate: 23.1	Mixed		
ZNF844	FLJ14959	ENSG00000223547	Zinc finger protein 844	19	12064699-12081565	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046982	Uncertain				Renal cancer:0.00e+0 (favourable)	Expressed in all	Mixed			thyroid gland: 20.3	Cell line enhanced		U-266/84: 12.3
ZNF845		ENSG00000213799	Zinc finger protein 845	19	53333749-53354869	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Renal cancer:3.98e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 7.6	Mixed		
ZNF846		ENSG00000196605	Zinc finger protein 846	19	9751993-9793180	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA034617, HPA034618	Approved		Approved	Actin filaments	Head and neck cancer:5.25e-8 (favourable)	Expressed in all	Mixed			seminal vesicle: 26.3	Mixed		
ZNF85	HPF4, HTF1	ENSG00000105750	Zinc finger protein 85	19	20923222-20950697	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA044760	Uncertain		Supported	Nucleus	Ovarian cancer:6.45e-6 (favourable), Endometrial cancer:5.20e-5 (unfavourable)	Mixed	Tissue enhanced		testis: 28.0	thyroid gland: 12.0	Mixed		
ZNF853	DKFZp434J1015	ENSG00000236609	Zinc finger protein 853	7	6615617-6624290	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067690	Approved		Approved	Nucleoli	Renal cancer:2.30e-6 (favourable)	Mixed	Mixed			cerebral cortex: 17.4	Cell line enhanced		AN3-CA: 18.6;SH-SY5Y: 31.3;U-2 OS: 20.5
ZNF860		ENSG00000197385	Zinc finger protein 860	3	31981771-31991628	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA063386	Uncertain		Approved	Nucleus<br>Nucleoli		Mixed	Mixed			prostate: 4.7	Cell line enriched	6	BEWO: 44.1
ZNF878		ENSG00000257446	Zinc finger protein 878	19	12043805-12052939	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA052735	Uncertain		Approved	Nucleus<br>Nucleoli		Tissue enriched	Mixed			placenta,testis: 1.0	Mixed		
ZNF879	DKFZp686E2433	ENSG00000234284	Zinc finger protein 879	5	179023752-179035064	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA068608	Uncertain		Approved	Nucleus		Mixed	Mixed			testis: 11.3	Mixed		
ZNF880		ENSG00000221923	Zinc finger protein 880	19	52369917-52385795	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Renal cancer:4.33e-8 (favourable)	Expressed in all	Expressed in all			thyroid gland: 31.2	Mixed		
ZNF883		ENSG00000228623	Zinc finger protein 883	9	112957722-113050043	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Stomach cancer:2.89e-6 (unfavourable), Renal cancer:7.07e-4 (unfavourable)	Mixed	Not detected			cervix, uterine: 0.3	Not detected		
ZNF891		ENSG00000214029	Zinc finger protein 891	12	133106817-133130473	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA040301	Uncertain					Mixed	Mixed			testis: 2.1	Mixed		
ZNF90	HTF9	ENSG00000213988	Zinc finger protein 90	19	20077994-20127076	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA003227	Uncertain		Approved	Nucleus<br>Golgi apparatus		Tissue enhanced	Tissue enhanced		parathyroid gland: 7.6	thyroid gland: 2.7	Cell line enhanced		AN3-CA: 9.0;NTERA-2: 16.5
ZNF91	HPF7, HTF10	ENSG00000167232	Zinc finger protein 91	19	23304991-23395560	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Urothelial cancer:3.48e-4 (favourable), Renal cancer:7.58e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 17.6	Mixed		
ZNF92	HPF12, TF12	ENSG00000146757	Zinc finger protein 92	7	65373799-65401135	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA003173			Approved	Nucleus	Liver cancer:6.56e-4 (unfavourable)	Expressed in all	Mixed			breast: 13.2	Expressed in all		
ZNF93	FLJ12488, HPF34, TF34, ZNF505	ENSG00000184635	Zinc finger protein 93	19	19900913-19935575	Predicted intracellular proteins, Transcription factors	Evidence at protein level						Ovarian cancer:9.31e-6 (favourable)	Mixed	Mixed			thyroid gland: 13.9	Cell line enhanced		NTERA-2: 41.8
ZNF98	F7175, ZNF739	ENSG00000197360	Zinc finger protein 98	19	22391019-22532485	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at transcript level							Tissue enhanced	Tissue enhanced		ovary: 14.4;testis: 14.1	thyroid gland: 7.9	Cell line enhanced		BEWO: 1.7;NB-4: 3.0;T-47d: 3.2;U-2197: 3.3
ZNF99	C19orf9, MGC24986	ENSG00000213973	Zinc finger protein 99	19	22752183-22784107	Predicted intracellular proteins, Transcription factors	Evidence at transcript level							Tissue enriched	Tissue enriched	7	testis: 3.0	cerebral cortex: 0.4	Not detected		
ZNFX1	FLJ11277, KIAA1404	ENSG00000124201	Zinc finger NFX1-type containing 1	20	49237946-49278426	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA046629	Approved		Approved	Mitochondria		Expressed in all	Expressed in all			parathyroid gland: 27.1	Expressed in all		
ZSCAN1	FLJ33779, ZNF915	ENSG00000152467	Zinc finger and SCAN domain containing 1	19	58034032-58054631	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007938	Uncertain		Approved	Nucleoli	Ovarian cancer:7.36e-4 (favourable)	Mixed	Tissue enhanced		epididymis: 7.4	cerebral cortex: 5.3	Cell line enhanced		EFO-21: 2.8;HMC-1: 1.8;NTERA-2: 2.1;T-47d: 2.9
ZSCAN10	ZNF206	ENSG00000130182	Zinc finger and SCAN domain containing 10	16	3088890-3099317	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level							Tissue enriched	Not detected			skin: 0.6	Cell line enriched	123	NTERA-2: 56.8
ZSCAN12	dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96	ENSG00000158691	Zinc finger and SCAN domain containing 12	6	28378955-28399734	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006637	Approved		Approved	Microtubules<br>Cytosol		Expressed in all	Mixed			thyroid gland: 8.7	Mixed		
ZSCAN16	dJ265C24.3, FLJ22191, ZNF392, ZNF435	ENSG00000196812	Zinc finger and SCAN domain containing 16	6	28124560-28130082	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007290	Supported		Approved	Nucleus	Ovarian cancer:1.14e-5 (favourable), Urothelial cancer:3.41e-5 (favourable), Lung cancer:3.19e-4 (favourable), Cervical cancer:5.73e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 12.6	Mixed		
ZSCAN2	FLJ20595, ZFP29, ZNF854	ENSG00000176371	Zinc finger and SCAN domain containing 2	15	84600986-84627796	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007296, HPA024331	Supported		Approved	Nucleoplasm<br>Cytosol	Urothelial cancer:4.16e-5 (favourable), Pancreatic cancer:3.52e-4 (favourable), Renal cancer:7.46e-4 (favourable)	Expressed in all	Expressed in all			testis: 13.8	Expressed in all		
ZSCAN20	KOX29, ZNF31, ZNF360	ENSG00000121903	Zinc finger and SCAN domain containing 20	1	33472645-33496507	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA017933	Uncertain		Approved	Nucleoplasm		Mixed	Mixed			parathyroid gland: 5.4	Mixed		
ZSCAN21	DKFZp434L134, NY-REN-21, Zipro1, ZNF38	ENSG00000166529	Zinc finger and SCAN domain containing 21	7	100049774-100065038	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA016948, HPA023591	Uncertain		Approved	Endoplasmic reticulum	Thyroid cancer:4.71e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 20.4	Expressed in all		
ZSCAN22	HKR2, ZNF50	ENSG00000182318	Zinc finger and SCAN domain containing 22	19	58327019-58342332	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA006471	Uncertain		Approved	Plasma membrane<br>Actin filaments<br>Cytosol		Expressed in all	Mixed			parathyroid gland: 3.3	Cell line enhanced		HEK 293: 13.4
ZSCAN23	dJ29K1.3.1, ZNF390, ZNF453	ENSG00000187987	Zinc finger and SCAN domain containing 23	6	28431930-28443502	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA035959, HPA035960	Uncertain					Not detected	Mixed			parathyroid gland: 2.1	Cell line enhanced		SCLC-21H: 2.1
ZSCAN25	FLJ32468, ZNF498	ENSG00000197037	Zinc finger and SCAN domain containing 25	7	99616946-99632407	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA055127, HPA057173	Uncertain		Approved	Nucleus<br>Nucleoli fibrillar center		Expressed in all	Mixed			parathyroid gland: 10.0	Expressed in all		
ZSCAN26	SRE-ZBP, ZNF187	ENSG00000197062	Zinc finger and SCAN domain containing 26	6	28267010-28278224	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA027521			Enhanced	Nucleus<br>Nucleoli	Renal cancer:6.79e-5 (unfavourable), Liver cancer:7.81e-5 (unfavourable), Urothelial cancer:1.68e-4 (favourable)	Expressed in all	Expressed in all			ovary: 40.4	Expressed in all		
ZSCAN29	FLJ35867, Zfp690, ZNF690	ENSG00000140265	Zinc finger and SCAN domain containing 29	15	43358172-43371025	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA007241, HPA011109	Enhanced		Approved	Nucleoplasm<br>Plasma membrane<br>Actin filaments		Expressed in all	Expressed in all			testis: 27.3	Expressed in all		
ZSCAN30	ZNF397OS, ZNF917	ENSG00000186814	Zinc finger and SCAN domain containing 30	18	35251058-35290245	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007289	Approved		Approved	Nucleoplasm<br>Cytosol		Expressed in all	Expressed in all			parathyroid gland: 26.4	Expressed in all		
ZSCAN31	ZNF310P, ZNF323	ENSG00000235109	Zinc finger and SCAN domain containing 31	6	28324693-28356271	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007124	Approved		Approved	Nucleoplasm<br>Cytosol	Renal cancer:2.19e-5 (favourable)	Expressed in all	Expressed in all			testis: 38.7	Cell line enhanced		EFO-21: 37.9;U-2 OS: 50.9
ZSCAN32	FLJ20417, ZNF434	ENSG00000140987	Zinc finger and SCAN domain containing 32	16	3382081-3401065	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA005758	Uncertain		Approved	Nucleoplasm		Mixed	Expressed in all			parathyroid gland: 13.6	Expressed in all		
ZSCAN4	FLJ35105, ZNF494	ENSG00000180532	Zinc finger and SCAN domain containing 4	19	57668935-57679152	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA006491	Uncertain					Tissue enhanced	Tissue enhanced		stomach: 2.5	placenta: 1.2	Not detected		
ZSCAN5A	MGC4161, ZNF495, ZSCAN5	ENSG00000131848	Zinc finger and SCAN domain containing 5A	19	56219670-56368383	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041263, HPA043123, HPA046836, HPA060667	Uncertain		Uncertain	Nuclear speckles		Mixed	Tissue enhanced		testis: 34.6	fallopian tube: 11.4	Expressed in all		
ZSCAN5B	ZNF371, ZNF495B	ENSG00000197213	Zinc finger and SCAN domain containing 5B	19	56189570-56197920	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043123, HPA046836, HPA059494, HPA060667	Uncertain		Uncertain	Nuclear speckles		Not detected	Tissue enriched	22	testis: 2.7	fallopian tube: 0.1	Not detected		
ZSCAN5C	ZNF495C, ZSCAN5CP	ENSG00000204532	Zinc finger and SCAN domain containing 5C	19	56202301-56209452	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041263, HPA043123, HPA046836, HPA060667	Uncertain		Uncertain	Nuclear speckles		Not detected	Not detected			testis: 0.1	Not detected		
ZSCAN9	PRD51, ZNF193	ENSG00000137185	Zinc finger and SCAN domain containing 9	6	28224886-28233482	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA054512, HPA059951	Uncertain		Approved	Nucleoplasm	Renal cancer:1.21e-6 (unfavourable), Urothelial cancer:1.16e-5 (favourable), Liver cancer:3.49e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 34.8	Mixed		
ZXDA	ZNF896	ENSG00000198205	Zinc finger, X-linked, duplicated A	X	57906708-57910820	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA043789	Approved		Approved	Nucleoplasm	Renal cancer:8.55e-4 (favourable)	Mixed	Mixed			ovary: 5.3	Mixed		
ZXDB	ZNF905	ENSG00000198455	Zinc finger, X-linked, duplicated B	X	57591652-57597545	Predicted intracellular proteins, Transcription factors	Evidence at transcript level	HPA043789	Approved		Approved	Nucleoplasm		Expressed in all	Expressed in all			parathyroid gland: 10.0	Mixed		
ZXDC	FLJ13861, MGC11349	ENSG00000070476	ZXD family zinc finger C	3	126437601-126475919	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA049593			Supported	Nucleoli<br>Vesicles	Liver cancer:2.27e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 25.4	Expressed in all		
